
<html lang="en"     class="pb-page"  data-request-id="e82522b1-42bb-458e-bb24-67a53f3494ec"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.6b00562;website:website:acspubs;issue:issue:10.1021/jmcmar.2016.59.issue-14;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Exploring Basic Tail Modifications of Coumarin-Based Dual Acetylcholinesterase-Monoamine Oxidase B Inhibitors: Identification of Water-Soluble, Brain-Permeant Neuroprotective Multitarget Agents" /></meta><meta name="dc.Creator" content="Leonardo  Pisani" /></meta><meta name="dc.Creator" content="Roberta  Farina" /></meta><meta name="dc.Creator" content="Marco  Catto" /></meta><meta name="dc.Creator" content="Rosa Maria  Iacobazzi" /></meta><meta name="dc.Creator" content="Orazio  Nicolotti" /></meta><meta name="dc.Creator" content="Saverio  Cellamare" /></meta><meta name="dc.Creator" content="Giuseppe Felice  Mangiatordi" /></meta><meta name="dc.Creator" content="Nunzio  Denora" /></meta><meta name="dc.Creator" content="Ramon  Soto-Otero" /></meta><meta name="dc.Creator" content="Lydia  Siragusa" /></meta><meta name="dc.Creator" content="Cosimo Damiano  Altomare" /></meta><meta name="dc.Creator" content="Angelo  Carotti" /></meta><meta name="dc.Description" content="Aiming at modulating two key enzymatic targets for Alzheimer’s disease (AD), i.e., acetylcholinesterase (AChE) and monoamine oxidase B (MAO B), a series of multitarget ligands was properly designed..." /></meta><meta name="Description" content="Aiming at modulating two key enzymatic targets for Alzheimer’s disease (AD), i.e., acetylcholinesterase (AChE) and monoamine oxidase B (MAO B), a series of multitarget ligands was properly designed..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 7, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b00562" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00562" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b00562" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00562" /></link>
        
    
    

<title>Exploring Basic Tail Modifications of Coumarin-Based Dual Acetylcholinesterase-Monoamine Oxidase B Inhibitors: Identification of Water-Soluble, Brain-Permeant Neuroprotective Multitarget Agents | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b00562" /></meta><meta property="og:title" content="Exploring Basic Tail Modifications of Coumarin-Based Dual Acetylcholinesterase-Monoamine Oxidase B Inhibitors: Identification of Water-Soluble, Brain-Permeant Neuroprotective Multitarget Agents" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00562/20160722/images/large/jm-2016-005625_0009.jpeg" /></meta><meta property="og:description" content="Aiming at modulating two key enzymatic targets for Alzheimer’s disease (AD), i.e., acetylcholinesterase (AChE) and monoamine oxidase B (MAO B), a series of multitarget ligands was properly designed by linking the 3,4-dimethylcoumarin scaffold to 1,3- and 1,4-substituted piperidine moieties, thus modulating the basicity to improve the hydrophilic/lipophilic balance. After in vitro enzymatic inhibition assays, multipotent inhibitors showing potencies in the nanomolar and in the low micromolar range for hMAO B and eeAChE, respectively, were prioritized and evaluated in human SH-SY5Y cell-based models for their cytotoxicity and neuroprotective effect against oxidative toxins (H2O2, rotenone, and oligomycin-A). The present study led to the identification of a promising multitarget hit compound (5b) exhibiting high hMAO B inhibitory activity (IC50 = 30 nM) and good MAO B/A selectivity (selectivity index, SI = 94) along with a micromolar eeAChE inhibition (IC50 = 1.03 μM). Moreover, 5b behaves as a water-soluble, brain-permeant neuroprotective agent against oxidative insults without interacting with P-gp efflux system." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b00562"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b00562">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b00562&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b00562&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b00562&amp;href=/doi/10.1021/acs.jmedchem.6b00562" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 14</span><span class="cit-fg-pageRange">, 6791-6806</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/14" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b00505" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b00608" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Exploring Basic Tail Modifications of Coumarin-Based Dual Acetylcholinesterase-Monoamine Oxidase B Inhibitors: Identification of Water-Soluble, Brain-Permeant Neuroprotective Multitarget Agents</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Leonardo++Pisani">Leonardo Pisani</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Roberta++Farina">Roberta Farina</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marco++Catto">Marco Catto</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rosa+Maria++Iacobazzi">Rosa Maria Iacobazzi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Orazio++Nicolotti">Orazio Nicolotti</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Saverio++Cellamare">Saverio Cellamare</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Giuseppe+Felice++Mangiatordi">Giuseppe Felice Mangiatordi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nunzio++Denora">Nunzio Denora</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ramon++Soto-Otero">Ramon Soto-Otero</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lydia++Siragusa">Lydia Siragusa</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cosimo+Damiano++Altomare">Cosimo Damiano Altomare</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Angelo++Carotti">Angelo Carotti</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Dipartimento di Farmacia—Scienze del Farmaco, Università degli Studi di Bari “Aldo Moro”, via E. Orabona 4, I-70125 Bari, Italy</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Departamento de Bioquimica y Biologia Molecular, Facultad de Medicina, Universidad de Santiago de Compostela, San Francisco I, E-15782 Santiago de Compostela, Spain</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Molecular Discovery Limited 215 Marsh Road, Pinner, Middlesex, London HA5 5NE, U.K.</span></div><div class="corresp-info"><strong>*</strong>Phone: +39-0805442780. Fax: +39-080-5442230. E-mail: <a href="/cdn-cgi/l/email-protection#adc0ccdfcec283ceccd9d9c2edd8c3c4cfcc83c4d9"><span class="__cf_email__" data-cfemail="b3ded2c1d0dc9dd0d2c7c7dcf3c6dddad1d29ddac7">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00562&amp;href=/doi/10.1021%2Facs.jmedchem.6b00562" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 14</span><span class="cit-pageRange">, 6791–6806</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 27, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>13 April 2016</li><li><span class="item_label"><b>Published</b> online</span>7 July 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 28 July 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b00562" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00562</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6791%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DLeonardo%2BPisani%252C%2BRoberta%2BFarina%252C%2BMarco%2BCatto%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D14%26contentID%3Dacs.jmedchem.6b00562%26title%3DExploring%2BBasic%2BTail%2BModifications%2Bof%2BCoumarin-Based%2BDual%2BAcetylcholinesterase-Monoamine%2BOxidase%2BB%2BInhibitors%253A%2BIdentification%2Bof%2BWater-Soluble%252C%2BBrain-Permeant%2BNeuroprotective%2BMultitarget%2BAgents%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6806%26publicationDate%3DJuly%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b00562"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1558</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">60</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b00562" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Exploring Basic Tail Modifications of Coumarin-Based Dual Acetylcholinesterase-Monoamine Oxidase B Inhibitors: Identification of Water-Soluble, Brain-Permeant Neuroprotective Multitarget Agents&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Leonardo&quot;,&quot;last_name&quot;:&quot;Pisani&quot;},{&quot;first_name&quot;:&quot;Roberta&quot;,&quot;last_name&quot;:&quot;Farina&quot;},{&quot;first_name&quot;:&quot;Marco&quot;,&quot;last_name&quot;:&quot;Catto&quot;},{&quot;first_name&quot;:&quot;Rosa&quot;,&quot;last_name&quot;:&quot;Maria Iacobazzi&quot;},{&quot;first_name&quot;:&quot;Orazio&quot;,&quot;last_name&quot;:&quot;Nicolotti&quot;},{&quot;first_name&quot;:&quot;Saverio&quot;,&quot;last_name&quot;:&quot;Cellamare&quot;},{&quot;first_name&quot;:&quot;Giuseppe&quot;,&quot;last_name&quot;:&quot;Felice Mangiatordi&quot;},{&quot;first_name&quot;:&quot;Nunzio&quot;,&quot;last_name&quot;:&quot;Denora&quot;},{&quot;first_name&quot;:&quot;Ramon&quot;,&quot;last_name&quot;:&quot;Soto-Otero&quot;},{&quot;first_name&quot;:&quot;Lydia&quot;,&quot;last_name&quot;:&quot;Siragusa&quot;},{&quot;first_name&quot;:&quot;Cosimo&quot;,&quot;last_name&quot;:&quot;Damiano Altomare&quot;},{&quot;first_name&quot;:&quot;Angelo&quot;,&quot;last_name&quot;:&quot;Carotti&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;07&quot;,&quot;issue&quot;:&quot;14&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;6791-6806&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b00562&quot;},&quot;abstract&quot;:&quot;Aiming at modulating two key enzymatic targets for Alzheimer’s disease (AD), i.e., acetylcholinesterase (AChE) and monoamine oxidase B (MAO B), a series of multitarget ligands was properly designed by linking the 3,4-dimethylcoumarin scaffold to 1,3- and 1,4-substituted piperidine moieties, thus modulating the basicity to improve the hydrophilic/lipophilic balance. After in vitro enzymatic inhibition assays, multipotent inhibitors showing potencies in the nanomolar and in the low micromolar range for hMAO B and eeAChE, respectively, were prioritized and evaluated in human SH-SY5Y cell-based models for their cytotoxicity and neuroprotective effect against oxidative toxins (H2O2, rotenone, and oligomycin-A). The present study led to the identification of a promising multitarget hit compound (5b) exhibiting high hMAO B inhibitory activity (IC50 = 30 nM) and good MAO B/A selectivity (selectivity index, SI = 94) along with a micromolar eeAChE inhibition (IC50 = 1.03 μM). Moreover, 5b behaves as a water-soluble, br&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00562&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00562" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00562&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00562" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00562&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00562" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00562&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00562&amp;href=/doi/10.1021/acs.jmedchem.6b00562" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b00562" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b00562" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b00562%26sid%3Dliteratum%253Aachs%26pmid%3D27347731%26genre%3Darticle%26aulast%3DPisani%26date%3D2016%26atitle%3DExploring%2BBasic%2BTail%2BModifications%2Bof%2BCoumarin-Based%2BDual%2BAcetylcholinesterase-Monoamine%2BOxidase%2BB%2BInhibitors%253A%2BIdentification%2Bof%2BWater-Soluble%252C%2BBrain-Permeant%2BNeuroprotective%2BMultitarget%2BAgents%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D14%26spage%3D6791%26epage%3D6806%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291454" title="Solubility">Solubility</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/14" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/jmcmar.2016.59.issue-14/20160728/jmcmar.2016.59.issue-14.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00562/20160722/images/medium/jm-2016-005625_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00562/20160722/images/large/jm-2016-005625_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00562&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Aiming at modulating two key enzymatic targets for Alzheimer’s disease (AD), i.e., acetylcholinesterase (AChE) and monoamine oxidase B (MAO B), a series of multitarget ligands was properly designed by linking the 3,4-dimethylcoumarin scaffold to 1,3- and 1,4-substituted piperidine moieties, thus modulating the basicity to improve the hydrophilic/lipophilic balance. After in vitro enzymatic inhibition assays, multipotent inhibitors showing potencies in the nanomolar and in the low micromolar range for hMAO B and eeAChE, respectively, were prioritized and evaluated in human SH-SY5Y cell-based models for their cytotoxicity and neuroprotective effect against oxidative toxins (H<sub>2</sub>O<sub>2</sub>, rotenone, and oligomycin-A). The present study led to the identification of a promising multitarget hit compound (<b>5b</b>) exhibiting high hMAO B inhibitory activity (IC<sub>50</sub> = 30 nM) and good MAO B/A selectivity (selectivity index, SI = 94) along with a micromolar eeAChE inhibition (IC<sub>50</sub> = 1.03 μM). Moreover, <b>5b</b> behaves as a water-soluble, brain-permeant neuroprotective agent against oxidative insults without interacting with P-gp efflux system.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67172" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67172" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The incidence and socio-economic costs of neurodegenerative diseases (NDs) are constantly growing as a consequence of the increased life expectancy and aging population. Among NDs, a major role is played by Alzheimer’s disease (AD), representing the most common cause of dementia. As population ages, the devastating impact of AD increases worldwide, being estimated that more than 100 million individuals will suffer from AD by 2050.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Alzheimer’s patients experience an irreversible cognitive decline, associated with severe memory, attention, and learning deficits impairing daily life activities. In the last decades, massive investments in both academic and private settings, even though lower than in other healthcare programs (e.g., anticancer therapies), have been devoted to the discovery of novel diagnostic and therapeutic tools against AD. Unfortunately, the road to effectively treat AD with both small molecules and immunotherapies addressing amyloid as well as tau hypotheses<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> has been paved with failures<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> even in late-stage clinical trials,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> and disease-modifying drugs are missing. The disheartening attrition rate has commonly been ascribed to the multifactorial etiopathogenesis of AD exhibiting several neuronal aberrations spanning from proteostasis,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> metal unbalance,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> and oxidative stress to mitochondrial dysfunctions,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> ultimately leading to disruption of cholinergic transmission in hippocampus and frontal cortex.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> It is still a matter of debate whether researchers are addressing the wrong targets and/or the disease models are not appropriate.</div><div class="NLM_p">So far, with the exception of memantine (approved in 2003),<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> the restoration of basal neurotransmitter acetylcholine (ACh) levels through acetylcholinesterase (AChE) inhibitors (<a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>; donepezil, galantamine, and rivastigmine) is the only approved, albeit palliative, therapeutic strategy in mild forms of AD.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> In more recent years, the research shifted to the more promising multitarget strategy,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> rooted on the principle that a combination of actions may be beneficial for multifactorial pathologies including AD<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> by hitting two or more relevant targets with the same molecular entity.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a> In many anti-Alzheimer multitargeting programs, chelation of biometals,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> agonism to 5-HT<sub>4</sub> receptors,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> antagonism to 5-HT<sub>1A</sub> receptors,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> radical scavenging,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> and release of vasodilating NO radical<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19, 20)</a> have been considered valuable biochemical activities that could synergistically improve the therapeutic potential of AChE inhibition often remaining the core feature of multipotent agents.</div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00562/20160722/images/medium/jm-2016-005625_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00562/20160722/images/large/jm-2016-005625_0011.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Approved Drugs for AD (Common Name, Mechanism of Action)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00562/20160722/images/large/jm-2016-005625_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00562&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">AChE (EC 3.1.1.7) is a serine hydrolase responsible for the deacetylation of ACh in both central and peripheral nervous system.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> A 20 Å narrow tunnel, chiefly lined by aromatic residues, separates a catalytic anionic site (CAS),<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> close to the catalytic triad, from another anionic subsite (peripheral anionic site, PAS) that binds the cationic heads of gorge-spanning dual binding site (DBS) inhibitors and acts as chaperone-like motif during the formation of Aβ oligomers.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Another ChE isoform (butyrylcholinesterase, BChE, EC 3.1.1.8)<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> has the same biological function, and its inhibitors may also have impact in the therapy of AD<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> because its activity increases in advanced AD forms.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> To alleviate oxidative stress conditions of degenerating neurons, the inhibition of MAO (amine-oxygen oxidoreductase; EC 1.4.3.4) activity might be addressed.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> This flavoenzyme catalyzes the degradation of endogenous and xenobiotic amines (including many neurotransmitters as catecholamines and serotonin) and contributes to increase reactive oxygen species (ROS) level through its catalytic cycle by producing the corresponding aldehyde metabolite and hydrogen peroxide as the end products. The two known isoforms, termed MAO A and MAO B,<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28, 29)</a> differ in amino acid sequences, tissue distribution, and selectivity for substrates and inhibitors. As far as the role of MAO in AD is concerned, the potential application of MAO inhibitors in therapy needs to address a crucial selectivity issue. In fact, strong dietary restrictions<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> are required to avoid unwanted side effects<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> associated with the blockade of peripheral MAO A by nonselective inhibitors. Moreover, MAO B predominates in brain tissue and its activity increased in the elderly, especially in glial cells.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></div><div class="NLM_p">As a part of our ongoing research on multifunctional ligands against NDs,<a onclick="showRef(event, 'ref17 ref33'); return false;" href="javascript:void(0);" class="ref ref17 ref33">(17, 33)</a> we recently devoted our efforts to the identification of coumarin-based AChE-MAO B inhibitors with improved drug-like properties.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Among privileged heterocycles, the coumarin core has been extensively decorated by several research groups addressing the discovery of novel selective MAO<a onclick="showRef(event, 'ref35 ref36 ref37 ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref35 ref36 ref37 ref38 ref39">(35-39)</a> and AChE<a onclick="showRef(event, 'ref40 ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref40 ref41 ref42">(40-42)</a> inhibitors as well as to build new molecular scaffolds with dual AChE-MAO activity<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> against NDs, in most cases through a conjugative approach.<a onclick="showRef(event, 'ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref44 ref45">(44, 45)</a> Over the past decade, our contribution to this field highlighted the important role of substituents at position 4 and 7 of coumarin in tuning MAO B activity and selectivity.<a onclick="showRef(event, 'ref46 ref47 ref48 ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref46 ref47 ref48 ref49 ref50">(46-50)</a> Aiming at obtaining multipotent compounds with good overall pharmacokinetic properties, we herein focused on modifications of the basic head of the side chain at C7 and of the spacer connecting the two key pharmacophore features (namely the basic head and the coumarin core) in order to improve aqueous solubility while maintaining a dual AChE-MAO B inhibitory activity. Starting from a potent multitarget directed ligand (MTDL),<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> the new molecular framework was built as depicted in <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>. The lipophilic phenyl ring was removed from the spacer, and the basic nitrogen was enclosed in a flexible piperidine cycle, thus modulating the p<i>K</i><sub>a</sub> of N-sp<sup>3</sup> and the aqueous solubility at physiological pH. By approaching this ring-closing strategy around the basic nitrogen, we conceived a series of 2<i>H</i>-chromen-2-ones bearing a donepezil-inspired benzylpiperidine moiety that may efficiently interact with AChE binding pocket.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> 3,4-Dimethylcoumarin was exploited as a molecular fragment to enhance MAO B affinity because this scaffold proved to be efficiently accommodated in the lipophilic enzymatic pocket that faces the FAD coenzyme and is unable to lodge sterically hindered groups.<a onclick="showRef(event, 'ref34 ref52 ref53'); return false;" href="javascript:void(0);" class="ref ref34 ref52 ref53">(34, 52, 53)</a></div><figure id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00562/20160722/images/medium/jm-2016-005625_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00562/20160722/images/large/jm-2016-005625_0001.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Rational design.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00562/20160722/images/large/jm-2016-005625_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00562&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The designed compounds were tested in vitro to evaluate their ability to inhibit both ChEs and MAOs. The ability of novel compounds to permeate the blood–brain barrier (BBB) was preliminarily calculated in silico by using Volsurf+ package (Molecular Discovery, London, UK) to compute Log BB, a molecular interaction field (MIF) based parameter useful to estimate the CNS distribution of small molecules.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> The most promising compounds fished out from both the enzymatic screening and in silico BBB-permeation prediction were prioritized and studied in human SH-SY5Y neuroblastoma cell lines for their cytotoxicity and potential neuroprotective effects against oxidative insults (hydrogen peroxide, rotenone, and oligomycin A). Moreover, compounds endowed with the highest neuroprotective effects were evaluated in vitro for their ability to cross BBB in a Madin–Darby canine kidney (MDCKII-MDR1) cell model and to interact with glycoprotein-P (P-gp) mediated transport. The hydrophilic/lipophilic balance of selected compounds was investigated through well-established turbidimetric determination of aqueous solubility and RP-HPLC lipophilicity measurements.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10328" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10328" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p"><a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> illustrates the synthetic pathway to piperidine derivatives <b>4a</b>–<b>m</b> and (±)-<b>5a</b>–<b>i</b> reported in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>. The preparation of compounds bearing a methylene spacer started from the activation of Boc-protected 3- and 4-piperidinemethanol <b>1b</b>,<b>c</b> as mesylate esters (<b>1d</b>,<b>e</b>) that underwent SN with 3,4-dimethyl-7-hydroxycoumarin in DMF at 70 °C by using cesium carbonate as the base and triethylamine to buffer the reaction mixture, thus obtaining intermediates <b>2b</b>,<b>c</b>. Coumarins lacking the methylene linker were synthesized starting from the Mitsunobu etherification to couple <b>1a</b> with 3,4-dimethyl-7-hydroxycoumarin<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> under buffered conditions through triethylamine, thus yielding <b>2a</b>. The removal of the carbamate protecting group of <b>2a</b>–<b>c</b> in acidic conditions by TFA unmasked the piperidine intermediates <b>3a</b>–<b>c</b> that underwent final alkylation under microwave-assisted nucleophilic substitution conditions (compounds <b>4b</b>–<b>h</b>, <b>4j</b>–<b>m</b>, (±)-<b>5b</b>–<b>h</b>) in acetonitrile with the appropriate benzyl bromide or methylation at room temperature (<b>4a</b>, <b>4i</b>, and (±)-<b>5a</b>). NaBH(OAc)<sub>3</sub> mediated the reductive amination of <b>3c</b> and commercially available 3,4-dimethoxybenzaldehyde to prepare coumarin (±)-<b>5i</b>. A sequential two-step alkylation protocol under microwave irradiation afforded the rigid 1,2,3,4-tetrahydroisoquinoline derivatives <b>7a</b>,<b>b</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Initially, 3,4-dimethyl-7-hydroxycoumarin was reacted with 1,3- or 1,4-dibromoalkane, thus furnishing intermediate bromides <b>6a</b>,<b>b</b>. Under the same reaction conditions, the suitable 1,2,3,4-tetrahydroisoquinoline was alkylated with <b>6a</b>,<b>b</b>, yielding the desired compounds <b>7a</b>,<b>b</b>.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00562/20160722/images/medium/jm-2016-005625_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00562/20160722/images/large/jm-2016-005625_0005.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>4a</b>–<b>m</b>, (±)-<b>5a</b>–<b>i</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00562/20160722/images/large/jm-2016-005625_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00562&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) methanesulfonyl chloride, triethylamine, CH<sub>2</sub>Cl<sub>2</sub>, 3 h, room temperature; (ii) for <b>2bc</b>, 3,4-dimethyl-7-hydroxycoumarin, triethylamine, Cs<sub>2</sub>CO<sub>3</sub>, dry DMF, 72 h, 70 °C; (iii) for <b>2a</b>, 3,4-dimethyl-7-hydroxycoumarin, ADDP, PPh<sub>3</sub>, triethylamine, anhydrous CH<sub>2</sub>Cl<sub>2</sub>, 15 h, room temperature; (iv) trifluoroacetic acid, CH<sub>2</sub>Cl<sub>2</sub>, 1 h, 0 °C to room temperature; (v) for <b>4a</b>, <b>4i</b>, and <b>5a</b>, methyl iodide, anhydrous K<sub>2</sub>CO<sub>3</sub>, acetone, 6 h, room temperature; for <b>4b</b>–<b>h</b>, <b>4j</b>–<b>m</b>, and <b>5b</b>–<b>h</b>, butyl iodide (for <b>4b</b>) or substituted benzyl bromide, anhydrous K<sub>2</sub>CO<sub>3</sub>, acetone, 30 min, 130 °C, MW; for <b>5i</b>, 3,4-dimethoxybenzaldehyde, sodium triacetoxyborohydride, 1,2-dichloroethane, 15 h, room temperature.</p></p></figure><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00562/20160722/images/medium/jm-2016-005625_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00562/20160722/images/large/jm-2016-005625_0006.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>7a</b>–<b>b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00562/20160722/images/large/jm-2016-005625_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00562&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) dibromoalkyl derivative, anhydrous K<sub>2</sub>CO<sub>3</sub>, acetone, 130 °C, 30 min, MW; (ii) 1,2,3,4-tetrahydroisoquinoline, anhydrous K<sub>2</sub>CO<sub>3</sub>, acetone, 130 °C, 30 min, MW.</p></p></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. MAOs and ChEs Inhibition Data for Compounds <b>4a</b>–<b>m</b>, (±)-<b>5a</b>–<b>i</b>, and <b>7a</b>,<b>b</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00562/20160722/images/medium/jm-2016-005625_0007.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00562/20160722/images/medium/jm-2016-005625_0008.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Calculated with Volsurf+ package (Molecular Discovery, Oxford, UK).</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">Human recombinant MAOs on Supersomes.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">AChE from electric eel.</p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">BChE from horse serum.</p></div><div class="footnote" id="t1fn5"><sup>Table e</sup><p class="last">Tested as hydrochloride salt.</p></div></div><div></div></div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Biological Assays</h3><div class="NLM_p">All compounds were tested in vitro for their inhibitory activities on human MAOs (hMAOs), electric eel AChE (eeAChE), and equine serum BChE (esBChE) enzymes. For hMAOs inhibition assay, the protocol was carried out with a fluorescence-based method using kynuramine as a nonselective substrate of hMAO A and hMAO B.<a onclick="showRef(event, 'ref34 ref56'); return false;" href="javascript:void(0);" class="ref ref34 ref56">(34, 56)</a> As for ChEs, the well-known Ellman’s spectrophotometric test<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> was used to determine IC<sub>50</sub>s for both isoforms. The inhibition data are reported in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> as IC<sub>50</sub> (μM) or, for poorly active compounds, as percentage of inhibition at 10 μM. The kinetic behavior of compound (±)-<b>5b</b> for the inhibition of eeAChE was investigated and is illustrated in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a> by means of a Lineweaver–Burk diagram, where the reciprocals of enzyme activity (eeAChE) vs reciprocals of substrate (S-acetylthiocholine) concentration in the presence of different concentrations (0–8 μM) of inhibitor have been reported.</div><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00562/20160722/images/medium/jm-2016-005625_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00562/20160722/images/large/jm-2016-005625_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Lineweaver–Burk plots of <i>ee</i>ACHE inhibition kinetics of compound (±)-<b>5b</b>. Reciprocals of enzyme activity (eeAChE) vs reciprocals of substrate (<i>S</i>-acetylthiocholine) concentration in the presence of different concentrations (0–8 μM) of inhibitor. Inset: Concentrations used for inhibitor are coded with different graphic symbols.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00562/20160722/images/large/jm-2016-005625_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00562&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Human neuroblastoma SH-SY5Y cell lines were used to evaluate the cytotoxic effect of compounds <b>4j</b>–<b>k</b>, (±)-<b>5a</b>–<b>e</b>, and (±)-<b>5i</b> through the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) viability assay (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>).<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> By using the same cellular models,<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> the ability of selected compounds to protect neurons against three different toxic insults (hydrogen peroxide, oligomycin-A, and rotenone) was studied (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>) and compared to donepezil taken as a reference anti-Alzheimer’s drug. Data concerning cytotoxicity and neuroprotection assays are expressed as percentage of viability referred to control experiment as illustrated in <a class="ref internalNav" href="#fig3" aria-label="Figures 3">Figures 3</a> and <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00562/20160722/images/medium/jm-2016-005625_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00562/20160722/images/large/jm-2016-005625_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Cytotoxicity of compounds <b>4j</b>–<b>k</b>, (±)-<b>5a</b>–<b>e</b>, (±)-<b>5i</b>, and donepezil tested at concentrations in the range 0.1–50 μM in human neuroblastoma SH-SY5Y cell lines for 24 h. Data are reported as percentage of cell survival vs untreated cells (control). Data represent means ± SD (<i>n</i> = 3).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00562/20160722/images/large/jm-2016-005625_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00562&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00562/20160722/images/medium/jm-2016-005625_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00562/20160722/images/large/jm-2016-005625_0004.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Neuroprotective effect on human neuroblastoma SH-SY5Y cells of selected compounds <b>4j</b>–<b>k</b>, (±)-<b>5a</b>–<b>e</b>, and (±)-<b>5i</b> after 24 h incubation at different concentrations (1 and 10 μM) with H<sub>2</sub>O<sub>2</sub> (300 μM (4a)), oligomycin-A (10 μM (4b)), and rotenone (20 μM (4c)). Data are expressed as percentage of viable cells (referred to control) and shown as mean ± SD (<i>n</i> = 3). Untreated cells were used as control. Donepezil was used as a reference anti-AD marketed drug. Statistical significance was calculated using a two-way analysis of variance (ANOVA) followed by the Bonferroni post-hoc tests (GraphPad Prism version 5); * <i>p</i> < 0.05, ** <i>p</i> < 0.01.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00562/20160722/images/large/jm-2016-005625_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00562&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As previously reported,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> cell-based transport studies were aimed at monitoring the BBB permeating potential of compounds (±)-<b>5a</b>,<b>b</b> and (±)-<b>5d</b> displaying the highest neuroprotective activity. Bidirectional transport studies were carried out by measuring apical to basolateral (AP-BL) and basolateral to apical (BL-AP) apparent permeability (<i>P</i><sub>app</sub>) in MDCK cells. After retroviral transfection with the human MDR1 cDNA (MDCKII-MDR1), these cells highly express P-gp, thus alerting compounds likely to be efflux pumps substrates. <i>P</i><sub>app</sub> (in units of cm/s) and efflux ratio (ER) were calculated and summarized in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Bidirectional Transport across MDCKII-MDR1 Cells of Compounds (±)-<b>5a</b>,<b>b</b> and (±)-<b>5d</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="±"><i>P</i><sub>app</sub>, AP-BL (cm/s)</th><th class="colsep0 rowsep0" align="center" char="±"><i>P</i><sub>app</sub>, BL-AP (cm/s)</th><th class="colsep0 rowsep0" align="center" char=".">ER<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(±)-<b>5a</b></td><td class="colsep0 rowsep0" align="char" char="±">2.23 ± 0.11 × 10<sup>–5</sup></td><td class="colsep0 rowsep0" align="char" char="±">2.02 ± 0.7 × 10<sup>–5</sup></td><td class="colsep0 rowsep0" align="char" char=".">0.90</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(±)-<b>5b</b></td><td class="colsep0 rowsep0" align="char" char="±">2.43 ± 0.65 × 10<sup>–5</sup></td><td class="colsep0 rowsep0" align="char" char="±">1.48 ± 0.30 × 10<sup>–5</sup></td><td class="colsep0 rowsep0" align="char" char=".">0.61</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(±)-<b>5d</b></td><td class="colsep0 rowsep0" align="char" char="±">8.40 ± 0.25 × 10<sup>–7</sup></td><td class="colsep0 rowsep0" align="char" char="±">2.16 ± 0.22 × 10<sup>–6</sup></td><td class="colsep0 rowsep0" align="char" char=".">2.56</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">diazepam</td><td class="colsep0 rowsep0" align="char" char="±">2.58 ± 0.03 × 10<sup>–5</sup></td><td class="colsep0 rowsep0" align="char" char="±">2.53 ± 0.05 × 10<sup>–5</sup></td><td class="colsep0 rowsep0" align="char" char=".">0.98</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FD-4</td><td class="colsep0 rowsep0" align="char" char="±">8.94 ± 0.15 × 10<sup>–6</sup></td><td class="colsep0 rowsep0" align="char" char="±">8.03 ± 0.20 × 10<sup>–6</sup></td><td class="colsep0 rowsep0" align="char" char=".">0.89</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Efflux ratio (ER) was calculated using the following equation: ER = <i>P</i><sub>app</sub>, BL-AP/<i>P</i><sub>app</sub>, AP-BL, where <i>P</i><sub>app</sub>, BL-AP is the apparent permeability of basal-to-apical transport, and <i>P</i><sub>app</sub>, AP-BL is the apparent permeability of apical-to-basal transport. An efflux ratio greater than 2 indicates that a test compound is likely to be a substrate for P-gp transport.</p></div></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50751" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50751" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">It is worth underlining that MAO B selectivity of the multipotent ligands reported herein was a pursued feature to avoid well-known side effects raising from the inhibition of peripheral MAO A isoform. On the other hand, isoform selectivity was not considered a crucial issue in the case of ChEs. In fact, in advanced AD increasing body of evidence supports the importance of BChE whose activity increases as the disease progresses. Both ChEs are capable of catalyzing the hydrolysis of ACh. Therefore, BChE inhibition can be a viable strategy to counteract the cholinergic depletion too.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><div class="NLM_p">Keeping the 3,4-dimethylcoumarin as the common structural feature, the main modifications regarded the flexibility and geometry of the linker tethering the coumarin backbone at position 7 to the basic head and the alkylation of the piperidine nitrogen.</div><div class="NLM_p">Looking at the inhibition data for piperidine-bearing coumarins reported in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>, as expected from the presence of the <i>N</i>-benzylpiperidine moiety mimicking donepezil, all compounds showed from good to high affinity toward AChE (IC<sub>50</sub>s ≤ 10 μM) along with good selectivity values over BChE. AChE inhibitory potencies shift was not remarkably influenced by the structural modification herein reported and IC<sub>50</sub>s for AChE laid in the range 0.68 μM (<b>4i</b>) −9.57 μM (<b>4l</b>). In contrast, a wider activity window could be observed for MAO B (0.030 μM for (±)-<b>5b</b> < IC<sub>50</sub><i>s</i> < 2.49 μM for <b>4g</b>), suggesting a more pronounced effect of the substitution pattern on the MAO affinity.</div><div class="NLM_p">All hybrids displayed from moderate to high affinity toward hMAO B with submicromolar IC<sub>50</sub>s but for <b>4b</b> and <b>4g</b>. All compounds inhibited selectively MAO B, with selectivity index (SI, IC<sub>50</sub> MAO A/IC<sub>50</sub> MAO B) ranging from 2 (<b>4e</b>,<b>f</b>) to 133 ((±)-<b>5h</b>).</div><div class="NLM_p">Furthermore, MAO B affinity was affected by the flexibility of the linker and the piperidine substitution site (3 vs 4) more than AChE affinity. In fact, higher MAO B inhibitory potencies could be fished out from compounds <b>4i</b>–<b>m</b> and (±)-<b>5a</b>–<b>i</b>, where a methylene spacer tethers the basic head to the planar coumarin. In absence of the spacer, increasing the size and lipophilicity of the substituent on piperidine nitrogen from methyl (<b>4a</b>) to <i>n</i>-butyl (<b>4b</b>) and benzyl group (<b>4c</b>) decreased MAO B affinity while improving AChE affinity. The opposite trend was observed in the presence of the methylene linker connecting the coumarin to the 3- and 4-substituted piperidinyl ring when moving from methyl to benzyl (<b>4i</b> vs <b>4j</b>, (±)-<b>5a</b> vs (±)-<b>5b</b>). Homologation of the terminal chain from benzyl (<b>4c</b>) to phenethyl (<b>4g</b>) group influenced negatively the affinities toward both MAOs and reduced AChE affinity, too. The introduction of a carbonyl group (<b>4h</b>) produced a 4-fold MAO B affinity improvement with respect to <b>4c</b>, whereas AChE inhibitory potency diminished.</div><div class="NLM_p">The substitution position at the piperidine cycle strongly influenced MAO B affinity. As a matter of fact, three derivatives out of the 4-substituted piperidine series (<b>4a</b>–<b>m</b>) showed an IC<sub>50</sub> < 0.250 μM whereas all 3-substituted piperidines (±)-<b>5a</b>–<b>i</b> showed MAO B inhibitory potencies <0.250 μM. The presence of 3-substituted piperidines was preferred from MAO B with respect to 4-piperidinyl moieties ((±)-<b>5a</b> > <b>4a</b> and <b>4i</b>; (±)-<b>5b</b> > <b>4c</b> and <b>4j</b>; (±)-<b>5c</b> > <b>4d</b> and <b>4k</b>; (±)-<b>5f</b> > <b>4e</b> and <b>4l</b>; (±)-<b>5h</b> > <b>4f</b> and <b>4m</b>), irrespective of the nitrogen substituents. Looking at the basic head, the introduction of halogens (3′-Cl, 3′-Br, 4′-F, 4′-Cl) as well as electron-withdrawing (4′-SO<sub>2</sub>CH<sub>3</sub> and 4′-CN) and electron-donating groups (3′,4′-diOMe) on the phenyl ring exhibited a detrimental effect regards to MAO B affinity and drastically reduced MAO B/A selectivity. Meta-substitution represented the preferred position for chlorine in the binding to MAO B enzymatic cleft, as inferred by comparing <b>4d</b> vs <b>4e</b>, <b>4k</b> vs <b>4l</b>, and (±)-<b>5c</b> vs (±)-<b>5f</b>. In the <i>para</i> position, a cyano group was preferred to chloro (<b>4e</b> < <b>4f</b>, <b>4l</b> < <b>4m</b>, (±)-<b>5f</b> < (±)-<b>5h</b>) in both MAO B and AChE. Sulfonyl derivative (±)-<b>5g</b> displayed the highest MAO A affinity along with a low IC<sub>50</sub> toward MAO B.</div><div class="NLM_p">To assess the AChE inhibition mechanism of donepezil-like <i>N</i>-benzyl-piperidines, the kinetic behavior of compound (±)-<b>5b</b> was investigated. As shown in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>, Lineweaver–Burk plot indicated a mixed-type inhibition with a <i>K</i><sub>i</sub> equal to 1.37 ± 0.05 μM, thus suggesting a partial occupancy of PAS and potential Aβ antiaggregating properties.</div><div class="NLM_p">HPLC separations were undertaken to check a possible influence of chirality in the binding interactions of this series, and racemic mixtures of <b>5b</b> and <b>5d</b> were resolved as prototypes on a CHIRALPAK IA column, yielding enantiomeric excess >99% (see <a href="/doi/suppl/10.1021/acs.jmedchem.6b00562/suppl_file/jm6b00562_si_001.pdf" class="ext-link">Supporting Information</a> for details). Regarding hMAO B affinity, an eudismic ratio equal to 8 was observed for both racemates. Eutomers (+)-<b>5b</b> and (+)-<b>5d</b> exhibited outstanding hMAO B affinities (IC<sub>50</sub> = 23 and 26 nM, respectively). Interestingly, the most potent enantiomer (+)-<b>5b</b> showed also an outstanding MAO B over MAO A selectivity (SI = 167), much greater than the other eutomer (+)-<b>5d</b> (SI = 21). Both mixtures displayed a lower activity ratio (≤2) toward hMAO A, being (+)-<b>5b</b> and (−)-<b>5d</b> the distomers. A lower and inverted eudismic ratio was found toward eeAChE for both pairs of enantiomers.</div><div class="NLM_p">To overcome the undesirable drawback of chirality, 1,2,3,4-tetrahydroisoquinoline derivatives <b>7a</b>,<b>b</b> were designed as rigid achiral analogues of the most potent hit compound ((±)-<b>5b</b>). In vitro evaluation proved a sharp drop of MAO B affinity, albeit the potency was still in the nanomolar range. Interestingly, compounds <b>7a</b>,<b>b</b> showed low micromolar affinities toward both ChEs, with <b>7a</b> being the most potent BChE inhibitor of the whole series with a submicromolar IC<sub>50</sub> = 0.95 μM. This result could be ascribed to the flatness and wideness of BChE enzymatic cleft that could better accommodate rigid and sterically hindered basic groups.</div><div class="NLM_p">To assess the brain-permeating capability of the novel multipotent molecules reported herein, Volsurf+ was employed to compute Log BB, a parameter expressing the logarithmic ratio between the concentration of a drug in brain and blood. More specifically, compounds showing Log BB value greater than 0.5 readily penetrate into CNS and are classified as BBB+. Log BB values lower than −0.5 disclose very poor brain permeation (BBB– compounds), whereas values higher than −0.5 and lower than 0.5 indicate moderate permeation (BBB± compounds).<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> Calculations suggested that most compounds in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> should rapidly be distributed into the brain (BBB+ compounds). Log BB of derivatives bearing polar substituents on the phenyl ring (a cyano-group for <b>4f</b>, <b>4m</b>, and (±)-<b>5h</b> or a dimethoxy-group for (±)-<b>5i</b>) and the keto-derivative <b>4h</b> suggested moderate permeation. The lowest Log BB value (0.011) was returned by (±)-<b>5g</b> with a highly hydrophilic substituent on the basic head (−SO<sub>2</sub>CH<sub>3</sub> group). The high confidence of Volsurf-based predictions was assessed through the projection of the studied compounds in the chemical space represented by its applicability domain, determined according to the Hotelling’s T-squared approach (see <a href="/doi/suppl/10.1021/acs.jmedchem.6b00562/suppl_file/jm6b00562_si_001.pdf" class="ext-link">Supporting Information</a>).<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a></div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Cell-Based Assays: Cytotoxicity, Neuroprotection, and Brain Permeation</h3><div class="NLM_p">By combining data from enzymatic screening with in silico calculations, a number of hits was shortlisted and selected for further assays in cell-based models in order to evaluate their cytotoxic and neuroprotective effects and their ability to permeate BBB without interacting with efflux pumps such as P-gp. Regarding the inhibitory properties, the following selection criteria were applied: (i) IC<sub>50</sub> toward MAO B < 150 nM, (ii) IC<sub>50</sub> toward AChE < 2 μM. With respect to brain permeation predictions, Log BB threshold was set equal to 0.450. Seven coumarin derivatives (<b>4j</b>, <b>4k</b>, (±)-<b>5a</b>, (±)-<b>5b</b>, (±)-<b>5c</b>, (±)-<b>5d</b>, and (±)-<b>5e</b>) met all the selection criteria and were submitted to preliminary in vitro investigations in human neuroblastoma SH-SY5Y cell lines. Compound (±)-<b>5i</b> was also included in the study in order to investigate the effect of the <i>ortho</i>-dimethoxyphenyl moiety.</div><div class="NLM_p">Because in vitro enzymatic assays for both enantiomers of <b>5b</b> and <b>5d</b> provided AChE inhibition activities close to racemate and the differences between enantiomers and racemate for MAO B were reasonably low (ratio of IC<sub>50</sub>s < 6 for both isomers in comparison to racemate <b>5b</b> and <b>5d</b>), we deemed unnecessary to perform the cell-based studies on single enantiomers at this early stage of investigations.</div><div class="NLM_p">As shown in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>, most compounds displayed negligible cytotoxicity up to 50 μM after 24 h incubations. Some derivatives produced a reasonable cellular damage only at highest concentrations. In particular, the concentrations responsible for 50% inhibition of cell growth (IC<sub>50</sub>s) for compounds (±)-<b>5a</b>, (±)-<b>5b</b>, (±)-<b>5c</b>, and (±)-<b>5i</b> were equal to 30 ± 0.01, 44 ± 0.02, 13 ± 0.01, and 10 ± 0.03 μM, respectively.</div><div class="NLM_p">The overproduction of harmful radicals, above all reactive oxygenated species (ROS), and the unbalance in detoxification systems produces severe oxidative stress conditions in neurons affected by AD. Nucleic acids, proteins, and lipids become loaded with aberrant alterations that, in turn, could trigger AD-related neurotoxicity, and indeed the reduction of oxidative stress has been claimed as a viable strategy to slow down the progression of the disease. Therefore, we tested also the ability of selected multitarget molecules to protect SH-SY5Y cells against oxidative injuries. The cytoprotective effect was determined by measuring cell viability after incubation with a radical initiator (hydrogen peroxide, H<sub>2</sub>O<sub>2</sub>) and two mitochondrial poisons (rotenone and oligomycin-A), both capable of arresting respiratory chain and energy production (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>). Rotenone induces cellular damage by interfering with the activity of complex I of the respiratory chain,<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> whereas oligomycin-A binds to F<sub>0</sub> part of H<sup>+</sup>-ATP-synthase<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> and exerts its pro-apoptotic effect by blocking ATP formation. Compounds under investigation were incubated at two concentrations (1 and 10 μM), and untreated cells were used as control. As depicted in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>a, compounds (±)-<b>5a</b>–<b>e</b> markedly protected SH-SY5Y cells against H<sub>2</sub>O<sub>2</sub> even at the lowest concentration (1 μM). A low increase of cell viability in the presence of oligomycin-A was produced by <b>4j</b> (at 1 and 10 μM), <b>4k</b> (at 1 μM), (±)-<b>5c</b> (at 10 μM), and (±)-<b>5i</b> (at 1 and 10 μM). Moreover, derivative (±)-<b>5a</b> was not able to counteract cellular damage induced by oligomycin-A, whereas it exerted a moderate neuroprotective activity against rotenone at 1 and 10 μM. A significant increase of viable cells was obtained when rotenone was coincubated with (±)-<b>5e</b> at 1 μM. Derivative (±)-<b>5b</b> and (±)-<b>5d</b> remarkably increased cell viability in the presence of both mitochondrial toxins used in this assay (rotenone and oligomycin-A) at 1 and 10 μM and exerted a cytoprotective activity by far superior to that of donepezil. Taken together, these results highlighted dual inhibitors (±)-<b>5b</b> and (±)-<b>5d</b> as the most promising neuroprotective agents of the series as they proved to be effective against all the insults employed in SH- SY5Y cell-based experimental models.</div><div class="NLM_p last">To endorse the potential of both compounds as promising multipotent anti-AD leads, in vitro transport studies were undertaken. As for CNS-acting drugs, a critical issue is represented by the ability to cross the BBB, acting as a highly lipophilic boundary.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> Compounds permeate BBB mainly by a passive diffusion mechanism, and several efflux systems prevent the entrance of xenobiotics into CNS. Because the extrusion activity is essentially governed by P-gp, the possible behavior of a hit as a P-gp substrate should be assessed in the early stage of drug discovery along with its brain permeation properties. MDCK cells were used as a model to examine the behavior of selected compounds in crossing the BBB and eventually interacting with extrusion pumps. When retrovirally transfected with the human MDR1 cDNA (MDCKII-MDR1), these cell lines highly express P-gp (MDR1) and represent a robust BBB mimicking in vitro model. Furthermore, permeation analyses were undertaken also with (±)-<b>5a</b>, being the most potent neuroprotective agent against H<sub>2</sub>O<sub>2</sub> at 10 μM and moderately effective against rotenone at both tested concentrations (1 and 10 μM). In contrast with the computed Log BB, lipophilic derivative (±)-<b>5d</b> was not able to permeate the monolayer (see <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>), probably because of quite high membrane retention as deduced from low permeation rate in both directions, i.e., apical-to-basolateral (AP-BL) and basolateral-to-apical (BL-AP). Moreover, an ER > 2 (ER = <i>P</i><sub>app</sub>, BL-AP/<i>P</i><sub>app</sub>, AP-BL) can be taken as a figure of undesirable interactions with P-gp. On the other hand, as shown in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a> compounds (±)-<b>5b</b> and (±)-<b>5a</b> confirmed rapid permeation and low ER comparable to diazepam used as reference CNS-active drug, thus envisaging good brain distribution and poor interactions as P-gp substrates.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Aqueous Solubility and Lipophilicity</h3><div class="NLM_p">In the present work, the aim of optimizing the aqueous solubility at pH 7.4 of a coumarin-based hit recently reported by us (7-(4-(<i>N</i>-benzyl-<i>N</i>-methylaminomethyl)benzyloxy)-4-(hydroxymethyl)-2<i>H</i>-chromen-2-one hydrochloride <b>I</b>;<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a><a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) while maintaining a dual AChE-MAO B inhibitory activity was pursued by introducing focused structural modification on the protonatable head and on the linker at position 7 of the coumarin core. Kinetic aqueous solubility at pH 7.4 was experimentally determined for compounds <b>I</b>, <b>4j</b>, <b>5a</b>, and <b>5b</b> by applying a turbidimetric method.</div><div class="NLM_p">As showed in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>, compound <b>I</b> returned the lowest value of water solubility (log <i>S</i> = −4.42) and the <i>N</i>-methylpiperidin-3-yl derivative <b>5a</b> exhibited the highest solubility (log <i>S</i> = −3.67). Compared to <b>I</b>, the piperidin-4-yl derivative <b>4j</b> showed only a modest increase of solubility (log <i>S</i> = −4.25), whereas the isomer piperidin-3-yl derivative <b>5b</b> proved to be 3-fold more soluble (119 μM, log <i>S</i> = −3.92).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Aqueous Solubility and Lipophilicity Index of Compounds <b>I</b>,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a><b>4j</b>, (±)-<b>5a</b>, and (±)-<b>5b</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="±">log <i>S</i> (pH 7.4)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">log <i>k</i>′<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">cLogP<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>I</b><a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></td><td class="colsep0 rowsep0" align="char" char="±">–4.42 ± 0.09</td><td class="colsep0 rowsep0" align="char" char=".">1.87</td><td class="colsep0 rowsep0" align="char" char=".">4.08</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4j</b></td><td class="colsep0 rowsep0" align="char" char="±">–4.25 ± 0.08</td><td class="colsep0 rowsep0" align="char" char=".">1.98</td><td class="colsep0 rowsep0" align="char" char=".">5.16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(±)-<b>5a</b></td><td class="colsep0 rowsep0" align="char" char="±">–3.67 ± 0.07</td><td class="colsep0 rowsep0" align="char" char=".">1.14</td><td class="colsep0 rowsep0" align="char" char=".">3.79</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(±)-<b>5b</b></td><td class="colsep0 rowsep0" align="char" char="±">–3.92 ± 0.05</td><td class="colsep0 rowsep0" align="char" char=".">2.01</td><td class="colsep0 rowsep0" align="char" char=".">5.55</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">log <i>S</i> (mol/L). Measured at pH 7.40 in 50 mM Tris-HCl, pH 7.4, at room temperature. Data are the mean ± SEM of three independent assays.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Extrapolated value at 65% of ammonium acetate buffer (pH 5.00) from six measurements. Mobile phase: methanol/ammonium acetate buffer (pH 5.00, 20 mM) v/v from 70% to 45%. Data are the mean ± SEM of three independent assays.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">Bio-Loom version 1.6, Biobyte Corp., Claremont, USA.</p></div></div></div><div class="NLM_p">The observed increase in water solubility at pH 7.4 of <b>4j</b>, <b>5a</b>, and <b>5b</b> over <b>I</b>, and the small but significant differences among them as well, could be reasonably explained taking into account the p<i>K</i><sub>a</sub> shift (i.e., the degree of amine protonation) in the examined molecules and their hydrophobicity. Regarding the basicity of the amino moiety at C(7) of the coumarin core, the ACD/Labs (Advanced Chemistry Development Inc., version 6.00) software estimates p<i>K</i><sub>a</sub>s of 7.8 for <b>I</b>, about 8.5 for <b>4j</b> and <b>5b</b>, and about 9.4 for <b>5a</b> (all values are however within the optimal range 7.5–10.5 proposed for CNS drugs).<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> The lipophilicity of the molecules in neutral form was assessed by calculation (Bio-Loom 1.6, Biobyte Corp., Claremont, USA), whereas a relative lipophilicity scale of the compounds, predominantly in the protonated form, was experimentally determined by a reversed phase (RP) HPLC method. Zorbax Eclypse-C18 column was used as the stationary phase, and mixtures of ammonium acetate buffer (20 mM, pH 5.00) and methanol were used as the mobile phases to measure chromatographic capacity factor (log <i>k</i>′) as a lipophilicity index.</div><div class="NLM_p last">Looking at the data in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>, interesting structure–property relations could be derived. Quite obviously, the most water-soluble is <b>5a</b>, that is, the most hydrophilic one (i.e., the lowest log <i>k</i>′ and cLogP values) and fully protonated at pH 7.4. Both <i>N</i>-benzylpiperidinyl derivatives <b>4j</b> and <b>5b</b>, despite their higher lipophilicity (as supported by the cLogP and log <i>k</i>′ values), are more soluble in water than <b>I</b>, most likely due to the different protonation degree of the amino group which, based on the estimated p<i>K</i><sub>a</sub>s, should be higher in <b>4j</b> and <b>5b</b> than in <b>I</b>. Albeit showing similar lipophilicity and very close basicity, the piperidin-3-yl derivative <b>5b</b> proved to be more than 2-fold more soluble in water that the isomer piperidin-4-yl compound <b>4j</b>. This result may be related on one hand to the disruption of molecular symmetry elements in <b>5b</b> with respect to <b>4j</b>, which could be an entropic factor favoring solubility in water, whereas on the other hand, the proximity of the polar groups in <b>5b</b>, which are closer than in <b>4j</b>, could explain the slightly better partitioning of <b>5b</b> in apolar media, as cLogP and log <i>k</i>′ values account for.</div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21135" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21135" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The multitarget approach has been extensively exploited by several research groups as a promising therapeutic option to face neurodegenerative disorders.<a onclick="showRef(event, 'ref66 ref67 ref68 ref69'); return false;" href="javascript:void(0);" class="ref ref66 ref67 ref68 ref69">(66-69)</a> In the case of AD, in the last decades inhibition of enzymatic activities of MAOs and ChEs has been pursued to identifying novel therapeutic agents with a potential disease-modifying effect.<a onclick="showRef(event, 'ref70 ref71'); return false;" href="javascript:void(0);" class="ref ref70 ref71">(70, 71)</a> A seminal discovery in the field is represented by ladostigil,<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> a dual AChE-MAO inhibitor<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> that has been recently announced to finish ad interim phase IIb and to enter phase III clinical trials by Avraham Pharmaceuticals for the treatment of mild cognitive impairment.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> Looking at the literature, common drawbacks of multitarget dual inhibitors hitting MAOs and ChEs are given by low MAO B over MAO A selectivity and, at least, one violation of Lipinski’s Rule of Five (in most cases MW > 500 and/or cLogP > 5), the latter representing a compromising feature for good oral bioavailability. Peripheral inhibition of MAO A implies safety issues arising from the so-called cheese effect.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> Over the years, we devoted attention to the development of coumarin-based dual AChE-MAO B inhibitors. To this end, our design strategy was aimed at improving the physicochemical properties for drug bioavailability (aqueous solubility, above all) of a previously described multipotent hit compound<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> while maintaining a dual AChE-MAO B inhibitory activity. Such a compound (i.e., derivative <b>I</b> in ref <a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">34</a>, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) showed outstanding in vitro inhibitory potencies against hAChE and hMAO B in the nanomolar range along with a limited aqueous solubility at pH 7.4 (38 μM).</div><div class="NLM_p">Structure–activity relationships (SARs) of multipotent compounds described herein shed light on the most relevant structural features modulating hMAO B affinity: (i) the flexibility of the spacer linking the coumarin core to the basic tail at position 7 and (ii) the substituents and the branching position on the piperidinyl ring (1,3 vs 1,4). AChE affinity was influenced by these structural modifications to a lesser extent. Interestingly, the presence of piperidinyl fragment along with its substitution pattern markedly influenced aqueous solubility.</div><div class="NLM_p last">The present study allowed the development of a novel multifunctional agent (±)-<b>5b</b> with a good balance of biochemical activities and improved aqueous solubility, definitively deserving further attention. In vitro enzymatic assays highlighted an outstanding hMAO B affinity (IC<sub>50</sub> = 30 nM) along with pronounced MAO B/A selectivity (SI = 94) and low micromolar eeAChE affinity (IC<sub>50</sub> = 1.03 μM). In cell-based assays, (±)-<b>5b</b> produced low cytotoxic damage (IC<sub>50</sub> = 44 ± 0.02 μM) after 24 h incubation and increased cell viability of human neuroblastoma lines incubated with some toxic insults (H<sub>2</sub>O<sub>2</sub>, rotenone, and oligomycin-A). Interestingly, its neuroprotective activity against the oxidative stress insults produced by hydrogen peroxide, oligomycin-A, and rotenone was superior to that of donepezil, used as a reference anti-AD drug. Bidirectional transport studies on MDCKII-MDR1 model denoted a rapid BBB permeation without suffering from likely P-gp interactions, thus suggesting good brain permeation and CNS distribution. Moreover, coumarin (±)-<b>5b</b> does not violate Lipinski’s Rule of Five (MW = 377.48, HB-donor = 0–1 depending on the protonation state, HB-acceptor = 2–3 depending on the protonation form, cLogP (ChemAxon) = 4.57). The presence of the basic piperidinyl moiety does increase water solubility of <b>5b</b> at pH 7.4 (3-fold increase compared to <b>I</b><a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a>). Taken together, these findings highlighted the potential of this class of compounds and particularly of (±)-<b>5b</b> as multitarget anti-AD neurotherapeutic, deserving further pharmacological investigations to prove its ability to prevent the onset, hamper the progression, or reverse the neurodegenerative process in animal models.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88687" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88687" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Chemistry</h3><div class="NLM_p">Starting materials, reagents, intermediate <b>1a</b>, and analytical grade solvents were purchased from Sigma-Aldrich (Europe). The purity of all the intermediates, checked by <sup>1</sup>H NMR and HPLC, was always better than 95%. All the newly prepared and tested compounds showed HPLC purity higher than 98%. Column chromatography was performed using Merck silica gel 60 (0.063–0.200 mm, 70–230 mesh). Flash chromatographic separations were performed on a Biotage SP1 purification system using flash cartridges prepacked with KP-Sil 32–63 μm, 60 Å silica. All reactions were routinely checked by TLC using Merck Kieselgel 60 F<sub>254</sub> aluminum plates and visualized by UV light or iodine. Regarding the reaction requiring the use of dry solvents, the glassware was flame-dried and then cooled under a stream of dry argon before use. Optical rotation was measured on a PerkinElmer 241 polarimeter with a Na lamp (589 nm). Nuclear magnetic resonance spectra were recorded on a Varian Mercury 300 instrument (at 300 MHz) or on a Agilent Technologies 500 apparatus (at 500 MHz) at ambient temperature in the specified deuterated solvent. Chemical shifts (δ) are quoted in parts per million (ppm) and are referenced to the residual solvent peak. The coupling constants <i>J</i> are given in hertz (Hz). The following abbreviations were used: s (singlet), d (doublet), dd (doublet of doublet), t (triplet), q (quadruplet), qn (quintuplet), m (multiplet), br s (broad signal); signals due to OH and NH protons were located by deuterium exchange with D<sub>2</sub>O. Chiral HPLC separations and enantiomeric excess determinations were carried out on CHIRALPAK IA (Chiral Technologies Europe, 25 cm × 0.46 cm I.D., 5 μm size particles) built on a Analytic Agilent 1260 Infinity multidetector system equipped with 1200 series UV-diode array in isocratic conditions. Elemental analyses were performed on the EuroEA 3000 analyzer only on the final compounds tested as MAOs and ChEs inhibitors. The measured values for C, H, and N agreed to within ±0.40% of the theoretical values. Melting points were determined by the capillary method on a Stuart Scientific SMP3 electrothermal apparatus and are uncorrected.</div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> General Procedure for the Synthesis of <i>tert</i>-Butyl 3- and 4-Hydroxymethylpiperidine-1-carboxylate (<b>1b</b>–<b>c</b>)</h4><div class="NLM_p">To a suspension of the suitable commercially available 3- and 4-hydroxymethylpiperidine (8.6 g, 75 mmol) in a mixture of acetonitrile (110 mL) and saturated aq sodium hydrogen carbonate solution (35 mL), di-<i>tert</i>-butyl dicarbonate (21 g, 94 mmol) was added in portions while cooling to 0 °C. The reaction mixture was then kept to room temperature and left under magnetic stirring for 18 h. Brine (300 mL) was added, and the aqueous layer was extracted with ethyl acetate (3 × 150 mL). The organic phases were collected, dried over sodium sulfate, and evaporated to dryness to give the desired product that was used without further purification.</div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i17" class="anchor-spacer"></div><h5 class="article-section__title" id="_i17"> <i>tert</i>-Butyl 4-(Hydroxymethyl)piperidine-1-carboxylate (<b>1b</b>)</h5><div class="NLM_p last">Yield: 88%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 1.06–1.19 (m, 2H), 1.44 (s, 9H), 1.60–1.74 (m, 4H), 2.69 (t, <i>J</i> = 12.7 Hz, 2H), 3.48 (t, <i>J</i> = 5.8 Hz, 2H), 4.09–4.13 (m, 2H, 1H dis. with D<sub>2</sub>O).</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i18" class="anchor-spacer"></div><h5 class="article-section__title" id="_i18"> <i>tert</i>-Butyl 3-(Hydroxymethyl)piperidine-1-carboxylate (<b>1c</b>)</h5><div class="NLM_p last">Yield: 94%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.01–1.10 (m, 1H), 1.21–1.47 (m, 3H), 1.37 (s, 9H), 1.52–1.68 (m, 2H), 2.63–2.72 (m, 1H), 3.11–3.19 (m, 1H), 3.21–3.28 (m, 1H), 3.73–3.81 (m, 1H), 3.87–3.96 (m, 1H), 4.48 (t, <i>J</i> = 8.8 Hz, 1H, dis. with D<sub>2</sub>O).</div></div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> General Procedure for the Synthesis of <i>tert</i>-Butyl 4-{[(Methylsulfonyl)oxy]methyl}piperidine-1-carboxylate (<b>1d</b>) and <i>tert</i>-Butyl 3-{[(Methylsulfonyl)oxy]methyl}piperidine-1-carboxylate (<b>1e</b>)</h4><div class="NLM_p">The suitable Boc-protected piperidine <b>1b</b>,<b>c</b> (7.5 g, 35 mmol) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (100 mL) before the addition of triethylamine (20 mL, 140 mmol). The mixture was cooled to 0 °C with an external ice bath, and methanesulfonyl chloride (3.0 mL, 39 mmol) was added dropwise. After warming at room temperature, the reaction was kept under magnetic stirring for 3 h. The mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> (200 mL) and washed with satd aq Na<sub>2</sub>CO<sub>3</sub> (3 × 200 mL). The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>. Evaporation of the solvent yielded the desired product in high purity.</div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i20" class="anchor-spacer"></div><h5 class="article-section__title" id="_i20"> <i>tert</i>-Butyl 4-{[(Methylsulfonyl)oxy]methyl}piperidine-1-carboxylate (<b>1d</b>)</h5><div class="NLM_p last">Yield: 86%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.03–1.11 (m, 2H), 1.38 (s, 9H), 1.61–1.65 (m, 2H), 1.82–1.88 (m, 1H), 2.62–2.75 (br s, 2H), 3.15 (s, 3H), 3.90–3.97 (m, 2H), 4.04 (d, <i>J</i> = 6.4 Hz, 2H).</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i21" class="anchor-spacer"></div><h5 class="article-section__title" id="_i21"> <i>tert</i>-Butyl 3-{[(Methylsulfonyl)oxy]methyl}piperidine-1-carboxylate (<b>1e</b>)</h5><div class="NLM_p last">Yield: 85%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.20–1.26 (m, 1H), 1.28–1.35 (m, 1H), 1.38 (s, 9H), 1.56–1.62 (m, 1H), 1.69–1.74 (m, 1H), 1.76–1.82 (m, 1H), 2.78–2.84 (m, 2H), 3.16 (s, 3H), 3.67–3.72 (br s, 2H), 4.01–4.10 (m, 2H).</div></div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> <i>tert</i>-Butyl 4-((3,4-Dimethyl-2-oxo-2<i>H</i>-chromen-7-yl)oxy)piperidine-1-carboxylate (<b>2a</b>)</h4><div class="NLM_p last">Triethylamine (17 mL, 120 mmol), commercially available <b>1a</b> (8.1 g, 40 mmol), and 1,1′-(azodicarbonyl)-dipiperidine (20 g, 80 mmol) were added to a suspension of 3,4-dimethyl-7-hydroxycoumarin (15 g, 80 mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (250 mL). The reaction mixture was kept to 0 °C and triphenylphosphine (21 g, 80 mmol), previously dissolved in CH<sub>2</sub>Cl<sub>2</sub> (100 mL), was added dropwise. The reaction was kept to room temperature and left under magnetic stirring overnight. The solvent was evaporated under reduced pressure, and the resulting crude solid was purified through flash chromatography (gradient eluent: ethyl acetate in <i>n</i>-hexane 20% → 60%). Yield: 60%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 1.47 (s, 9H), 1.71–1.82 (m, 2H), 1.92–1.98 (m, 2H), 2.18 (s, 3H), 2.37 (s, 3H), 3.31–3.39 (m, 2H), 3.66–3.74 (m, 2H), 4.48–4.55 (m, 1H), 6.80 (d, <i>J</i> = 2.2 Hz, 1H), 6.84 (dd, <i>J</i><sub>1</sub> = 2.2 Hz, <i>J</i><sub>2</sub> = 8.8 Hz, 1H), 7.50 (d, <i>J</i> = 8.8 Hz, 1H).</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> General Procedure for the Synthesis of <i>tert</i>-Butyl 3- or 4-(((3,4-Dimethyl-2-oxo-2<i>H</i>-chromen-7-yl)oxy)methyl)piperidine-1-carboxylate (<b>2b</b>,<b>c</b>)</h4><div class="NLM_p">The appropriate mesylate ester <b>1d</b>,<b>e</b> (8.2 g, 28 mmol) was dissolved in dry DMF (50 mL) followed by the addition of triethylamine (7.8 g, 56 mmol), cesium carbonate (9.1 g, 28 mmol), and 3,4-dimethyl-7-hydroxycoumarin (4.5 g, 28 mmol). After heating at 70 °C for 72 h, the mixture was poured onto crushed ice (500 g). The precipitate was collected and thoroughly washed with water, thus furnishing the desired derivative <b>2b</b>,<b>c</b>.</div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i24" class="anchor-spacer"></div><h5 class="article-section__title" id="_i24"> <i>tert</i>-Butyl 4-{[(3,4-Dimethyl-2-oxo-2<i>H</i>-chromen-7-yl)oxy]methyl}piperidine-1-carboxylate (<b>2b</b>)</h5><div class="NLM_p last">Yield: 85%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 1.24–1.33 (m, 2H), 1.46 (s, 9H), 1.77–1.86 (m, 2H), 1.93–2.03 (m, 1H), 2.18 (s, 3H), 2.37 (s, 3H), 2.75 (t, <i>J</i> = 12.4 Hz, 2H), 3.84–3.86 (m, 2H), 4.16–4.18 (m, 2H), 6.77 (d, <i>J</i> = 2.5 Hz, 1H), 6.83 (dd, <i>J</i><sub>1</sub> = 2.5 Hz, <i>J</i><sub>2</sub> = 8.8 Hz, 1H), 7.49 (d, <i>J</i> = 8.8 Hz, 1H).</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i25" class="anchor-spacer"></div><h5 class="article-section__title" id="_i25"> <i>tert</i>-Butyl 3-{[(3,4-Dimethyl-2-oxo-2<i>H</i>-chromen-7-yl)oxy]methyl}piperidine-1-carboxylate (<b>2c</b>)</h5><div class="NLM_p last">Yield: 89%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.33 (s, 9H), 1.26–1.35 (m, 2H), 1.59–1.66 (m, 1H), 1.71–1.83 (m, 1H), 1.85–1.91 (m, 1H), 2.00 (s, 3H), 2.35 (s, 3H), 2.80–2.95 (m, 2H), 3.88–3.97 (m, 4H), 6.91–6.95 (m, 2H), 7.68 (d, <i>J</i> = 8.8 Hz, 1H).</div></div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> General Procedure for the Synthesis of 3,4-Dimethyl-7-(piperidin-4-yloxy)-2<i>H</i>-chromen-2-one (<b>3a</b>) and 3,4-Dimethyl-7-(piperidin-3- and 4-ylmethoxy)-2<i>H</i>-chromen-2-one (<b>3b</b>,<b>c</b>)</h4><div class="NLM_p">To a solution of <b>2a</b> (7.5 g, 20 mmol) or <b>2b</b>,<b>c</b> (7.7 g, 20 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (40 mL), trifluoroacetic acid (40 mL) was added dropwise while cooling to 0 °C. After 15 min, the reaction mixture was kept to room temperature and left under magnetic stirring for 1 h. The solvents and excess trifluoroacetic acid were removed under reduced pressure. The resulting oil was diluted with ethyl acetate (100 mL) and washed with Na<sub>2</sub>CO<sub>3</sub> (3 × 30 mL). The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated to dryness, thus obtaining the unprotected piperidines as white solids.</div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i27" class="anchor-spacer"></div><h5 class="article-section__title" id="_i27"> 3,4-Dimethyl-7-(piperidin-4-yloxy)-2<i>H</i>-chromen-2-one (<b>3a</b>)</h5><div class="NLM_p last">Yield: 83%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.77–1.84 (m, 2H), 2.06 (s, 3H), 2.08–2.15 (m, 2H), 2.35 (s, 3H), 3.06–3.12 (m, 2H), 3.22–3.31 (m, 2H), 4.73–4.78 (m, 1H), 6.96–6.98 (m, 1H), 7.07–7.08 (m, 1H), 7.68–7.70 (m, 1H), NH not detected.</div></div><div id="sec5_1_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i28" class="anchor-spacer"></div><h5 class="article-section__title" id="_i28"> 3,4-Dimethyl-7-(piperidin-4-ylmethoxy)-2<i>H</i>-chromen-2-one (<b>3b</b>)</h5><div class="NLM_p last">Yield: 89%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.38–1.51 (m, 2H), 1.86–1.95 (m, 2H), 2.03–2.11 (m, 5H), 2.35 (s, 3H), 2.84–2.98 (m, 2H), 3.25–3.34 (m, 2H), 3.95–3.97 (m, 2H), 6.91 (d, <i>J</i> = 2.5 Hz, 1H), 6.94 (dd, <i>J</i><sub>1</sub> = 2.5 Hz, <i>J</i><sub>2</sub> = 8.8 Hz, 1H), 7.68 (d, <i>J</i> = 8.8 Hz, 1H).</div></div><div id="sec5_1_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i29" class="anchor-spacer"></div><h5 class="article-section__title" id="_i29"> 3,4-Dimethyl-7-(piperidin-3-ylmethoxy)-2<i>H</i>-chromen-2-one (<b>3c</b>)</h5><div class="NLM_p last">Yield: 92%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.21–1.38 (m, 2H), 1.58–1.64 (m, 1H), 1.80–1.84 (m, 2H), 2.05 (s, 3H), 2.19 (br s, 1H), 2.34 (s, 3H), 2.73–2.81 (m, 2H), 3.22–3.37 (m, 2H), 3.92–4.05 (m, 2H), 6.91–6.95 (m, 2H), 7.69 (d, <i>J</i> = 8.3 Hz, 1H).</div></div></div><div id="sec5_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> General Procedure for the Synthesis of Final Compounds <b>4a</b>, <b>4i</b>, and <b>5a</b></h4><div class="NLM_p">The appropriate coumarin <b>3a</b>–<b>c</b> (0.50 mmol) was suspended in dry acetone (5 mL) before the addition of potassium carbonate (0.069 g, 0.50 mmol) and methyl iodide (0.031 mL, 0.50 mmol). The mixture was stirred at room temperature for 6 h. The inorganic residue was then filtered off, and the resulting solution was concentrated to dryness under rotary evaporation. The desired products were purified as described below.</div><div id="sec5_1_16" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> 3,4-Dimethyl-7-[(<i>N</i>-methylpiperidin-4-yl)oxy]-2<i>H</i>-chromen-2-one (<b>4a</b>)</h5><div class="NLM_p last">Purification procedure: the crude was treated with THF, and the insoluble residue was filtered off. Evaporation of the solvent under rotary evaporation and crystallization from <i>n</i>-hexane furnished the desired product. Yield: 59%; mp 95–96 °C (<i>n</i>-hexane). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 1.88–1.96 (m, 2H), 2.10–2.15 (m, 2H), 2.18 (s, 3H), 2.37 (s, 3H), 2.38 (s, 3H), 2.40–2.50 (m, 2H), 2.75–2.80 (m, 2H), 4.41 (br s, 1H), 6.80 (d, <i>J</i> = 2.5 Hz, 1H), 6.84 (dd, <i>J</i><sub>1</sub> = 2.5 Hz, <i>J</i><sub>2</sub> = 8.8 Hz, 1H), 7.49 (d, <i>J</i> = 8.8 Hz, 1H). Anal. (C<sub>17</sub>H<sub>21</sub>NO<sub>3</sub>) Calcd %: C, 71.06; H, 7.37; N, 4.87. Found %: C, 71.39; H, 7.23; N, 5.02.</div></div><div id="sec5_1_17" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> 3,4-Dimethyl-7-[(<i>N</i>-methylpiperidin-4-yl)methoxy]-2<i>H</i>-chromen-2-one Hydrochloride (<b>4i</b>)</h5><div class="NLM_p last">Purification procedure: the crude was treated with HCl 1.25 N in ethanol, collecting the precipitate. Yield: 65%; mp > 250 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.57–1.65 (m, 2H), 1.91–1.96 (m, 3H), 2.05 (s, 3H), 2.35 (s, 3H), 2.68 (s, 3H), 2.89–2.99 (m, 2H), 3.36–3.42 (m, 2H), 3.94 (d, <i>J</i> = 6.0 Hz, 2H), 6.91–6.97 (m, 2H), 7.69 (d, <i>J</i> = 9.0 Hz, 1H), 10.40 (br s, 1H, dis. with D<sub>2</sub>O). Anal. (C<sub>18</sub>H<sub>23</sub>NO<sub>3</sub>·HCl) Calcd %: C, 63.99; H, 7.16; N, 4.15. Found %: C, 64.31; H, 7.26; N, 4.20.</div></div><div id="sec5_1_18" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> (±)-3,4-Dimethyl-7-[(<i>N</i>-methylpiperidin-3-yl)methoxy]-2<i>H</i>-chromen-2-one Hydrochloride (<b>5a</b>)</h5><div class="NLM_p last">Purification procedure: the crude was treated with HCl 1.25 N in ethanol, yielding a precipitate that was collected and washed with ethanol. Yield: 60%; mp 150–152 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.19–1.30 (m, 1H), 1.70–1.89 (m, 4H), 2.06 (s, 3H), 2.35 (s, 3H), 2.76 (s, 3H), 3.25–3.54 (m, 4H), 3.89–4.08 (m, 2H), 6.91–6.97 (m, 2H), 7.70 (d, <i>J</i> = 9.0 Hz, 1H), 9.91 (br s, 1H, dis. with D<sub>2</sub>O). Anal. (C<sub>18</sub>H<sub>23</sub>NO<sub>3</sub>·HCl) Calcd %: C, 63.99; H, 7.16; N, 4.15. Found %: C, 63.89; H, 7.21; N, 3.93.</div></div></div><div id="sec5_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> General Procedure for the Synthesis of Final Compounds <b>4b</b>–<b>h</b>, <b>4j</b>–<b>m</b>, and (±)-<b>5b</b>–<b>h</b></h4><div class="NLM_p">A Pyrex vessel was charged with a magnetic stirring and a Weflon bar, and then the appropriate 3,4-dimethyl-7-(piperidin-4-yloxy)-2<i>H</i>-chromen-2-one <b>3a</b>, or 3,4-dimethyl-7-(piperidin-3- and 4-ylmethoxy)-2<i>H</i>-chromen-2-one <b>3b</b>,<b>c</b> derivative (0.50 mmol) and potassium carbonate (1.0 mmol) were suspended in acetone (4.0 mL). The suitable commercially available butyl chloride (0.50 mmol, for <b>4b</b>) or substituted benzyl bromide (0.5 mmol) was added. The reactor was placed in a microwave apparatus and irradiated at 130 °C for 30 min. After cooling to room temperature, the solid residue was filtered off after thorough washing with CH<sub>2</sub>Cl<sub>2</sub>. The solution was concentrated to dryness, and the resulting crude was purified as detailed below. Compounds <b>4j</b>–<b>m</b>, (±)-<b>5b</b>–<b>h</b>, <b>7a</b>,<b>b</b> were obtained as hydrochloride salts as described below.</div><div id="sec5_1_20" class="NLM_sec NLM_sec_level_4"><div id="ac_i35" class="anchor-spacer"></div><h5 class="article-section__title" id="_i35"> 3,4-Dimethyl-7-[(<i>N</i>-butylpiperidin-4-yl)oxy]-2<i>H</i>-chromen-2-one (<b>4b</b>)</h5><div class="NLM_p last">Isolation procedure: column chromatography (eluent: methanol in chloroform 5%) followed by crystallization from hot ethanol. Yield: 55%; mp 86–87 °C (ethanol). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 0.98 (t, <i>J</i> = 7.3 Hz, 3H), 1.39–1.46 (m, 2H), 1.91–1.98 (m, 2H), 2.18–2.23 (m, 2H), 2.20 (s, 3H), 2.38 (s, 3H), 2.76–2.83 (m, 2H), 2.93–3.04 (m, 2H), 3.06–3.12 (m, 2H), 3.42–3.46 (m, 2H), 4.76–4.79 (m, 1H), 6.81–6.85 (m, 2H), 7.54 (d, <i>J</i> = 8.5 Hz, 1H). Anal. (C<sub>20</sub>H<sub>27</sub>NO<sub>3</sub>) Calcd %: C, 72.92; H, 8.26; N, 4.25. Found %: C, 73.34; H, 8.10; N, 3.97.</div></div><div id="sec5_1_21" class="NLM_sec NLM_sec_level_4"><div id="ac_i36" class="anchor-spacer"></div><h5 class="article-section__title" id="_i36"> 3,4-Dimethyl-7-[(<i>N</i>-benzylpiperidin-4-yl)oxy]-2<i>H</i>-chromen-2-one (<b>4c</b>)</h5><div class="NLM_p last">Isolation procedure: crystallization from hot ethanol. Yield: 82%; mp 111–112 °C (ethanol). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 1.89–2.07 (m, 4H), 2.19 (s, 3H), 2.32–2.38 (m, 5H), 2.77–2.85 (m, 2H), 3.51–3.57 (m, 2H), 4.37–4.45 (m, 1H), 6.77–6.90 (m, 2H), 7.24–7.34 (m, 5H), 7.49 (d, <i>J</i> = 8.5 Hz, 1H). Anal. (C<sub>23</sub>H<sub>25</sub>NO<sub>3</sub>) Calcd %: C, 76.00; H, 6.93; N, 3.85. Found %: C, 76.01; H, 6.89; N, 4.01.</div></div><div id="sec5_1_22" class="NLM_sec NLM_sec_level_4"><div id="ac_i37" class="anchor-spacer"></div><h5 class="article-section__title" id="_i37"> 3,4-Dimethyl-7-[(<i>N</i>-(3-chlorobenzyl)piperidin-4-yl)oxy]-2<i>H</i>-chromen-2-one (<b>4d</b>)</h5><div class="NLM_p last">Isolation procedure: crystallization from hot ethanol. Yield: 84%; mp 106–107 °C (ethanol). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 1.83–1.91 (m, 2H), 2.02–2.07 (m, 2H), 2.18 (s, 3H), 2.34–2.40 (m, 5H), 2.70–2.77 (m, 2H), 3.51–3.56 (m, 2H), 4.37–4.43 (m, 1H), 6.80 (d, <i>J</i> = 2.5 Hz, 1H), 6.83 (dd, <i>J</i><sub>1</sub> = 2.5 Hz, <i>J</i><sub>2</sub> = 8.5 Hz, 1H), 7.23–7.29 (m, 3H), 7.37 (s, 1H), 7.49 (d, <i>J</i> = 8.5 Hz, 1H). Anal. (C<sub>23</sub>H<sub>24</sub>ClNO<sub>3</sub>) Calcd %: C, 69.43; H, 6.08; N, 3.52. Found %: C, 69.70; H, 6.06; N, 3.56.</div></div><div id="sec5_1_23" class="NLM_sec NLM_sec_level_4"><div id="ac_i38" class="anchor-spacer"></div><h5 class="article-section__title" id="_i38"> 3,4-Dimethyl-7-[(<i>N</i>-(4-chlorobenzyl)piperidin-4-yl)oxy]-2<i>H</i>-chromen-2-one (<b>4e</b>)</h5><div class="NLM_p last">Isolation procedure: crystallization from hot ethanol. Yield: 87%; mp 140–141 °C (ethanol). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 1.83–1.89 (m, 2H), 1.98–2.05 (m, 2H), 2.18 (s, 3H), 2.27–2.33 (m, 2H), 2.36 (s, 3H), 2.70–2.77 (m, 2H), 3.52 (s, 2H), 4.36–4.41 (m, 1H), 6.79 (d, <i>J</i> = 2.5 Hz, 1H), 6.83 (dd, <i>J</i><sub>1</sub> = 2.5 Hz, <i>J</i><sub>2</sub> = 8.5 Hz, 1H), 7.28–7.33 (m, 4H), 7.48 (d, <i>J</i> = 8.5 Hz, 1H). Anal. (C<sub>23</sub>H<sub>24</sub>ClNO<sub>3</sub>) Calcd %: C, 69.43; H, 6.08; N, 3.52. Found %: C, 69.43; H, 6.13; N, 3.85.</div></div><div id="sec5_1_24" class="NLM_sec NLM_sec_level_4"><div id="ac_i39" class="anchor-spacer"></div><h5 class="article-section__title" id="_i39"> 4-[(4-((3,4-Dimethyl-2<i>H</i>-2-oxochromen-7-yl)oxy)piperidin-1-yl)methyl]benzonitrile (<b>4f</b>)</h5><div class="NLM_p last">Isolation procedure: crystallization from hot ethanol. Yield: 71%; mp 120–121 °C (ethanol). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 1.79–2.00 (m, 4H), 2.18 (s, 3H), 2.35–2.38 (m, 5H), 2.78–2.82 (m, 2H), 3.50–3.56 (m, 2H), 4.41 (s, 1H), 6.79 (d, <i>J</i> = 2.5 Hz, 1H), 6.82 (dd, <i>J</i><sub>1</sub> = 2.5 Hz, <i>J</i><sub>2</sub> = 8.8 Hz, 1H), 7.15–7.33 (m, 4H), 7.49 (d, <i>J</i> = 8.8 Hz, 1H). Anal. (C<sub>24</sub>H<sub>24</sub>N<sub>2</sub>O<sub>3</sub>) Calcd %: C, 74.21; H, 6.23; N, 7.21. Found %: C, 74.74; H, 6.19; N, 7.21.</div></div><div id="sec5_1_25" class="NLM_sec NLM_sec_level_4"><div id="ac_i40" class="anchor-spacer"></div><h5 class="article-section__title" id="_i40"> 3,4-Dimethyl-7-[(<i>N</i>-(2-phenylethyl)piperidin-4-yl)oxy]-2<i>H</i>-chromen-2-one (<b>4g</b>)</h5><div class="NLM_p last">Isolation procedure: crystallization from hot ethanol. Yield: 87%; mp 107–108 °C (ethanol). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 1.93–2.01 (m, 2H), 2.17–2.20 (m, 4H), 2.35–2.39 (m, 4H), 2.72–2.95 (m, 8H), 4.45–4.51 (m, 1H), 6.81 (d, <i>J</i> = 2.5 Hz, 1H), 6.84 (dd, <i>J</i><sub>1</sub> = 2.5 Hz, <i>J</i><sub>2</sub> = 8.5 Hz, 1H), 7.22–7.33 (m, 5H), 7.50 (d, <i>J</i> = 8.5 Hz, 1H). Anal. (C<sub>24</sub>H<sub>27</sub>NO<sub>3</sub>) Calcd %: C, 76.36; H, 7.21; N, 3.71. Found %: C, 76.53; H, 7.14; N, 3.97.</div></div><div id="sec5_1_26" class="NLM_sec NLM_sec_level_4"><div id="ac_i41" class="anchor-spacer"></div><h5 class="article-section__title" id="_i41"> 3,4-Dimethyl-7-[(<i>N</i>-(2-phenyl-2-oxoethyl)piperidin-4-yl)oxy]-2<i>H</i>-chromen-2-one (<b>4h</b>)</h5><div class="NLM_p last">Isolation procedure: crystallization from hot ethanol. Yield: 90%; mp 94–96 °C (dec) from ethanol. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 1.63–1.72 (m, 2H), 2.05–2.16 (m, 2H), 2.19 (s, 3H), 2.34–2.41 (m, 5H), 2.96–3.02 (m, 2H), 4.19–4.27 (m, 2H), 4.57–4.63 (m, 1H), 6.85 (d, <i>J</i> = 2.5 Hz, 1H), 6.89 (dd, <i>J</i><sub>1</sub> = 2.5 Hz, <i>J</i><sub>2</sub> = 8.8 Hz, 1H), 7.51 (t, <i>J</i> = 7.1 Hz, 2H), 7.52 (d, <i>J</i> = 8.8 Hz, 1H), 7.64 (t, <i>J</i> = 7.1 Hz, 1H), 7.98 (d, <i>J</i> = 7.1 Hz, 2H). Anal. (C<sub>24</sub>H<sub>25</sub>NO<sub>4</sub>) Calcd %: C, 73.64; H, 6.44; N, 3.58. Found %: C, 74.15; H, 6.38; N, 3.85.</div></div><div id="sec5_1_27" class="NLM_sec NLM_sec_level_4"><div id="ac_i42" class="anchor-spacer"></div><h5 class="article-section__title" id="_i42"> 3,4-Dimethyl-7-[(<i>N</i>-benzylpiperidin-4-yl)methoxy]-2<i>H</i>-chromen-2-one Hydrochloride (<b>4j</b>)</h5><div class="NLM_p last">Isolation procedure: column chromatography (eluent: ethyl acetate in chloroform 50%). The compound was transformed into the corresponding hydrochloride salt by dissolving the solid free base in the minimum volume of 1,4-dioxane before adding HCl 4.0 N in 1,4-dioxane. The resulting precipitate was collected by filtration and washed with dry dioxane, yielding <b>4j</b>. Yield: 60%; mp 215–216 °C (dec). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.87–1.95 (m, 2H), 2.06 (s, 3H), 2.22–2.29 (m, 3H), 2.35 (s, 3H), 2.79–2.84 (m, 2H), 3.13–3.20 (m, 2H), 3.91–4.03 (m, 2H), 4.31–4.35 (m, 2H), 6.88–6.96 (m, 2H), 7.46–7.58 (m, 5H), 7.69 (d, <i>J</i> = 9.1 Hz, 1H), 9.68 (s, 1H, dis. with D<sub>2</sub>O). Anal. (C<sub>24</sub>H<sub>27</sub>NO<sub>3</sub>·HCl) Calcd %: C, 69.64; H, 6.82; N, 3.38. Found %: C, 70.09; H, 6.55; N, 3.40.</div></div><div id="sec5_1_28" class="NLM_sec NLM_sec_level_4"><div id="ac_i43" class="anchor-spacer"></div><h5 class="article-section__title" id="_i43"> 3,4-Dimethyl-7-[(<i>N</i>-(3-chlorobenzyl)piperidin-4-yl)methoxy]-2<i>H</i>-chromen-2-one Hydrochloride (<b>4k</b>)</h5><div class="NLM_p last">Isolation procedure: the crude was suspended in 1,4-dioxane and the insoluble residue discarded. HCl 4.0 N in 1,4-dioxane was added to the solution, yielding a white precipitate that was filtered and crystallized from hot ethanol. Yield: 99%; mp 246–248 °C (ethanol). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.55–1.66 (m, 2H), 1.90–1.97 (m, 3H), 2.06 (s, 3H), 2.35 (s, 3H), 2.89–3.00 (m, 2H), 3.35–3.42 (m, 2H), 3.94 (d, <i>J</i> = 6.0 Hz, 2H), 4.26–4.30 (m, 2H), 6.91 (dd, <i>J</i><sub>1</sub> = 2.5 Hz, <i>J</i><sub>2</sub> = 8.8 Hz, 1H), 6.95 (d, <i>J</i> = 2.5 Hz, 1H), 7.48–7.55 (m, 3H), 7.66–7.71 (m, 2H), 10.16 (s, 1H, dis. with D<sub>2</sub>O). Anal. (C<sub>24</sub>H<sub>26</sub>ClNO<sub>3</sub>·HCl) Calcd %: C, 64.29; H, 6.07; N, 3.12. Found %: C, 64.68; H, 5.88; N, 2.83.</div></div><div id="sec5_1_29" class="NLM_sec NLM_sec_level_4"><div id="ac_i44" class="anchor-spacer"></div><h5 class="article-section__title" id="_i44"> 3,4-Dimethyl-7-[(<i>N</i>-(4-chlorobenzyl)piperidin-4-yl)methoxy]-2<i>H</i>-chromen-2-one Hydrochloride (<b>4l</b>)</h5><div class="NLM_p last">Isolation procedure: the crude was suspended in 1,4-dioxane and the insoluble residue was discarded after filtration. HCl 4.0 N in 1,4-dioxane was added to the solution, yielding a white precipitate that was filtered and crystallized from hot ethanol. Yield: 77%; mp > 250 °C (ethanol). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.57–1.65 (m, 2H), 1.92–1.97 (m, 3H), 2.05 (s, 3H), 2.35 (s, 3H), 2.91–2.99 (m, 2H), 3.38–3.45 (m, 2H), 3.94 (d, <i>J</i> = 6.0 Hz, 2H), 4.25–4.28 (m, 2H), 6.91 (dd, <i>J</i><sub>1</sub> = 2.5 Hz, <i>J</i><sub>2</sub> = 8.5 Hz, 1H), 6.95 (d, <i>J</i> = 2.5 Hz, 1H), 7.53 (d, <i>J</i> = 8.8 Hz, 2H), 7.58 (d, <i>J</i> = 8.8 Hz, 2H), 7.67 (d, <i>J</i> = 8.5 Hz, 1H), 10.12 (s, 1H, dis. with D<sub>2</sub>O). Anal. (C<sub>24</sub>H<sub>26</sub>ClNO<sub>3</sub>·HCl) Calcd %: C, 64.29; H, 6.07; N, 3.12. Found %: C, 64.70; H, 6.00; N, 3.05.</div></div><div id="sec5_1_30" class="NLM_sec NLM_sec_level_4"><div id="ac_i45" class="anchor-spacer"></div><h5 class="article-section__title" id="_i45"> 4-[(4-((3,4-Dimethyl-2<i>H</i>-2-oxochromen-7-yl)oxymethyl)piperidin-1-yl)methyl]benzonitrile Hydrochloride (<b>4m</b>)</h5><div class="NLM_p last">Isolation procedure: the crude was suspended in 1,4-dioxane and the insoluble residue was filtered off. HCl 4.0 N in 1,4-dioxane was added to the solution, yielding a white precipitate that was filtered and crystallized from hot ethanol. Yield: 93%; mp > 250 °C (ethanol). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.64–1.79 (m, 2H), 1.88–1.97 (m, 3H), 2.05 (s, 3H), 2.34 (s, 3H), 2.94 (q, <i>J</i> = 12.0 Hz, 2H), 3.36–3.43 (m, 2H), 3.93 (d, <i>J</i> = 6.3 Hz, 2H), 4.32–4.37 (m, 2H), 6.90–6.99 (m, 2H), 7.68 (d, <i>J</i> = 8.5 Hz, 1H), 7.86 (d, <i>J</i> = 8.4 Hz, 2H), 7.94 (d, <i>J</i> = 8.4 Hz, 2H), 11.17 (s, 1H, dis. with D<sub>2</sub>O). Anal. (C<sub>25</sub>H<sub>26</sub>N<sub>2</sub>O<sub>3</sub>·HCl) Calcd %: C, 68.41; H, 6.20; N, 6.38. Found %: C, 68.86; H, 6.03; N, 6.17.</div></div><div id="sec5_1_31" class="NLM_sec NLM_sec_level_4"><div id="ac_i46" class="anchor-spacer"></div><h5 class="article-section__title" id="_i46"> (±)-3,4-Dimethyl-7-[(<i>N</i>-benzylpiperidin-3-yl)methoxy]-2<i>H</i>-chromen-2-one Hydrochloride (<b>5b</b>)</h5><div class="NLM_p last">Isolation procedure: column chromatography (eluent: ethyl acetate in chloroform 50%). The compound was transformed into the corresponding hydrochloride salt by dissolving the solid free base in the minimum volume of 1,4-dioxane before adding HCl 4.0 N in 1,4-dioxane. The resulting precipitate was collected by filtration and washed with dry dioxane, yielding <b>5b</b>. Yield: 62%; mp 215–216 °C (dec). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.20–1.34 (m, 1H), 1.60–1.75 (m, 1H), 1.77–1.90 (m, 2H), 2.06 (s, 3H), 2.20–2.27 (m, 1H), 2.35 (s, 3H), 2.72–2.86 (m, 2H), 3.30–3.49 (m, 2H), 3.90–4.07 (m, 2H), 4.28–4.33 (m, 2H), 6.90 (dd, <i>J</i><sub>1</sub> = 2.5 Hz, <i>J</i><sub>2</sub> = 8.8 Hz, 1H), 6.93 (d, <i>J</i> = 2.5 Hz, 1H), 7.42–7.57 (m, 5H), 7.69 (d, <i>J</i> = 8.8 Hz, 1H), 10.12 (br s, 1H, dis. with D<sub>2</sub>O). Anal. (C<sub>24</sub>H<sub>27</sub>NO<sub>3</sub>·HCl) Calcd %: C, 69.64; H, 6.82; N, 3.38. Found %: C, 69.90; H, 6.81; N, 3.56.</div></div><div id="sec5_1_32" class="NLM_sec NLM_sec_level_4"><div id="ac_i47" class="anchor-spacer"></div><h5 class="article-section__title" id="_i47"> (+)-3,4-Dimethyl-7-[(<i>N</i>-benzylpiperidin-3-yl)methoxy]-2<i>H</i>-chromen-2-one (<b>5b</b>)</h5><div class="NLM_p last">HPLC purification of (±)-<b>5b</b> on a CHIRALPAK IA, mobile phase, A = methanol, B = acetonitrile; isocratic elution, 20% B; flow rate = 1 mL/min; λ = 320 nm; 100 μL injection; <i>k</i><sub>2</sub>. Melting point: 117–119 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.09–1.15 (m, 1H), 1.43–1.51 (m, 1H), 1.61–1.66 (m, 1H), 1.71–1.75 (m, 1H), 1.86–2.02 (m, 3H), 2.05 (s, 3H), 2.34 (s, 3H), 2.62–2.67 (m, 1H), 2.81–2.85 (m, 1H), 3.41 (d, <i>J</i> = 13.7 Hz, 1H), 3.47 (d, <i>J</i> = 13.7 Hz, 1H), 3.92 (d, <i>J</i> = 6.4 Hz, 2H), 6.87–6.90 (m, 2H), 7.19–7.23 (m, 1H), 7.25–7.30 (m, 4H), 7.65 (d, <i>J</i> = 8.8 Hz, 1H). [α]<sup>20</sup><sub>D</sub> = +18.5° (<i>c</i> 0.13, MeOH). Anal. (C<sub>24</sub>H<sub>27</sub>NO<sub>3</sub>) Calcd %: C, 76.36; H, 7.21; N, 3.71. Found %: C, 76.50; H, 7.05; N, 3.46.</div></div><div id="sec5_1_33" class="NLM_sec NLM_sec_level_4"><div id="ac_i48" class="anchor-spacer"></div><h5 class="article-section__title" id="_i48"> (−)-3,4-Dimethyl-7-[(<i>N</i>-benzylpiperidin-3-yl)methoxy]-2<i>H</i>-chromen-2-one (<b>5b</b>)</h5><div class="NLM_p last">HPLC purification of (±)-<b>5b</b> on a CHIRALPAK IA, mobile phase, A = methanol, B = acetonitrile; isocratic elution, 20% B; flow rate = 1 mL/min; λ = 320 nm; 100 μL injection; <i>k</i><sub>1</sub>. Melting point: 117–119 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.07–1.14 (m, 1H), 1.42–1.51 (m, 1H), 1.61–1.66 (m, 1H), 1.70–1.78 (m, 1H), 1.84–2.02 (m, 3H), 2.05 (s, 3H), 2.34 (s, 3H), 2.62–2.67 (m, 1H), 2.81–2.85 (m, 1H), 3.42 (d, <i>J</i> = 13.7 Hz, 1H), 3.47 (d, <i>J</i> = 13.7 Hz, 1H), 3.91 (d, <i>J</i> = 6.4 Hz, 2H), 6.87–6.90 (m, 2H), 7.18–7.23 (m, 1H), 7.26–7.30 (m, 4H), 7.64 (d, <i>J</i> = 8.8 Hz, 1H). [α]<sup>20</sup><sub>D</sub> = −18.5° (<i>c</i> 0.13, MeOH). Anal. (C<sub>24</sub>H<sub>27</sub>NO<sub>3</sub>) Calcd %: C, 76.36; H, 7.21; N, 3.71. Found %: C, 76.80; H, 6.91; N, 3.55.</div></div><div id="sec5_1_34" class="NLM_sec NLM_sec_level_4"><div id="ac_i49" class="anchor-spacer"></div><h5 class="article-section__title" id="_i49"> (±)-3,4-Dimethyl-7-[(<i>N</i>-(3-chlorobenzyl)piperidin-3-yl)methoxy]-2<i>H</i>-chromen-2-one Hydrochloride (<b>5c</b>)</h5><div class="NLM_p last">Isolation procedure: the crude was suspended in 1,4-dioxane and the insoluble residue was filtered off. HCl 4.0 N in 1,4-dioxane was added to the solution, yielding a white precipitate that was filtered and crystallized from hot ethanol. Yield: 98%; mp 246–248 °C (dec) from ethanol. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.21–1.35 (m, 1H), 1.77–1.85 (m, 3H), 2.05 (s, 3H), 2.34 (s, 3H), 2.36–2.43 (m, 1H), 2.81 (qn, <i>J</i> = 11.5 Hz, 2H), 3.37–3.48 (m, 2H), 3.94–4.06 (m, 2H), 4.32 (br s, 2H), 6.85–6.93 (m, 2H), 7.45–7.54 (m, 3H), 7.45–7.70 (m, 2H), 10.30 (br s, 1H, dis. with D<sub>2</sub>O). Anal. (C<sub>24</sub>H<sub>26</sub>ClNO<sub>3</sub>·HCl) Calcd %: C, 64.29; H, 6.07; N, 3.12. Found %: C, 63.82; H, 5.85; N, 2.93.</div></div><div id="sec5_1_35" class="NLM_sec NLM_sec_level_4"><div id="ac_i50" class="anchor-spacer"></div><h5 class="article-section__title" id="_i50"> (±)-7-{[1-(3-Bromobenzyl)piperidin-3-yl]methoxy}-3,4-dimethyl-2<i>H</i>-chromen-2-one Hydrochloride (<b>5d</b>)</h5><div class="NLM_p last">Isolation procedure: flash chromatography (gradient eluent: ethyl acetate in <i>n</i>-hexane 20% → 80%). The compound was transformed into the corresponding hydrochloride salt by dissolving the solid free base in the minimum volume of 1,4-dioxane before adding HCl 4.0 N in 1,4-dioxane. The resulting precipitate was collected by filtration and washed with dry dioxane, yielding racemic <b>5d</b>. Yield: 87%; mp 231–232 °C. <sup>1</sup>H NMR (free base, 300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.05–1.18 (m, 1H), 1.46–1.53 (m, 1H), 1.62–1.75 (m, 2H), 1.89–1.97 (m, 3H), 2.05 (s, 3H), 2.34 (s, 3H), 2.61–2.65 (m, 1H), 2.79–2.82 (m, 1H), 3.39–3.51 (m, 2H), 3.94 (d, <i>J</i> = 6.1 Hz, 2H), 6.86–6.89 (m, 2H), 7.21–7.29 (m, 2H), 7.40–7.45 (m, 2H), 7.65 (d, <i>J</i> = 9.6 Hz, 1H). Anal. (C<sub>24</sub>H<sub>26</sub>BrNO<sub>3</sub>·HCl) Calcd %: C, 58.49; H, 5.52; N, 2.84. Found %: C, 58.14; H, 5.48; N, 2.98.</div></div><div id="sec5_1_36" class="NLM_sec NLM_sec_level_4"><div id="ac_i51" class="anchor-spacer"></div><h5 class="article-section__title" id="_i51"> (+)-7-{[1-(3-Bromobenzyl)piperidin-3-yl]methoxy}-3,4-dimethyl-2<i>H</i>-chromen-2-one (<b>5d</b>)</h5><div class="NLM_p last">HPLC purification of (±)-<b>5d</b> on a CHIRALPAK IA, mobile phase, A = methanol, B = acetonitrile; isocratic elution, 30% B; flow rate = 1 mL/min; λ = 320 nm; 100 μL injection; <i>k</i><sub>2</sub>. Melting point: 119–120 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.03–1.18 (m, 1H), 1.46–1.53 (m, 1H), 1.64–1.75 (m, 2H), 1.87–1.97 (m, 3H), 2.05 (s, 3H), 2.34 (s, 3H), 2.60–2.65 (m, 1H), 2.79–2.82 (m, 1H), 3.39–3.51 (m, 2H), 3.93 (d, <i>J</i> = 6.1 Hz, 2H), 6.86–6.89 (m, 2H), 7.22–7.29 (m, 2H), 7.40–7.45 (m, 2H), 7.65 (d, <i>J</i> = 9.6 Hz, 1H). [α]<sup>20</sup><sub>D</sub> = +33.5° (<i>c</i> 0.08, MeOH). Anal. (C<sub>24</sub>H<sub>26</sub>BrNO<sub>3</sub>) Calcd %: C, 63.16; H, 5.74; N, 3.07. Found %: C, 63.50; H, 5.58; N, 3.00.</div></div><div id="sec5_1_37" class="NLM_sec NLM_sec_level_4"><div id="ac_i52" class="anchor-spacer"></div><h5 class="article-section__title" id="_i52"> (−)-7-{[1-(3-Bromobenzyl)piperidin-3-yl]methoxy}-3,4-dimethyl-2<i>H</i>-chromen-2-one (<b>5d</b>)</h5><div class="NLM_p last">HPLC purification of (±)-<b>5d</b> on a CHIRALPAK IA, mobile phase, A = methanol, B = acetonitrile; isocratic elution, 30% B; flow rate = 1 mL/min; λ = 320 nm; 100 μL injection; <i>k</i><sub>1</sub>. Melting point: 119–120 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.05–1.18 (m, 1H), 1.46–1.53 (m, 1H), 1.62–1.75 (m, 2H), 1.89–1.97 (m, 3H), 2.07 (s, 3H), 2.33 (s, 3H), 2.61–2.67 (m, 1H), 2.80–2.84 (m, 1H), 3.36–3.51 (m, 2H), 3.94 (d, <i>J</i> = 6.1 Hz, 2H), 6.86–6.89 (m, 2H), 7.21–7.29 (m, 2H), 7.44–7.49 (m, 2H), 7.64 (d, <i>J</i> = 9.6 Hz, 1H). [α]<sup>20</sup><sub>D</sub> = −33.5° (<i>c</i> 0.08, MeOH). Anal. (C<sub>24</sub>H<sub>26</sub>BrNO<sub>3</sub>) Calcd %: C, 63.16; H, 5.74; N, 3.07. Found %: C, 63.49; H, 5.36; N, 2.96.</div></div><div id="sec5_1_38" class="NLM_sec NLM_sec_level_4"><div id="ac_i53" class="anchor-spacer"></div><h5 class="article-section__title" id="_i53"> (±)-3,4-Dimethyl-7-[(<i>N</i>-(4-fluorobenzyl)piperidin-3-yl)methoxy]-2<i>H-</i>chromen-2-one Hydrochloride (<b>5e</b>)</h5><div class="NLM_p last">Isolation procedure: the crude was suspended in 1,4-dioxane and the insoluble residue was filtered off. HCl 4.0 N in 1,4-dioxane was added to the solution, yielding a white precipitate that was filtered and crystallized from hot ethanol. Yield: 98%; mp 228–230 °C (dec). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.18–1.33 (m, 1H), 1.77–1.88 (m, 3H), 2.05 (s, 3H), 2.34 (s, 3H), 2.36–2.41 (m, 1H), 2.78 (qn, <i>J</i> = 9.9 Hz, 2H), 3.40–3.46 (m, 2H), 3.90–4.05 (m, 2H), 4.27–4.32 (m, 2H), 6.89 (dd, <i>J</i><sub>1</sub> = 8.8 Hz, <i>J</i><sub>2</sub> = 2.5 Hz, 1H), 6.93 (d, <i>J</i> = 2.5 Hz, 1H), 7.26–7.32 (m, 2H), 7.59–7.64 (m, 2H), 7.68 (d, <i>J</i> = 8.8 Hz, 1H), 10.34 (br s, 1H, dis. with D<sub>2</sub>O). Anal. (C<sub>24</sub>H<sub>26</sub>FNO<sub>3</sub>·HCl) Calcd %: C, 66.74; H, 6.30; N, 3.24. Found %: C, 66.34; H, 6.22; N, 3.17.</div></div><div id="sec5_1_39" class="NLM_sec NLM_sec_level_4"><div id="ac_i54" class="anchor-spacer"></div><h5 class="article-section__title" id="_i54"> (±)-3,4-Dimethyl-7-[(<i>N</i>-(4-chlorobenzyl)piperidin-3-yl)methoxy]-2<i>H</i>-chromen-2-one Hydrochloride (<b>5f</b>)</h5><div class="NLM_p last">Isolation procedure: the crude was suspended in 1,4-dioxane and the insoluble residue was filtered off. HCl 4.0 N in 1,4-dioxane was added to the solution, yielding a white precipitate that was filtered and crystallized from hot ethanol. Yield: 91%; mp 219–221 °C (dec) from ethanol. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.18–1.34 (m, 1H), 1.76–1.88 (m, 3H), 2.05 (s, 3H), 2.35 (s, 3H), 2.36–2.41 (m, 1H), 2.71–2.86 (m, 2H), 3.39–3.46 (m, 2H), 3.90–4.05 (m, 2H), 4.29–4.31 (m, 2H), 6.88 (d, <i>J</i> = 2.5 Hz, 1H), 6.93 (dd, <i>J</i><sub>1</sub> = 2.5 Hz, <i>J</i><sub>2</sub> = 8.8 Hz, 1H), 7.53 (d, <i>J</i> = 8.5 Hz, 2H), 7.59 (d, <i>J</i> = 8.5 Hz, 2H), 7.68 (d, <i>J</i> = 8.8 Hz, 1H), 10.37 (br s, 1H, dis. with D<sub>2</sub>O). Anal. (C<sub>24</sub>H<sub>26</sub>ClNO<sub>3</sub>·HCl) Calcd %: C, 64.29; H, 6.07; N, 3.12. Found %: C, 63.86; H, 5.97; N, 3.09.</div></div><div id="sec5_1_40" class="NLM_sec NLM_sec_level_4"><div id="ac_i55" class="anchor-spacer"></div><h5 class="article-section__title" id="_i55"> (±)-3,4-Dimethyl-7-[(<i>N</i>-(4-(methylsulfonyl)benzyl)piperidin-3-yl)methoxy]-2<i>H-</i>chromen-2-one Hydrochloride (<b>5g</b>)</h5><div class="NLM_p last">Isolation procedure: the crude was suspended in 1,4-dioxane and the insoluble residue was filtered off. HCl 4.0 N in 1,4-dioxane was added to the solution, yielding a white precipitate that was filtered and crystallized from hot ethanol. Yield: 99%; mp 172–174 °C (ethanol). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.20–1.36 (m, 1H), 1.80–1.87 (m, 3H), 2.05 (s, 3H), 2.34 (s, 3H), 2.40–2.46 (m, 1H), 2.76–2.87 (m, 2H), 3.24 (s, 3H), 3.28–3.48 (m, 2H), 3.91–4.03 (m, 2H), 4.40–4.45 (m, 2H), 6.89 (dd, <i>J</i><sub>1</sub> = 2.5 Hz, <i>J</i><sub>2</sub> = 8.8 Hz, 1H), 6.93 (d, <i>J</i> = 2.5 Hz, 1H), 7.68 (d, <i>J</i> = 8.8 Hz, 1H), 7.89 (d, <i>J</i> = 8.7 Hz, 2H), 8.00 (d, <i>J</i> = 8.7 Hz, 2H), 10.91 (br s, 1H, dis. with D<sub>2</sub>O). Anal. (C<sub>25</sub>H<sub>29</sub>NO<sub>5</sub>S·HCl) Calcd %: C, 61.03; H, 6.15; N, 2.85. Found %: C, 60.65; H, 5.84; N, 2.91.</div></div><div id="sec5_1_41" class="NLM_sec NLM_sec_level_4"><div id="ac_i56" class="anchor-spacer"></div><h5 class="article-section__title" id="_i56"> (±)-4-[(3-((3,4-Dimethyl-2<i>H</i>-2-oxochromen-7-yl)oxymethyl)piperidin-1-yl)methyl]benzonitrile Hydrochloride (<b>5h</b>)</h5><div class="NLM_p last">Isolation procedure: the crude was suspended in 1,4-dioxane and the insoluble residue was filtered off. HCl 4.0 N in 1,4-dioxane was added to the solution, yielding a white precipitate that was filtered and crystallized from hot ethanol. Yield: 76%; mp 220–222 °C (ethanol). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.26–1.30 (m, 1H), 1.80–1.85 (m, 3H), 2.06 (s, 3H), 2.35 (s, 3H), 2.39–2.43 (m, 1H), 2.76–2.87 (m, 2H), 3.30–3.31 (m, 1H), 3.44–3.48 (m, 1H), 3.91–4.05 (m, 2H), 4.37–4.44 (m, 2H), 6.88–6.94 (m, 2H), 7.69 (d, <i>J</i> = 8.7 Hz, 1H), 7.77 (d, <i>J</i> = 7.8 Hz, 2H), 7.95 (d, <i>J</i> = 7.8 Hz, 2H), 10.30 (br s, 1H, dis. with D<sub>2</sub>O). Anal. (C<sub>25</sub>H<sub>26</sub>N<sub>2</sub>O<sub>3</sub>·HCl) Calcd %: C, 68.41; H, 6.20; N, 6.38. Found %: C, 68.77; H, 6.05; N, 6.17.</div></div><div id="sec5_1_42" class="NLM_sec NLM_sec_level_4"><div id="ac_i57" class="anchor-spacer"></div><h5 class="article-section__title" id="_i57"> (±)-7-((1-(3,4-Dimethoxybenzyl)piperidin-3-yl)methoxy)-3,4-dimethyl-2<i>H</i>-chromen-2-one (<b>5i</b>)</h5><div class="NLM_p last">3,4-Dimethyl-7-(piperidin-3-ylmethoxy)-2<i>H</i>-chromen-2-one (0.12 g, 0.40 mmol) was dissolved under magnetic stirring with 1.3 mL of 1,2-dichloroethane in a flame-dried round-bottomed flask. 3,4-Dimethoxybenzaldehyde (0.66 g, 0.40 mmol) and sodium triacetoxyborohydride (0.12 g, 0.56 mmol) were added, and the reaction mixture was left under magnetic stirring at room temperature and under nitrogen atmosphere overnight. After the removal of the solvent, the solid crude was purified through flash chromatography (gradient eluent: methanol in CH<sub>2</sub>Cl<sub>2</sub> 0% → 10%). Yield: 45%; mp 62–64 °C (dec). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.16–1.18 (m, 1H), 1.42–1.51 (m, 1H), 1.59–1.64 (m, 1H), 1.69–1.77 (m, 1H), 1.83–1.99 (m, 3H), 2.05 (s, 3H), 2.34 (s, 3H), 2.60–2.67 (m, 1H), 2.77–2.83 (m, 1H), 3.31 (d, <i>J</i> = 13.5 Hz, 1H), 3.40 (d, <i>J</i> = 13.5 Hz, 1H), 3.67 (s, 3H), 3.70 (s, 3H), 3.92–3.94 (m, 2H), 6.74–6.77 (m, 1H), 6.82–6.84 (m, 2H), 6.86–6.90 (m, 2H), 7.65 (d, <i>J</i> = 8.5 Hz, 1H). Anal. (C<sub>26</sub>H<sub>31</sub>NO<sub>5</sub>) Calcd %: C, 71.37; H, 7.14; N, 3.20. Found %: C, 71.56; H, 7.10; N, 3.09.</div></div></div><div id="sec5_1_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> General Procedure for the Synthesis of 7-(4- and 3-Bromoalkyloxy)-3,4-dimethyl-2<i>H</i>-chromen-2-one <b>6a</b>,<b>b</b></h4><div class="NLM_p">A Pyrex vessel was charged with a magnetic stirring and Weflon bar and then 7-hydroxy-3,4-dimethyl-2<i>H</i>-chromen-2-one (0.57 g, 3.0 mmol) and anhydrous potassium carbonate (0.83 g, 6.0 mmol) were suspended in acetone (10 mL). The suitable commercially available dibromoalkyl derivative (15 mmol) was added. The reactor was placed in a microwave apparatus and irradiated at 130 °C for 30 min. After cooling to room temperature, the solid residue was filtered and washed with CH<sub>2</sub>Cl<sub>2</sub>. The solution was concentrated to dryness, and the resulting crude was purified through flash chromatography (gradient eluent as indicated below).</div><div id="sec5_1_44" class="NLM_sec NLM_sec_level_4"><div id="ac_i59" class="anchor-spacer"></div><h5 class="article-section__title" id="_i59"> 7-(3-Bromopropoxy)-3,4-dimethyl-2<i>H</i>-chromen-2-one (<b>6a</b>)</h5><div class="NLM_p last">Purified by flash chromatography (gradient eluent: ethyl acetate in <i>n</i>-hexane 0% → 60%). Yield: 79%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 2.07 (s, 3H), 2.27 (q, <i>J</i> = 6.4 Hz, 2H), 2.36 (s, 3H), 3.67 (t, <i>J</i> = 6.4 Hz, 2H), 4.18 (t, <i>J</i> = 6.4 Hz, 2H), 6.95–6.98 (m, 2H), 7.70 (d, <i>J</i> = 8.8 Hz, 1H).</div></div><div id="sec5_1_45" class="NLM_sec NLM_sec_level_4"><div id="ac_i60" class="anchor-spacer"></div><h5 class="article-section__title" id="_i60"> 7-(4-Bromobutoxy)-3,4-dimethyl-2<i>H</i>-chromen-2-one (<b>6b</b>)</h5><div class="NLM_p last">Purified by flash chromatography (gradient eluent: ethyl acetate in <i>n</i>-hexane 0% → 50%). Yield: 88%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.85 (qn, <i>J</i> = 6.4 Hz, 2H), 1.97 (qn, <i>J</i> = 6.4 Hz, 2H), 2.07 (s, 3H), 2.36 (s, 3H), 3.61 (t, <i>J</i> = 6.4 Hz, 2H), 4.10 (t, <i>J</i> = 6.4 Hz, 2H), 6.92–6.95 (m, 2H), 7.68 (d, <i>J</i> = 8.8 Hz, 1H).</div></div></div><div id="sec5_1_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> General Procedure for the Synthesis of Final Compounds <b>7a</b>,<b>b</b></h4><div class="NLM_p">Appropriate bromide derivative <b>6a</b>,<b>b</b> (0.50 mmol) was suspended under magnetic stirring in acetone (4 mL) in a Pyrex microwave reactor in the presence of anhydrous potassium carbonate (0.21 g, 1.5 mmol) and catalytic amount of potassium iodide. 1,2,3,4-Tetrahydroisoquinoline (0.080 g, 0.60 mmol) was added, and the vessel was placed in a microwave apparatus and heated at 130 °C for 30 min. After cooling to room temperature, the solid residue was filtered off after washing with CH<sub>2</sub>Cl<sub>2</sub>. The solution was concentrated to dryness, and the resulting crude was purified through flash chromatography (gradient eluent: ethyl acetate in <i>n</i>-hexane 20% → 80%). The resulting solids were transformed into the corresponding hydrochlorides by dissolving the base in the minimum amount of 1,4-dioxane followed by the addition of HCl 4.0 N in 1,4-dioxane. The precipitate was collected after filtration and washed with dry 1,4-dioxane under an Ar atmosphere.</div><div id="sec5_1_47" class="NLM_sec NLM_sec_level_4"><div id="ac_i62" class="anchor-spacer"></div><h5 class="article-section__title" id="_i62"> 7-[3-(3,4-Dihydroisoquinolin-2(1<i>H</i>)-yl)propoxy]-3,4-dimethyl-2<i>H</i>-chromen-2-one Hydrochloride (<b>7a</b>)</h5><div class="NLM_p last">Yield: 74%; mp > 250 °C. <sup>1</sup>H NMR (free base, 300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.98 (qn, <i>J</i> = 6.4 Hz, 2H), 2.05 (s, 3H), 2.34 (s, 3H), 2.59 (t, <i>J</i> = 6.4 Hz, 2H), 2.65 (t, <i>J</i> = 5.8 Hz, 2H), 2.79 (t, <i>J</i> = 5.8 Hz, 2H), 3.55 (s, 2H), 4.13 (t, <i>J</i> = 6.4 Hz, 2H), 6.91–6.94 (m, 2H), 7.01–7.09 (m, 4H), 7.66 (d, <i>J</i> = 9.9 Hz, 1H). Anal. (C<sub>23</sub>H<sub>25</sub>NO<sub>3</sub>·HCl) Calcd %: C, 69.08; H, 6.55; N, 3.50. Found %: C, 69.45; H, 6.58; N, 3.75.</div></div><div id="sec5_1_48" class="NLM_sec NLM_sec_level_4"><div id="ac_i63" class="anchor-spacer"></div><h5 class="article-section__title" id="_i63"> 7-[4-(3,4-Dihydroisoquinolin-2(1<i>H</i>)-yl)butoxy]-3,4-dimethyl-2<i>H</i>-chromen-2-one hydrochloride (<b>7b</b>)</h5><div class="NLM_p last">Yield: 72%; mp 206–208 °C. <sup>1</sup>H NMR (free base, 500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.67 (qn, <i>J</i> = 6.9 Hz, 2H), 1.79 (qn, <i>J</i> = 6.9 Hz, 2H), 2.07 (s, 3H), 2.36 (s, 3H), 2.46–2.48 (m, 2H), 2.64 (t, <i>J</i> = 5.4 Hz, 2H), 2.79 (t, <i>J</i> = 5.4 Hz, 2H), 3.53 (s, 2H), 4.10 (t, <i>J</i> = 6.9 Hz, 2H), 6.92–6.96 (m, 2H), 7.01–7.08 (m, 4H), 7.67 (d, <i>J</i> = 9.8 Hz, 1H). Anal. (C<sub>24</sub>H<sub>27</sub>NO<sub>3</sub>·HCl) Calcd %: C, 69.64; H, 6.82; N, 3.38. Found %: C, 69.62; H, 6.79; N, 3.63.</div></div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> HPLC Chiral Resolution</h3><div class="NLM_p last">HPLC chiral resolution of racemic <b>5b</b> and <b>5d</b> were performed on a Analytic Agilent 1260 Infinity multidetector system equipped with 1200 series UV-diode array detector using one of the following methods in a semipreparative polar mode at room temperature. UV spectra were recorded at 230, 254, 280, and 320 nm. Twenty aliquots (100 μL each) of the appropriate stock solutions (5 mg/mL in methanol for <b>5b</b> and 5 mg/mL in acetonitrile for <b>5d</b>) were injected. After collection and evaporation of the solvent, enantiomeric excess was measured with the same conditions as the separation. Method A (for <b>5b</b>): Chiralpak IA (Chiral Technologies Europe, 25 cm × 0.46 cm I.D.); mobile phase, A = methanol, B = acetonitrile; isocratic solvent, 20% B; flow rate = 1 mL/min; λ = 320 nm; 100 μL injection. Method B (for <b>5d</b>): Chiralpak IA (Chiral Technologies Europe, 25 cm × 0.46 cm I. D.); mobile phase, A = methanol, B = acetonitrile; isocratic solvent, 30% B; flow rate = 1 mL/min; λ = 320 nm; 100 μL injection. Data were integrated and reported using OpenLAB software (Agilent Technologies). All compounds display enantiomeric excess >99% as determined by this method. Chromatographic analyses are reported in the <a href="/doi/suppl/10.1021/acs.jmedchem.6b00562/suppl_file/jm6b00562_si_001.pdf" class="ext-link">Supporting Information</a>.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> Volsurf+ Calculations</h3><div class="NLM_p last">Volsurf+ (Molecular Discovery, Oxford, UK) was employed to compute different MIF-based<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> Log BB, a distribution parameter used to roughly assess the drug capability to cross the blood–brain barrier (BBB).<a onclick="showRef(event, 'ref46 ref76'); return false;" href="javascript:void(0);" class="ref ref46 ref76">(46, 76)</a></div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> Aqueous Solubility Measurement: Turbidimetric Method</h3><div class="NLM_p last">The compound under study was dissolved in DMSO (at concentration of 2.5 and 30 mg/mL for <b>5b</b> as free base, 2 and 25 mg/mL for <b>I</b>,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a><b>4j</b>, and <b>5a</b>) and added in portions to 50 mM Tris-HCl, pH 7.4, at room temperature. An Agilent 8453E UV–visible spectrophotometer equipped with a cell changer was used to detect light scattering produced by the addition of stock solutions to Tris-HCl buffer, and solubility calculations were performed as previously reported<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> from a bilinear curve fit in a plot of the absorbance (<i>y</i> axis) versus μL of DMSO (<i>x</i> axis). Increased UV absorbance was measured in the 580–780 nm range. The solubility at pH 7.4 was the mean ± SEM of three independent assays and was expressed as log <i>S</i> (mol/L).</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> RP-HPLC Determination of Lipophilicity Index (log <i>k</i>′)</h3><div class="NLM_p last">log <i>k′</i> determinations were carried out using a Zorbax Eclypse-C18 4.6 mm × 250 mm, with 5 μm size particles, built on a Waters double pump HPLC system in isocratic conditions. Injection volumes were 10 μL, flow rate was 1 mL/min, and detection was performed with UV (λ = 230 and 280 nm). Samples of compounds <b>I</b>, <b>4j</b>, <b>5a</b>, and <b>5b</b> were prepared in methanol at concentration 1 mM. The mobile phase was filtered through a Nylon-66 membrane 0.45 μm (Supelco, USA) before use. log <i>k′</i> values were calculated using the following equation:<span class="NLM_disp-formula" id="ueq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00562/20160722/images/jm-2016-005625_m001.gif" alt="" /></img></span>where retention times (<i>t</i><sub>r</sub>) were measured at least from three separate injections, and dead time (<i>t</i><sub>0</sub>) was the retention time of KI (1 mg/mL in methanol). The mobile phase consisted of different mixtures of methanol and ammonium acetate buffer (20 mM, pH 5.0): methanol/buffer 70% (v/v), methanol/buffer 65% (v/v), methanol/buffer 60% (v/v), methanol/buffer 55% (v/v), methanol/buffer 50% (v/v), methanol/buffer 45% (v/v).</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> Human Monoamine Oxidases Inhibition Assays</h3><div class="NLM_p last">Human monoamine oxidase inhibition assays were carried out with a fluorescence based method,<a onclick="showRef(event, 'ref34 ref56'); return false;" href="javascript:void(0);" class="ref ref34 ref56">(34, 56)</a> using kynuramine as nonselective MAO A and MAO B substrate. Human recombinant MAO A and MAO B (microsomes from baculovirus infected insect cells; Sigma-Aldrich) were used. IC<sub>50</sub>s for most active compounds were determined from seven concentrations ranging from 10<sup>–4</sup> to 10<sup>–11</sup> M. Reactions were performed in triplicates in black, round-bottomed polystyrene 96-well microtiter plates (Greiner). Samples were preincubated 20 min at 37 °C before adding MAO solutions, then incubated for additional 30 min. Fluorescence was recorded at excitation/emission wavelengths of 320/400 nm (20 nm slit width for excitation, 30 nm slit width for emission) in a 96-well microplate fluorescence reader (Tecan Infinite M100 Pro). Inhibitory activities were determined by means of nonlinear regressions performed with GraphPad Prism 5.0 software and are expressed as IC<sub>50</sub> (μM) or as percentage of inhibition at 10 μM. Results are the mean of three independent experiments.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> Electric Eel and Equine Serum Cholinesterases Inhibition Assays</h3><div class="NLM_p last">In vitro ChEs inhibition assays were performed on AChE from electric eel (463 U/mg; Sigma) and BChE from equine serum (13 U/mg; Sigma), according to the well-known spectrophotometric Ellman’s method.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> The experimental protocol for inhibition determination and kinetic studies has been adapted to a 96-well plate procedure from a previously reported method.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> Inhibitory activities were determined by means of nonlinear regressions of the response/log(concentration) curve performed with GraphPad Prism 5.0 and are reported as IC<sub>50</sub> (μM) or as percentage of inhibition at 10 μM for less active compounds. Experiments were performed in triplicates in transparent, flat-bottomed polystyrene 96-well microtiter plates. Seven concentrations of inhibitor, ranging from 10<sup>–4</sup> to 10<sup>–10</sup> M, were used; results are the mean of three independent experiments. Kinetic studies were performed with the same test conditions, using six concentrations of substrate (from 0.033 to 0.2 mM) and four concentrations of inhibitor (0 to 8 μM). Apparent inhibition constants and kinetic parameters were calculated within the “Enzyme Kinetics” module of Prism.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> Cytotoxicity Assays and Neuroprotection against Oxidative Stress Insults</h3><div class="NLM_p last">The cytotoxic damage produced by selected compounds and the ability to rescue cells from oxidative insults was investigated by following a protocol already described.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> The viability of human neuroblastoma cells SH-SY5Y was determined through the MTT assay<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> in 96-well microtiter plates after 24 h incubation at 37 °C with studied compounds at concentrations 0.1, 1, 5, 10, and 50 μM and expressed as concentration responsible for 50% inhibition of cell growth (IC<sub>50</sub>) or percentage of viable cells vs untreated cells (control). The absorbance at 570 nm was determined using a PerkinElmer 2030 multilabel reader Victor TM X3. In the same cell lines, the protective effect of selected compounds and donepezil incubated for 24 h at two different concentrations (1 and 10 μM) against three cytotoxic insults (H<sub>2</sub>O<sub>2</sub> 300 μM, oligomycin-A 10 μM, rotenone 20 μM) was studied.<a onclick="showRef(event, 'ref34 ref78'); return false;" href="javascript:void(0);" class="ref ref34 ref78">(34, 78)</a> Each compound was tested in triplicate, and the experiments were repeated three times. Cells incubated without insults and compounds were used as control. Data are determined through MTT assay and are expressed as percentage of viable cells vs untreated cells (control). Standard error of the mean (SD) is given. Statistical significance was determined using a two-way analysis of variance (ANOVA) followed by the Bonferroni post hoc tests (GraphPad Prism version 5) and was assigned to <i>p</i> < 0.05 (*) and <i>p</i> < 0.01 (**).</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> Bidirectional Transport Studies on MDCKII-MDR1 Monolayers</h3><div class="NLM_p">As previously reported,<a onclick="showRef(event, 'ref34 ref78'); return false;" href="javascript:void(0);" class="ref ref34 ref78">(34, 78)</a> Madin–Darby canine kidney (MDCK) cells were retrovirally transfected with the human MDR1 cDNA (MDCKII-MDR1).<a onclick="showRef(event, 'ref79 ref80'); return false;" href="javascript:void(0);" class="ref ref79 ref80">(79, 80)</a> MDCKII-MDR1 cells were cultured in DMEM medium and seeded at a density of 100000 cell/cm<sup>2</sup> onto polyester 12-well Transwell inserts (pore size 0.4 μm, 12 mm diameter, apical volume 0.5 mL, basolateral volume 1.5 mL). MDCKII-MDR1 cell barrier function was verified prior to the described transport experiments by measuring trans-epithelial electrical resistance (TEER) using an EVOM apparatus and the flux of fluorescein isothiocyanate-dextran (FD4, Sigma-Aldrich, Italy) (200 μg/mL) and diazepam (75 μM). The analysis of compounds (±)-<b>5a</b>,<b>b</b> and (±)-<b>5e</b> were performed through UV–visible spectroscopy using a PerkinElmer double-beam UV–visible spectrophotometer Lambda Bio 20 (Milan, Italy), equipped with 10 mm path-length-matched quartz cells. Standard calibration curves were prepared at maximum absorption wavelength of each compound using PBS as solvent and were linear (<i>r</i><sup>2</sup> = 0.999) over the range of tested concentration (from 5 to 75 μM). The FD4 samples were analyzed with a Victor3 fluorimeter (Wallac Victor3, 1420 Multilabel Counter, PerkinElmer) at excitation and emission wavelengths of 485 and 535 nm, respectively. Each compound was tested in triplicate, and the experiments were repeated three times. Data are reported as the apparent permeability (<i>P</i><sub>app</sub>), in units of cm/s, determined as indicated in the following equation:<span class="NLM_disp-formula" id="ueq2"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00562/20160722/images/jm-2016-005625_m002.gif" alt="" /></img></span>where “<i>V</i><sub>A</sub>” is the volume in the acceptor well, “area” is the surface area of the membrane, “time” is the total transport time, “[drug]<sub>acceptor</sub>” is the concentration of the drug measured by UV-spectroscopy, and “[drug]<sub>initial</sub>” is the initial drug concentration in the AP or BL chamber.</div><div class="NLM_p last">Efflux ratio (ER) was calculated using the following equation: ER = <i>P</i><sub>app</sub>, BL-AP/<i>P</i><sub>app</sub>, AP-BL, where <i>P</i><sub>app</sub>, BL-AP is the apparent permeability of basal-to-apical transport, and <i>P</i><sub>app</sub>, AP-BL is the apparent permeability of apical-to-basal transport. An efflux ratio greater than 2 indicates that a test compound is likely to be a substrate for P-gp transport.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i72"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00562">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56163" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56163" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b00562" class="ext-link">10.1021/acs.jmedchem.6b00562</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Applicability domain for Volsurf+ predictions; chiral-HPLC analysis on enantiomeric excess for (+)-<b>5b</b>, (−)-<b>5b</b>, (+)-<b>5d</b>, and (−)-<b>5d</b>; protocols of MAOs and ChEs inhibition assays (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00562/suppl_file/jm6b00562_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00562/suppl_file/jm6b00562_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00562/suppl_file/jm6b00562_si_001.pdf">jm6b00562_si_001.pdf (452.77 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00562/suppl_file/jm6b00562_si_002.csv">jm6b00562_si_002.csv (1.42 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b00562" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46078" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46078" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marco Catto</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Farmacia—Scienze del Farmaco, Università degli Studi di Bari “Aldo Moro”, via E. Orabona 4, I-70125 Bari, Italy</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#fe939f8c9d91d09d9f8a8a91be8b90979c9fd0978a"><span class="__cf_email__" data-cfemail="036e6271606c2d606277776c43766d6a61622d6a77">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Leonardo Pisani</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Farmacia—Scienze del Farmaco, Università degli Studi di Bari “Aldo Moro”, via E. Orabona 4, I-70125 Bari, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roberta Farina</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Farmacia—Scienze del Farmaco, Università degli Studi di Bari “Aldo Moro”, via E. Orabona 4, I-70125 Bari, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rosa Maria Iacobazzi</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Farmacia—Scienze del Farmaco, Università degli Studi di Bari “Aldo Moro”, via E. Orabona 4, I-70125 Bari, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Orazio Nicolotti</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Farmacia—Scienze del Farmaco, Università degli Studi di Bari “Aldo Moro”, via E. Orabona 4, I-70125 Bari, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Saverio Cellamare</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Farmacia—Scienze del Farmaco, Università degli Studi di Bari “Aldo Moro”, via E. Orabona 4, I-70125 Bari, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Giuseppe Felice Mangiatordi</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Farmacia—Scienze del Farmaco, Università degli Studi di Bari “Aldo Moro”, via E. Orabona 4, I-70125 Bari, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nunzio Denora</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Farmacia—Scienze del Farmaco, Università degli Studi di Bari “Aldo Moro”, via E. Orabona 4, I-70125 Bari, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ramon Soto-Otero</span> - <span class="hlFld-Affiliation affiliation">Departamento
de Bioquimica y Biologia Molecular, Facultad de Medicina, Universidad de Santiago de Compostela, San Francisco I, E-15782 Santiago de Compostela, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lydia Siragusa</span> - <span class="hlFld-Affiliation affiliation">Molecular
Discovery Limited 215
Marsh Road, Pinner, Middlesex,  London HA5 5NE, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cosimo Damiano Altomare</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Farmacia—Scienze del Farmaco, Università degli Studi di Bari “Aldo Moro”, via E. Orabona 4, I-70125 Bari, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Angelo Carotti</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Farmacia—Scienze del Farmaco, Università degli Studi di Bari “Aldo Moro”, via E. Orabona 4, I-70125 Bari, Italy</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d52e4459-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i73">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52671" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52671" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The financial support from MIUR, Italy (Grant Futuro in Ricerca 2012, RBFR12SJA8_003) is kindly acknowledged.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i74" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i74"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i75" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i75"> Abbreviations Used</h2><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term">CAS</td><td class="NLM_def"><p class="first last">catalytic anionic binding site</p></td></tr><tr><td class="NLM_term">FAD</td><td class="NLM_def"><p class="first last">flavin adenine dinucleotide</p></td></tr><tr><td class="NLM_term">FD4</td><td class="NLM_def"><p class="first last">fluorescein isothiocyanate-dextran</p></td></tr><tr><td class="NLM_term">MDCKII-MDR1</td><td class="NLM_def"><p class="first last">Madin–Darby canine kidney cells retrovirally transfected with the human MDR1 cDNA</p></td></tr><tr><td class="NLM_term">MIF</td><td class="NLM_def"><p class="first last">molecular interaction field</p></td></tr><tr><td class="NLM_term">MTDL</td><td class="NLM_def"><p class="first last">multitarget directed ligand</p></td></tr><tr><td class="NLM_term">MTT</td><td class="NLM_def"><p class="first last">3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide</p></td></tr><tr><td class="NLM_term"><i>P</i><sub>app</sub></td><td class="NLM_def"><p class="first last">apparent permeability</p></td></tr><tr><td class="NLM_term"><i>P</i><sub>app</sub>, AP-BL</td><td class="NLM_def"><p class="first last">apparent permeability apical-to-basal</p></td></tr><tr><td class="NLM_term"><i>P</i><sub>app</sub>, BL-AP</td><td class="NLM_def"><p class="first last">apparent permeability basal-to-apical</p></td></tr><tr><td class="NLM_term">PAS</td><td class="NLM_def"><p class="first last">peripheral anionic binding site</p></td></tr><tr><td class="NLM_term">P-gp</td><td class="NLM_def"><p class="first last">P-glycoprotein</p></td></tr><tr><td class="NLM_term">ROS</td><td class="NLM_def"><p class="first last">reactive oxygen species</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationships</p></td></tr><tr><td class="NLM_term">TEER</td><td class="NLM_def"><p class="first last">trans-epithelial electrical resistance</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i76">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60726" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60726" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 80 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Wimo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonsson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bond, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prince, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winblad, B.</span><span> </span><span class="NLM_article-title">The Worldwide Economic Impact of Dementia 2010</span> <span class="citation_source-journal">Alzheimer's Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span><span class="refDoi"> DOI: 10.1016/j.jalz.2012.11.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1016%2Fj.jalz.2012.11.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=23305821" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A280%3ADC%252BC3s3osVemsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=1-11&author=A.+Wimoauthor=L.+Jonssonauthor=J.+Bondauthor=M.+Princeauthor=B.+Winblad&title=The+Worldwide+Economic+Impact+of+Dementia+2010&doi=10.1016%2Fj.jalz.2012.11.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The worldwide economic impact of dementia 2010</span></div><div class="casAuthors">Wimo Anders; Jonsson Linus; Bond John; Prince Martin; Winblad Bengt</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia : the journal of the Alzheimer's Association</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-11.e3</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  To acquire an understanding of the societal costs of dementia and how they affect families, health and social care services, and governments to improve the lives of people with dementia and their caregivers.  METHODS:  The basic design of this study was a societal, prevalence-based, gross cost-of-illness study in which costs were aggregated to World Health Organization regions and World Bank income groupings.  RESULTS:  The total estimated worldwide costs of dementia were US$604 billion in 2010.  About 70% of the costs occurred in western Europe and North America.  In such high-income regions, costs of informal care and the direct costs of social care contribute similar proportions of total costs, whereas the direct medical costs were much lower.  In low- and middle-income countries, informal care accounts for the majority of total costs; direct social care costs are negligible.  CONCLUSIONS:  Worldwide costs of dementia are enormous and distributed inequitably.  There is considerable potential for cost increases in coming years as the diagnosis and treatment gap is reduced.  There is also likely to be a trend in low- and middle-income countries for social care costs to shift from the informal to the formal sector, with important implications for future aggregated costs and the financing of long-term care.  Only by investing now in research and the development of cost-effective approaches to early diagnosis and care can future societal costs be anticipated and managed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTDQ-QL6sAr2dbHMBt0mMIXfW6udTcc2eYwW048d-CCOLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s3osVemsw%253D%253D&md5=279024dbdf6d4678e070a8bae82e6ffc</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2012.11.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2012.11.006%26sid%3Dliteratum%253Aachs%26aulast%3DWimo%26aufirst%3DA.%26aulast%3DJonsson%26aufirst%3DL.%26aulast%3DBond%26aufirst%3DJ.%26aulast%3DPrince%26aufirst%3DM.%26aulast%3DWinblad%26aufirst%3DB.%26atitle%3DThe%2520Worldwide%2520Economic%2520Impact%2520of%2520Dementia%25202010%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2013%26volume%3D9%26spage%3D1%26epage%3D11%26doi%3D10.1016%2Fj.jalz.2012.11.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Querfurth, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFerla, F. M.</span><span> </span><span class="NLM_article-title">Alzheimer’s Disease</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">362</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">344</span><span class="refDoi"> DOI: 10.1056/NEJMra0909142</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1056%2FNEJMra0909142" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=20107219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1aqt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=2010&pages=329-344&author=H.+W.+Querfurthauthor=F.+M.+LaFerla&title=Alzheimer%E2%80%99s+Disease&doi=10.1056%2FNEJMra0909142"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease</span></div><div class="casAuthors">Querfurth, Henry W.; LaFerla, Frank M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">362</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">329-344</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review.  The role of β-amyloid peptide in spontaneous self-aggregation in brain in Alzheimer's disease is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPeniV_Jn6orVg90H21EOLACvtfcHk0ljV8dhdPiTrfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1aqt7s%253D&md5=c116f6a6b8fed9af9f5282cc4b755c70</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1056%2FNEJMra0909142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra0909142%26sid%3Dliteratum%253Aachs%26aulast%3DQuerfurth%26aufirst%3DH.%2BW.%26aulast%3DLaFerla%26aufirst%3DF.%2BM.%26atitle%3DAlzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2010%26volume%3D362%26spage%3D329%26epage%3D344%26doi%3D10.1056%2FNEJMra0909142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Cummings, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morstorf, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, K.</span><span> </span><span class="NLM_article-title">Alzheimer’s Disease Drug-development Pipeline: Few Candidates, Frequent Failures</span> <span class="citation_source-journal">Alzheimer's Res. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="refDoi"> DOI: 10.1186/alzrt269</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1186%2Falzrt269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=25024750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A280%3ADC%252BC2cbisFWjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=37&author=J.+L.+Cummingsauthor=T.+Morstorfauthor=K.+Zhong&title=Alzheimer%E2%80%99s+Disease+Drug-development+Pipeline%3A+Few+Candidates%2C+Frequent+Failures&doi=10.1186%2Falzrt269"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease drug-development pipeline: few candidates, frequent failures</span></div><div class="casAuthors">Cummings Jeffrey L; Zhong Kate; Morstorf Travis</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's research & therapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">37</span>
        ISSN:<span class="NLM_cas:issn">1758-9193</span>.
    </div><div class="casAbstract">INTRODUCTION:  Alzheimer's disease (AD) is increasing in frequency as the global population ages.  Five drugs are approved for treatment of AD, including four cholinesterase inhibitors and an N-methyl-D-aspartate (NMDA)-receptor antagonist.  We have an urgent need to find new therapies for AD.  METHODS:  We examined Clinicaltrials.gov, a public website that records ongoing clinical trials.  We examined the decade of 2002 to 2012, to better understand AD-drug development.  We reviewed trials by sponsor, sites, drug mechanism of action, duration, number of patients required, and rate of success in terms of advancement from one phase to the next.  We also reviewed the current AD therapy pipeline.  RESULTS:  During the 2002 to 2012 observation period, 413 AD trials were performed: 124 Phase 1 trials, 206 Phase 2 trials, and 83 Phase 3 trials.  Seventy-eight percent were sponsored by pharmaceutical companies.  The United States of America (U.S.) remains the single world region with the greatest number of trials; cumulatively, more non-U.S. than U.S. trials are performed.  The largest number of registered trials addressed symptomatic agents aimed at improving cognition (36.6%), followed by trials of disease-modifying small molecules (35.1%) and trials of disease-modifying immunotherapies (18%).  The mean length of trials increases from Phase 2 to Phase 3, and the number of participants in trials increases between Phase 2 and Phase 3.  Trials of disease-modifying agents are larger and longer than those for symptomatic agents.  A very high attrition rate was found, with an overall success rate during the 2002 to 2012 period of 0.4% (99.6% failure).  CONCLUSIONS:  The Clinicaltrials.gov database demonstrates that relatively few clinical trials are undertaken for AD therapeutics, considering the magnitude of the problem.  The success rate for advancing from one phase to another is low, and the number of compounds progressing to regulatory review is among the lowest found in any therapeutic area.  The AD drug-development ecosystem requires support.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT__DMPwHFhGGPgL4LrC-0VfW6udTcc2eYpW46jRRl3Urntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbisFWjtQ%253D%253D&md5=85b84800ce02d7031a4c1046e837e568</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1186%2Falzrt269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Falzrt269%26sid%3Dliteratum%253Aachs%26aulast%3DCummings%26aufirst%3DJ.%2BL.%26aulast%3DMorstorf%26aufirst%3DT.%26aulast%3DZhong%26aufirst%3DK.%26atitle%3DAlzheimer%25E2%2580%2599s%2520Disease%2520Drug-development%2520Pipeline%253A%2520Few%2520Candidates%252C%2520Frequent%2520Failures%26jtitle%3DAlzheimer%2527s%2520Res.%2520Ther.%26date%3D2014%26volume%3D6%26spage%3D37%26doi%3D10.1186%2Falzrt269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Berk, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabbagh, M. N.</span><span> </span><span class="NLM_article-title">Successes and Failures for Drugs in Late-stage Development for Alzheimer’s Disease</span> <span class="citation_source-journal">Drugs Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">783</span><span class="NLM_x">–</span> <span class="NLM_lpage">792</span><span class="refDoi"> DOI: 10.1007/s40266-013-0108-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1007%2Fs40266-013-0108-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=23943247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVWmt7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2013&pages=783-792&author=C.+Berkauthor=M.+N.+Sabbagh&title=Successes+and+Failures+for+Drugs+in+Late-stage+Development+for+Alzheimer%E2%80%99s+Disease&doi=10.1007%2Fs40266-013-0108-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Successes and Failures for Drugs in Late-Stage Development for Alzheimer's Disease</span></div><div class="casAuthors">Berk, Camryn; Sabbagh, Marwan N.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs & Aging</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">783-792</span>CODEN:
                <span class="NLM_cas:coden">DRAGE6</span>;
        ISSN:<span class="NLM_cas:issn">1170-229X</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">A review.  To date, symptomatic medications prevail as the mainstay of treatment options for Alzheimer's disease (AD).  There have been tremendous investments made to increase the nos. of drugs approved and the targets engaged, in an effort to alter the disease course or pathophysiol. of AD.  Unfortunately, almost all studies have not met expectations and no new drug (beyond medical foods) has been approved for the treatment of AD in the last decade.  This review is a comparison of novel AD therapies in the late phases of clin. testing, including recent high-profile clin. failures, and agents in development with relatively unexplored mechanisms of action, with a focus on their potential as therapeutic agents and their proposed advantages over the treatments currently in use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGru8C4Zf__NMrVg90H21EOLACvtfcHk0lhcTRxsh1ebjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVWmt7bM&md5=92a0562710d6e1e36ce087d1457a936c</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2Fs40266-013-0108-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40266-013-0108-6%26sid%3Dliteratum%253Aachs%26aulast%3DBerk%26aufirst%3DC.%26aulast%3DSabbagh%26aufirst%3DM.%2BN.%26atitle%3DSuccesses%2520and%2520Failures%2520for%2520Drugs%2520in%2520Late-stage%2520Development%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DDrugs%2520Aging%26date%3D2013%26volume%3D30%26spage%3D783%26epage%3D792%26doi%3D10.1007%2Fs40266-013-0108-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Narayan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehsani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindquist, S.</span><span> </span><span class="NLM_article-title">Combating Neurodegenerative Disease with Chemical Probes and Model Systems</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">911</span><span class="NLM_x">–</span> <span class="NLM_lpage">920</span><span class="refDoi"> DOI: 10.1038/nchembio.1663</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1038%2Fnchembio.1663" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=25325702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslOisrzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=911-920&author=P.+Narayanauthor=S.+Ehsaniauthor=S.+Lindquist&title=Combating+Neurodegenerative+Disease+with+Chemical+Probes+and+Model+Systems&doi=10.1038%2Fnchembio.1663"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Combating neurodegenerative disease with chemical probes and model systems</span></div><div class="casAuthors">Narayan, Priyanka; Ehsani, Sepehr; Lindquist, Susan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">911-920</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The disheartening results of recent clin. trials for neurodegenerative disease (ND) therapeutics underscore the need for a more comprehensive understanding of the underlying disease biol. before effective therapies can be devised.  One hallmark of many NDs is a disruption in protein homeostasis.  Therefore, investigating the role of protein homeostasis in these diseases is central to delineating their underlying pathobiol.  Here, we review the seminal role that chem. biol. has played in furthering the research on and treatment of dysfunctional protein homeostasis in NDs.  We also discuss the vital and predictive role of model systems in identifying conserved homeostasis pathways and genes therein that are altered in neurodegeneration.  Integrating approaches from chem. biol. with the use of model systems yields a powerful toolkit with which to unravel the complexities of ND biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXPyatlzrBVLVg90H21EOLACvtfcHk0lhcTRxsh1ebjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslOisrzE&md5=440b79365af1fb637ad7db8e51b1149f</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1663&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1663%26sid%3Dliteratum%253Aachs%26aulast%3DNarayan%26aufirst%3DP.%26aulast%3DEhsani%26aufirst%3DS.%26aulast%3DLindquist%26aufirst%3DS.%26atitle%3DCombating%2520Neurodegenerative%2520Disease%2520with%2520Chemical%2520Probes%2520and%2520Model%2520Systems%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26spage%3D911%26epage%3D920%26doi%3D10.1038%2Fnchembio.1663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Bush, A. I.</span><span> </span><span class="NLM_article-title">The Metal Theory of Alzheimer’s Disease</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">S277</span><span class="NLM_x">–</span> <span class="NLM_lpage">S281</span><span class="refDoi"> DOI: 10.3233/JAD-2012-129011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.3233%2FJAD-2012-129011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=22635102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvV2ksr7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=S277-S281&author=A.+I.+Bush&title=The+Metal+Theory+of+Alzheimer%E2%80%99s+Disease&doi=10.3233%2FJAD-2012-129011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The Metal Theory of Alzheimer's Disease</span></div><div class="casAuthors">Perry, George; Zhu, Xiongwei; Smith, Mark A.; Sorensen, Aaron; Avila, Jesus; Bush, Ashley I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">S277-S281</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  Brain homeostasis of transition metals is severely perturbed in Alzheimer's disease (AD), with extracellular pooling of zinc and copper in amyloid, and intraneuronal accumulation of iron.  Rapidly accumulating evidence indicates that these perturbances themselves may contribute significantly to the cognitive loss and neurodegeneration, even in the absence of AD proteopathy.  There is now strong evidence that each of the major protein participants in AD pathol. has physiol. important interactions with transition metals: AβPP is the neuronal iron export ferroxidase with a major interaction with ferroportin, presenilins are needed for the import of ≈50% of cellular copper and zinc, and tau promotes the export of neuronal iron by facilitating the trafficking of AβPP to the surface.  Therefore, amyloid and tau pathol. arise in a milieu of constitutively high metal flux, and the major components of AD pathol. may contribute to the disease by failing in their metal transport roles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoloM-8UGgtLrVg90H21EOLACvtfcHk0lhcTRxsh1ebjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvV2ksr7K&md5=6332fc77a50144f8f2ea34adfebe44be</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.3233%2FJAD-2012-129011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2012-129011%26sid%3Dliteratum%253Aachs%26aulast%3DBush%26aufirst%3DA.%2BI.%26atitle%3DThe%2520Metal%2520Theory%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2013%26volume%3D33%26spage%3DS277%26epage%3DS281%26doi%3D10.3233%2FJAD-2012-129011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, B.</span><span> </span><span class="NLM_article-title">Oxidative Stress and the Pathogenesis of Alzheimer’s Disease</span> <span class="citation_source-journal">Oxid. Med. Cell. Longevity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">2013</span><span class="NLM_x">, </span> <span class="NLM_fpage">316523</span><span class="refDoi"> DOI: 10.1155/2013/316523</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1155%2F2013%2F316523" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=23983897" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A280%3ADC%252BC3sbjtVOmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2013&publication_year=2013&pages=316523&author=Y.+Zhaoauthor=B.+Zhao&title=Oxidative+Stress+and+the+Pathogenesis+of+Alzheimer%E2%80%99s+Disease&doi=10.1155%2F2013%2F316523"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative stress and the pathogenesis of Alzheimer's disease</span></div><div class="casAuthors">Zhao Yan; Zhao Baolu</div><div class="citationInfo"><span class="NLM_cas:title">Oxidative medicine and cellular longevity</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">2013</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">316523</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Alzheimer's disease (AD) is the most common neurodegenerative disease that causes dementia in the elderly.  Patients with AD suffer a gradual deterioration of memory and other cognitive functions, which eventually leads to a complete incapacity and death.  A complicated array of molecular events has been implicated in the pathogenesis of AD.  The major pathological characteristics of AD brains are the presence of senile plaques, neurofibrillary tangles, and neuronal loss.  Growing evidence has demonstrated that oxidative stress is an important factor contributing to the initiation and progression of AD.  However, the mechanisms that lead to the disruption of redox balance and the sources of free radicals remain elusive.  The excessive reactive oxygen species may be generated from mechanisms such as mitochondria dysfunction and/or aberrant accumulation of transition metals, while the abnormal accumulation of Abeta and tau proteins appears to promote the redox imbalance.  The resulted oxidative stress has been implicated in Abeta- or tau-induced neurotoxicity.  In addition, evidence has suggested that oxidative stress may augment the production and aggregation of Abeta and facilitate the phosphorylation and polymerization of tau, thus forming a vicious cycle that promotes the initiation and progression of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS8bk2b0ed4E9bHMBt0mMIXfW6udTcc2eZwvGhFPVpwuLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sbjtVOmsw%253D%253D&md5=876ca56576e14f4e0a3aaf2ccd512118</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1155%2F2013%2F316523&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2013%252F316523%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DB.%26atitle%3DOxidative%2520Stress%2520and%2520the%2520Pathogenesis%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DOxid.%2520Med.%2520Cell.%2520Longevity%26date%3D2013%26volume%3D2013%26spage%3D316523%26doi%3D10.1155%2F2013%2F316523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Terry, A. V.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buccafusco, J. J.</span><span> </span><span class="NLM_article-title">The Cholinergic Hypothesis of Age and Alzheimer’s Disease-related Cognitive Deficits: Recent Challenges and Their Implications for Novel Drug Development</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">306</span><span class="NLM_x">, </span> <span class="NLM_fpage">821</span><span class="NLM_x">–</span> <span class="NLM_lpage">827</span><span class="refDoi"> DOI: 10.1124/jpet.102.041616</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1124%2Fjpet.102.041616" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=12805474" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvVehsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=306&publication_year=2003&pages=821-827&author=A.+V.+Terryauthor=J.+J.+Buccafusco&title=The+Cholinergic+Hypothesis+of+Age+and+Alzheimer%E2%80%99s+Disease-related+Cognitive+Deficits%3A+Recent+Challenges+and+Their+Implications+for+Novel+Drug+Development&doi=10.1124%2Fjpet.102.041616"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: Recent challenges and their implications for novel drug development</span></div><div class="casAuthors">Terry, A. V., Jr.; Buccafusco, J. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">306</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">821-827</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  The cholinergic hypothesis was initially presented over 20 yr ago and suggests that a dysfunction of acetylcholine contg. neurons in the brain contributes substantially to the cognitive decline obsd. in those with advanced age and Alzheimer's disease (AD).  This premise has since served as the basis for the majority of treatment strategies and drug development approaches for AD to date.  Recent studies of the brains of patients who had mild cognitive impairment or early stage AD in which choline acetyltransferase and/or acetylcholinesterase activity was unaffected (or even up-regulated) have, however, led some to challenge the validity of the hypothesis as well as the rationale for using cholinomimetics to treat the disorder, particularly in the earlier stages.  These challenges, primarily based on assays of post mortem enzyme activity, should be taken in perspective and evaluated within the wide range of cholinergic abnormalities known to exist in both aging and AD.  The results of both post mortem and antemortem studies in aged humans and AD patients, as well as animal expts. suggest that a host of cholinergic abnormalities including alterations in choline transport, acetylcholine release, nicotinic and muscarinic receptor expression, neurotrophin support, and perhaps axonal transport may all contribute to cognitive abnormalities in aging and AD.  Cholinergic abnormalities may also contribute to noncognitive behavioral abnormalities as well as the deposition of toxic neuritic plaques in AD.  Therefore, cholinergic-based strategies will likely remain valid as one approach to rational drug development for the treatment of AD other forms of dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPatJs_N3wu7Vg90H21EOLACvtfcHk0lg9-IFa6A8-UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvVehsb8%253D&md5=bd52a7d752cc5e51a3866c3ed2ace8f0</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.041616&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.041616%26sid%3Dliteratum%253Aachs%26aulast%3DTerry%26aufirst%3DA.%2BV.%26aulast%3DBuccafusco%26aufirst%3DJ.%2BJ.%26atitle%3DThe%2520Cholinergic%2520Hypothesis%2520of%2520Age%2520and%2520Alzheimer%25E2%2580%2599s%2520Disease-related%2520Cognitive%2520Deficits%253A%2520Recent%2520Challenges%2520and%2520Their%2520Implications%2520for%2520Novel%2520Drug%2520Development%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2003%26volume%3D306%26spage%3D821%26epage%3D827%26doi%3D10.1124%2Fjpet.102.041616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Johnson, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotermanski, S. E.</span><span> </span><span class="NLM_article-title">Mechanism of Action of Memantine</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span><span class="refDoi"> DOI: 10.1016/j.coph.2005.09.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1016%2Fj.coph.2005.09.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=16368266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsVygtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=61-67&author=J.+W.+Johnsonauthor=S.+E.+Kotermanski&title=Mechanism+of+Action+of+Memantine&doi=10.1016%2Fj.coph.2005.09.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of action of Memantine</span></div><div class="casAuthors">Johnson, Jon W.; Kotermanski, Shawn E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-67</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Memantine is a clin. useful drug in many neurol. disorders, including Alzheimer's disease.  The principal mechanism of action of Memantine is believed to be the blockade of current flow through channels of N-methylaspartate (NMDA) receptors - a glutamate receptor subfamily broadly involved in brain function.  Surprisingly, other drugs that block NMDA receptor channels, such as ketamine, exhibit serious deleterious effects.  The unusual therapeutic utility of Memantine probably results from inhibitory mechanisms shared with ketamine, combined with actions specific to Memantine.  These potentially important differences between Memantine and ketamine include effects on gating of blocked channels and binding of Memantine to 2 sites on NMDA receptors.  Because modulation of NMDA receptor activity can increase or decrease excitability of neuronal circuits, subtle differences in the mechanisms of action of NMDA receptor antagonists can strongly impact on their clin. effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrS8uhDNxLehLVg90H21EOLACvtfcHk0lg9-IFa6A8-UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsVygtA%253D%253D&md5=5c34d27940d101a2ec674eed28a977d8</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2005.09.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2005.09.007%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DJ.%2BW.%26aulast%3DKotermanski%26aufirst%3DS.%2BE.%26atitle%3DMechanism%2520of%2520Action%2520of%2520Memantine%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2006%26volume%3D6%26spage%3D61%26epage%3D67%26doi%3D10.1016%2Fj.coph.2005.09.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Muñoz-Torrero, D.</span><span> </span><span class="NLM_article-title">Acetylcholinesterase Inhibitors as Disease Modifying Therapies for Alzheimer’s Disease</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2433</span><span class="NLM_x">–</span> <span class="NLM_lpage">2455</span><span class="refDoi"> DOI: 10.2174/092986708785909067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.2174%2F092986708785909067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=18855672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFCqsLbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=2433-2455&author=D.+Mu%C3%B1oz-Torrero&title=Acetylcholinesterase+Inhibitors+as+Disease+Modifying+Therapies+for+Alzheimer%E2%80%99s+Disease&doi=10.2174%2F092986708785909067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Acetylcholinesterase inhibitors as disease-modifying therapies for Alzheimer's disease</span></div><div class="casAuthors">Munoz-Torrero, D.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">2433-2455</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The therapeutic arsenal for the treatment of Alzheimer's disease (AD) remains confined to a group of four inhibitors of AChE and one NMDA receptor antagonist, which are used to provide a relief of the very late symptoms of the dementia, i.e. the cognitive and functional decline.  In line with the growing body of evidence of the pivotal role of the β-amyloid peptide (Aβ) in the pathogenesis of AD, alternative classes of drugs targeting mainly the formation or the aggregation of Aβ are actively pursued by the pharmaceutical industry, as they could pos. modify the course of AD, stopping or slowing down disease progression.  While the first amyloid-directed disease-modifying drugs go ahead with their clin. development and could reach the market as soon as 2009, mounting preclin. and clin. evidences is pointing towards a disease-modifying role also for currently marketed anti-Alzheimer AChE inhibitors (AChEIs), particularly for donepezil.  In this review, the neuroprotective effects exhibited by currently commercialized AChEIs will be briefly discussed, together with the secondary mechanisms through which they could exert such effects.  This review will focus also on particular classes of AChEIs, namely dual binding site AChEIs, which are being purposely designed to target Aβ aggregation and / or other biol. targets that contribute to AD pathogenesis, thus constituting very promising disease-modifying anti-Alzheimer drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqII-Yg4R84wrVg90H21EOLACvtfcHk0lgo-sca-_QYKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFCqsLbI&md5=a27eaf0ba08a4d9e5c8363f6b5621e5d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2174%2F092986708785909067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986708785909067%26sid%3Dliteratum%253Aachs%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DAcetylcholinesterase%2520Inhibitors%2520as%2520Disease%2520Modifying%2520Therapies%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2008%26volume%3D15%26spage%3D2433%26epage%3D2455%26doi%3D10.2174%2F092986708785909067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Zimmermann, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehár, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keith, C. T.</span><span> </span><span class="NLM_article-title">Multi-target Therapeutics: When the Whole is Greater than the Sum of the Parts</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">34</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span><span class="refDoi"> DOI: 10.1016/j.drudis.2006.11.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1016%2Fj.drudis.2006.11.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=17198971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A280%3ADC%252BD2s%252Fgt1ygtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=34-42&author=G.+R.+Zimmermannauthor=J.+Leh%C3%A1rauthor=C.+T.+Keith&title=Multi-target+Therapeutics%3A+When+the+Whole+is+Greater+than+the+Sum+of+the+Parts&doi=10.1016%2Fj.drudis.2006.11.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target therapeutics: when the whole is greater than the sum of the parts</span></div><div class="casAuthors">Zimmermann Grant R; Lehar Joseph; Keith Curtis T</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">34-42</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">Drugs designed to act against individual molecular targets cannot usually combat multigenic diseases such as cancer, or diseases that affect multiple tissues or cell types such as diabetes and immunoinflammatory disorders.  Combination drugs that impact multiple targets simultaneously are better at controlling complex disease systems, are less prone to drug resistance and are the standard of care in many important therapeutic areas.  The combination drugs currently employed are primarily of rational design, but the increased efficacy they provide justifies in vitro discovery efforts for identifying novel multi-target mechanisms.  In this review, we discuss the biological rationale for combination therapeutics, review some existing combination drugs and present a systematic approach to identify interactions between molecular pathways that could be leveraged for therapeutic benefit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTI14vYK2Q1LENHe_gFldTbfW6udTcc2ebzI43-5UCnPLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s%252Fgt1ygtQ%253D%253D&md5=66715499ce21c2855dc6c477aa87f161</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2006.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2006.11.008%26sid%3Dliteratum%253Aachs%26aulast%3DZimmermann%26aufirst%3DG.%2BR.%26aulast%3DLeh%25C3%25A1r%26aufirst%3DJ.%26aulast%3DKeith%26aufirst%3DC.%2BT.%26atitle%3DMulti-target%2520Therapeutics%253A%2520When%2520the%2520Whole%2520is%2520Greater%2520than%2520the%2520Sum%2520of%2520the%2520Parts%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2007%26volume%3D12%26spage%3D34%26epage%3D42%26doi%3D10.1016%2Fj.drudis.2006.11.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Leon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span> </span><span class="NLM_article-title">Recent Advances in the Multitarget-Directed Ligands Approach for the Treatment of Alzheimer’s Disease</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">189</span><span class="refDoi"> DOI: 10.1002/med.20248</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1002%2Fmed.20248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=21793014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVCktrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=139-189&author=R.+Leonauthor=A.+G.+Garciaauthor=J.+Marco-Contelles&title=Recent+Advances+in+the+Multitarget-Directed+Ligands+Approach+for+the+Treatment+of+Alzheimer%E2%80%99s+Disease&doi=10.1002%2Fmed.20248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Leon, Rafael; Garcia, Antonio G.; Marco-Contelles, Jose</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">139-189</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  With 27 million cases worldwide documented in 2006, Alzheimer's disease (AD) constitutes an overwhelming health, social, economic, and political problem to nations.  Unless a new medicine capable to delay disease progression is found, the no. of cases will reach 107 million in 2050.  So far, the therapeutic paradigm one-compd.-one-target has failed.  This could be due to the multiple pathogenic mechanisms involved in AD including amyloid β (Aβ) aggregation to form plaques, τ hyperphosphorylation to disrupt microtubule to form neurofibrillary tangles, calcium imbalance, enhanced oxidative stress, impaired mitochondrial function, apoptotic neuronal death, and deterioration of synaptic transmission, particularly at cholinergic neurons.  Approx. 100 compds. are presently been investigated directed to single targets, namely inhibitors of β and γ secretase, vaccines or antibodies that clear Aβ, metal chelators to inhibit Aβ aggregation, blockers of glycogen synthase kinase 3β, enhancers of mitochondrial function, antioxidants, modulators of calcium-permeable channels such as voltage-dependent calcium channels, N-methyl-D-aspartate receptors for glutamate, or enhancers of cholinergic neurotransmission such as inhibitors of acetylcholinesterase or butyrylcholinesterase.  In view of this complex pathogenic mechanisms, and the successful treatment of chronic diseases such as HIV or cancer, with multiple drugs having complementary mechanisms of action, the concern is growing that AD could better be treated with a single compd. targeting two or more of the pathogenic mechanisms leading to neuronal death.  This review summarizes the current therapeutic strategies based on the paradigm one-compd.-various targets to treat AD.  A treatment that delays disease onset and/or progression by 5 years could halve the no. of people requiring institutionalization and/or dying from AD.  © 2011 Wiley Periodicals, Inc.  Med Res Rev.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8YQ_Czzj5brVg90H21EOLACvtfcHk0lgo-sca-_QYKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVCktrvL&md5=b08806a8a4ca71c35a3594338c881e74</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1002%2Fmed.20248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20248%26sid%3Dliteratum%253Aachs%26aulast%3DLeon%26aufirst%3DR.%26aulast%3DGarcia%26aufirst%3DA.%2BG.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26atitle%3DRecent%2520Advances%2520in%2520the%2520Multitarget-Directed%2520Ligands%2520Approach%2520for%2520the%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2013%26volume%3D33%26spage%3D139%26epage%3D189%26doi%3D10.1002%2Fmed.20248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnamoorthy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savelieff, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brender, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derrick, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kochi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramamoorthy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowers, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, M. H.</span><span> </span><span class="NLM_article-title">Rational Design of a Structural Framework with Potential Use to Develop Chemical Reagents that Target and Modulate Multiple Facets of Alzheimer’s Disease</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">299</span><span class="NLM_x">–</span> <span class="NLM_lpage">310</span><span class="refDoi"> DOI: 10.1021/ja409801p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja409801p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC3sXitVWnsL3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=299-310&author=S.+Leeauthor=X.+Zhengauthor=J.+Krishnamoorthyauthor=M.+G.+Savelieffauthor=H.+M.+Parkauthor=J.+R.+Brenderauthor=J.+H.+Kimauthor=J.+S.+Derrickauthor=A.+Kochiauthor=H.+J.+Leeauthor=C.+Kimauthor=A.+Ramamoorthyauthor=M.+T.+Bowersauthor=M.+H.+Lim&title=Rational+Design+of+a+Structural+Framework+with+Potential+Use+to+Develop+Chemical+Reagents+that+Target+and+Modulate+Multiple+Facets+of+Alzheimer%E2%80%99s+Disease&doi=10.1021%2Fja409801p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Design of a Structural Framework with Potential Use to Develop Chemical Reagents That Target and Modulate Multiple Facets of Alzheimer's Disease</span></div><div class="casAuthors">Lee, Sanghyun; Zheng, Xueyun; Krishnamoorthy, Janarthanan; Savelieff, Masha G.; Park, Hyun Min; Brender, Jeffrey R.; Kim, Jin Hoon; Derrick, Jeffrey S.; Kochi, Akiko; Lee, Hyuck Jin; Kim, Cheal; Ramamoorthy, Ayyalusamy; Bowers, Michael T.; Lim, Mi Hee</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">299-310</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is characterized by multiple, intertwined pathol. features, including amyloid-β (Aβ) aggregation, metal ion dyshomeostasis, and oxidative stress.  The authors report a novel compd. (ML) prototype of a rationally designed mol. obtained by integrating structural elements for Aβ aggregation control, metal chelation, reactive oxygen species (ROS) regulation, and antioxidant activity within a single mol.  Chem., biochem., ion mobility mass spectrometric, and NMR studies indicate that the compd. ML targets metal-free and metal-bound Aβ (metal-Aβ) species, suppresses Aβ aggregation in vitro, and diminishes toxicity induced by Aβ and metal-treated Aβ in living cells.  Comparison of ML to its structural moieties (i.e., 4-(dimethylamino)-phenol (DAP) and (8-aminoquinolin-2-yl)-methanol ) for reactivity with Aβ and metal-Aβ suggests the synergy of incorporating structural components for both metal chelation and Aβ interaction.  Moreover, ML is water-sol. and potentially brain permeable, as well as regulates the formation and presence of free radicals.  Overall, the authors demonstrate that a rational structure-based design strategy can generate a small mol. that can target and modulate multiple factors, providing a new tool to uncover and address AD complexity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcx8TkzbV9U7Vg90H21EOLACvtfcHk0lgDsjOzGQiG3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXitVWnsL3I&md5=808d231c5dca419453c176265d16bfe3</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fja409801p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja409801p%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DKrishnamoorthy%26aufirst%3DJ.%26aulast%3DSavelieff%26aufirst%3DM.%2BG.%26aulast%3DPark%26aufirst%3DH.%2BM.%26aulast%3DBrender%26aufirst%3DJ.%2BR.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DDerrick%26aufirst%3DJ.%2BS.%26aulast%3DKochi%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DH.%2BJ.%26aulast%3DKim%26aufirst%3DC.%26aulast%3DRamamoorthy%26aufirst%3DA.%26aulast%3DBowers%26aufirst%3DM.%2BT.%26aulast%3DLim%26aufirst%3DM.%2BH.%26atitle%3DRational%2520Design%2520of%2520a%2520Structural%2520Framework%2520with%2520Potential%2520Use%2520to%2520Develop%2520Chemical%2520Reagents%2520that%2520Target%2520and%2520Modulate%2520Multiple%2520Facets%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26spage%3D299%26epage%3D310%26doi%3D10.1021%2Fja409801p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Prati, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Simone, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisignano, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armirotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pizzirani, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarpelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Castillo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monti, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massenzio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polito, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Racchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favia, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottegoni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span> </span><span class="NLM_article-title">Multitarget Drug Discovery for Alzheimer’s Disease: Triazinones as BACE-1 and GSK-3β Inhibitors</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1578</span><span class="NLM_x">–</span> <span class="NLM_lpage">1582</span><span class="refDoi"> DOI: 10.1002/anie.201410456</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1002%2Fanie.201410456" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVyhtrjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2015&pages=1578-1582&author=F.+Pratiauthor=A.+De+Simoneauthor=P.+Bisignanoauthor=A.+Armirottiauthor=M.+Summaauthor=D.+Pizziraniauthor=R.+Scarpelliauthor=D.+I.+Perezauthor=V.+Andrisanoauthor=A.+Perez-Castilloauthor=B.+Montiauthor=F.+Massenzioauthor=L.+Politoauthor=M.+Racchiauthor=A.+D.+Faviaauthor=G.+Bottegoniauthor=A.+Martinezauthor=M.+L.+Bolognesiauthor=A.+Cavalli&title=Multitarget+Drug+Discovery+for+Alzheimer%E2%80%99s+Disease%3A+Triazinones+as+BACE-1+and+GSK-3%CE%B2+Inhibitors&doi=10.1002%2Fanie.201410456"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Multitarget Drug Discovery for Alzheimer's Disease: Triazinones as BACE-1 and GSK-3β Inhibitors</span></div><div class="casAuthors">Prati, Federica; De Simone, Angela; Bisignano, Paola; Armirotti, Andrea; Summa, Maria; Pizzirani, Daniela; Scarpelli, Rita; Perez, Daniel I.; Andrisano, Vincenza; Perez-Castillo, Ana; Monti, Barbara; Massenzio, Francesca; Polito, Letizia; Racchi, Marco; Favia, Angelo D.; Bottegoni, Giovanni; Martinez, Ana; Bolognesi, Maria Laura; Cavalli, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1578-1582</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Cumulative evidence strongly supports that the amyloid and tau hypotheses are not mutually exclusive, but concomitantly contribute to neurodegeneration in Alzheimer's disease (AD).  Thus, the development of multitarget drugs which are involved in both pathways might represent a promising therapeutic strategy.  Accordingly, reported here in is the discovery of 6-amino-4-phenyl-3,4-dihydro-1,3,5-triazin-2(1H)-ones as the first class of mols. able to simultaneously modulate BACE-1 and GSK-3β.  Notably, one triazinone showed well-balanced in vitro potencies against the two enzymes (IC50 of (18.03±0.01) μM and (14.67±0.78) μM for BACE-1 and GSK-3β, resp.).  In cell-based assays, it displayed effective neuroprotective and neurogenic activities and no neurotoxicity.  It also showed good brain permeability in a preliminary pharmacokinetic assessment in mice.  Overall, triazinones might represent a promising starting point towards high quality lead compds. with an AD-modifying potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr709_eEcKrqrVg90H21EOLACvtfcHk0lgDsjOzGQiG3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVyhtrjE&md5=9d372688168ec28086c92d557a1ed708</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1002%2Fanie.201410456&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201410456%26sid%3Dliteratum%253Aachs%26aulast%3DPrati%26aufirst%3DF.%26aulast%3DDe%2BSimone%26aufirst%3DA.%26aulast%3DBisignano%26aufirst%3DP.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DSumma%26aufirst%3DM.%26aulast%3DPizzirani%26aufirst%3DD.%26aulast%3DScarpelli%26aufirst%3DR.%26aulast%3DPerez%26aufirst%3DD.%2BI.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DPerez-Castillo%26aufirst%3DA.%26aulast%3DMonti%26aufirst%3DB.%26aulast%3DMassenzio%26aufirst%3DF.%26aulast%3DPolito%26aufirst%3DL.%26aulast%3DRacchi%26aufirst%3DM.%26aulast%3DFavia%26aufirst%3DA.%2BD.%26aulast%3DBottegoni%26aufirst%3DG.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DCavalli%26aufirst%3DA.%26atitle%3DMultitarget%2520Drug%2520Discovery%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%253A%2520Triazinones%2520as%2520BACE-1%2520and%2520GSK-3%25CE%25B2%2520Inhibitors%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2015%26volume%3D54%26spage%3D1578%26epage%3D1582%26doi%3D10.1002%2Fanie.201410456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Zheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridkin, M.</span><span> </span><span class="NLM_article-title">Site-activated Chelators Targeting Acetylcholinesterase and Monoamine Oxidase for Alzheimer’s Therapy</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">603</span><span class="NLM_x">–</span> <span class="NLM_lpage">610</span><span class="refDoi"> DOI: 10.1021/cb900264w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb900264w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=603-610&author=H.+Zhengauthor=M.+B.+H.+Youdimauthor=M.+Fridkin&title=Site-activated+Chelators+Targeting+Acetylcholinesterase+and+Monoamine+Oxidase+for+Alzheimer%E2%80%99s+Therapy&doi=10.1021%2Fcb900264w"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fcb900264w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb900264w%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26aulast%3DFridkin%26aufirst%3DM.%26atitle%3DSite-activated%2520Chelators%2520Targeting%2520Acetylcholinesterase%2520and%2520Monoamine%2520Oxidase%2520for%2520Alzheimer%25E2%2580%2599s%2520Therapy%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2010%26volume%3D5%26spage%3D603%26epage%3D610%26doi%3D10.1021%2Fcb900264w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Rochais, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lecoutey, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaven, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giannoni, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamidouche, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubost, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genest, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yahiaoui, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freret, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouet, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dauphin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sopkova de Oliveira Santos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballandonne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corvaisier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malzert-Fréon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Legay, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulouard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claeysen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dallemagne, P.</span><span> </span><span class="NLM_article-title">Novel Multitarget-directed Ligands (MTDLs) with Acetylcholinesterase (AChE) Inhibitory and Serotonergic Subtype 4 Receptor (5-HT4R) Agonist Activities as Potential Agents against Alzheimer’s Disease: the Design of Donecopride</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">3172</span><span class="NLM_x">–</span> <span class="NLM_lpage">3187</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00115</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00115" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC2MXkvFWjsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3172-3187&author=C.+Rochaisauthor=C.+Lecouteyauthor=F.+Gavenauthor=P.+Giannoniauthor=K.+Hamidoucheauthor=D.+Hedouauthor=E.+Dubostauthor=D.+Genestauthor=S.+Yahiaouiauthor=T.+Freretauthor=V.+Bouetauthor=F.+Dauphinauthor=J.+Sopkova+de+Oliveira+Santosauthor=C.+Ballandonneauthor=S.+Corvaisierauthor=A.+Malzert-Fr%C3%A9onauthor=R.+Legayauthor=M.+Boulouardauthor=S.+Claeysenauthor=P.+Dallemagne&title=Novel+Multitarget-directed+Ligands+%28MTDLs%29+with+Acetylcholinesterase+%28AChE%29+Inhibitory+and+Serotonergic+Subtype+4+Receptor+%285-HT4R%29+Agonist+Activities+as+Potential+Agents+against+Alzheimer%E2%80%99s+Disease%3A+the+Design+of+Donecopride&doi=10.1021%2Facs.jmedchem.5b00115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Multitarget-Directed Ligands (MTDLs) with Acetylcholinesterase (AChE) Inhibitory and Serotonergic Subtype 4 Receptor (5-HT4R) Agonist Activities As Potential Agents against Alzheimer's Disease: The Design of Donecopride</span></div><div class="casAuthors">Rochais, Christophe; Lecoutey, Cedric; Gaven, Florence; Giannoni, Patrizia; Hamidouche, Katia; Hedou, Damien; Dubost, Emmanuelle; Genest, David; Yahiaoui, Samir; Freret, Thomas; Bouet, Valentine; Dauphin, Francois; Sopkova de Oliveira Santos, Jana; Ballandonne, Celine; Corvaisier, Sophie; Malzert-Freon, Aurelie; Legay, Remi; Boulouard, Michel; Claeysen, Sylvie; Dallemagne, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3172-3187</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors describe the synthesis and in vitro evaluation of a novel series of multitarget-directed ligands (MTDL) displaying both nanomolar dual-binding site (DBS) acetylcholinesterase inhibitory effects and partial 5-HT4R agonist activity, among which donecopride was selected for further in vivo evaluations in mice.  The latter displayed procognitive and antiamnesic effects and enhanced sAPPα release, accounting for a potential symptomatic and disease-modifying therapeutic benefit in the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmfqjY4Tl4ObVg90H21EOLACvtfcHk0liPNNs8vxXx8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXkvFWjsrw%253D&md5=435652a2503e322ad880bd9607838103</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00115%26sid%3Dliteratum%253Aachs%26aulast%3DRochais%26aufirst%3DC.%26aulast%3DLecoutey%26aufirst%3DC.%26aulast%3DGaven%26aufirst%3DF.%26aulast%3DGiannoni%26aufirst%3DP.%26aulast%3DHamidouche%26aufirst%3DK.%26aulast%3DHedou%26aufirst%3DD.%26aulast%3DDubost%26aufirst%3DE.%26aulast%3DGenest%26aufirst%3DD.%26aulast%3DYahiaoui%26aufirst%3DS.%26aulast%3DFreret%26aufirst%3DT.%26aulast%3DBouet%26aufirst%3DV.%26aulast%3DDauphin%26aufirst%3DF.%26aulast%3DSopkova%2Bde%2BOliveira%2BSantos%26aufirst%3DJ.%26aulast%3DBallandonne%26aufirst%3DC.%26aulast%3DCorvaisier%26aufirst%3DS.%26aulast%3DMalzert-Fr%25C3%25A9on%26aufirst%3DA.%26aulast%3DLegay%26aufirst%3DR.%26aulast%3DBoulouard%26aufirst%3DM.%26aulast%3DClaeysen%26aufirst%3DS.%26aulast%3DDallemagne%26aufirst%3DP.%26atitle%3DNovel%2520Multitarget-directed%2520Ligands%2520%2528MTDLs%2529%2520with%2520Acetylcholinesterase%2520%2528AChE%2529%2520Inhibitory%2520and%2520Serotonergic%2520Subtype%25204%2520Receptor%2520%25285-HT4R%2529%2520Agonist%2520Activities%2520as%2520Potential%2520Agents%2520against%2520Alzheimer%25E2%2580%2599s%2520Disease%253A%2520the%2520Design%2520of%2520Donecopride%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3172%26epage%3D3187%26doi%3D10.1021%2Facs.jmedchem.5b00115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Pau, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinna, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frau, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murineddu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asproni, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curzu, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loza, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brea, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinna, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Multitarget-directed Tricyclic Pyridazinones as Ligands of Selected G-protein Coupled Receptors and Inhibitors of Cholinesterases</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1054</span><span class="NLM_x">–</span> <span class="NLM_lpage">1070</span><span class="refDoi"> DOI: 10.1002/cmdc.201500124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1002%2Fcmdc.201500124" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1054-1070&author=A.+Pauauthor=M.+Cattoauthor=G.+Pinnaauthor=S.+Frauauthor=G.+Murinedduauthor=B.+Asproniauthor=M.+M.+Curzuauthor=L.+Pisaniauthor=F.+Leonettiauthor=M.+I.+Lozaauthor=J.+Breaauthor=G.+A.+Pinnaauthor=A.+Carotti&title=Multitarget-directed+Tricyclic+Pyridazinones+as+Ligands+of+Selected+G-protein+Coupled+Receptors+and+Inhibitors+of+Cholinesterases&doi=10.1002%2Fcmdc.201500124"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500124%26sid%3Dliteratum%253Aachs%26aulast%3DPau%26aufirst%3DA.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DPinna%26aufirst%3DG.%26aulast%3DFrau%26aufirst%3DS.%26aulast%3DMurineddu%26aufirst%3DG.%26aulast%3DAsproni%26aufirst%3DB.%26aulast%3DCurzu%26aufirst%3DM.%2BM.%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DLoza%26aufirst%3DM.%2BI.%26aulast%3DBrea%26aufirst%3DJ.%26aulast%3DPinna%26aufirst%3DG.%2BA.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DMultitarget-directed%2520Tricyclic%2520Pyridazinones%2520as%2520Ligands%2520of%2520Selected%2520G-protein%2520Coupled%2520Receptors%2520and%2520Inhibitors%2520of%2520Cholinesterases%26jtitle%3DChemMedChem%26date%3D2015%26volume%3D10%26spage%3D1054%26epage%3D1070%26doi%3D10.1002%2Fcmdc.201500124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Fernández-Bachiller, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monjas, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rademann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodríguez-Franco, M. I.</span><span> </span><span class="NLM_article-title">New Tacrine–4-Oxo-4H-chromene Hybrids as Multifunctional Agents for the Treatment of Alzheimer’s Disease, with Cholinergic, Antioxidant, and β-Amyloid-Reducing Properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1303</span><span class="NLM_x">–</span> <span class="NLM_lpage">1317</span><span class="refDoi"> DOI: 10.1021/jm201460y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201460y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC38XntFKisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1303-1317&author=M.+I.+Fern%C3%A1ndez-Bachillerauthor=C.+P%C3%A9rezauthor=L.+Monjasauthor=J.+Rademannauthor=M.+I.+Rodr%C3%ADguez-Franco&title=New+Tacrine%E2%80%934-Oxo-4H-chromene+Hybrids+as+Multifunctional+Agents+for+the+Treatment+of+Alzheimer%E2%80%99s+Disease%2C+with+Cholinergic%2C+Antioxidant%2C+and+%CE%B2-Amyloid-Reducing+Properties&doi=10.1021%2Fjm201460y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">New Tacrine-4-Oxo-4H-chromene Hybrids as Multifunctional Agents for the Treatment of Alzheimer's Disease, with Cholinergic, Antioxidant, and β-Amyloid-Reducing Properties</span></div><div class="casAuthors">Fernandez-Bachiller, Maria Isabel; Perez, Concepcion; Monjas, Leticia; Rademann, Jorg; Rodriguez-Franco, Maria Isabel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1303-1317</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">By using fragments endowed with interesting and complementary properties for the treatment of Alzheimer's disease (AD), a new family of tacrine-4-oxo-4H-chromene hybrids has been designed, synthesized, and evaluated biol.  The tacrine fragment was selected for its inhibition of cholinesterases, and the flavonoid scaffold derived from 4-oxo-4H -chromene was chosen for its radical capture and β-secretase 1 (BACE-1) inhibitory activities.  At nano- and picomolar concns., the new tacrine-4-oxo-4H-chromene hybrids inhibit human acetyl- and butyrylcholinesterase (h-AChE and h-BuChE), being more potent than the parent inhibitor, tacrine.  They are also potent inhibitors of human BACE-1, better than the parent flavonoid, apigenin.  They show interesting antioxidant properties and could be able to penetrate into the CNS according to the in vitro PAMPA-BBB assay.  Among the hybrids investigated, 6-hydroxy-4-oxo- N-{10-[(1,2,3,4-tetrahydroacridin-9-yl)amino]decyl}-4 H-chromene-2-carboxamide (I) shows potent combined inhibition of human BACE-1 and ChEs, as well as good antioxidant and CNS-permeable properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiMx-NagCpeLVg90H21EOLACvtfcHk0liPNNs8vxXx8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntFKisw%253D%253D&md5=9391af9439e43f5eda518919839bd473</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm201460y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201460y%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez-Bachiller%26aufirst%3DM.%2BI.%26aulast%3DP%25C3%25A9rez%26aufirst%3DC.%26aulast%3DMonjas%26aufirst%3DL.%26aulast%3DRademann%26aufirst%3DJ.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26atitle%3DNew%2520Tacrine%25E2%2580%25934-Oxo-4H-chromene%2520Hybrids%2520as%2520Multifunctional%2520Agents%2520for%2520the%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%252C%2520with%2520Cholinergic%252C%2520Antioxidant%252C%2520and%2520%25CE%25B2-Amyloid-Reducing%2520Properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1303%26epage%3D1317%26doi%3D10.1021%2Fjm201460y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span> </span><span class="NLM_article-title">Tacrine–Ferulic Acid–Nitric Oxide (NO) Donor Trihybrids as Potent, Multifunctional Acetyl- and Butyrylcholinesterase Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4309</span><span class="NLM_x">–</span> <span class="NLM_lpage">4321</span><span class="refDoi"> DOI: 10.1021/jm300106z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300106z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4309-4321&author=Y.+Chenauthor=J.+Sunauthor=L.+Fangauthor=M.+Liuauthor=S.+Pengauthor=H.+Liaoauthor=J.+Lehmannauthor=Y.+Zhang&title=Tacrine%E2%80%93Ferulic+Acid%E2%80%93Nitric+Oxide+%28NO%29+Donor+Trihybrids+as+Potent%2C+Multifunctional+Acetyl-+and+Butyrylcholinesterase+Inhibitors&doi=10.1021%2Fjm300106z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm300106z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300106z%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DFang%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DLiao%26aufirst%3DH.%26aulast%3DLehmann%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DTacrine%25E2%2580%2593Ferulic%2520Acid%25E2%2580%2593Nitric%2520Oxide%2520%2528NO%2529%2520Donor%2520Trihybrids%2520as%2520Potent%252C%2520Multifunctional%2520Acetyl-%2520and%2520Butyrylcholinesterase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4309%26epage%3D4321%26doi%3D10.1021%2Fjm300106z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Fang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appenroth, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiehntopf, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lupp, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleck, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, J.</span><span> </span><span class="NLM_article-title">NO-Donating Tacrine Hybrid Compounds Improve Scopolamine-Induced Cognition Impairment and Show Less Hepatotoxicity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">7666</span><span class="NLM_x">–</span> <span class="NLM_lpage">7669</span><span class="refDoi"> DOI: 10.1021/jm801131a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801131a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=7666-7669&author=L.+Fangauthor=D.+Appenrothauthor=M.+Deckerauthor=M.+Kiehntopfauthor=A.+Luppauthor=S.+Pengauthor=C.+Fleckauthor=Y.+Zhangauthor=J.+Lehmann&title=NO-Donating+Tacrine+Hybrid+Compounds+Improve+Scopolamine-Induced+Cognition+Impairment+and+Show+Less+Hepatotoxicity&doi=10.1021%2Fjm801131a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm801131a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801131a%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DL.%26aulast%3DAppenroth%26aufirst%3DD.%26aulast%3DDecker%26aufirst%3DM.%26aulast%3DKiehntopf%26aufirst%3DM.%26aulast%3DLupp%26aufirst%3DA.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DFleck%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLehmann%26aufirst%3DJ.%26atitle%3DNO-Donating%2520Tacrine%2520Hybrid%2520Compounds%2520Improve%2520Scopolamine-Induced%2520Cognition%2520Impairment%2520and%2520Show%2520Less%2520Hepatotoxicity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D7666%26epage%3D7669%26doi%3D10.1021%2Fjm801131a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Dvir, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silman, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberry, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sussman, J. L.</span><span> </span><span class="NLM_article-title">Acetylcholinesterase: From 3D Structure to Function</span> <span class="citation_source-journal">Chem.-Biol. Interact.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">187</span><span class="NLM_x">, </span> <span class="NLM_fpage">10</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span><span class="refDoi"> DOI: 10.1016/j.cbi.2010.01.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1016%2Fj.cbi.2010.01.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=20138030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC3cXps1Wgsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=187&publication_year=2010&pages=10-22&author=H.+Dvirauthor=I.+Silmanauthor=M.+Harelauthor=T.+L.+Rosenberryauthor=J.+L.+Sussman&title=Acetylcholinesterase%3A+From+3D+Structure+to+Function&doi=10.1016%2Fj.cbi.2010.01.042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Acetylcholinesterase: From 3D structure to function</span></div><div class="casAuthors">Dvir, Hay; Silman, Israel; Harel, Michal; Rosenberry, Terrone L.; Sussman, Joel L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">187</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">10-22</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  By rapid hydrolysis of the neurotransmitter, acetylcholine, acetylcholinesterase (AChE) terminates neurotransmission at cholinergic synapses.  AChE is a very fast enzyme, functioning at a rate approaching that of a diffusion-controlled reaction.  The powerful toxicity of organophosphate poisons is attributed primarily to their potent inhibition of AChE.  AChE inhibitors are utilized in the treatment of various neurol. disorders, and are the principal drugs approved thus far by the FDA for management of Alzheimer's disease.  Many organophosphates and carbamates serve as potent insecticides, by selectively inhibiting insect AChE.  The detn. of the crystal structure of Torpedo californica AChE permitted visualization, for the 1st time, at at. resoln., of a binding pocket for acetylcholine.  It also allowed identification of the active site of AChE, which, unexpectedly, is located at the bottom of a deep gorge lined largely by arom. residues.  The crystal structure of recombinant human AChE in its apo-state is similar in its overall features to that of the Torpedo enzyme; however, the unique crystal packing reveals a novel peptide sequence which blocks access to the active site gorge.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnLqJTiC2TYrVg90H21EOLACvtfcHk0li2uxnrygTX1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXps1Wgsbc%253D&md5=9a6121388b34b77af442d1f039ba9a9c</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.cbi.2010.01.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbi.2010.01.042%26sid%3Dliteratum%253Aachs%26aulast%3DDvir%26aufirst%3DH.%26aulast%3DSilman%26aufirst%3DI.%26aulast%3DHarel%26aufirst%3DM.%26aulast%3DRosenberry%26aufirst%3DT.%2BL.%26aulast%3DSussman%26aufirst%3DJ.%2BL.%26atitle%3DAcetylcholinesterase%253A%2520From%25203D%2520Structure%2520to%2520Function%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2010%26volume%3D187%26spage%3D10%26epage%3D22%26doi%3D10.1016%2Fj.cbi.2010.01.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Harel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schalk, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehret-Sabatier, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouet, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goeldner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirth, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Axelsen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silman, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sussman, J. L.</span><span> </span><span class="NLM_article-title">Quaternary Ligand Binding to Aromatic Residues in the Active-site Gorge of Acetylcholinesterase</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">9031</span><span class="NLM_x">–</span> <span class="NLM_lpage">9035</span><span class="refDoi"> DOI: 10.1073/pnas.90.19.9031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1073%2Fpnas.90.19.9031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=8415649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADyaK3sXmsVCgtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1993&pages=9031-9035&author=M.+Harelauthor=I.+Schalkauthor=L.+Ehret-Sabatierauthor=F.+Bouetauthor=M.+Goeldnerauthor=C.+Hirthauthor=P.+H.+Axelsenauthor=I.+Silmanauthor=J.+L.+Sussman&title=Quaternary+Ligand+Binding+to+Aromatic+Residues+in+the+Active-site+Gorge+of+Acetylcholinesterase&doi=10.1073%2Fpnas.90.19.9031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase</span></div><div class="casAuthors">Harel, M.; Schalk, I.; Ehret-Sabatier, L.; Bouet, F.; Goeldner, M.; Hirth, C.; Axelsen, P. H.; Silman, I.; Sussman, J. L.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">9031-5</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">The binding sites of Torpedo acetylcholinesterase (AChE; EC 3.1.1.7) for quaternary ligands were investigated by x-ray crystallog. and photoaffinity labeling.  The crystal structures of complexes with ligands were detd. at 2.8-Å resoln.  In a complex with edrophonium, the quaternary N atom of the ligand interacted with the indole of Trp-84, and its m-OH group displayed bifurcated H-bonding to 2 members of the catalytic triad, Ser-200 and His-440.  In a complex with tacrine, the acridine was stacked against the indole of Trp-84.  The bisquaternary ligand, decamethonium, was oriented along the narrow gorge leading to the active site; one quaternary group was apposed to the indole of Trp-84 and the other to that of Trp-279, near the top of the gorge.  The only major conformational difference between the 3 complexes was in the orientation of the Ph ring of Phe-330.  In the decamethonium complex, it lay parallel to the surface of the gorge; in the other 2 complexes it was positioned to make contact with the bound ligand.  This close interaction was confirmed by photoaffinity labeling by the photosensitive probe, 3H-labeled p-(N,N-dimethylamino)benzenediazonium fluoroborate, which labeled, predominantly, Phe-330 within the active site.  The labeling of Trp-279 was also obsd.  One mole of label was incorporated per mol of AChE inactivated, indicating that the labeling of Trp-279 and that of Phe-330 were mutually exclusive.  The structural and chem. data, together, showed the important role of arom. groups as binding sites for quaternary ligands, and they provided complementary evidence assigning Trp-84 and Phe-330 to the anionic subsite of the active site and Trp-279 to the peripheral anionic site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVCccIwJSrW7Vg90H21EOLACvtfcHk0li2uxnrygTX1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXmsVCgtrc%253D&md5=6ee8dbaf1919d254a1cb62895f1a4444</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1073%2Fpnas.90.19.9031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.90.19.9031%26sid%3Dliteratum%253Aachs%26aulast%3DHarel%26aufirst%3DM.%26aulast%3DSchalk%26aufirst%3DI.%26aulast%3DEhret-Sabatier%26aufirst%3DL.%26aulast%3DBouet%26aufirst%3DF.%26aulast%3DGoeldner%26aufirst%3DM.%26aulast%3DHirth%26aufirst%3DC.%26aulast%3DAxelsen%26aufirst%3DP.%2BH.%26aulast%3DSilman%26aufirst%3DI.%26aulast%3DSussman%26aufirst%3DJ.%2BL.%26atitle%3DQuaternary%2520Ligand%2520Binding%2520to%2520Aromatic%2520Residues%2520in%2520the%2520Active-site%2520Gorge%2520of%2520Acetylcholinesterase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1993%26volume%3D90%26spage%3D9031%26epage%3D9035%26doi%3D10.1073%2Fpnas.90.19.9031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Inestrosa, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicente, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casanueva, O. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrido, J.</span><span> </span><span class="NLM_article-title">Acetylcholinesterase Accelerates Assembly of Amyloid-β-peptides into Alzheimer’s Fibrils: Possible Role of the Peripheral Site of the Enzyme</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">891</span><span class="refDoi"> DOI: 10.1016/S0896-6273(00)80108-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1016%2FS0896-6273%2800%2980108-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=8608006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADyaK28XislCmsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1996&pages=881-891&author=N.+C.+Inestrosaauthor=A.+Alvarezauthor=C.+A.+P%C3%A9rezauthor=R.+D.+Morenoauthor=M.+Vicenteauthor=C.+Linkerauthor=O.+I.+Casanuevaauthor=C.+Sotoauthor=J.+Garrido&title=Acetylcholinesterase+Accelerates+Assembly+of+Amyloid-%CE%B2-peptides+into+Alzheimer%E2%80%99s+Fibrils%3A+Possible+Role+of+the+Peripheral+Site+of+the+Enzyme&doi=10.1016%2FS0896-6273%2800%2980108-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Acetylcholinesterase accelerates assembly of amyloid-β-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme</span></div><div class="casAuthors">Inestrosa, Nibaldo C.; Alvarez, Alejandra; Perez, Cristian A.; Moreno, Ricardo D.; Vicente, Matias; Linker, Claudia; Casanueva, Olivia I.; Soto, Claudio; Garrido, Jorge</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">881-891</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Acetylcholinesterase (AChE), an important component of cholinergic synapses, colocalizes with amyloid-β peptide (Aβ) deposits of Alzheimer's brain.  The authors report here that bovine brain AChE, as well as the human and mouse recombinant enzyme, accelerates amyloid formation from wild-type Aβ and a mutant Aβ peptide, which alone produces few amyloid-like fibrils.  The action of AChE was independent of the subunit array of the enzyme, was not affected by edrophonium, an active site inhibitor, but it was affected by propidium, a peripheral anionic binding site ligand.  Butyrylcholinesterase, an enzyme that lacks the peripheral site, did not affect amyloid formation.  Furthermore, AChE is a potent amyloid-promoting factor when compared with other Aβ-assocd. proteins.  Thus, in addn. to its role in cholinergic synapses, AChE may function by accelerating Aβ formation and could play a role during amyloid deposition in Alzheimer's brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqx2wsrjgQa0LVg90H21EOLACvtfcHk0ljzM3TaUX3uhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XislCmsLk%253D&md5=299031351f764e5376b98407c3dc7278</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2FS0896-6273%2800%2980108-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0896-6273%252800%252980108-7%26sid%3Dliteratum%253Aachs%26aulast%3DInestrosa%26aufirst%3DN.%2BC.%26aulast%3DAlvarez%26aufirst%3DA.%26aulast%3DP%25C3%25A9rez%26aufirst%3DC.%2BA.%26aulast%3DMoreno%26aufirst%3DR.%2BD.%26aulast%3DVicente%26aufirst%3DM.%26aulast%3DLinker%26aufirst%3DC.%26aulast%3DCasanueva%26aufirst%3DO.%2BI.%26aulast%3DSoto%26aufirst%3DC.%26aulast%3DGarrido%26aufirst%3DJ.%26atitle%3DAcetylcholinesterase%2520Accelerates%2520Assembly%2520of%2520Amyloid-%25CE%25B2-peptides%2520into%2520Alzheimer%25E2%2580%2599s%2520Fibrils%253A%2520Possible%2520Role%2520of%2520the%2520Peripheral%2520Site%2520of%2520the%2520Enzyme%26jtitle%3DNeuron%26date%3D1996%26volume%3D16%26spage%3D881%26epage%3D891%26doi%3D10.1016%2FS0896-6273%2800%2980108-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Lockridge, O.</span><span> </span><span class="NLM_article-title">Review of Human Butyrylcholinesterase Structure, Function, Genetic Variants, History of Use in the Clinic, and Potential Therapeutic Uses</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">148</span><span class="NLM_x">, </span> <span class="NLM_fpage">34</span><span class="NLM_x">–</span> <span class="NLM_lpage">46</span><span class="refDoi"> DOI: 10.1016/j.pharmthera.2014.11.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1016%2Fj.pharmthera.2014.11.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=25448037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFOgsb%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2015&pages=34-46&author=O.+Lockridge&title=Review+of+Human+Butyrylcholinesterase+Structure%2C+Function%2C+Genetic+Variants%2C+History+of+Use+in+the+Clinic%2C+and+Potential+Therapeutic+Uses&doi=10.1016%2Fj.pharmthera.2014.11.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Review of human butyrylcholinesterase structure, function, genetic variants, history of use in the clinic, and potential therapeutic uses</span></div><div class="casAuthors">Lockridge, Oksana</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">34-46</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Phase I clin. trials have shown that pure human butyrylcholinesterase (BChE) is safe when administered to humans.  A potential therapeutic use of BChE is for prevention of nerve agent toxicity.  A recombinant mutant of BChE that rapidly inactivates cocaine is being developed as a treatment to help recovering cocaine addicts avoid relapse into drug taking.  These clin. applications rely on knowledge of the structure, stability, and properties of BChE, information that is reviewed here.  Gene therapy with a vector that sustains expression for a year from a single injection is a promising method for delivering therapeutic quantities of BChE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovtlcbO5w0-bVg90H21EOLACvtfcHk0ljzM3TaUX3uhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFOgsb%252FK&md5=7219bb957d1e99415414978b948ce98e</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2014.11.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2014.11.011%26sid%3Dliteratum%253Aachs%26aulast%3DLockridge%26aufirst%3DO.%26atitle%3DReview%2520of%2520Human%2520Butyrylcholinesterase%2520Structure%252C%2520Function%252C%2520Genetic%2520Variants%252C%2520History%2520of%2520Use%2520in%2520the%2520Clinic%252C%2520and%2520Potential%2520Therapeutic%2520Uses%26jtitle%3DPharmacol.%2520Ther.%26date%3D2015%26volume%3D148%26spage%3D34%26epage%3D46%26doi%3D10.1016%2Fj.pharmthera.2014.11.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Lane, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potkin, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enz, A.</span><span> </span><span class="NLM_article-title">Targeting Acetylcholinesterase and Butyrylcholinesterase in Dementia</span> <span class="citation_source-journal">Int. J. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span><span class="refDoi"> DOI: 10.1017/S1461145705005833</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1017%2FS1461145705005833" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=16083515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1ehtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=101-124&author=R.+M.+Laneauthor=S.+G.+Potkinauthor=A.+Enz&title=Targeting+Acetylcholinesterase+and+Butyrylcholinesterase+in+Dementia&doi=10.1017%2FS1461145705005833"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting acetylcholinesterase and butyrylcholinesterase in dementia</span></div><div class="casAuthors">Lane, Roger M.; Potkin, Steven G.; Enz, Albert</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">101-124</span>CODEN:
                <span class="NLM_cas:coden">IJNUFB</span>;
        ISSN:<span class="NLM_cas:issn">1461-1457</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">A review.  The cholinesterase inhibitors (ChE-Is) attenuate the cholinergic deficit underlying the cognitive and neuropsychiatric dysfunctions in patients with AD.  Inhibition of brain acetylcholinesterase (AChE) has been the major therapeutic target of ChE-I treatment strategies for Alzheimer's disease (AD).  AChE-pos. neurons project diffusely to the cortex, modulating cortical processing and responses to new and relevant stimuli.  Butyrylcholinesterase (BuChE)-pos. neurons project specifically to the frontal cortex, and may have roles in attention, executive function, emotional memory and behavior.  Furthermore, BuChE activity progressively increases as the severity of dementia advances, while AChE activity declines.  Therefore, inhibition of BuChE may provide addnl. benefits.  The two cholinesterase (ChE) enzymes that metabolize acetylcholine (ACh) differ significantly in substrate specificity, enzyme kinetics, expression and activity in different brain regions, and complexity of gene regulation.  In addn., recent evidence suggests that AChE and BuChE may have roles beyond classical' co-regulatory esterase functions in terminating ACh-mediated neurotransmission.  Non-classical' roles in modulating the activity of other proteins, regional cerebral blood flow, tau phosphorylation, and the amyloid cascade may affect rates of AD progression.  If these addnl. mechanisms are demonstrated to underlie clin. meaningful effects, modification of the over-simplistic cholinergic hypothesis in AD that is limited to symptomatic treatment, ignoring the potential of cholinergic therapies to modify the disease process, may be appropriate.  The specificity of ChE inhibitory activity, up-regulation of AChE activity and changes in the compn. of AChE mol. forms over time, selectivity for AD-relevant ChE mol. forms, brain vs. peripheral selectivity, and pharmacokinetic profile may be important determinants of the acute and long-term efficacy, safety and tolerability profiles of the different ChE-Is.  This review focuses on new evidence for the roles of BuChE and AChE in symptom generation and rate of underlying disease progression in dementia, and argues that it may be appropriate to re-evaluate the place of ChE-Is in the treatment of dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYzIuEFXpTS7Vg90H21EOLACvtfcHk0ljzM3TaUX3uhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1ehtw%253D%253D&md5=b5871dacc777b6c8769be565106cb988</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1017%2FS1461145705005833&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS1461145705005833%26sid%3Dliteratum%253Aachs%26aulast%3DLane%26aufirst%3DR.%2BM.%26aulast%3DPotkin%26aufirst%3DS.%2BG.%26aulast%3DEnz%26aufirst%3DA.%26atitle%3DTargeting%2520Acetylcholinesterase%2520and%2520Butyrylcholinesterase%2520in%2520Dementia%26jtitle%3DInt.%2520J.%2520Neuropsychopharmacol.%26date%3D2006%26volume%3D9%26spage%3D101%26epage%3D124%26doi%3D10.1017%2FS1461145705005833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Giacobini, E.</span><span> </span><span class="NLM_article-title">Selective Inhibitors of Butyrylcholinesterase: a Valid Alternative for Therapy of Alzheimer’s Disease?</span> <span class="citation_source-journal">Drugs Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">891</span><span class="NLM_x">–</span> <span class="NLM_lpage">898</span><span class="refDoi"> DOI: 10.2165/00002512-200118120-00001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.2165%2F00002512-200118120-00001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=11888344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BD38XjtFOhu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2001&pages=891-898&author=E.+Giacobini&title=Selective+Inhibitors+of+Butyrylcholinesterase%3A+a+Valid+Alternative+for+Therapy+of+Alzheimer%E2%80%99s+Disease%3F&doi=10.2165%2F00002512-200118120-00001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibitors of butyrylcholinesterase: A valid alternative for therapy of Alzheimer's disease?</span></div><div class="casAuthors">Giacobini, Ezio</div><div class="citationInfo"><span class="NLM_cas:title">Drugs & Aging</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">891-898</span>CODEN:
                <span class="NLM_cas:coden">DRAGE6</span>;
        ISSN:<span class="NLM_cas:issn">1170-229X</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">A review.  The brain of mammals contains two major forms of cholinesterases (ChEs): acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE).  The two forms differ genetically, structurally and in their kinetics.  Butyrylcholine is not a physiol. substrate in mammalian brains which makes the function of BuChE difficult to interpret.  In human brains, BuChE is found in neurons and glial cells as well as in neuritic plaques and tangles in patients with Alzheimer's disease (AD).  While AChE activity decreases progressively in the brain of patients with AD, BuChE activity shows some increase.  To study the function of BuChE, we perfused intracortically the rat brain with a selective BuChE inhibitor.  We found that extracellular acetylcholine levels increased 15-fold from 5 nmol/L to 75 nmol/L concns., with little cholinergic adverse effect in the animal.  Based on these data, we postulated that two pools of ChEs may be present in the brain: one mainly neuronal and AChE dependent; and one mainly glial and BuChE dependent.  The two pools show different kinetic properties with regard to regulation of acetylcholine concn. in the brain and can be sepd. with selective inhibitors.  The recent development of highly selective BuChE inhibitors will allow us to test these new agents in patients with AD to find out whether or not they represent an advantage for the treatment of patients with AD as compared with selective (donepezil) or relatively non-selective (rivastigmine, galantamine) ChE inhibitors presently in use.  The assocn. between a BuChE-K variant and AD has not been confirmed in several studies.  In conclusion, addnl. exptl. and clin. work is necessary to elucidate the role of BuChE in normal brain function and in the brains of patients with AD.  In the future, it may be possible that selective BuChE inhibitors will have a role in treatment of patients with advanced AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3OyEluyykwbVg90H21EOLACvtfcHk0ljvfLTPAtq-SQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjtFOhu7w%253D&md5=5740f558ad07fd4226f199744032be82</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.2165%2F00002512-200118120-00001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00002512-200118120-00001%26sid%3Dliteratum%253Aachs%26aulast%3DGiacobini%26aufirst%3DE.%26atitle%3DSelective%2520Inhibitors%2520of%2520Butyrylcholinesterase%253A%2520a%2520Valid%2520Alternative%2520for%2520Therapy%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%253F%26jtitle%3DDrugs%2520Aging%26date%3D2001%26volume%3D18%26spage%3D891%26epage%3D898%26doi%3D10.2165%2F00002512-200118120-00001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Riederer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielczyk, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruenblatt, E.</span><span> </span><span class="NLM_article-title">Monoamine Oxidase-B Inhibition in Alzheimer’s Disease</span> <span class="citation_source-journal">NeuroToxicology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">277</span><span class="refDoi"> DOI: 10.1016/S0161-813X(03)00106-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1016%2FS0161-813X%2803%2900106-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=14697902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtVSjtLjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=271-277&author=P.+Riedererauthor=W.+Danielczykauthor=E.+Gruenblatt&title=Monoamine+Oxidase-B+Inhibition+in+Alzheimer%E2%80%99s+Disease&doi=10.1016%2FS0161-813X%2803%2900106-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Monoamine oxidase-B inhibition in Alzheimer's disease</span></div><div class="casAuthors">Riederer, Peter; Danielczyk, Walter; Gruenblatt, Edna</div><div class="citationInfo"><span class="NLM_cas:title">Neurotoxicology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">271-277</span>CODEN:
                <span class="NLM_cas:coden">NRTXDN</span>;
        ISSN:<span class="NLM_cas:issn">0161-813X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is the most common cause of dementia in late life.  There is still no clear-cut consensus whether this disease involves genetic or environmental factors or both.  There is a great need to find a way to delay the disease, as delaying the onset of the disease will bring a great relieve on social and medical resources.  The monoamine oxidase-B (MAO-B) inhibitors were shown to be effective in treating Parkinson's disease and possibly AD, with concomitant extension of life span.  This article gives a short review on MAO-B inhibitors and their mechanism for neuroprotective effects in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGru-IfT1tqOu7Vg90H21EOLACvtfcHk0ljvfLTPAtq-SQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtVSjtLjJ&md5=e5966c4b79474e843f80aa939a427d35</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2FS0161-813X%2803%2900106-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0161-813X%252803%252900106-2%26sid%3Dliteratum%253Aachs%26aulast%3DRiederer%26aufirst%3DP.%26aulast%3DDanielczyk%26aufirst%3DW.%26aulast%3DGruenblatt%26aufirst%3DE.%26atitle%3DMonoamine%2520Oxidase-B%2520Inhibition%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DNeuroToxicology%26date%3D2004%26volume%3D25%26spage%3D271%26epage%3D277%26doi%3D10.1016%2FS0161-813X%2803%2900106-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">De Colibus, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binda, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lustig, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmondson, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattevi, A.</span><span> </span><span class="NLM_article-title">Three-Dimensional Structure of Human Monoamine Oxidase A (MAO A): Relation to the Structures of Rat MAO A and Human MAO B</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">12684</span><span class="NLM_x">–</span> <span class="NLM_lpage">12689</span><span class="refDoi"> DOI: 10.1073/pnas.0505975102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1073%2Fpnas.0505975102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=16129825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVWktLnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=12684-12689&author=L.+De+Colibusauthor=M.+Liauthor=C.+Bindaauthor=A.+Lustigauthor=D.+E.+Edmondsonauthor=A.+Mattevi&title=Three-Dimensional+Structure+of+Human+Monoamine+Oxidase+A+%28MAO+A%29%3A+Relation+to+the+Structures+of+Rat+MAO+A+and+Human+MAO+B&doi=10.1073%2Fpnas.0505975102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Three-dimensional structure of human monoamine oxidase A (MAO A): Relation to the structures of rat MAO A and human MAO B</span></div><div class="casAuthors">De Colibus, Luigi; Li, Min; Binda, Claudia; Lustig, Ariel; Edmondson, Dale E.; Mattevi, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">12684-12689</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The 3-dimensional x-ray crystal structure of recombinant human monoamine oxidase A (hMAO A) as its clorgyline-inhibited adduct is described.  Although the chain-fold of hMAO A was similar to that of rat MAO A and human MAO B (hMAO B), hMAO A was unique in that it crystd. as a monomer and exhibited the soln. hydrodynamic behavior of a monomeric form rather than the dimeric form of hMAO B and rat MAO A.  The hMAO A active site consisted of a single hydrophobic cavity of ∼550 Å3, which was smaller than that detd. from the structure of deprenyl-inhibited hMAO B (∼700 Å3) but larger than that of rat MAO A (∼450 Å3).  An important component of the active site structure of hMAO A was the loop conformation of residues 210-216, which differred from that of hMAO B and rat MAO A.  The origin of this structural alteration was suggested to have resulted from long-range interactions in the monomeric form of the enzyme.  In addn. to serving as a basis for the development of hMAO A-specific inhibitors, these data supported the proposal that hMAO A involves a change from the dimeric to the monomeric form through a E151K mutation that is specific to hMAO A.  These considerations place into question the use of MAO A from non-human sources in drug development for use in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPY_EaAsj_1rVg90H21EOLACvtfcHk0ljvfLTPAtq-SQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVWktLnJ&md5=5db5a50007df0a15df8cbfbc72670de9</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0505975102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0505975102%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BColibus%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DLustig%26aufirst%3DA.%26aulast%3DEdmondson%26aufirst%3DD.%2BE.%26aulast%3DMattevi%26aufirst%3DA.%26atitle%3DThree-Dimensional%2520Structure%2520of%2520Human%2520Monoamine%2520Oxidase%2520A%2520%2528MAO%2520A%2529%253A%2520Relation%2520to%2520the%2520Structures%2520of%2520Rat%2520MAO%2520A%2520and%2520Human%2520MAO%2520B%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D12684%26epage%3D12689%26doi%3D10.1073%2Fpnas.0505975102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Binda, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newton-Vinson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubalek, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmondson, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattevi, A.</span><span> </span><span class="NLM_article-title">Structure of Human Monoamine Oxidase B, a Drug Target for the Treatment of Neurological Disorders</span> <span class="citation_source-journal">Nat. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">22</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span><span class="refDoi"> DOI: 10.1038/nsb732</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1038%2Fnsb732" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=11753429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BD38XitV2rsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=22-26&author=C.+Bindaauthor=P.+Newton-Vinsonauthor=F.+Hubalekauthor=D.+E.+Edmondsonauthor=A.+Mattevi&title=Structure+of+Human+Monoamine+Oxidase+B%2C+a+Drug+Target+for+the+Treatment+of+Neurological+Disorders&doi=10.1038%2Fnsb732"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders</span></div><div class="casAuthors">Binda, Claudia; Newton-Vinson, Paige; Hubalek, Frantisek; Edmondson, Dale E.; Mattevi, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-26</span>CODEN:
                <span class="NLM_cas:coden">NSBIEW</span>;
        ISSN:<span class="NLM_cas:issn">1072-8368</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">Monoamine oxidase B (MAO B) is a mitochondrial outer membrane flavoenzyme that is a well-known target for antidepressant and neuroprotective drugs.  Here, the authors detd. the structure of the human liver enzyme to 3 Å resoln.  Human liver MAO B was found to bind to the membrane through a C-terminal transmembrane helix and apolar loops located at various positions in the sequence.  The electron d. showed that pargyline, an analog of the clin. used MAO B inhibitor, deprenyl, binds covalently to the flavin N5 atom.  The active site of MAO B consisted of a 420-Å3 hydrophobic substrate cavity interconnected to an entrance cavity of 290 Å3.  The recognition site for the substrate amino group was an arom. cage formed by Tyr-398 and Tyr-435.  The structure provides a framework for probing the catalytic mechanism, understanding the differences between the MAO A and B isoforms and designing specific inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8p43h-vsPi7Vg90H21EOLACvtfcHk0lgbKDN7r7rM6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XitV2rsg%253D%253D&md5=261d3b1375d833bbfd0a23bdade49be6</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fnsb732&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsb732%26sid%3Dliteratum%253Aachs%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DNewton-Vinson%26aufirst%3DP.%26aulast%3DHubalek%26aufirst%3DF.%26aulast%3DEdmondson%26aufirst%3DD.%2BE.%26aulast%3DMattevi%26aufirst%3DA.%26atitle%3DStructure%2520of%2520Human%2520Monoamine%2520Oxidase%2520B%252C%2520a%2520Drug%2520Target%2520for%2520the%2520Treatment%2520of%2520Neurological%2520Disorders%26jtitle%3DNat.%2520Struct.%2520Biol.%26date%3D2002%26volume%3D9%26spage%3D22%26epage%3D26%26doi%3D10.1038%2Fnsb732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Rapaport, M. H.</span><span> </span><span class="NLM_article-title">Dietary Restrictions and Drug Interactions with Monoamine Oxidase Inhibitors: the State of the Art</span> <span class="citation_source-journal">J. Clin. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">42</span><span class="NLM_x">–</span> <span class="NLM_lpage">46</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.4088%2FJCP.0407e11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=17640157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsFGntbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2007&pages=42-46&author=M.+H.+Rapaport&title=Dietary+Restrictions+and+Drug+Interactions+with+Monoamine+Oxidase+Inhibitors%3A+the+State+of+the+Art"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Dietary restrictions and drug interactions with monoamine oxidase inhibitors: the state of the art</span></div><div class="casAuthors">Rapaport, Mark Hyman</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Psychiatry (Memphis, TN, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">Suppl. 8</span>),
    <span class="NLM_cas:pages">42-46</span>CODEN:
                <span class="NLM_cas:coden">JCLPDE</span>;
        ISSN:<span class="NLM_cas:issn">0160-6689</span>.
    
            (<span class="NLM_cas:orgname">Physicians Postgraduate Press, Inc.</span>)
        </div><div class="casAbstract">A review.  Antidepressant activity of monoamine oxidase inhibitors (MAOIs) was initially noted in the 1950s, and by the early 1960s, they were a mainstay of antidepressant treatment.  Reports of adverse events such as acute hypertensive reactions following the ingestion of certain foods and beverages tempered clinicians' enthusiasm for MAOIs.  Introduction of the tricyclic antidepressants and the selective serotonin reuptake inhibitors led to declines in the use of MAOIs.  However, MAOIs have been well established as an effective intervention for people with treatment-resistant depression, and transdermal formulations may provide a valuable therapeutic option and eliminate the drug-food interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAB7QVJPRN57Vg90H21EOLACvtfcHk0lgbKDN7r7rM6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsFGntbc%253D&md5=90577be6b6c24e5e6829c40f59997271</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.4088%2FJCP.0407e11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4088%252FJCP.0407e11%26sid%3Dliteratum%253Aachs%26aulast%3DRapaport%26aufirst%3DM.%2BH.%26atitle%3DDietary%2520Restrictions%2520and%2520Drug%2520Interactions%2520with%2520Monoamine%2520Oxidase%2520Inhibitors%253A%2520the%2520State%2520of%2520the%2520Art%26jtitle%3DJ.%2520Clin.%2520Psychiatry%26date%3D2007%26volume%3D68%26spage%3D42%26epage%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Wimbiscus, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kostenko, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malone, D.</span><span> </span><span class="NLM_article-title">MAO Inhibitors: Risks, Benefits, and Lore</span> <span class="citation_source-journal">Cleve. Clin. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">859</span><span class="NLM_x">–</span> <span class="NLM_lpage">882</span><span class="refDoi"> DOI: 10.3949/ccjm.77a.09103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.3949%2Fccjm.77a.09103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=21147941" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A280%3ADC%252BC3M%252FktVehsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2010&pages=859-882&author=M.+Wimbiscusauthor=O.+Kostenkoauthor=D.+Malone&title=MAO+Inhibitors%3A+Risks%2C+Benefits%2C+and+Lore&doi=10.3949%2Fccjm.77a.09103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">MAO inhibitors: risks, benefits, and lore</span></div><div class="casAuthors">Wimbiscus Molly; Kostenko Olga; Malone Donald</div><div class="citationInfo"><span class="NLM_cas:title">Cleveland Clinic journal of medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">859-82</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Monoamine oxidase (MAO) inhibitors were the first antidepressants introduced, but their use has dwindled because of their reported side effects, their food and drug interactions, and the introduction of other classes of agents.  However, interest in MAO inhibitors is reviving.  Here, we discuss their use, risks, and benefits in clinical medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS5l3ppB6CZKLmQt-ICR3qNfW6udTcc2eZNbt4Vtdu1n7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M%252FktVehsw%253D%253D&md5=557ad1fb6c82cd0fa448fdc72252f690</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.3949%2Fccjm.77a.09103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3949%252Fccjm.77a.09103%26sid%3Dliteratum%253Aachs%26aulast%3DWimbiscus%26aufirst%3DM.%26aulast%3DKostenko%26aufirst%3DO.%26aulast%3DMalone%26aufirst%3DD.%26atitle%3DMAO%2520Inhibitors%253A%2520Risks%252C%2520Benefits%252C%2520and%2520Lore%26jtitle%3DCleve.%2520Clin.%2520J.%2520Med.%26date%3D2010%26volume%3D77%26spage%3D859%26epage%3D882%26doi%3D10.3949%2Fccjm.77a.09103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Barnham, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masters, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, A. I.</span><span> </span><span class="NLM_article-title">Neurodegenerative Diseases and Oxidative Stress</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">214</span><span class="refDoi"> DOI: 10.1038/nrd1330</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1038%2Fnrd1330" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=15031734" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BD2cXit12nsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=205-214&author=K.+J.+Barnhamauthor=C.+L.+Mastersauthor=A.+I.+Bush&title=Neurodegenerative+Diseases+and+Oxidative+Stress&doi=10.1038%2Fnrd1330"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Neurodegenerative diseases and oxidative stress</span></div><div class="casAuthors">Barnham, Kevin J.; Masters, Colin L.; Bush, Ashley I.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">205-214</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Oxidative stress has been implicated in the progression of Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis.  Oxygen is vital for life but is also potentially dangerous, and a complex system of checks and balances exists for utilizing this essential element.  Oxidative stress is the result of an imbalance in pro-oxidant/antioxidant homeostasis that leads to the generation of toxic reactive oxygen species.  The systems in place to cope with the biochem. of oxygen are complex, and many questions about the mechanisms of oxygen regulation remain unanswered.  However, this same complexity provides a no. of therapeutic targets, and different strategies, including novel metal-protein attenuating compds., aimed at a variety of targets have shown promise in clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPqGR8Vlz1hLVg90H21EOLACvtfcHk0lgbKDN7r7rM6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXit12nsL4%253D&md5=73a09223923e8b895ebee89405e5c7fd</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fnrd1330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1330%26sid%3Dliteratum%253Aachs%26aulast%3DBarnham%26aufirst%3DK.%2BJ.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DBush%26aufirst%3DA.%2BI.%26atitle%3DNeurodegenerative%2520Diseases%2520and%2520Oxidative%2520Stress%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D205%26epage%3D214%26doi%3D10.1038%2Fnrd1330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Tonelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tasso, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iusco, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Stradis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denora, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sparatore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boido, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sparatore, F.</span><span> </span><span class="NLM_article-title">Multitarget Therapeutic Leads for Alzheimer’s disease. Quinolizidinyl Derivatives of Bi- and Tri-cyclic Systems as Dual Inhibitors of Cholinesterases and Aβ Aggregation</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1040</span><span class="NLM_x">–</span> <span class="NLM_lpage">1053</span><span class="refDoi"> DOI: 10.1002/cmdc.201500104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1002%2Fcmdc.201500104" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1040-1053&author=M.+Tonelliauthor=M.+Cattoauthor=B.+Tassoauthor=F.+Novelliauthor=C.+Canuauthor=G.+Iuscoauthor=L.+Pisaniauthor=A.+De+Stradisauthor=N.+Denoraauthor=A.+Sparatoreauthor=V.+Boidoauthor=A.+Carottiauthor=F.+Sparatore&title=Multitarget+Therapeutic+Leads+for+Alzheimer%E2%80%99s+disease.+Quinolizidinyl+Derivatives+of+Bi-+and+Tri-cyclic+Systems+as+Dual+Inhibitors+of+Cholinesterases+and+A%CE%B2+Aggregation&doi=10.1002%2Fcmdc.201500104"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500104%26sid%3Dliteratum%253Aachs%26aulast%3DTonelli%26aufirst%3DM.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DTasso%26aufirst%3DB.%26aulast%3DNovelli%26aufirst%3DF.%26aulast%3DCanu%26aufirst%3DC.%26aulast%3DIusco%26aufirst%3DG.%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DDe%2BStradis%26aufirst%3DA.%26aulast%3DDenora%26aufirst%3DN.%26aulast%3DSparatore%26aufirst%3DA.%26aulast%3DBoido%26aufirst%3DV.%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DSparatore%26aufirst%3DF.%26atitle%3DMultitarget%2520Therapeutic%2520Leads%2520for%2520Alzheimer%25E2%2580%2599s%2520disease.%2520Quinolizidinyl%2520Derivatives%2520of%2520Bi-%2520and%2520Tri-cyclic%2520Systems%2520as%2520Dual%2520Inhibitors%2520of%2520Cholinesterases%2520and%2520A%25CE%25B2%2520Aggregation%26jtitle%3DChemMedChem%26date%3D2015%26volume%3D10%26spage%3D1040%26epage%3D1053%26doi%3D10.1002%2Fcmdc.201500104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Farina, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gadaleta, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denora, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto-Otero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendez-Alvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Passos, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muncipinto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altomare, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nurisso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrupt, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Structure-Based Design and Optimization of Multitarget-Directed 2H-Chromen-2-one Derivatives as Potent Inhibitors of Monoamine Oxidase B and Cholinesterases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">5561</span><span class="NLM_x">–</span> <span class="NLM_lpage">5578</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00599</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00599" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVKitL7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=5561-5578&author=R.+Farinaauthor=L.+Pisaniauthor=M.+Cattoauthor=O.+Nicolottiauthor=D.+Gadaletaauthor=N.+Denoraauthor=R.+Soto-Oteroauthor=E.+Mendez-Alvarezauthor=C.+S.+Passosauthor=G.+Muncipintoauthor=C.+D.+Altomareauthor=A.+Nurissoauthor=P.+A.+Carruptauthor=A.+Carotti&title=Structure-Based+Design+and+Optimization+of+Multitarget-Directed+2H-Chromen-2-one+Derivatives+as+Potent+Inhibitors+of+Monoamine+Oxidase+B+and+Cholinesterases&doi=10.1021%2Facs.jmedchem.5b00599"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design and Optimization of Multitarget-Directed 2H-Chromen-2-one Derivatives as Potent Inhibitors of Monoamine Oxidase B and Cholinesterases</span></div><div class="casAuthors">Farina, Roberta; Pisani, Leonardo; Catto, Marco; Nicolotti, Orazio; Gadaleta, Domenico; Denora, Nunzio; Soto-Otero, Ramon; Mendez-Alvarez, Estefania; Passos, Carolina S.; Muncipinto, Giovanni; Altomare, Cosimo D.; Nurisso, Alessandra; Carrupt, Pierre-Alain; Carotti, Angelo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5561-5578</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The multifactorial nature of Alzheimer's disease calls for the development of multitarget agents addressing key pathogenic processes.  To this end, by following a docking-assisted hybridization strategy, a no. of aminocoumarins were designed, prepd., and tested as monoamine oxidases (MAOs) and acetyl- and butyryl-cholinesterase (AChE and BChE) inhibitors.  Highly flexible N-benzyl-N-alkyloxy coumarins 2-12 showed good inhibitory activities at MAO-B, AChE, and BChE but low selectivity.  More rigid inhibitors, bearing meta- and para-xylyl linkers, displayed good inhibitory activities and high MAO-B selectivity.  Compds. 21, 24, 37, and 39, the last two featuring an improved hydrophilic/lipophilic balance, exhibited excellent activity profiles with nanomolar inhibitory potency toward hMAO-B, high hMAO-B over hMAO-A selectivity and submicromolar potency at hAChE.  Cell-based assays of BBB permeation, neurotoxicity, and neuroprotection supported the potential of compd. 37 as a BBB-permeant neuroprotective agent against H2O2-induced oxidative stress with poor interaction as P-gp substrate and very low cytotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpy2Qk3gFsdSrVg90H21EOLACvtfcHk0lh0uLg4SQDT2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVKitL7P&md5=b15458c0ce6d2ea9c182edcd685c0aff</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00599%26sid%3Dliteratum%253Aachs%26aulast%3DFarina%26aufirst%3DR.%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DGadaleta%26aufirst%3DD.%26aulast%3DDenora%26aufirst%3DN.%26aulast%3DSoto-Otero%26aufirst%3DR.%26aulast%3DMendez-Alvarez%26aufirst%3DE.%26aulast%3DPassos%26aufirst%3DC.%2BS.%26aulast%3DMuncipinto%26aufirst%3DG.%26aulast%3DAltomare%26aufirst%3DC.%2BD.%26aulast%3DNurisso%26aufirst%3DA.%26aulast%3DCarrupt%26aufirst%3DP.%2BA.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DStructure-Based%2520Design%2520and%2520Optimization%2520of%2520Multitarget-Directed%25202H-Chromen-2-one%2520Derivatives%2520as%2520Potent%2520Inhibitors%2520of%2520Monoamine%2520Oxidase%2520B%2520and%2520Cholinesterases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D5561%26epage%3D5578%26doi%3D10.1021%2Facs.jmedchem.5b00599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Matos, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terán, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez-Castillo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uriarte, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santana, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viña, D.</span><span> </span><span class="NLM_article-title">Synthesis and Study of a Series of 3-Arylcoumarins as Potent and Selective Monoamine Oxidase B Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">7127</span><span class="NLM_x">–</span> <span class="NLM_lpage">7137</span><span class="refDoi"> DOI: 10.1021/jm200716y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200716y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1ClsLbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7127-7137&author=M.+J.+Matosauthor=C.+Ter%C3%A1nauthor=Y.+P%C3%A9rez-Castilloauthor=E.+Uriarteauthor=L.+Santanaauthor=D.+Vi%C3%B1a&title=Synthesis+and+Study+of+a+Series+of+3-Arylcoumarins+as+Potent+and+Selective+Monoamine+Oxidase+B+Inhibitors&doi=10.1021%2Fjm200716y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Study of a Series of 3-Arylcoumarins as Potent and Selective Monoamine Oxidase B Inhibitors</span></div><div class="casAuthors">Matos, Maria J.; Teran, Carmen; Perez-Castillo, Yunierkis; Uriarte, Eugenio; Santana, Lourdes; Vina, Dolores</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7127-7137</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">New series of 6-substituted-3-arylcoumarins displaying several alkyl, hydroxyl, halogen, and alkoxy groups in the two benzene rings have been designed, synthesized, and evaluated in vitro as human monoamine oxidase A and B (hMAO-A and hMAO-B) inhibitors.  Most of the studied compds. showed a high affinity and selectivity to the hMAO-B isoenzyme, with IC50 values on nanomolar and picomolar range.  Ten of the 22 described compds. displayed higher MAO-B inhibitory activity and selectivity than selegiline.  Coumarin I is the most active compd. of this series, being 64 times more active than selegiline and also showing the highest hMAO-B specificity.  In addn., docking expts. were carried out on hMAO-A and h-MAO-B structures.  This study provided new information about the enzyme-inhibitor interaction and the potential therapeutic application of this 3-arylcoumarin scaffold.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotg_Ewi_Rdz7Vg90H21EOLACvtfcHk0lh0uLg4SQDT2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1ClsLbO&md5=5d33aabf0583fa6025334ded40030177</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm200716y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200716y%26sid%3Dliteratum%253Aachs%26aulast%3DMatos%26aufirst%3DM.%2BJ.%26aulast%3DTer%25C3%25A1n%26aufirst%3DC.%26aulast%3DP%25C3%25A9rez-Castillo%26aufirst%3DY.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DSantana%26aufirst%3DL.%26aulast%3DVi%25C3%25B1a%26aufirst%3DD.%26atitle%3DSynthesis%2520and%2520Study%2520of%2520a%2520Series%2520of%25203-Arylcoumarins%2520as%2520Potent%2520and%2520Selective%2520Monoamine%2520Oxidase%2520B%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7127%26epage%3D7137%26doi%3D10.1021%2Fjm200716y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Mertens, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gütschow, M.</span><span> </span><span class="NLM_article-title">Alkynyl–coumarinyl Ethers as MAO-B Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1916</span><span class="NLM_x">–</span> <span class="NLM_lpage">1928</span><span class="refDoi"> DOI: 10.1016/j.bmc.2014.01.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1016%2Fj.bmc.2014.01.046" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=1916-1928&author=M.+D.+Mertensauthor=S.+Hinzauthor=C.+E.+M%C3%BCllerauthor=M.+G%C3%BCtschow&title=Alkynyl%E2%80%93coumarinyl+Ethers+as+MAO-B+Inhibitors&doi=10.1016%2Fj.bmc.2014.01.046"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.01.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.01.046%26sid%3Dliteratum%253Aachs%26aulast%3DMertens%26aufirst%3DM.%2BD.%26aulast%3DHinz%26aufirst%3DS.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DG%25C3%25BCtschow%26aufirst%3DM.%26atitle%3DAlkynyl%25E2%2580%2593coumarinyl%2520Ethers%2520as%2520MAO-B%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D1916%26epage%3D1928%26doi%3D10.1016%2Fj.bmc.2014.01.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Secci, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carradori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolasco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chimenti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yáñez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortuso, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcaro, S.</span><span> </span><span class="NLM_article-title">Synthesis and Selective Human Monoamine Oxidase Inhibition of 3-Carbonyl, 3-Acyl, and 3-Carboxyhydrazido Coumarin Derivatives</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">4846</span><span class="NLM_x">–</span> <span class="NLM_lpage">4852</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2011.07.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1016%2Fj.ejmech.2011.07.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=21872365" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1amt7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=4846-4852&author=D.+Secciauthor=S.+Carradoriauthor=A.+Bolascoauthor=P.+Chimentiauthor=M.+Y%C3%A1%C3%B1ezauthor=F.+Ortusoauthor=S.+Alcaro&title=Synthesis+and+Selective+Human+Monoamine+Oxidase+Inhibition+of+3-Carbonyl%2C+3-Acyl%2C+and+3-Carboxyhydrazido+Coumarin+Derivatives&doi=10.1016%2Fj.ejmech.2011.07.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and selective human monoamine oxidase inhibition of 3-carbonyl, 3-acyl, and 3-carboxyhydrazido coumarin derivatives</span></div><div class="casAuthors">Secci, Daniela; Carradori, Simone; Bolasco, Adriana; Chimenti, Paola; Yanez, Matilde; Ortuso, Francesco; Alcaro, Stefano</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4846-4852</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Several 3-acyl-, 3-carboxy-, and 3-hydrazinocarbonylcoumarins have been synthesized in high yields (72-99%) and tested in vitro for their human monoamine oxidase A and B (hMAO-A and hMAO-B) inhibitory activity.  Different substituents on the coumarin nucleus were evaluated for their effect on biol. activity and isoform selectivity.  Substitution at position 7 of coumarin-3-carboxylate, or the 3-hydrazinocarbonyl substituent, were important to obtain highly potent and selective hMAO-B inhibitors with IC50 values in the nanomolar range.  Some derivs. were also submitted to a stability test and showed no chem. cleavage in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr42WEMp4WOVLVg90H21EOLACvtfcHk0lhxtTVmIwyR0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1amt7zE&md5=2575c7e7360109c25f64c342ab6ffc4a</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.07.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.07.017%26sid%3Dliteratum%253Aachs%26aulast%3DSecci%26aufirst%3DD.%26aulast%3DCarradori%26aufirst%3DS.%26aulast%3DBolasco%26aufirst%3DA.%26aulast%3DChimenti%26aufirst%3DP.%26aulast%3DY%25C3%25A1%25C3%25B1ez%26aufirst%3DM.%26aulast%3DOrtuso%26aufirst%3DF.%26aulast%3DAlcaro%26aufirst%3DS.%26atitle%3DSynthesis%2520and%2520Selective%2520Human%2520Monoamine%2520Oxidase%2520Inhibition%2520of%25203-Carbonyl%252C%25203-Acyl%252C%2520and%25203-Carboxyhydrazido%2520Coumarin%2520Derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D4846%26epage%3D4852%26doi%3D10.1016%2Fj.ejmech.2011.07.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Patil, P. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bari, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Firke, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshmukh, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donda, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patil, D. A.</span><span> </span><span class="NLM_article-title">A Comprehensive Review on Synthesis and Designing Aspects of Coumarin Derivatives as Monoamine Oxidase Inhibitors for Depression and Alzheimer’s Disease</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2434</span><span class="NLM_x">–</span> <span class="NLM_lpage">2450</span><span class="refDoi"> DOI: 10.1016/j.bmc.2013.02.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1016%2Fj.bmc.2013.02.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=23517722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktlSiuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=2434-2450&author=P.+O.+Patilauthor=S.+B.+Bariauthor=S.+D.+Firkeauthor=P.+K.+Deshmukhauthor=S.+T.+Dondaauthor=D.+A.+Patil&title=A+Comprehensive+Review+on+Synthesis+and+Designing+Aspects+of+Coumarin+Derivatives+as+Monoamine+Oxidase+Inhibitors+for+Depression+and+Alzheimer%E2%80%99s+Disease&doi=10.1016%2Fj.bmc.2013.02.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">A comprehensive review on synthesis and designing aspects of coumarin derivatives as monoamine oxidase inhibitors for depression and Alzheimer's disease</span></div><div class="casAuthors">Patil, Pravin O.; Bari, Sanjay B.; Firke, Sandip D.; Deshmukh, Prashant K.; Donda, Shailesh T.; Patil, Dilip A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2434-2450</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Monoamine oxidase (MAO) enzyme inhibition is a crucial target for the management of depression and Alzheimer disease and inhibitors of MAO are the most important drugs for their management.  Coumarins are a large family of compds., of natural and synthetic origin, that exhibit a variety of pharmacol. activities, including MAO inhibition.  The current review highlights the design and synthetic methods of coumarin derivs. as well as coumarins obtained from plant source as MAO inhibitors for treatment of depression and Alzheimer disease with salient finding related to structure-activity relationship.  The aim of present review is to find out natural as well as synthetic coumarins as MAO inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBZYAH89AyobVg90H21EOLACvtfcHk0lhxtTVmIwyR0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktlSiuro%253D&md5=15c84861ae6fc00bcf9ffba764223694</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.02.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.02.017%26sid%3Dliteratum%253Aachs%26aulast%3DPatil%26aufirst%3DP.%2BO.%26aulast%3DBari%26aufirst%3DS.%2BB.%26aulast%3DFirke%26aufirst%3DS.%2BD.%26aulast%3DDeshmukh%26aufirst%3DP.%2BK.%26aulast%3DDonda%26aufirst%3DS.%2BT.%26aulast%3DPatil%26aufirst%3DD.%2BA.%26atitle%3DA%2520Comprehensive%2520Review%2520on%2520Synthesis%2520and%2520Designing%2520Aspects%2520of%2520Coumarin%2520Derivatives%2520as%2520Monoamine%2520Oxidase%2520Inhibitors%2520for%2520Depression%2520and%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D2434%26epage%3D2450%26doi%3D10.1016%2Fj.bmc.2013.02.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Delogu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picciau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quezada, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podda, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uriarte, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viña, D.</span><span> </span><span class="NLM_article-title">Synthesis, Human Monoamine Oxidase Inhibitory Activity and Molecular Docking Studies of 3-Heteroaryl Coumarin Derivatives</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1147</span><span class="NLM_x">–</span> <span class="NLM_lpage">1152</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2011.01.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1016%2Fj.ejmech.2011.01.033" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=1147-1152&author=G.+Deloguauthor=C.+Picciauauthor=G.+Ferinoauthor=E.+Quezadaauthor=G.+Poddaauthor=E.+Uriarteauthor=D.+Vi%C3%B1a&title=Synthesis%2C+Human+Monoamine+Oxidase+Inhibitory+Activity+and+Molecular+Docking+Studies+of+3-Heteroaryl+Coumarin+Derivatives&doi=10.1016%2Fj.ejmech.2011.01.033"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.01.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.01.033%26sid%3Dliteratum%253Aachs%26aulast%3DDelogu%26aufirst%3DG.%26aulast%3DPicciau%26aufirst%3DC.%26aulast%3DFerino%26aufirst%3DG.%26aulast%3DQuezada%26aufirst%3DE.%26aulast%3DPodda%26aufirst%3DG.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DVi%25C3%25B1a%26aufirst%3DD.%26atitle%3DSynthesis%252C%2520Human%2520Monoamine%2520Oxidase%2520Inhibitory%2520Activity%2520and%2520Molecular%2520Docking%2520Studies%2520of%25203-Heteroaryl%2520Coumarin%2520Derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D1147%26epage%3D1152%26doi%3D10.1016%2Fj.ejmech.2011.01.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesce, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanachi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cellamare, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Design, Synthesis and Biological Evaluation of Coumarin Alkylamines as Potent and Selective Dual Binding Site Inhibitors of Acetylcholinesterase</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">146</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span><span class="refDoi"> DOI: 10.1016/j.bmc.2012.10.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1016%2Fj.bmc.2012.10.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=23199476" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslCktbvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=146-152&author=M.+Cattoauthor=L.+Pisaniauthor=F.+Leonettiauthor=O.+Nicolottiauthor=P.+Pesceauthor=A.+Stefanachiauthor=S.+Cellamareauthor=A.+Carotti&title=Design%2C+Synthesis+and+Biological+Evaluation+of+Coumarin+Alkylamines+as+Potent+and+Selective+Dual+Binding+Site+Inhibitors+of+Acetylcholinesterase&doi=10.1016%2Fj.bmc.2012.10.045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of coumarin alkylamines as potent and selective dual binding site inhibitors of acetylcholinesterase</span></div><div class="casAuthors">Catto, Marco; Pisani, Leonardo; Leonetti, Francesco; Nicolotti, Orazio; Pesce, Paolo; Stefanachi, Angela; Cellamare, Saverio; Carotti, Angelo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">146-152</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Acetylcholinesterase inhibitors (AChEIs) are currently the drugs of choice, although only symptomatic and palliative, for the treatment of Alzheimer's disease (AD).  Donepezil is one of most used AChEIs in AD therapy, acting as a dual binding site, reversible inhibitor of AChE with high selectivity over butyrylcholinesterase (BChE).  Through a combined target- and ligand-based approach, a series of coumarin alkylamines matching the structural determinants of donepezil were designed and prepd. 6,7-Dimethoxycoumarin derivs. carrying a protonatable benzylamino group, linked to position 3 by suitable linkers, exhibited fairly good AChE inhibitory activity and a high selectivity over BChE.  The inhibitory potency was strongly influenced by the length and shape of the spacer and by the methoxy substituents on the coumarin scaffold.  The inhibition mechanism, assessed for the most active compd. (I) (IC50 7.6 nM) resulted in a mixed-type, thus confirming its binding at both the catalytic and peripheral binding sites of AChE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAeZ1Mvxg--bVg90H21EOLACvtfcHk0lgR_KBkbpuBug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslCktbvK&md5=c36fd204f63c76a1ad185b4535300e56</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2012.10.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2012.10.045%26sid%3Dliteratum%253Aachs%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DPesce%26aufirst%3DP.%26aulast%3DStefanachi%26aufirst%3DA.%26aulast%3DCellamare%26aufirst%3DS.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DDesign%252C%2520Synthesis%2520and%2520Biological%2520Evaluation%2520of%2520Coumarin%2520Alkylamines%2520as%2520Potent%2520and%2520Selective%2520Dual%2520Binding%2520Site%2520Inhibitors%2520of%2520Acetylcholinesterase%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D146%26epage%3D152%26doi%3D10.1016%2Fj.bmc.2012.10.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Alipour, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khoobi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moradi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadri, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moghadam, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasanpour, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foroumadi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shafiee, A.</span><span> </span><span class="NLM_article-title">Synthesis and Anti-cholinesterase Activity of New 7-Hydroxycoumarin Derivatives</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">536</span><span class="NLM_x">–</span> <span class="NLM_lpage">544</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2014.05.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1016%2Fj.ejmech.2014.05.056" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2014&pages=536-544&author=M.+Alipourauthor=M.+Khoobiauthor=A.+Moradiauthor=H.+Nadriauthor=F.+H.+Moghadamauthor=S.+Emamiauthor=Z.+Hasanpourauthor=A.+Foroumadiauthor=A.+Shafiee&title=Synthesis+and+Anti-cholinesterase+Activity+of+New+7-Hydroxycoumarin+Derivatives&doi=10.1016%2Fj.ejmech.2014.05.056"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.05.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.05.056%26sid%3Dliteratum%253Aachs%26aulast%3DAlipour%26aufirst%3DM.%26aulast%3DKhoobi%26aufirst%3DM.%26aulast%3DMoradi%26aufirst%3DA.%26aulast%3DNadri%26aufirst%3DH.%26aulast%3DMoghadam%26aufirst%3DF.%2BH.%26aulast%3DEmami%26aufirst%3DS.%26aulast%3DHasanpour%26aufirst%3DZ.%26aulast%3DForoumadi%26aufirst%3DA.%26aulast%3DShafiee%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520Anti-cholinesterase%2520Activity%2520of%2520New%25207-Hydroxycoumarin%2520Derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D82%26spage%3D536%26epage%3D544%26doi%3D10.1016%2Fj.ejmech.2014.05.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giangreco, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanachi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cellamare, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Design, Synthesis and Biological Evaluation of Coumarin Derivatives Tethered to an Edrophonium-like Fragment as Highly Potent and Selective Dual Binding Site Acetylcholinesterase Inhibitors</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1616</span><span class="NLM_x">–</span> <span class="NLM_lpage">1630</span><span class="refDoi"> DOI: 10.1002/cmdc.201000210</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1002%2Fcmdc.201000210" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=1616-1630&author=L.+Pisaniauthor=M.+Cattoauthor=I.+Giangrecoauthor=F.+Leonettiauthor=O.+Nicolottiauthor=A.+Stefanachiauthor=S.+Cellamareauthor=A.+Carotti&title=Design%2C+Synthesis+and+Biological+Evaluation+of+Coumarin+Derivatives+Tethered+to+an+Edrophonium-like+Fragment+as+Highly+Potent+and+Selective+Dual+Binding+Site+Acetylcholinesterase+Inhibitors&doi=10.1002%2Fcmdc.201000210"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201000210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201000210%26sid%3Dliteratum%253Aachs%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DGiangreco%26aufirst%3DI.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DStefanachi%26aufirst%3DA.%26aulast%3DCellamare%26aufirst%3DS.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DDesign%252C%2520Synthesis%2520and%2520Biological%2520Evaluation%2520of%2520Coumarin%2520Derivatives%2520Tethered%2520to%2520an%2520Edrophonium-like%2520Fragment%2520as%2520Highly%2520Potent%2520and%2520Selective%2520Dual%2520Binding%2520Site%2520Acetylcholinesterase%2520Inhibitors%26jtitle%3DChemMedChem%26date%3D2010%26volume%3D5%26spage%3D1616%26epage%3D1630%26doi%3D10.1002%2Fcmdc.201000210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Wang, Z.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, G.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, L.-Y.</span><span> </span><span class="NLM_article-title">Synthesis and Evaluation of 6-Substituted 3-Arylcoumarin Derivatives as Multifunctional Acetylcholinesterase/monoamine Oxidase B Dual Inhibitors for the Treatment of Alzheimer’s Disease</span> <span class="citation_source-journal">RSC Adv.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">104122</span><span class="NLM_x">–</span> <span class="NLM_lpage">104137</span><span class="refDoi"> DOI: 10.1039/C5RA22296F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1039%2FC5RA22296F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFykt7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=104122-104137&author=Z.-M.+Wangauthor=X.-M.+Liauthor=G.-M.+Xueauthor=W.+Xuauthor=X.-B.+Wangauthor=L.-Y.+Kong&title=Synthesis+and+Evaluation+of+6-Substituted+3-Arylcoumarin+Derivatives+as+Multifunctional+Acetylcholinesterase%2Fmonoamine+Oxidase+B+Dual+Inhibitors+for+the+Treatment+of+Alzheimer%E2%80%99s+Disease&doi=10.1039%2FC5RA22296F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of 6-substituted 3-arylcoumarin derivatives as multifunctional acetylcholinesterase/monoamine oxidase B dual inhibitors for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Wang, Zhi-Min; Li, Xue-Mei; Xue, Gui-Min; Xu, Wei; Wang, Xiao-Bing; Kong, Ling-Yi</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">126</span>),
    <span class="NLM_cas:pages">104122-104137</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Considering the complex etiol. of Alzheimer's disease (AD), multifunctional agents may exhibit important properties against this disease.  A series of 6-substituted 3-arylcoumarins (5a-t) were designed, synthesized and evaluated as cholinesterase (ChE) and monoamino oxidase (MAO) inhibitors.  Among them, compds. 5o [IC50, 195 nM for human acetylcholinesterase (hAChE), selectivity index, SI (human butyrylcholinesterase, hBuChE/hAChE) = 145; IC50, 63.5 nM for human monoamine oxidase-B (hMAO-B), SI (human monoamine oxidase-A, hMAO-A/hMAO-B) = 25] and 5p [IC50, 185 nM for hAChE, SI (hBuChE/hAChE) = 182; IC50, 196 nM for hMAO-B, SI (hMAO-A/hMAO-B) > 510] were found to selectively inhibit both hAChE and hMAO-B with IC50 values in the nanomolar range.  The abilities of 5o and 5p to bind to hAChE and hMAO-B were confirmed by mol. docking and kinetic studies.  Moreover, 5o and 5p were found to exhibit significant inhibition of self-induced Aβ42 aggregation (61% and 52%, at 20 μM), have antioxidant properties (0.81 and 1.17 trolox equiv. by ABTS assay), provide neuroprotection against Aβ42-induced cytotoxicity and blood-brain barrier (BBB) penetration capacity (PAMPA-BBB+), and are thus potential anti-Alzheimer agents with balanced activities.  Overall, the study provided meaningful information for further development of multifunctional drugs for AD therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqt7hLsrl0vQbVg90H21EOLACvtfcHk0lgR_KBkbpuBug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFykt7rL&md5=3437763ed8b0a5f5dc6b5c2b785be383</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1039%2FC5RA22296F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5RA22296F%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.-M.%26aulast%3DLi%26aufirst%3DX.-M.%26aulast%3DXue%26aufirst%3DG.-M.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DX.-B.%26aulast%3DKong%26aufirst%3DL.-Y.%26atitle%3DSynthesis%2520and%2520Evaluation%2520of%25206-Substituted%25203-Arylcoumarin%2520Derivatives%2520as%2520Multifunctional%2520Acetylcholinesterase%252Fmonoamine%2520Oxidase%2520B%2520Dual%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DRSC%2520Adv.%26date%3D2015%26volume%3D5%26spage%3D104122%26epage%3D104137%26doi%3D10.1039%2FC5RA22296F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Xie, S.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, K. D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, J.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, L.-Y.</span><span> </span><span class="NLM_article-title">Multi-target Tacrine-coumarin Hybrids: Cholinesterase and Monoamine Oxidase B Inhibition Properties against Alzheimer’s Disease</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">165</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2015.03.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1016%2Fj.ejmech.2015.03.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=25812965" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltFWjsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2015&pages=153-165&author=S.-S.+Xieauthor=X.+Wangauthor=N.+Jiangauthor=W.+Yuauthor=K.+D.+G.+Wangauthor=J.-S.+Lanauthor=Z.-R.+Liauthor=L.-Y.+Kong&title=Multi-target+Tacrine-coumarin+Hybrids%3A+Cholinesterase+and+Monoamine+Oxidase+B+Inhibition+Properties+against+Alzheimer%E2%80%99s+Disease&doi=10.1016%2Fj.ejmech.2015.03.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target tacrine-coumarin hybrids: Cholinesterase and monoamine oxidase B inhibition properties against Alzheimer's disease</span></div><div class="casAuthors">Xie, Sai-Sai; Wang, Xiaobing; Jiang, Neng; Yu, Wenying; Wang, Kelvin D. G.; Lan, Jin-Shuai; Li, Zhong-Rui; Kong, Ling-Yi</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">153-165</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of novel tacrine-coumarin hybrids were designed, synthesized and evaluated as multi-target agents against Alzheimer's disease.  The biol. assays indicated that most of compds. displayed potent inhibitory activity toward AChE and BuChE, and clearly selective inhibition for MAO-B.  Among these compds., 3,4-Dimethyl-7-(2-(4-(3-((1,2,3,4-tetrahydroacridin-9-yl)amino)propyl)piperazin-1-yl)ethoxy)-2H-chromen-2-one (I), exhibited strong inhibitory activity for AChE (IC50 values of 33.63 nM for eeAChE and 16.11 nM for hAChE) and BuChE (IC50 values of 80.72 nM for eqBuChE and 112.72 nM for hBuChE), and the highest inhibitory activity against hMAO-B (IC50 value of 0.24 μM).  Kinetic and mol. modeling studies revealed that (I) was a mixed-type inhibitor, binding simultaneously to catalytic, peripheral and mid-gorge sites of AChE.  It was also a competitive inhibitor, which covered the substrate and entrance cavities of MAO-B.  Moreover, (I) could penetrate the CNS and show low cell toxicity.  Overall, these results suggested that (I) might be an excellent multi-target agent for AD treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVTl9JCLOwBrVg90H21EOLACvtfcHk0liGBzmbiW9qSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltFWjsLo%253D&md5=cd1d6c79030dd81976643ff8b14f4bd4</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.03.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.03.040%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DS.-S.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DJiang%26aufirst%3DN.%26aulast%3DYu%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DK.%2BD.%2BG.%26aulast%3DLan%26aufirst%3DJ.-S.%26aulast%3DLi%26aufirst%3DZ.-R.%26aulast%3DKong%26aufirst%3DL.-Y.%26atitle%3DMulti-target%2520Tacrine-coumarin%2520Hybrids%253A%2520Cholinesterase%2520and%2520Monoamine%2520Oxidase%2520B%2520Inhibition%2520Properties%2520against%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D95%26spage%3D153%26epage%3D165%26doi%3D10.1016%2Fj.ejmech.2015.03.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Jameel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umar, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoda, N.</span><span> </span><span class="NLM_article-title">Coumarin: A Privileged Scaffold for the Design and Development of Antineurodegenerative Agents</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">38</span><span class="refDoi"> DOI: 10.1111/cbdd.12629</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1111%2Fcbdd.12629" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=26242562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsV2lu7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2016&pages=21-38&author=E.+Jameelauthor=T.+Umarauthor=J.+Kumarauthor=N.+Hoda&title=Coumarin%3A+A+Privileged+Scaffold+for+the+Design+and+Development+of+Antineurodegenerative+Agents&doi=10.1111%2Fcbdd.12629"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Coumarin: A Privileged Scaffold for the Design and Development of Antineurodegenerative Agents</span></div><div class="casAuthors">Jameel, Ehtesham; Umar, Tarana; Kumar, Jitendra; Hoda, Nasimul</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-38</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Drug development for neurodegenerative diseases (NDs) is foremost task for the medicinal chemists in the 21st century.  Coumarins are exemplary of an assorted and aptitudinally useful set of drugs.  Coumarins play a momentous role in several pharmacol. and medicinal aspects.  Its analogs are anticipated to play a significant role in the development of new therapeutic leads for NDs.  Their promising applications in the field of ND medication are exemplified by clin. candidates such as nodakenin that have been potent for demoting memory impairment.  Apart from ND, clin. used anticoagulant warfarin, anticoagulant dicoumarol, and antibiotic coumermycin, novobiocin and chartesium grab the interest of researchers in coumarins.  It would be worthwhile to look at the different biol. processes that could cause neurodegeneration, thereby establishing a link with distinct coumarin derivs. to serve the purpose of medication.  This review undertakes estn. of the wide spectrum of studies focusing coumarin to the domain of drug research for ND.  Herein, we search for multitarget coumarin-based inhibitors and their scope for NDs.  Future challenges in coumarin-based drug development have been discussed, and emphases have been laid on the future perspectives of coumarins as possible drugs in the future for the treatment of NDs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkGmS5nfpCM7Vg90H21EOLACvtfcHk0liGBzmbiW9qSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsV2lu7vJ&md5=bacefa47f3f14eab3b0548fc6361e655</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1111%2Fcbdd.12629&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcbdd.12629%26sid%3Dliteratum%253Aachs%26aulast%3DJameel%26aufirst%3DE.%26aulast%3DUmar%26aufirst%3DT.%26aulast%3DKumar%26aufirst%3DJ.%26aulast%3DHoda%26aufirst%3DN.%26atitle%3DCoumarin%253A%2520A%2520Privileged%2520Scaffold%2520for%2520the%2520Design%2520and%2520Development%2520of%2520Antineurodegenerative%2520Agents%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2016%26volume%3D87%26spage%3D21%26epage%3D38%26doi%3D10.1111%2Fcbdd.12629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muncipinto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miscioscia, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caccia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvati, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto-Otero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendez-Alvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Passeleu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Discovery of a Novel Class of Potent Coumarin Monoamine Oxidase B Inhibitors: Development and Biopharmacological Profiling of 7-[(3-Chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one Methanesulfonate (NW-1772) as a Highly Potent, Selective, Reversible, and Orally Active Monoamine Oxidase B Inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6685</span><span class="NLM_x">–</span> <span class="NLM_lpage">6706</span><span class="refDoi"> DOI: 10.1021/jm9010127</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9010127" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1artL3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6685-6706&author=L.+Pisaniauthor=G.+Muncipintoauthor=T.+F.+Misciosciaauthor=O.+Nicolottiauthor=F.+Leonettiauthor=M.+Cattoauthor=C.+Cacciaauthor=P.+Salvatiauthor=R.+Soto-Oteroauthor=E.+Mendez-Alvarezauthor=C.+Passeleuauthor=A.+Carotti&title=Discovery+of+a+Novel+Class+of+Potent+Coumarin+Monoamine+Oxidase+B+Inhibitors%3A+Development+and+Biopharmacological+Profiling+of+7-%5B%283-Chlorobenzyl%29oxy%5D-4-%5B%28methylamino%29methyl%5D-2H-chromen-2-one+Methanesulfonate+%28NW-1772%29+as+a+Highly+Potent%2C+Selective%2C+Reversible%2C+and+Orally+Active+Monoamine+Oxidase+B+Inhibitor&doi=10.1021%2Fjm9010127"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Novel Class of Potent Coumarin Monoamine Oxidase B Inhibitors: Development and Biopharmacological Profiling of 7-[(3-Chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one Methanesulfonate (NW-1772) as a Highly Potent, Selective, Reversible, and Orally Active Monoamine Oxidase B Inhibitor</span></div><div class="casAuthors">Pisani, Leonardo; Muncipinto, Giovanni; Miscioscia, Teresa Fabiola; Nicolotti, Orazio; Leonetti, Francesco; Catto, Marco; Caccia, Carla; Salvati, Patricia; Soto-Otero, Ramon; Mendez-Alvarez, Estefania; Passeleu, Celine; Carotti, Angelo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6685-6706</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In an effort to discover novel selective monoamine oxidase (MAO) B inhibitors with favorable physicochem. and pharmacokinetic profiles, 7-[(m-halogeno)benzyloxy]coumarins bearing properly selected polar substituents at position 4 were designed, synthesized, and evaluated as MAO inhibitors.  Several compds. with MAO-B inhibitory activity in the nanomolar range and excellent MAO-B selectivity (selectivity index SI > 400) were identified.  Structure-affinity relationships and docking simulations provided valuable insights into the enzyme-inhibitor binding interactions at position 4, which has been poorly explored.  Furthermore, computational and exptl. studies led to the identification and biopharmacol. characterization of 7-[(3-chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one methanesulfonate (I) (NW-1772) as an in vitro and in vivo potent and selective MAO-B inhibitor, with rapid blood-brain barrier penetration, short-acting and reversible inhibitory activity, slight inhibition of selected cytochrome P450s, and low in vitro toxicity.  On the basis of this preliminary preclin. profile, inhibitor I might be viewed as a promising clin. candidate for the treatment of neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX-2hebE1dsbVg90H21EOLACvtfcHk0liGBzmbiW9qSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1artL3N&md5=b5cdda9e190504fced3ed6c5157c3266</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm9010127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9010127%26sid%3Dliteratum%253Aachs%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DMuncipinto%26aufirst%3DG.%26aulast%3DMiscioscia%26aufirst%3DT.%2BF.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DCaccia%26aufirst%3DC.%26aulast%3DSalvati%26aufirst%3DP.%26aulast%3DSoto-Otero%26aufirst%3DR.%26aulast%3DMendez-Alvarez%26aufirst%3DE.%26aulast%3DPasseleu%26aufirst%3DC.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520a%2520Novel%2520Class%2520of%2520Potent%2520Coumarin%2520Monoamine%2520Oxidase%2520B%2520Inhibitors%253A%2520Development%2520and%2520Biopharmacological%2520Profiling%2520of%25207-%255B%25283-Chlorobenzyl%2529oxy%255D-4-%255B%2528methylamino%2529methyl%255D-2H-chromen-2-one%2520Methanesulfonate%2520%2528NW-1772%2529%2520as%2520a%2520Highly%2520Potent%252C%2520Selective%252C%2520Reversible%252C%2520and%2520Orally%2520Active%2520Monoamine%2520Oxidase%2520B%2520Inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6685%26epage%3D6706%26doi%3D10.1021%2Fjm9010127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barletta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto-Otero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendez-Alvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Introcaso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanachi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cellamare, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altomare, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Discovery, Biological Evaluation, and Structure–Activity and – Selectivity Relationships of 6′-Substituted (E)-2-(Benzofuran-3(2H)-ylidene)-N-methylacetamides, a Novel Class of Potent and Selective Monoamine Oxidase Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">2651</span><span class="NLM_x">–</span> <span class="NLM_lpage">2664</span><span class="refDoi"> DOI: 10.1021/jm4000769</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4000769" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=2651-2664&author=L.+Pisaniauthor=M.+Barlettaauthor=R.+Soto-Oteroauthor=O.+Nicolottiauthor=E.+Mendez-Alvarezauthor=M.+Cattoauthor=A.+Introcasoauthor=A.+Stefanachiauthor=S.+Cellamareauthor=C.+Altomareauthor=A.+Carotti&title=Discovery%2C+Biological+Evaluation%2C+and+Structure%E2%80%93Activity+and+%E2%80%93+Selectivity+Relationships+of+6%E2%80%B2-Substituted+%28E%29-2-%28Benzofuran-3%282H%29-ylidene%29-N-methylacetamides%2C+a+Novel+Class+of+Potent+and+Selective+Monoamine+Oxidase+Inhibitors&doi=10.1021%2Fjm4000769"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm4000769&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4000769%26sid%3Dliteratum%253Aachs%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DBarletta%26aufirst%3DM.%26aulast%3DSoto-Otero%26aufirst%3DR.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DMendez-Alvarez%26aufirst%3DE.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DIntrocaso%26aufirst%3DA.%26aulast%3DStefanachi%26aufirst%3DA.%26aulast%3DCellamare%26aufirst%3DS.%26aulast%3DAltomare%26aufirst%3DC.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DDiscovery%252C%2520Biological%2520Evaluation%252C%2520and%2520Structure%25E2%2580%2593Activity%2520and%2520%25E2%2580%2593%2520Selectivity%2520Relationships%2520of%25206%25E2%2580%25B2-Substituted%2520%2528E%2529-2-%2528Benzofuran-3%25282H%2529-ylidene%2529-N-methylacetamides%252C%2520a%2520Novel%2520Class%2520of%2520Potent%2520and%2520Selective%2520Monoamine%2520Oxidase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D2651%26epage%3D2664%26doi%3D10.1021%2Fjm4000769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favia, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto-Otero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendez-Alvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Structural Insights into Monoamine Oxidase Inhibitory Potency and Selectivity of 7-Substituted Coumarins from Ligand- and Target-Based Approaches</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4912</span><span class="NLM_x">–</span> <span class="NLM_lpage">4925</span><span class="refDoi"> DOI: 10.1021/jm060183l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060183l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4912-4925&author=M.+Cattoauthor=O.+Nicolottiauthor=F.+Leonettiauthor=A.+Carottiauthor=A.+D.+Faviaauthor=R.+Soto-Oteroauthor=E.+Mendez-Alvarezauthor=A.+Carotti&title=Structural+Insights+into+Monoamine+Oxidase+Inhibitory+Potency+and+Selectivity+of+7-Substituted+Coumarins+from+Ligand-+and+Target-Based+Approaches&doi=10.1021%2Fjm060183l"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm060183l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060183l%26sid%3Dliteratum%253Aachs%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DFavia%26aufirst%3DA.%2BD.%26aulast%3DSoto-Otero%26aufirst%3DR.%26aulast%3DMendez-Alvarez%26aufirst%3DE.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DStructural%2520Insights%2520into%2520Monoamine%2520Oxidase%2520Inhibitory%2520Potency%2520and%2520Selectivity%2520of%25207-Substituted%2520Coumarins%2520from%2520Ligand-%2520and%2520Target-Based%2520Approaches%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4912%26epage%3D4925%26doi%3D10.1021%2Fjm060183l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Carotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altomare, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gnerre, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Marco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Testa, B.</span><span> </span><span class="NLM_article-title">Lipophilicity Plays a Major Role in Modulating Monoamine Oxidase B (MAO-B). Inhibition by 7-Substituted Coumarins</span> <span class="citation_source-journal">Chem. Biodiversity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">134</span><span class="NLM_x">–</span> <span class="NLM_lpage">144</span><span class="refDoi"> DOI: 10.1002/cbdv.200690017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1002%2Fcbdv.200690017" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=134-144&author=A.+Carottiauthor=C.+Altomareauthor=M.+Cattoauthor=C.+Gnerreauthor=L.+Summoauthor=A.+De+Marcoauthor=S.+Roseauthor=P.+Jennerauthor=B.+Testa&title=Lipophilicity+Plays+a+Major+Role+in+Modulating+Monoamine+Oxidase+B+%28MAO-B%29.+Inhibition+by+7-Substituted+Coumarins&doi=10.1002%2Fcbdv.200690017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1002%2Fcbdv.200690017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbdv.200690017%26sid%3Dliteratum%253Aachs%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DAltomare%26aufirst%3DC.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DGnerre%26aufirst%3DC.%26aulast%3DSummo%26aufirst%3DL.%26aulast%3DDe%2BMarco%26aufirst%3DA.%26aulast%3DRose%26aufirst%3DS.%26aulast%3DJenner%26aufirst%3DP.%26aulast%3DTesta%26aufirst%3DB.%26atitle%3DLipophilicity%2520Plays%2520a%2520Major%2520Role%2520in%2520Modulating%2520Monoamine%2520Oxidase%2520B%2520%2528MAO-B%2529.%2520Inhibition%2520by%25207-Substituted%2520Coumarins%26jtitle%3DChem.%2520Biodiversity%26date%3D2006%26volume%3D3%26spage%3D134%26epage%3D144%26doi%3D10.1002%2Fcbdv.200690017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Braccio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto-Otero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendez-Alvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanachi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gadaleta, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Fine Molecular Tuning at Position 4 of 2H-Chromen-2-one Derivatives in the Search of Potent and Selective Monoamine Oxidase B Inhibitors</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">723</span><span class="NLM_x">–</span> <span class="NLM_lpage">739</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2013.09.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1016%2Fj.ejmech.2013.09.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=24231308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFOqu7%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2013&pages=723-739&author=L.+Pisaniauthor=M.+Cattoauthor=O.+Nicolottiauthor=G.+Grossiauthor=M.+Di+Braccioauthor=R.+Soto-Oteroauthor=E.+Mendez-Alvarezauthor=A.+Stefanachiauthor=D.+Gadaletaauthor=A.+Carotti&title=Fine+Molecular+Tuning+at+Position+4+of+2H-Chromen-2-one+Derivatives+in+the+Search+of+Potent+and+Selective+Monoamine+Oxidase+B+Inhibitors&doi=10.1016%2Fj.ejmech.2013.09.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Fine molecular tuning at position 4 of 2H-chromen-2-one derivatives in the search of potent and selective monoamine oxidase B inhibitors</span></div><div class="casAuthors">Pisani, Leonardo; Catto, Marco; Nicolotti, Orazio; Grossi, Giancarlo; Di Braccio, Mario; Soto-Otero, Ramon; Mendez-Alvarez, Estefania; Stefanachi, Angela; Gadaleta, Domenico; Carotti, Angelo</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">723-739</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The effects on the inhibition potencies of monoamine oxidase isoforms A (MAO-A) and B (MAO-B) depending upon changes in the physicochem. properties (size, shape, H-bonding, lipophilicity, etc.) of substituents at the C4 position of 2H-chromen-2-one derivs. were extensively investigated, and the results significantly added to our knowledge on this class of MAO inhibitors.  All the 67 examd. compds. showed high MAO-B selectivity, some of them achieving potency in the low nanomolar range.  In particular, 7-meta-chlorobenzyloxy-4-oxyacetamido-2H-chromen-2-one showed single digit nanomolar MAO-B potency (IC50 = 3.1 nM) and high selectivity over the MAO-A isoform (selectivity ratio = 7244).  The great variety of the investigated substituents at C4 of the 2H-chromen-2-one nucleus, combined with binding models generated from docking studies carried out on selected compds., allowed us to shed light on the main mol. requirements for potent and selective MAO-B inhibition, highlighting the dominant role of the steric effects.  Interestingly, many of the designed substituents could be metabolically related to each other (e.g., CH3/CH2OH/CHO/COOH; NH2/NHCH3, NHAc), and therefore the results obtained may help in predicting the in vivo activity of some putative metabolites of lead MAO-B inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7YkDy75tEzbVg90H21EOLACvtfcHk0ljl4OmvCIizwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFOqu7%252FJ&md5=69adf68e70301614b8b7529eb7385aff</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2013.09.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2013.09.034%26sid%3Dliteratum%253Aachs%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DGrossi%26aufirst%3DG.%26aulast%3DDi%2BBraccio%26aufirst%3DM.%26aulast%3DSoto-Otero%26aufirst%3DR.%26aulast%3DMendez-Alvarez%26aufirst%3DE.%26aulast%3DStefanachi%26aufirst%3DA.%26aulast%3DGadaleta%26aufirst%3DD.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DFine%2520Molecular%2520Tuning%2520at%2520Position%25204%2520of%25202H-Chromen-2-one%2520Derivatives%2520in%2520the%2520Search%2520of%2520Potent%2520and%2520Selective%2520Monoamine%2520Oxidase%2520B%2520Inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D70%26spage%3D723%26epage%3D739%26doi%3D10.1016%2Fj.ejmech.2013.09.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Cheung, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudolph, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burshteyn, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassidy, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gary, E. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Love, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franklin, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Height, J. J.</span><span> </span><span class="NLM_article-title">Structures of Human Acetylcholinesterase in Complex with Pharmacologically Important Ligands</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">10282</span><span class="NLM_x">–</span> <span class="NLM_lpage">10286</span><span class="refDoi"> DOI: 10.1021/jm300871x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300871x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVGqtLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10282-10286&author=J.+Cheungauthor=M.+J.+Rudolphauthor=F.+Burshteynauthor=M.+S.+Cassidyauthor=E.+N.+Garyauthor=J.+Loveauthor=M.+C.+Franklinauthor=J.+J.+Height&title=Structures+of+Human+Acetylcholinesterase+in+Complex+with+Pharmacologically+Important+Ligands&doi=10.1021%2Fjm300871x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of Human Acetylcholinesterase in Complex with Pharmacologically Important Ligands</span></div><div class="casAuthors">Cheung, Jonah; Rudolph, Michael J.; Burshteyn, Fiana; Cassidy, Michael S.; Gary, Ebony N.; Love, James; Franklin, Matthew C.; Height, Jude J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10282-10286</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human acetylcholinesterase (AChE) is a significant target for therapeutic drugs.  Here we present high resoln. crystal structures of human AChE, alone and in complexes with drug ligands; donepezil, an Alzheimer's disease drug, binds differently to human AChE than it does to Torpedo AChE.  These crystals of human AChE provide a more accurate platform for further drug development than previously available.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdjhYPmZBMf7Vg90H21EOLACvtfcHk0lhUduPDJ57gvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVGqtLnN&md5=c27461e0288f42ac96af354cbefd387e</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm300871x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300871x%26sid%3Dliteratum%253Aachs%26aulast%3DCheung%26aufirst%3DJ.%26aulast%3DRudolph%26aufirst%3DM.%2BJ.%26aulast%3DBurshteyn%26aufirst%3DF.%26aulast%3DCassidy%26aufirst%3DM.%2BS.%26aulast%3DGary%26aufirst%3DE.%2BN.%26aulast%3DLove%26aufirst%3DJ.%26aulast%3DFranklin%26aufirst%3DM.%2BC.%26aulast%3DHeight%26aufirst%3DJ.%2BJ.%26atitle%3DStructures%2520of%2520Human%2520Acetylcholinesterase%2520in%2520Complex%2520with%2520Pharmacologically%2520Important%2520Ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10282%26epage%3D10286%26doi%3D10.1021%2Fjm300871x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farina, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gadaleta, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto-Otero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Braccio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendez-Alvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">In Silico Design of Novel 2H-Chromen-2-one Derivatives as Potent and Selective MAO-B Inhibitors</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">98</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2014.10.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1016%2Fj.ejmech.2014.10.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=25462230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslGjtrnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2015&pages=98-105&author=L.+Pisaniauthor=R.+Farinaauthor=O.+Nicolottiauthor=D.+Gadaletaauthor=R.+Soto-Oteroauthor=M.+Cattoauthor=M.+Di+Braccioauthor=E.+Mendez-Alvarezauthor=A.+Carotti&title=In+Silico+Design+of+Novel+2H-Chromen-2-one+Derivatives+as+Potent+and+Selective+MAO-B+Inhibitors&doi=10.1016%2Fj.ejmech.2014.10.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">In silico design of novel 2H-chromen-2-one derivatives as potent and selective MAO-B inhibitors</span></div><div class="casAuthors">Pisani, Leonardo; Farina, Roberta; Nicolotti, Orazio; Gadaleta, Domenico; Soto-Otero, Ramon; Catto, Marco; Di Braccio, Mario; Mendez-Alvarez, Estefania; Carotti, Angelo</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">98-105</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Inhibition data on rat monoamine oxidase B isoform of a large no. of 7-metahalobenzyloxy-2H-chromen-2-one derivs. (67 compds.) carrying at position 4 a variety of substituents differing in steric, electrostatic, lipophilic and H-bonding properties, were modeled by Gaussian field-based 3D-QSAR and docking simulations carried out on rat MAO-B homol. model.  The computational study combining two different approaches provided easily interpretable binding modes, highlighting the dominant role of the steric effects at position 4, and guided the design of new, potent and selective MAO-B inhibitors.  The 4-hydroxyethyl-, 4-chloroethyl-, 4-carboxamidoethyl-coumarin derivs. 70, 71, and 76, resp., were endowed with high MAO-B inhibitory potency (pIC50 = 8.13, 7.89 and 7.82, resp.) and good selectivity over MAO-A (pIC50 = 5.33, 3% inhibition at 10 μM, and pIC50 = 5.37, resp.).  New compds. with moderate to low MAO-B inhibitory activity were also designed and prepd. to challenge the predictive power of our docking-based 3D-QSAR model.  The good match between predicted and exptl. pIC50 values for all the newly designed compds. confirmed the robustness of our model (r2 = 0.856, RMSE = 0.421) and its transparent rationale in unveiling the main mol. determinants for high potency towards MAO-B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOjxQzx8cccrVg90H21EOLACvtfcHk0lhUduPDJ57gvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslGjtrnF&md5=b572643e528cef0bfe6b5e4e9fbaf13e</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.10.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.10.029%26sid%3Dliteratum%253Aachs%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DFarina%26aufirst%3DR.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DGadaleta%26aufirst%3DD.%26aulast%3DSoto-Otero%26aufirst%3DR.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DDi%2BBraccio%26aufirst%3DM.%26aulast%3DMendez-Alvarez%26aufirst%3DE.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DIn%2520Silico%2520Design%2520of%2520Novel%25202H-Chromen-2-one%2520Derivatives%2520as%2520Potent%2520and%2520Selective%2520MAO-B%2520Inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D89%26spage%3D98%26epage%3D105%26doi%3D10.1016%2Fj.ejmech.2014.10.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Bruhlmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ooms, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrupt, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Testa, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altomare, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Coumarins Derivatives as Dual Inhibitors of Acetylcholinesterase and Monoamine Oxidase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">3195</span><span class="NLM_x">–</span> <span class="NLM_lpage">3198</span><span class="refDoi"> DOI: 10.1021/jm010894d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm010894d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=3195-3198&author=C.+Bruhlmannauthor=F.+Oomsauthor=P.+A.+Carruptauthor=B.+Testaauthor=M.+Cattoauthor=F.+Leonettiauthor=C.+Altomareauthor=A.+Carotti&title=Coumarins+Derivatives+as+Dual+Inhibitors+of+Acetylcholinesterase+and+Monoamine+Oxidase&doi=10.1021%2Fjm010894d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm010894d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010894d%26sid%3Dliteratum%253Aachs%26aulast%3DBruhlmann%26aufirst%3DC.%26aulast%3DOoms%26aufirst%3DF.%26aulast%3DCarrupt%26aufirst%3DP.%2BA.%26aulast%3DTesta%26aufirst%3DB.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DAltomare%26aufirst%3DC.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DCoumarins%2520Derivatives%2520as%2520Dual%2520Inhibitors%2520of%2520Acetylcholinesterase%2520and%2520Monoamine%2520Oxidase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D3195%26epage%3D3198%26doi%3D10.1021%2Fjm010894d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Cruciani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crivori, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrupt, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Testa, B.</span><span> </span><span class="NLM_article-title">Molecular Fields in Quantitative Structure-Permeation Relationships: The VolSurf Approach</span> <span class="citation_source-journal">J. Mol. Struct.: THEOCHEM</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">503</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span><span class="refDoi"> DOI: 10.1016/S0166-1280(99)00360-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1016%2FS0166-1280%2899%2900360-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjsVehur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=503&publication_year=2000&pages=17-30&author=G.+Crucianiauthor=P.+Crivoriauthor=P.+A.+Carruptauthor=B.+Testa&title=Molecular+Fields+in+Quantitative+Structure-Permeation+Relationships%3A+The+VolSurf+Approach&doi=10.1016%2FS0166-1280%2899%2900360-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular fields in quantitative structure-permeation relationships: the VolSurf approach</span></div><div class="casAuthors">Cruciani, G.; Crivori, P.; Carrupt, P.-A.; Testa, B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Structure: THEOCHEM</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">503</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">17-30</span>CODEN:
                <span class="NLM_cas:coden">THEODJ</span>;
        ISSN:<span class="NLM_cas:issn">0166-1280</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Calcd. mol. properties from 3D mol. fields of interaction energies have become a valuable approach to correlate 3D mol. structures with physicochem. and pharmacodynamic properties.  In contrast, their use in correlations with pharmacokinetic properties is still poorly explored and exploited. 3D mol. fields can be obtained from ab initio, semiempirical or mol. mechanics levels of calcn.  The newly developed procedure called VolSurf is able to compress the relevant information present in 3D maps into a few descriptors characterized by the simplicity of their use and interpretation.  These descriptors can be quant. compared and used to build multivariate models correlating 3D mol. structures with biol. responses.  The VolSurf procedure is applied here to generate descriptors and models of structure-permeation relationships.  The VolSurf procedure, which was originally designed to handle a medium amt. of data, can easily be applied to problems of large size such as bioisostere databases, CombyChem databases and related approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoN3Z9YdGVBV7Vg90H21EOLACvtfcHk0lhUduPDJ57gvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjsVehur0%253D&md5=d61ee7f523b6f8b0a7d75ede0994a66f</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2FS0166-1280%2899%2900360-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0166-1280%252899%252900360-7%26sid%3Dliteratum%253Aachs%26aulast%3DCruciani%26aufirst%3DG.%26aulast%3DCrivori%26aufirst%3DP.%26aulast%3DCarrupt%26aufirst%3DP.%2BA.%26aulast%3DTesta%26aufirst%3DB.%26atitle%3DMolecular%2520Fields%2520in%2520Quantitative%2520Structure-Permeation%2520Relationships%253A%2520The%2520VolSurf%2520Approach%26jtitle%3DJ.%2520Mol.%2520Struct.%253A%2520THEOCHEM%26date%3D2000%26volume%3D503%26spage%3D17%26epage%3D30%26doi%3D10.1016%2FS0166-1280%2899%2900360-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Gnerre, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrupt, P.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altomare, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Testa, B.</span><span> </span><span class="NLM_article-title">Inhibition of Monoamine Oxidases by Functionalized Coumarin Derivatives: Biological Activities, QSARs, and 3D-QSARs</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">4747</span><span class="NLM_x">–</span> <span class="NLM_lpage">4758</span><span class="refDoi"> DOI: 10.1021/jm001028o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm001028o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnvFarsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=4747-4758&author=C.+Gnerreauthor=M.+Cattoauthor=F.+Leonettiauthor=P.+Weberauthor=P.-A.+Carruptauthor=C.+Altomareauthor=A.+Carottiauthor=B.+Testa&title=Inhibition+of+Monoamine+Oxidases+by+Functionalized+Coumarin+Derivatives%3A+Biological+Activities%2C+QSARs%2C+and+3D-QSARs&doi=10.1021%2Fjm001028o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Monoamine Oxidases by Functionalized Coumarin Derivatives: Biological Activities, QSARs, and 3D-QSARs</span></div><div class="casAuthors">Gnerre, Carmela; Catto, Marco; Leonetti, Francesco; Weber, Peter; Carrupt, Pierre-Alain; Altomare, Cosimo; Carotti, Angelo; Testa, Bernard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">4747-4758</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A large series of coumarin derivs. (71 compds.) were tested for their monoamine oxidase A and B (MAO-A and MAO-B) inhibitory activity.  Most of the compds. acted preferentially on MAO-B with IC50 values in the micromolar to low-nanomolar range; high inhibitory activities toward MAO-A were also measured for sulfonic acid esters.  The most active compd. was 7-[(3,4-difluorobenzyl)oxy]-3,4-dimethylcoumarin, with an IC50 value toward MAO-B of 1.14 nM.  A QSAR study of 7-X-benzyloxy meta-substituted 3,4-dimethylcoumarin derivs. acting on MAO-B yielded good statistical results (q2 = 0.72, r2 = 0.86), revealing the importance of lipophilic interactions in modulating the inhibition and excluding any dependence on electronic properties. CoMFA was performed on two data sets of MAO-A and MAO-B inhibitors.  The GOLPE procedure, with variable selection criteria, was applied to improve the predictivity of the models and to facilitate the graphical interpretation of results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKLfIzVMIHY7Vg90H21EOLACvtfcHk0li0TCOGRbaBEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnvFarsbY%253D&md5=352a58cd9a0ca135466949b75fee5137</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fjm001028o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm001028o%26sid%3Dliteratum%253Aachs%26aulast%3DGnerre%26aufirst%3DC.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DWeber%26aufirst%3DP.%26aulast%3DCarrupt%26aufirst%3DP.-A.%26aulast%3DAltomare%26aufirst%3DC.%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DTesta%26aufirst%3DB.%26atitle%3DInhibition%2520of%2520Monoamine%2520Oxidases%2520by%2520Functionalized%2520Coumarin%2520Derivatives%253A%2520Biological%2520Activities%252C%2520QSARs%252C%2520and%25203D-QSARs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D4747%26epage%3D4758%26doi%3D10.1021%2Fjm001028o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Novaroli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favre, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bravo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrupt, P.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reist, M.</span><span> </span><span class="NLM_article-title">Impact of Species-dependent Differences on Screening, Design, and Development of MAO-B Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6264</span><span class="NLM_x">–</span> <span class="NLM_lpage">6272</span><span class="refDoi"> DOI: 10.1021/jm060441e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060441e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6264-6272&author=L.+Novaroliauthor=A.+Dainaauthor=E.+Favreauthor=J.+Bravoauthor=A.+Carottiauthor=F.+Leonettiauthor=M.+Cattoauthor=P.-A.+Carruptauthor=M.+Reist&title=Impact+of+Species-dependent+Differences+on+Screening%2C+Design%2C+and+Development+of+MAO-B+Inhibitors&doi=10.1021%2Fjm060441e"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fjm060441e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060441e%26sid%3Dliteratum%253Aachs%26aulast%3DNovaroli%26aufirst%3DL.%26aulast%3DDaina%26aufirst%3DA.%26aulast%3DFavre%26aufirst%3DE.%26aulast%3DBravo%26aufirst%3DJ.%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DCarrupt%26aufirst%3DP.-A.%26aulast%3DReist%26aufirst%3DM.%26atitle%3DImpact%2520of%2520Species-dependent%2520Differences%2520on%2520Screening%252C%2520Design%252C%2520and%2520Development%2520of%2520MAO-B%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6264%26epage%3D6272%26doi%3D10.1021%2Fjm060441e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Ellman, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtney, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andres, V.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Featherstone, R. M.</span><span> </span><span class="NLM_article-title">A New and Rapid Colorimetric Determination of Acetylcholinesterase Activity</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1961</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">88</span><span class="NLM_x">–</span> <span class="NLM_lpage">95</span><span class="refDoi"> DOI: 10.1016/0006-2952(61)90145-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1016%2F0006-2952%2861%2990145-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=13726518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADyaF3MXht1Gns7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1961&pages=88-95&author=G.+L.+Ellmanauthor=K.+D.+Courtneyauthor=V.+Andresauthor=R.+M.+Featherstone&title=A+New+and+Rapid+Colorimetric+Determination+of+Acetylcholinesterase+Activity&doi=10.1016%2F0006-2952%2861%2990145-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">A new and rapid colorimetric determination of acetylcholinesterase activity</span></div><div class="casAuthors">Ellman, George L.; Courtney, K. Diane; Andres, Valentino, Jr.; Featherstone, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1961</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">88-95</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">A photometric method for detg. acetylcholinesterase activity of tissue exts., homogenates, cell suspensions, etc. was described.  The enzyme activity of acetylcholinesterase was measured by following the increase of yellow color produced from thiocholine when it reacts with dithiobisnitrobenzoate ion, based on the reactions: acetylthiocholine (enzyme.rdblhar.) thioeholine + acetate.  Thiocholine + dithiobisnitrobenzoate .rdblhar. yellow color.  The method was used to study the enzyme in human erythrocytes and homogenates of rat brain, kidney, lungs, liver, and muscle tissue.  Hydrolysis rates [(moles/l./min.) × 10-6/g. tissue] by these homogenates of tissues on acetylthiocholine were 10.31, 0.28, 1.63, 1.07, and 1.82, and on butyrylthiocholine were 0.31, 0.21, 0.54, 0.65, and 0.12, resp.  Data obtained with acetylthiocholine as substrate were similar to those with acetylcholine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq21LY6gwNKrVg90H21EOLACvtfcHk0li0TCOGRbaBEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF3MXht1Gns7o%253D&md5=46f891b7e338036a7c7d4333b82b6874</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2861%2990145-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252861%252990145-9%26sid%3Dliteratum%253Aachs%26aulast%3DEllman%26aufirst%3DG.%2BL.%26aulast%3DCourtney%26aufirst%3DK.%2BD.%26aulast%3DAndres%26aufirst%3DV.%26aulast%3DFeatherstone%26aufirst%3DR.%2BM.%26atitle%3DA%2520New%2520and%2520Rapid%2520Colorimetric%2520Determination%2520of%2520Acetylcholinesterase%2520Activity%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1961%26volume%3D7%26spage%3D88%26epage%3D95%26doi%3D10.1016%2F0006-2952%2861%2990145-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Denizot, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, R.</span><span> </span><span class="NLM_article-title">Rapid Colorimetric Assay for Cell Growth and Survival. Modifications to the Tetrazolium Dye Procedure Giving Improved Sensitivity and Reliability</span> <span class="citation_source-journal">J. Immunol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">277</span><span class="refDoi"> DOI: 10.1016/0022-1759(86)90368-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1016%2F0022-1759%2886%2990368-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=3486233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A280%3ADyaL287psl2jsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=1986&pages=271-277&author=F.+Denizotauthor=R.+Lang&title=Rapid+Colorimetric+Assay+for+Cell+Growth+and+Survival.+Modifications+to+the+Tetrazolium+Dye+Procedure+Giving+Improved+Sensitivity+and+Reliability&doi=10.1016%2F0022-1759%2886%2990368-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability</span></div><div class="casAuthors">Denizot F; Lang R</div><div class="citationInfo"><span class="NLM_cas:title">Journal of immunological methods</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">271-7</span>
        ISSN:<span class="NLM_cas:issn">0022-1759</span>.
    </div><div class="casAbstract">A convenient way to estimate the number of viable cells growing in microtitre tray wells is to use a colorimetric assay and an automatic microplate scanning spectrophotometer.  One such assay, developed by Mosmann, depends on the reduction by living cells of tetrazolium salt, MTT, to form a blue formazan product.  However the original technique has several technical limitations, namely a less than optimal sensitivity, a variable background due to protein precipitation on adding an organic solvent to dissolve the blue formazan product, and a low solubility of the product.  These problems have been overcome by the following modifications: avoidance of serum in the incubation medium, thus overcoming precipitation problems in the organic solvent; avoidance of phenol red in the incubation medium, thus avoiding the use of acid in the final solvent which altered the spectral properties of the formazan; elimination of the medium containing MTT after the reaction and subsequent use of pure propanol or ethanol to rapidly solubilize the formazan; use of a higher concentration of MTT; use of half-area microtitre trays to increase the spectrophotometer readings from a given amount of formazan; use of a more judicious reference wavelength in a dual wavelength spectrophotometer.  With these modifications the reliability and sensitivity of the test have been increased to the point where it can in many cases replace the [3H]thymidine uptake assay to measure cell proliferation or survival in growth factor or cytotoxicity assays.  Examples of its use in IL-2 assays are given.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRpURYu5ihmxO98rul4nhSdfW6udTcc2eZiNcWevmSjb7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL287psl2jsA%253D%253D&md5=9e5506f28a0b29b20046b7e21bb5527e</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2F0022-1759%2886%2990368-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-1759%252886%252990368-6%26sid%3Dliteratum%253Aachs%26aulast%3DDenizot%26aufirst%3DF.%26aulast%3DLang%26aufirst%3DR.%26atitle%3DRapid%2520Colorimetric%2520Assay%2520for%2520Cell%2520Growth%2520and%2520Survival.%2520Modifications%2520to%2520the%2520Tetrazolium%2520Dye%2520Procedure%2520Giving%2520Improved%2520Sensitivity%2520and%2520Reliability%26jtitle%3DJ.%2520Immunol.%2520Methods%26date%3D1986%26volume%3D89%26spage%3D271%26epage%3D277%26doi%3D10.1016%2F0022-1759%2886%2990368-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Denora, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laquintana, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopalco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iacobazzi, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopedota, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutrignelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iacobellis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annese, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cascione, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leporatti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franco, M.</span><span> </span><span class="NLM_article-title">In vitro targeting and imaging the translocator protein TSPO 18-kDa through G(4)-PAMAM-FITC labeled dendrimer</span> <span class="citation_source-journal">J. Controlled Release</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">172</span><span class="NLM_x">, </span> <span class="NLM_fpage">1111</span><span class="NLM_x">–</span> <span class="NLM_lpage">1125</span><span class="refDoi"> DOI: 10.1016/j.jconrel.2013.09.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1016%2Fj.jconrel.2013.09.024" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2013&pages=1111-1125&author=N.+Denoraauthor=V.+Laquintanaauthor=A.+Lopalcoauthor=R.+M.+Iacobazziauthor=A.+Lopedotaauthor=A.+Cutrignelliauthor=G.+Iacobellisauthor=C.+Anneseauthor=M.+Cascioneauthor=S.+Leporattiauthor=M.+Franco&title=In+vitro+targeting+and+imaging+the+translocator+protein+TSPO+18-kDa+through+G%284%29-PAMAM-FITC+labeled+dendrimer&doi=10.1016%2Fj.jconrel.2013.09.024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.jconrel.2013.09.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jconrel.2013.09.024%26sid%3Dliteratum%253Aachs%26aulast%3DDenora%26aufirst%3DN.%26aulast%3DLaquintana%26aufirst%3DV.%26aulast%3DLopalco%26aufirst%3DA.%26aulast%3DIacobazzi%26aufirst%3DR.%2BM.%26aulast%3DLopedota%26aufirst%3DA.%26aulast%3DCutrignelli%26aufirst%3DA.%26aulast%3DIacobellis%26aufirst%3DG.%26aulast%3DAnnese%26aufirst%3DC.%26aulast%3DCascione%26aufirst%3DM.%26aulast%3DLeporatti%26aufirst%3DS.%26aulast%3DFranco%26aufirst%3DM.%26atitle%3DIn%2520vitro%2520targeting%2520and%2520imaging%2520the%2520translocator%2520protein%2520TSPO%252018-kDa%2520through%2520G%25284%2529-PAMAM-FITC%2520labeled%2520dendrimer%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2013%26volume%3D172%26spage%3D1111%26epage%3D1125%26doi%3D10.1016%2Fj.jconrel.2013.09.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Crivori, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cruciani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrupt, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Testa, B.</span><span> </span><span class="NLM_article-title">Predicting Blood-Brain Barrier Permeation from Three-Dimensional Molecular Structure</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">2204</span><span class="NLM_x">–</span> <span class="NLM_lpage">2216</span><span class="refDoi"> DOI: 10.1021/jm990968+</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990968%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjtFKhtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=2204-2216&author=P.+Crivoriauthor=G.+Crucianiauthor=P.+A.+Carruptauthor=B.+Testa&title=Predicting+Blood-Brain+Barrier+Permeation+from+Three-Dimensional+Molecular+Structure&doi=10.1021%2Fjm990968%2B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Predicting blood-brain barrier permeation from three-dimensional molecular structure</span></div><div class="casAuthors">Crivori, Patrizia; Cruciani, Gabriele; Carrupt, Pierre-Alain; Testa, Bernard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2204-2216</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Predicting blood-brain barrier (BBB) permeation remains a challenge in drug design.  Since it is impossible to det. exptl. the BBB partitioning of large nos. of preclin. candidates, alternative evaluation methods based on computerized models are desirable.  The present study was conducted to demonstrate the value of descriptors derived from 3D mol. fields in estg. the BBB permeation of a large set of compds. and to produce a simple math. model suitable for external prediction.  The method used (VolSurf) transforms 3D fields into descriptors and correlates them to the exptl. permeation by a discriminant partial least squares procedure.  The model obtained here correctly predicts more than 90% of the BBB permeation data.  By quantifying the favorable and unfavorable contributions of physicochem. and structural properties, it also offers valuable insights for drug design, pharmacol. profiling, and screening.  The computational procedure is fully automated and quite fast.  The method thus appears as a valuable new tool in virtual screening where selection or prioritization of candidates is required from large collections of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoURsaBTpmsObVg90H21EOLACvtfcHk0ljzWUE4Vd1IOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjtFKhtLk%253D&md5=569f3500268859660bb9e5206da270fe</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fjm990968%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990968%252B%26sid%3Dliteratum%253Aachs%26aulast%3DCrivori%26aufirst%3DP.%26aulast%3DCruciani%26aufirst%3DG.%26aulast%3DCarrupt%26aufirst%3DP.%2BA.%26aulast%3DTesta%26aufirst%3DB.%26atitle%3DPredicting%2520Blood-Brain%2520Barrier%2520Permeation%2520from%2520Three-Dimensional%2520Molecular%2520Structure%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D2204%26epage%3D2216%26doi%3D10.1021%2Fjm990968%2B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tropsha, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gramatica, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gombar, V.</span><span> </span><span class="NLM_article-title">The Importance of Being Earnest: Validation is the Absolute Essential for Successful Application and Interpretation of QSPR Models</span> <span class="citation_source-journal">QSAR Comb. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span><span class="refDoi"> DOI: 10.1002/qsar.200390007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1002%2Fqsar.200390007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkslOqsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=69-77&author=A.+Tropshaauthor=P.+Gramaticaauthor=V.+Gombar&title=The+Importance+of+Being+Earnest%3A+Validation+is+the+Absolute+Essential+for+Successful+Application+and+Interpretation+of+QSPR+Models&doi=10.1002%2Fqsar.200390007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61aR"><div class="casContent"><span class="casTitleNuber">61a</span><div class="casTitle"><span class="NLM_cas:atitle">The importance of being earnest: Validation is the absolute essential for successful application and interpretation of QSPR models</span></div><div class="casAuthors">Tropsha, Alexander; Gramatica, Paola; Gombar, Vijay K.</div><div class="citationInfo"><span class="NLM_cas:title">QSAR & Combinatorial Science</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">69-77</span>CODEN:
                <span class="NLM_cas:coden">QCSSAU</span>;
        ISSN:<span class="NLM_cas:issn">1611-020X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">This paper emphasizes the importance of rigorous validation as a crucial, integral component of Quant. Structure Property Relationship (QSPR) model development.  We consider some examples of published QSPR models, which in spite of their high fitted accuracy for the training sets and apparent mechanistic appeal, fail rigorous validation tests, and, thus, may lack practical utility as reliable screening tools.  We present a set of simple guidelines for developing validated and predictive QSPR models.  To this end, we discuss several validation strategies including: (1) Randomization of the modeled property, also called Y-scrambling, (2) Multiple leave-many-out cross-validations, and (3) External validation using rational division of a dataset into training and test sets.  We also highlight the need to establish the domain of model applicability in the chem. space to flag mols. for which predictions may be unreliable, and discuss some algorithms that can be used for this purpose.  We advocate the broad use of these guidelines in the development of predictive QSPR models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoh8MNeROliyrVg90H21EOLACvtfcHk0ljzWUE4Vd1IOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkslOqsrw%253D&md5=5c3c6a74a22fc614e57f1b68d4339ae2</span></div><a href="/servlet/linkout?suffix=cit61a&amp;dbid=16384&amp;doi=10.1002%2Fqsar.200390007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fqsar.200390007%26sid%3Dliteratum%253Aachs%26aulast%3DTropsha%26aufirst%3DA.%26aulast%3DGramatica%26aufirst%3DP.%26aulast%3DGombar%26aufirst%3DV.%26atitle%3DThe%2520Importance%2520of%2520Being%2520Earnest%253A%2520Validation%2520is%2520the%2520Absolute%2520Essential%2520for%2520Successful%2520Application%2520and%2520Interpretation%2520of%2520QSPR%2520Models%26jtitle%3DQSAR%2520Comb.%2520Sci.%26date%3D2003%26volume%3D22%26spage%3D69%26epage%3D77%26doi%3D10.1002%2Fqsar.200390007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit61b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Eriksson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaworska, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worth, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cronin, M. T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDowell, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gramatica, P.</span><span> </span><span class="NLM_article-title">Methods for Reliability and Uncertainty Assessment and for Applicability Evaluations of Classification- and Regression- Based QSARs</span> <span class="citation_source-journal">Environ. Health Perspect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">1351</span><span class="NLM_x">–</span> <span class="NLM_lpage">1375</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2003&pages=1351-1375&author=L.+Erikssonauthor=J.+Jaworskaauthor=A.+Worthauthor=M.+T.+D.+Croninauthor=R.+M.+McDowellauthor=P.+Gramatica&title=Methods+for+Reliability+and+Uncertainty+Assessment+and+for+Applicability+Evaluations+of+Classification-+and+Regression-+Based+QSARs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEriksson%26aufirst%3DL.%26aulast%3DJaworska%26aufirst%3DJ.%26aulast%3DWorth%26aufirst%3DA.%26aulast%3DCronin%26aufirst%3DM.%2BT.%2BD.%26aulast%3DMcDowell%26aufirst%3DR.%2BM.%26aulast%3DGramatica%26aufirst%3DP.%26atitle%3DMethods%2520for%2520Reliability%2520and%2520Uncertainty%2520Assessment%2520and%2520for%2520Applicability%2520Evaluations%2520of%2520Classification-%2520and%2520Regression-%2520Based%2520QSARs%26jtitle%3DEnviron.%2520Health%2520Perspect.%26date%3D2003%26volume%3D111%26spage%3D1351%26epage%3D1375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ragheb, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawler, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sturgis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajwa, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melendez, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, J. P.</span><span> </span><span class="NLM_article-title">Mitochondrial Complex I Inhibitor Rotenone Induces Apoptosis through Enhancing Mitochondrial Reactive Oxygen Species Production</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">8516</span><span class="NLM_x">–</span> <span class="NLM_lpage">8525</span><span class="refDoi"> DOI: 10.1074/jbc.M210432200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1074%2Fjbc.M210432200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=12496265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhsF2htrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=8516-8525&author=N.+Liauthor=K.+Raghebauthor=G.+Lawlerauthor=J.+Sturgisauthor=B.+Rajwaauthor=A.+J.+Melendezauthor=J.+P.+Robinson&title=Mitochondrial+Complex+I+Inhibitor+Rotenone+Induces+Apoptosis+through+Enhancing+Mitochondrial+Reactive+Oxygen+Species+Production&doi=10.1074%2Fjbc.M210432200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial Complex I Inhibitor Rotenone Induces Apoptosis through Enhancing Mitochondrial Reactive Oxygen Species Production</span></div><div class="casAuthors">Li, Nianyu; Ragheb, Kathy; Lawler, Gretchen; Sturgis, Jennie; Rajwa, Bartek; Melendez, J. Andres; Robinson, J. Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">8516-8525</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Inhibition of mitochondrial respiratory chain complex I by rotenone had been found to induce cell death in a variety of cells.  However, the mechanism is still elusive.  Because reactive oxygen species (ROS) play an important role in apoptosis and inhibition of mitochondrial respiratory chain complex I by rotenone was thought to be able to elevate mitochondrial ROS prodn., we investigated the relationship between rotenone-induced apoptosis and mitochondrial reactive oxygen species.  Rotenone was able to induce mitochondrial complex I substrate-supported mitochondrial ROS prodn. both in isolated mitochondria from HL-60 cells as well as in cultured cells.  Rotenone-induced apoptosis was confirmed by DNA fragmentation, cytochrome c release, and caspase 3 activity.  A quant. correlation between rotenone-induced apoptosis and rotenone-induced mitochondrial ROS prodn. was identified.  Rotenone-induced apoptosis was inhibited by treatment with antioxidants (glutathione, N-acetylcysteine, and vitamin C).  The role of rotenone-induced mitochondrial ROS in apoptosis was also confirmed by the finding that HT1080 cells overexpressing magnesium superoxide dismutase were more resistant to rotenone-induced apoptosis than control cells.  These results suggest that rotenone is able to induce apoptosis via enhancing the amt. of mitochondrial reactive oxygen species prodn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQz9q2QbEOErVg90H21EOLACvtfcHk0lhD-HJ_63rs8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhsF2htrg%253D&md5=3b5921aa876f55001b3c2e83cfead91e</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M210432200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M210432200%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DN.%26aulast%3DRagheb%26aufirst%3DK.%26aulast%3DLawler%26aufirst%3DG.%26aulast%3DSturgis%26aufirst%3DJ.%26aulast%3DRajwa%26aufirst%3DB.%26aulast%3DMelendez%26aufirst%3DA.%2BJ.%26aulast%3DRobinson%26aufirst%3DJ.%2BP.%26atitle%3DMitochondrial%2520Complex%2520I%2520Inhibitor%2520Rotenone%2520Induces%2520Apoptosis%2520through%2520Enhancing%2520Mitochondrial%2520Reactive%2520Oxygen%2520Species%2520Production%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D8516%26epage%3D8525%26doi%3D10.1074%2Fjbc.M210432200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Shchepina, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pletjushkina, O. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avetisyan, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakeeva, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fetisova, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izyumov, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saprunova, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyssokikh, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chernyak, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skulachev, V. P.</span><span> </span><span class="NLM_article-title">Oligomycin, Inhibitor of the F0 Part of H+-ATP-synthase, Suppresses the TNF-induced Apoptosis</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">8149</span><span class="NLM_x">–</span> <span class="NLM_lpage">8157</span><span class="refDoi"> DOI: 10.1038/sj.onc.1206053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1038%2Fsj.onc.1206053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=12444550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BD38XovVWhsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2002&pages=8149-8157&author=L.+A.+Shchepinaauthor=O.+Y.+Pletjushkinaauthor=A.+V.+Avetisyanauthor=L.+E.+Bakeevaauthor=E.+K.+Fetisovaauthor=D.+S.+Izyumovauthor=V.+B.+Saprunovaauthor=M.+Y.+Vyssokikhauthor=B.+V.+Chernyakauthor=V.+P.+Skulachev&title=Oligomycin%2C+Inhibitor+of+the+F0+Part+of+H%2B-ATP-synthase%2C+Suppresses+the+TNF-induced+Apoptosis&doi=10.1038%2Fsj.onc.1206053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Oligomycin, inhibitor of the F0 part of H+-ATP-synthase, suppresses the TNF-induced apoptosis</span></div><div class="casAuthors">Shchepina, Liarisa A.; Pletjushkina, Olga Y.; Avetisyan, Armine V.; Bakeeva, Liora E.; Fetisova, Elena K.; Izyumov, Denis S.; Saprunova, Valeria B.; Vyssokikh, Mikhail Y.; Chernyak, Boris V.; Skulachev, Vladimir P.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">53</span>),
    <span class="NLM_cas:pages">8149-8157</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The release of cytochrome c from the intermembrane space of mitochondria into the cytosol is one of the crit. events in apoptotic cell death.  In the present study, it is shown that release of cytochrome c and apoptosis induced by tumor necrosis factor α (TNF) in HeLa cells can be inhibited by (i) overexpression of an oncoprotein Bcl-2, (ii) cyclosporin A, an inhibitor of the mitochondrial permeability transition pore (PTP) or (iii) oligomycin, an inhibitor of H+- ATP-synthase.  Staurosporine-induced apoptosis is sensitive to Bcl-2 but insensitive to cyclosporin A and oligomycin.  The effect of oligomycin is not due to changes in mitochondrial membrane potential or to inhibition of ATP synthesis/hydrolysis since (a) uncouplers (CCCP, DNP) which discharge the membrane potential fail to abolish the protective action of oligomycin and (b) aurovertin B (another inhibitor of H+-ATP-synthase, affecting its F1 component) does not affect apoptosis.  A role of the oligomycin-sensitive F0 component of H+-ATP-synthase in TNF-induced PTP opening and apoptosis is suggested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbViNtpAZkGLVg90H21EOLACvtfcHk0lhD-HJ_63rs8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovVWhsrk%253D&md5=4eed975b7d3f475da709aeb10b7ea94d</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1206053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1206053%26sid%3Dliteratum%253Aachs%26aulast%3DShchepina%26aufirst%3DL.%2BA.%26aulast%3DPletjushkina%26aufirst%3DO.%2BY.%26aulast%3DAvetisyan%26aufirst%3DA.%2BV.%26aulast%3DBakeeva%26aufirst%3DL.%2BE.%26aulast%3DFetisova%26aufirst%3DE.%2BK.%26aulast%3DIzyumov%26aufirst%3DD.%2BS.%26aulast%3DSaprunova%26aufirst%3DV.%2BB.%26aulast%3DVyssokikh%26aufirst%3DM.%2BY.%26aulast%3DChernyak%26aufirst%3DB.%2BV.%26aulast%3DSkulachev%26aufirst%3DV.%2BP.%26atitle%3DOligomycin%252C%2520Inhibitor%2520of%2520the%2520F0%2520Part%2520of%2520H%252B-ATP-synthase%252C%2520Suppresses%2520the%2520TNF-induced%2520Apoptosis%26jtitle%3DOncogene%26date%3D2002%26volume%3D21%26spage%3D8149%26epage%3D8157%26doi%3D10.1038%2Fsj.onc.1206053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">CNS Drug Design: Balancing Physicochemical Properties for Optimal Brain Exposure</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2584</span><span class="NLM_x">–</span> <span class="NLM_lpage">2608</span><span class="refDoi"> DOI: 10.1021/jm501535r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501535r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVyhsrrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2584-2608&author=Z.+Rankovic&title=CNS+Drug+Design%3A+Balancing+Physicochemical+Properties+for+Optimal+Brain+Exposure&doi=10.1021%2Fjm501535r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">CNS Drug Design: Balancing Physicochemical Properties for Optimal Brain Exposure</span></div><div class="casAuthors">Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2584-2608</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The human brain is a uniquely complex organ, which has evolved a sophisticated protection system to prevent injury from external insults and toxins.  Designing mols. that can overcome this protection system and achieve optimal concn. at the desired therapeutic target in the brain is a specific and major challenge for medicinal chemists working in CNS drug discovery.  Analogous to the now widely accepted rule of 5 in the design of oral drugs, the physicochem. properties required for optimal brain exposure have been extensively studied in an attempt to similarly define the attributes of successful CNS drugs and drug candidates.  This body of work is systematically reviewed here, with a particular emphasis on the interplay between the most crit. physicochem. and pharmacokinetic parameters of CNS drugs as well as their impact on medicinal chem. strategies toward mols. with optimal brain exposure.  A summary of modern CNS pharmacokinetic concepts and methods is also provided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8V0N1j49uuLVg90H21EOLACvtfcHk0lifx9YHlLCJ-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVyhsrrP&md5=f01e3f2dc4e2eff7b0618124277a5cf8</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fjm501535r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501535r%26sid%3Dliteratum%253Aachs%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DCNS%2520Drug%2520Design%253A%2520Balancing%2520Physicochemical%2520Properties%2520for%2520Optimal%2520Brain%2520Exposure%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2584%26epage%3D2608%26doi%3D10.1021%2Fjm501535r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Pajouhesh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, G. R.</span><span> </span><span class="NLM_article-title">Medicinal Chemical Properties of Successful Central Nervous System Drugs</span> <span class="citation_source-journal">NeuroRx</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">541</span><span class="NLM_x">–</span> <span class="NLM_lpage">553</span><span class="refDoi"> DOI: 10.1602/neurorx.2.4.541</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1602%2Fneurorx.2.4.541" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=16489364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=541-553&author=H.+Pajouheshauthor=G.+R.+Lenz&title=Medicinal+Chemical+Properties+of+Successful+Central+Nervous+System+Drugs&doi=10.1602%2Fneurorx.2.4.541"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemical properties of successful central nervous system drugs</span></div><div class="casAuthors">Pajouhesh Hassan; Lenz George R</div><div class="citationInfo"><span class="NLM_cas:title">NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">541-53</span>
        ISSN:<span class="NLM_cas:issn">1545-5343</span>.
    </div><div class="casAbstract">Fundamental physiochemical features of CNS drugs are related to their ability to penetrate the blood-brain barrier affinity and exhibit CNS activity.  Factors relevant to the success of CNS drugs are reviewed.  CNS drugs show values of molecular weight, lipophilicity, and hydrogen bond donor and acceptor that in general have a smaller range than general therapeutics.  Pharmacokinetic properties can be manipulated by the medicinal chemist to a significant extent.  The solubility, permeability, metabolic stability, protein binding, and human ether-ago-go-related gene inhibition of CNS compounds need to be optimized simultaneously with potency, selectivity, and other biological parameters.  The balance between optimizing the physiochemical and pharmacokinetic properties to make the best compromises in properties is critical for designing new drugs likely to penetrate the blood brain barrier and affect relevant biological systems.  This review is intended as a guide to designing CNS therapeutic agents with better drug-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_ncsy3yuEinl8icjszYl0fW6udTcc2eZ52EcUf0dD3Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D&md5=0815084e2d107b9243b785d0782dfc3a</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1602%2Fneurorx.2.4.541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1602%252Fneurorx.2.4.541%26sid%3Dliteratum%253Aachs%26aulast%3DPajouhesh%26aufirst%3DH.%26aulast%3DLenz%26aufirst%3DG.%2BR.%26atitle%3DMedicinal%2520Chemical%2520Properties%2520of%2520Successful%2520Central%2520Nervous%2520System%2520Drugs%26jtitle%3DNeuroRx%26date%3D2005%26volume%3D2%26spage%3D541%26epage%3D553%26doi%3D10.1602%2Fneurorx.2.4.541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Fernandez-Bachiller, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monjas, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rademann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodríguez-Franco, M. I.</span><span> </span><span class="NLM_article-title">New Tacrine–4-Oxo-4H-chromene Hybrids as Multifunctional Agents for the Treatment of Alzheimer’s Disease, with Cholinergic, Antioxidant, and β-Amyloid-Reducing Properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1303</span><span class="NLM_x">–</span> <span class="NLM_lpage">1317</span><span class="refDoi"> DOI: 10.1021/jm201460y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201460y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1303-1317&author=M.+I.+Fernandez-Bachillerauthor=C.+Perezauthor=L.+Monjasauthor=J.+Rademannauthor=M.+I.+Rodr%C3%ADguez-Franco&title=New+Tacrine%E2%80%934-Oxo-4H-chromene+Hybrids+as+Multifunctional+Agents+for+the+Treatment+of+Alzheimer%E2%80%99s+Disease%2C+with+Cholinergic%2C+Antioxidant%2C+and+%CE%B2-Amyloid-Reducing+Properties&doi=10.1021%2Fjm201460y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1021%2Fjm201460y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201460y%26sid%3Dliteratum%253Aachs%26aulast%3DFernandez-Bachiller%26aufirst%3DM.%2BI.%26aulast%3DPerez%26aufirst%3DC.%26aulast%3DMonjas%26aufirst%3DL.%26aulast%3DRademann%26aufirst%3DJ.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26atitle%3DNew%2520Tacrine%25E2%2580%25934-Oxo-4H-chromene%2520Hybrids%2520as%2520Multifunctional%2520Agents%2520for%2520the%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%252C%2520with%2520Cholinergic%252C%2520Antioxidant%252C%2520and%2520%25CE%25B2-Amyloid-Reducing%2520Properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1303%26epage%3D1317%26doi%3D10.1021%2Fjm201460y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Otto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penzis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaube, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adolph, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fohr, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warncke, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robaa, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appenroth, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleck, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enzensperger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winckler, T.</span><span> </span><span class="NLM_article-title">Evaluation of Homobivalent Carbolines as Designed Multiple Ligands for the Treatment of Neurodegenerative Disorders</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">6710</span><span class="NLM_x">–</span> <span class="NLM_lpage">6715</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00958</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00958" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlequ7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6710-6715&author=R.+Ottoauthor=R.+Penzisauthor=F.+Gaubeauthor=O.+Adolphauthor=K.+J.+Fohrauthor=P.+Warnckeauthor=D.+Robaaauthor=D.+Appenrothauthor=C.+Fleckauthor=C.+Enzenspergerauthor=J.+Lehmannauthor=T.+Winckler&title=Evaluation+of+Homobivalent+Carbolines+as+Designed+Multiple+Ligands+for+the+Treatment+of+Neurodegenerative+Disorders&doi=10.1021%2Facs.jmedchem.5b00958"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of Homobivalent Carbolines as Designed Multiple Ligands for the Treatment of Neurodegenerative Disorders</span></div><div class="casAuthors">Otto, Robert; Penzis, Robert; Gaube, Friedemann; Adolph, Oliver; Foehr, Karl J.; Warncke, Paul; Robaa, Dina; Appenroth, Dorothea; Fleck, Christian; Enzensperger, Christoph; Lehmann, Jochen; Winckler, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6710-6715</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Neurodegenerative diseases represent a challenge for biomedical research due to their high prevalence and lack of mechanism-based treatments.  Because of the complex pathol. of neurodegenerative disorders, multifunctional drugs have been increasingly recognized as potential treatments.  We identified homobivalent γ-carbolinium salts as potent inhibitors of both cholinesterases, N-methyl-D-aspartate receptors, and monoamine oxidases.  Homobivalent γ-carbolines displayed similar structure-activity relationships on all tested targets and may present promising designed multiple ligands for the treatment of neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoggGUTF85gz7Vg90H21EOLACvtfcHk0lifx9YHlLCJ-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlequ7fP&md5=ccd884b3ed035287c7bbfd5bf17582c8</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00958&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00958%26sid%3Dliteratum%253Aachs%26aulast%3DOtto%26aufirst%3DR.%26aulast%3DPenzis%26aufirst%3DR.%26aulast%3DGaube%26aufirst%3DF.%26aulast%3DAdolph%26aufirst%3DO.%26aulast%3DFohr%26aufirst%3DK.%2BJ.%26aulast%3DWarncke%26aufirst%3DP.%26aulast%3DRobaa%26aufirst%3DD.%26aulast%3DAppenroth%26aufirst%3DD.%26aulast%3DFleck%26aufirst%3DC.%26aulast%3DEnzensperger%26aufirst%3DC.%26aulast%3DLehmann%26aufirst%3DJ.%26aulast%3DWinckler%26aufirst%3DT.%26atitle%3DEvaluation%2520of%2520Homobivalent%2520Carbolines%2520as%2520Designed%2520Multiple%2520Ligands%2520for%2520the%2520Treatment%2520of%2520Neurodegenerative%2520Disorders%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6710%26epage%3D6715%26doi%3D10.1021%2Facs.jmedchem.5b00958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Di Pietro, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez-Areales, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juárez-Jiménez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espargaró, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clos, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavilla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabaté, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muñoz-Torrero, D.</span><span> </span><span class="NLM_article-title">Tetrahydrobenzo[h][1,6]naphthyridine-6-chlorotacrine Hybrids as a New Family of Anti-Alzheimer Agents Targeting β-Amyloid, Tau, and Cholinesterase Pathologies</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">117</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2014.07.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1016%2Fj.ejmech.2014.07.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=25016233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Grs7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2014&pages=107-117&author=O.+Di+Pietroauthor=F.+J.+P%C3%A9rez-Arealesauthor=J.+Ju%C3%A1rez-Jim%C3%A9nezauthor=A.+Espargar%C3%B3author=M.+V.+Closauthor=B.+P%C3%A9rezauthor=R.+Lavillaauthor=R.+Sabat%C3%A9author=F.+J.+Luqueauthor=D.+Mu%C3%B1oz-Torrero&title=Tetrahydrobenzo%5Bh%5D%5B1%2C6%5Dnaphthyridine-6-chlorotacrine+Hybrids+as+a+New+Family+of+Anti-Alzheimer+Agents+Targeting+%CE%B2-Amyloid%2C+Tau%2C+and+Cholinesterase+Pathologies&doi=10.1016%2Fj.ejmech.2014.07.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Tetrahydrobenzo[h][1,6]naphthyridine-6-chlorotacrine hybrids as a new family of anti-Alzheimer agents targeting β-amyloid, tau, and cholinesterase pathologies</span></div><div class="casAuthors">Di Pietro, Ornella; Perez-Areales, F. Javier; Juarez-Jimenez, Jordi; Espargaro, Alba; Clos, M. Victoria; Perez, Belen; Lavilla, Rodolfo; Sabate, Raimon; Luque, F. Javier; Munoz-Torrero, Diego</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">107-117</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Optimization of an essentially inactive 3,4-dihydro-2H-pyrano[3,2-c]quinoline carboxylic ester deriv. as acetylcholinesterase (AChE) peripheral anionic site (PAS)-binding motif by double O → NH bioisosteric replacement, combined with mol. hybridization with the AChE catalytic anionic site (CAS) inhibitor 6-chlorotacrine and mol. dynamics-driven optimization of the length of the linker has resulted in the development of the trimethylene-linked 1,2,3,4-tetrahydrobenzo[h][1,6]naphthyridine-6-chlorotacrine hybrid I as a picomolar inhibitor of human AChE (hAChE).  The tetra-, penta-, and octamethylene-linked homologs I [X = (CH2)4, (CH2)5, (CH2)8] have been also synthesized for comparison purposes, and found to retain the nanomolar hAChE inhibitory potency of the parent 6-chlorotacrine.  Further biol. profiling of hybrids I has shown that they are also potent inhibitors of human butyrylcholinesterase and moderately potent Aβ42 and tau antiaggregating agents, with IC50 values in the submicromolar and low micromolar range, resp.  Also, in vitro studies using an artificial membrane model have predicted a good brain permeability for hybrids I, and hence, their ability to reach their targets in the central nervous system.  The multitarget profile of the novel hybrids makes them promising leads for developing anti-Alzheimer drug candidates with more balanced biol. activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOcQV1Ii0VkbVg90H21EOLACvtfcHk0lhLIoSg9NJ2qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Grs7fI&md5=c52fbb0243247cd8088d94a368c33186</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.07.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.07.021%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BPietro%26aufirst%3DO.%26aulast%3DP%25C3%25A9rez-Areales%26aufirst%3DF.%2BJ.%26aulast%3DJu%25C3%25A1rez-Jim%25C3%25A9nez%26aufirst%3DJ.%26aulast%3DEspargar%25C3%25B3%26aufirst%3DA.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DP%25C3%25A9rez%26aufirst%3DB.%26aulast%3DLavilla%26aufirst%3DR.%26aulast%3DSabat%25C3%25A9%26aufirst%3DR.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DTetrahydrobenzo%255Bh%255D%255B1%252C6%255Dnaphthyridine-6-chlorotacrine%2520Hybrids%2520as%2520a%2520New%2520Family%2520of%2520Anti-Alzheimer%2520Agents%2520Targeting%2520%25CE%25B2-Amyloid%252C%2520Tau%252C%2520and%2520Cholinesterase%2520Pathologies%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D84%26spage%3D107%26epage%3D117%26doi%3D10.1016%2Fj.ejmech.2014.07.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Viayna, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sola, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Simone, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tapia-Rojas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serrano, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabaté, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juarez-Jimenez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clos, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inestrosa, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muñoz-Torrero, D.</span><span> </span><span class="NLM_article-title">Synthesis and Multitarget Biological Profiling of a Novel Family of Rhein Derivatives As Disease-Modifying Anti-Alzheimer Agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">2549</span><span class="NLM_x">–</span> <span class="NLM_lpage">2567</span><span class="refDoi"> DOI: 10.1021/jm401824w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401824w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtVeqsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2549-2567&author=E.+Viaynaauthor=I.+Solaauthor=M.+Bartoliniauthor=A.+De+Simoneauthor=C.+Tapia-Rojasauthor=F.+G.+Serranoauthor=R.+Sabat%C3%A9author=J.+Juarez-Jimenezauthor=B.+Perezauthor=F.+J.+Luqueauthor=V.+Andrisanoauthor=M.+V.+Closauthor=N.+C.+Inestrosaauthor=D.+Mu%C3%B1oz-Torrero&title=Synthesis+and+Multitarget+Biological+Profiling+of+a+Novel+Family+of+Rhein+Derivatives+As+Disease-Modifying+Anti-Alzheimer+Agents&doi=10.1021%2Fjm401824w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Multitarget Biological Profiling of a Novel Family of Rhein Derivatives As Disease-Modifying Anti-Alzheimer Agents</span></div><div class="casAuthors">Viayna, Elisabet; Sola, Irene; Bartolini, Manuela; De Simone, Angela; Tapia-Rojas, Cheril; Serrano, Felipe G.; Sabate, Raimon; Juarez-Jimenez, Jordi; Perez, Belen; Luque, F. Javier; Andrisano, Vincenza; Clos, M. Victoria; Inestrosa, Nibaldo C.; Munoz-Torrero, Diego</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2549-2567</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have synthesized a family of rhein-huprine hybrids I [X = (CH2)n, n = 5-11; X = CH2-p-phenylene-CH2] to hit several key targets for Alzheimer's disease.  Biol. screening performed in vitro and in Escherichia coli cells has shown that these hybrids exhibit potent inhibitory activities against human acetylcholinesterase, butyrylcholinesterase, and BACE-1, dual Aβ42 and tau antiaggregating activity, and brain permeability.  Ex vivo studies with the leads (+)- and (-)-I [X = (CH2)9] (II) in brain slices of C57bl6 mice have revealed that they efficiently protect against the Aβ-induced synaptic dysfunction, preventing the loss of synaptic proteins and/or have a pos. effect on the induction of long-term potentiation.  In vivo studies in APP-PS1 transgenic mice treated i.p. for 4 wk with (+)- and (-)-II have shown a central sol. Aβ lowering effect, accompanied by an increase in the levels of mature amyloid precursor protein (APP).  Thus, (+)- and (-)-II emerge as very promising disease-modifying anti-Alzheimer drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeoyGkrcOQArVg90H21EOLACvtfcHk0lhLIoSg9NJ2qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtVeqsrc%253D&md5=711450b3c2289a3fb2037d536e9a7a7b</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fjm401824w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401824w%26sid%3Dliteratum%253Aachs%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DSola%26aufirst%3DI.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DDe%2BSimone%26aufirst%3DA.%26aulast%3DTapia-Rojas%26aufirst%3DC.%26aulast%3DSerrano%26aufirst%3DF.%2BG.%26aulast%3DSabat%25C3%25A9%26aufirst%3DR.%26aulast%3DJuarez-Jimenez%26aufirst%3DJ.%26aulast%3DPerez%26aufirst%3DB.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DInestrosa%26aufirst%3DN.%2BC.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DSynthesis%2520and%2520Multitarget%2520Biological%2520Profiling%2520of%2520a%2520Novel%2520Family%2520of%2520Rhein%2520Derivatives%2520As%2520Disease-Modifying%2520Anti-Alzheimer%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D2549%26epage%3D2567%26doi%3D10.1021%2Fjm401824w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Wu, M.; Esteban, G.; Brogi, S.; Shionoya, M.; Wang, L.; Campiani, G.; Unzeta, M.; Inokuchi, T.; Butini, S.; Marco-Contelles, J.</span><span> </span><span class="NLM_article-title">Donepezil-like Multifunctional Agents: Design, Synthesis, Molecular Modeling and Biological Evaluation</span>.  <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span>DOI:<span class="refDoi"> DOI: 10.1016/j.ejmech.2015.10.001</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1016%2Fj.ejmech.2015.10.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=M.+Wu&author=G.+Esteban&author=S.+Brogi&author=M.+Shionoya&author=L.+Wang&author=G.+Campiani&author=M.+Unzeta&author=T.+Inokuchi&author=S.+Butini&author=J.+Marco-Contelles&title=Donepezil-like+Multifunctional+Agents%3A+Design%2C+Synthesis%2C+Molecular+Modeling+and+Biological+Evaluation&doi=10.1016%2Fj.ejmech.2015.10.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.10.001%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DM.%26atitle%3DDonepezil-like%2520Multifunctional%2520Agents%253A%2520Design%252C%2520Synthesis%252C%2520Molecular%2520Modeling%2520and%2520Biological%2520Evaluation%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26doi%3D10.1016%2Fj.ejmech.2015.10.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esteban, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ojima, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bautista-Aguilera, O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inokuchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moraleda, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iriepa, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samadi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soriano, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández Fernández, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martínez-Murillo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unzeta, M.</span><span> </span><span class="NLM_article-title">Donepezil + Propargylamine + 8-Hydroxyquinoline Hybrids as New Multifunctional Metal-chelators, ChE and MAO Inhibitors for the Potential Treatment of Alzheimer’s Disease</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">543</span><span class="NLM_x">–</span> <span class="NLM_lpage">561</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2014.04.078</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1016%2Fj.ejmech.2014.04.078" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=24813882" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovVensL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2014&pages=543-561&author=L.+Wangauthor=G.+Estebanauthor=M.+Ojimaauthor=O.+M.+Bautista-Aguileraauthor=T.+Inokuchiauthor=I.+Moraledaauthor=I.+Iriepaauthor=A.+Samadiauthor=M.+B.+H.+Youdimauthor=A.+Romeroauthor=E.+Sorianoauthor=R.+Herreroauthor=A.+P.+Fern%C3%A1ndez+Fern%C3%A1ndezauthor=R.+Mart%C3%ADnez-Murilloauthor=J.+Marco-Contellesauthor=M.+Unzeta&title=Donepezil+%2B+Propargylamine+%2B+8-Hydroxyquinoline+Hybrids+as+New+Multifunctional+Metal-chelators%2C+ChE+and+MAO+Inhibitors+for+the+Potential+Treatment+of+Alzheimer%E2%80%99s+Disease&doi=10.1016%2Fj.ejmech.2014.04.078"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Donepezil + propargylamine + 8-hydroxyquinoline hybrids as new multifunctional metal-chelators, ChE and MAO inhibitors for the potential treatment of Alzheimer's disease</span></div><div class="casAuthors">Wang, Li; Esteban, Gerard; Ojima, Masaki; Bautista-Aguilera, Oscar M.; Inokuchi, Tsutomu; Moraleda, Ignacio; Iriepa, Isabel; Samadi, Abdelouahid; Youdim, Moussa B. H.; Romero, Alejandro; Soriano, Elena; Herrero, Raquel; Fernandez Fernandez, Ana Patricia; Ricardo-Martinez-Murillo; Marco-Contelles, Jose; Unzeta, Mercedes</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">543-561</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The synthesis, biochem. evaluation, ADMET, toxicity and mol. modeling of novel multi-target-directed Donepezil + Propargylamine + 8-Hydroxyquinoline (DPH) hybrids for the potential prevention and treatment of Alzheimer's disease is described.  The most interesting deriv. was racemic α-aminotrile4-(1-benzylpiperidin-4-yl)-2-(((8-hydroxyquinolin-5-yl)methyl)(prop-2-yn-1-yl)amino) butanenitrile (DPH6) [MAO A (IC50 = 6.2±0.7 μM); MAO B (IC50 = 10.2±0.9 μM); AChE (IC50 = 1.8±0.1 μM); BuChE (IC50 = 1.6±0.25 μM)], an irreversible MAO A/B inhibitor and mixed-type AChE inhibitor with metal-chelating properties.  According to docking studies, both DPH6 enantiomers interact simultaneously with the catalytic and peripheral site of EeAChE through a linker of appropriate length, supporting the obsd. mixed-type AChE inhibition.  Both enantiomers exhibited a relatively similar position of both hydroxyquinoline and benzyl moieties with the rest of the mol. easily accommodated in the relatively large cavity of MAO A.  For MAO B, the quinoline system was hosted at the cavity entrance, whereas for MAO A this system occupied the substrate cavity.  In this disposition the quinoline moiety interacted directly with the FAD arom. ring.  Very similar binding affinity values were also obsd. for both enantiomers with ChE and MAO enzymes.  DPH derivs. exhibited moderate to good ADMET properties and brain penetration capacity for CNS activity.  DPH6 was less toxic than donepezil at high concns.; while at low concns. both displayed a similar cell viability profile.  Finally, in a passive avoidance task, the antiamnesic effect of DPH6 was tested on mice with exptl. induced amnesia.  DPH6 was capable to significantly decrease scopolamine-induced learning deficits in healthy adult mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphrIxeM4RW2rVg90H21EOLACvtfcHk0lj8opSUmRJovg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovVensL8%253D&md5=2e1f262b4002653cbac7a6dafabe3548</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.04.078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.04.078%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DEsteban%26aufirst%3DG.%26aulast%3DOjima%26aufirst%3DM.%26aulast%3DBautista-Aguilera%26aufirst%3DO.%2BM.%26aulast%3DInokuchi%26aufirst%3DT.%26aulast%3DMoraleda%26aufirst%3DI.%26aulast%3DIriepa%26aufirst%3DI.%26aulast%3DSamadi%26aufirst%3DA.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26aulast%3DRomero%26aufirst%3DA.%26aulast%3DSoriano%26aufirst%3DE.%26aulast%3DHerrero%26aufirst%3DR.%26aulast%3DFern%25C3%25A1ndez%2BFern%25C3%25A1ndez%26aufirst%3DA.%2BP.%26aulast%3DMart%25C3%25ADnez-Murillo%26aufirst%3DR.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26aulast%3DUnzeta%26aufirst%3DM.%26atitle%3DDonepezil%2520%252B%2520Propargylamine%2520%252B%25208-Hydroxyquinoline%2520Hybrids%2520as%2520New%2520Multifunctional%2520Metal-chelators%252C%2520ChE%2520and%2520MAO%2520Inhibitors%2520for%2520the%2520Potential%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D80%26spage%3D543%26epage%3D561%26doi%3D10.1016%2Fj.ejmech.2014.04.078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Weinstock, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bejar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poltyrev, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finberg, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span> </span><span class="NLM_article-title">TV3326, a Novel Neuroprotective Drug with Cholinesterase and Monoamine Oxidase Inhibitory Activities for the Treatment of Alzheimer’s Disease</span> <span class="citation_source-journal">J. Neural Transm. Suppl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">169</span><span class="refDoi"> DOI: 10.1007/978-3-7091-6301-6_10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1007%2F978-3-7091-6301-6_10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=11205137" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=157-169&author=M.+Weinstockauthor=C.+Bejarauthor=R.+H.+Wangauthor=T.+Poltyrevauthor=A.+Grossauthor=J.+P.+Finbergauthor=M.+B.+Youdim&title=TV3326%2C+a+Novel+Neuroprotective+Drug+with+Cholinesterase+and+Monoamine+Oxidase+Inhibitory+Activities+for+the+Treatment+of+Alzheimer%E2%80%99s+Disease&doi=10.1007%2F978-3-7091-6301-6_10"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1007%2F978-3-7091-6301-6_10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-7091-6301-6_10%26sid%3Dliteratum%253Aachs%26aulast%3DWeinstock%26aufirst%3DM.%26aulast%3DBejar%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DR.%2BH.%26aulast%3DPoltyrev%26aufirst%3DT.%26aulast%3DGross%26aufirst%3DA.%26aulast%3DFinberg%26aufirst%3DJ.%2BP.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26atitle%3DTV3326%252C%2520a%2520Novel%2520Neuroprotective%2520Drug%2520with%2520Cholinesterase%2520and%2520Monoamine%2520Oxidase%2520Inhibitory%2520Activities%2520for%2520the%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Neural%2520Transm.%2520Suppl.%26date%3D2000%26volume%3D60%26spage%3D157%26epage%3D169%26doi%3D10.1007%2F978-3-7091-6301-6_10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Sterling, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herzig, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goren, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finkelstein, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldenberg, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miskolczi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molnar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rantal, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamas, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zagyva, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zekany, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavian, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Razin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krais, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chorev, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstock, M.</span><span> </span><span class="NLM_article-title">Novel Dual Inhibitors of AChE and MAO Derived from Hydroxy Aminoindan and Phenethylamine as Potential Treatment for Alzheimer’s Disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">5260</span><span class="NLM_x">–</span> <span class="NLM_lpage">5279</span><span class="refDoi"> DOI: 10.1021/jm020120c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020120c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BD38XotVymsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=5260-5279&author=J.+Sterlingauthor=Y.+Herzigauthor=T.+Gorenauthor=N.+Finkelsteinauthor=D.+Lernerauthor=W.+Goldenbergauthor=I.+Miskolcziauthor=S.+Molnarauthor=F.+Rantalauthor=T.+Tamasauthor=G.+Tothauthor=A.+Zagyvaauthor=A.+Zekanyauthor=G.+Lavianauthor=A.+Grossauthor=R.+Friedmanauthor=M.+Razinauthor=W.+Huangauthor=B.+Kraisauthor=M.+Chorevauthor=M.+B.+H.+Youdimauthor=M.+Weinstock&title=Novel+Dual+Inhibitors+of+AChE+and+MAO+Derived+from+Hydroxy+Aminoindan+and+Phenethylamine+as+Potential+Treatment+for+Alzheimer%E2%80%99s+Disease&doi=10.1021%2Fjm020120c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Dual Inhibitors of AChE and MAO Derived from Hydroxy Aminoindan and Phenethylamine as Potential Treatment for Alzheimer's Disease</span></div><div class="casAuthors">Sterling, Jeffrey; Herzig, Yaacov; Goren, Tamar; Finkelstein, Nina; Lerner, David; Goldenberg, Willy; Miskolczi, Istvan; Molnar, Sandor; Rantal, Ferenc; Tamas, Tivadar; Toth, Gyorgy; Zagyva, Adela; Zekany, Andras; Lavian, Gila; Gross, Aviva; Friedman, Rachel; Razin, Michal; Huang, Wei; Krais, Boris; Chorev, Michael; Youdim, Moussa B.; Weinstock, Marta</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">5260-5279</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Carbamate derivs. of N-propargylaminoindanes (Series I) and N-propargylphenethylamines (Series II) were synthesized via multistep procedures from the corresponding hydroxy precursors.  The resp. rasagiline- and selegiline-related series were designed to combine inhibitory activities of both acetylcholine esterase (AChE) and monoamine oxidase (MAO) by virtue of their carbamoyl and propargylamine pharmacophores.  Each compd. was tested for these activities in vitro in order to find mols. with similar potencies against each enzyme.  Compds. with such dual AChE and MAO inhibitory activities are expected to have potential for the treatment of Alzheimer's disease.  The obsd. SAR also offers insight into the requirements of the active sites on these enzymes.  A carbamate moiety was found to be essential for AChE inhibition, which was absent in the corresponding hydroxy precursors.  The propargyl group caused 2-70-fold decrease in AChE inhibitory activity (depending on the position of the carbamoyl group) of Series I, but had little or no effect in Series II.  Thus, the 6- and 7-carbamyloxyphenyls in Series I were either equipotent to, or slightly (2- to 5-fold) less active as AChE inhibitors than, the corresponding compds. in Series II, while the 4-carbamyloxyphenyls were more potent.  The presence of the carbamate moiety in 6- and 7-carbamyloxyphenyls of Series I, considerably decreased MAO-A and -B inhibitory activity, compared to that of the parent hydroxy analogs, while the opposite was true for Series II.  Thus, the 6- and 7-carbamyloxyphenyls in Series I were 2-3 orders of magnitude weaker MAO inhibitors while the 4- carbamyloxyphenyls were equipotent with the corresponding compds. in Series II.  In both series, N-methylation of the propargylamine enhanced the MAO (A and B equally) inhibitory activities and decreased the AChE inhibitory activity.  Two candidates belonging to the indan and tetralin ring systems (HCl salts of I and II) and one phenethylamine (mesylate salt of III) were identified as possible leads for further development based on the following criteria: (a) comparable AChE and MAO-B inhibitory activities, (b) good to moderate AChE inhibitory activity, and (c) lack of strong MAO-A selectivity.  However, it is likely that these compds. will be metabolized to the corresponding phenols, with inhibitory activities against AChE and/or MAO-A or -B, different from those of the parent carbamates.  Thus, the apparent enzyme inhibition will be a result of the combined inhibition of all of these individual metabolites.  The results of our ongoing in vivo screening programs will be published elsewhere.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0RScteajUEbVg90H21EOLACvtfcHk0lj8opSUmRJovg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotVymsLg%253D&md5=62136a48889ce0fe28a76aa70e577eb9</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Fjm020120c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020120c%26sid%3Dliteratum%253Aachs%26aulast%3DSterling%26aufirst%3DJ.%26aulast%3DHerzig%26aufirst%3DY.%26aulast%3DGoren%26aufirst%3DT.%26aulast%3DFinkelstein%26aufirst%3DN.%26aulast%3DLerner%26aufirst%3DD.%26aulast%3DGoldenberg%26aufirst%3DW.%26aulast%3DMiskolczi%26aufirst%3DI.%26aulast%3DMolnar%26aufirst%3DS.%26aulast%3DRantal%26aufirst%3DF.%26aulast%3DTamas%26aufirst%3DT.%26aulast%3DToth%26aufirst%3DG.%26aulast%3DZagyva%26aufirst%3DA.%26aulast%3DZekany%26aufirst%3DA.%26aulast%3DLavian%26aufirst%3DG.%26aulast%3DGross%26aufirst%3DA.%26aulast%3DFriedman%26aufirst%3DR.%26aulast%3DRazin%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DKrais%26aufirst%3DB.%26aulast%3DChorev%26aufirst%3DM.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26aulast%3DWeinstock%26aufirst%3DM.%26atitle%3DNovel%2520Dual%2520Inhibitors%2520of%2520AChE%2520and%2520MAO%2520Derived%2520from%2520Hydroxy%2520Aminoindan%2520and%2520Phenethylamine%2520as%2520Potential%2520Treatment%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D5260%26epage%3D5279%26doi%3D10.1021%2Fjm020120c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span> </span><span class="NLM_article-title">Avraham Pharmaceuticals Announces Successful Second Interim Results in Phase 2b Study of Ladostigil for the Treatment of Mild Cognitive Impairment</span>, Business Wire July 28,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">, </span><a href="http://www.businesswire.com/news/home/20150728005672/en/Avraham-Pharmaceuticals-Announces-Successful-Interim-Results-Phase" class="extLink">http://www.businesswire.com/news/home/20150728005672/en/Avraham-Pharmaceuticals-Announces-Successful-Interim-Results-Phase</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Avraham+Pharmaceuticals+Announces+Successful+Second+Interim+Results+in+Phase+2b+Study+of+Ladostigil+for+the+Treatment+of+Mild+Cognitive+Impairment%2C+Business+Wire+July+28%2C+2015%2C+http%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20150728005672%2Fen%2FAvraham-Pharmaceuticals-Announces-Successful-Interim-Results-Phase."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26atitle%3DAvraham%2520Pharmaceuticals%2520Announces%2520Successful%2520Second%2520Interim%2520Results%2520in%2520Phase%25202b%2520Study%2520of%2520Ladostigil%2520for%2520the%2520Treatment%2520of%2520Mild%2520Cognitive%2520Impairment%26jtitle%3DBusiness%2520Wire%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Anderson, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCrodden, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tipton, K. F.</span><span> </span><span class="NLM_article-title">Monoamine Oxidase Inhibitors and the Cheese Effect</span> <span class="citation_source-journal">Neurochem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1145</span><span class="NLM_x">–</span> <span class="NLM_lpage">1149</span><span class="refDoi"> DOI: 10.1007/BF00978365</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1007%2FBF00978365" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=8255365" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADyaK2cXitlWjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1993&pages=1145-1149&author=M.+C.+Andersonauthor=F.+Hasanauthor=J.+M.+McCroddenauthor=K.+F.+Tipton&title=Monoamine+Oxidase+Inhibitors+and+the+Cheese+Effect&doi=10.1007%2FBF00978365"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Monoamine oxidase inhibitors and the cheese effect</span></div><div class="casAuthors">Anderson, Mary C.; Hasan, Farris; McCrodden, John M.; Tipton, Keith F.</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemical Research</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1145-9</span>CODEN:
                <span class="NLM_cas:coden">NEREDZ</span>;
        ISSN:<span class="NLM_cas:issn">0364-3190</span>.
    </div><div class="casAbstract">The behavior of inhibitors of monoamine oxidase-A (MAO-A) is considered in terms of the possibility of having an effective antidepressant that does not give rise to hypertensive interactions with dietary tyramine.  Studies with punch-biopsy samples of human intestine and rat intestinal samples show MAO-A to be the predominant form of the enzyme in both species.  Transport studies with everted rat intestinal prepns. indicate that tyramine is extensively metabolized during transport through the intestine.  Selective inhibition of MAO-A by clorgyline results in a large increase in the amt. of unchanged tyramine transported, whereas selective inhibition of MAO-B with L-deprenyl (selegiline) has no significant effect.  The behavior of reversible MAO-A inhibitors can significantly reduce, but not entirely eliminate, these effects on the intestinal metab. of tyramine, but only if the inhibition is competitive in nature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDISgk8VH-8LVg90H21EOLACvtfcHk0lh6i_pcqrgVAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXitlWjsQ%253D%253D&md5=e9d85b743f7fdde68276428940940cac</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1007%2FBF00978365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00978365%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DM.%2BC.%26aulast%3DHasan%26aufirst%3DF.%26aulast%3DMcCrodden%26aufirst%3DJ.%2BM.%26aulast%3DTipton%26aufirst%3DK.%2BF.%26atitle%3DMonoamine%2520Oxidase%2520Inhibitors%2520and%2520the%2520Cheese%2520Effect%26jtitle%3DNeurochem.%2520Res.%26date%3D1993%26volume%3D18%26spage%3D1145%26epage%3D1149%26doi%3D10.1007%2FBF00978365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Lobell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molnár, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keserü, G. M.</span><span> </span><span class="NLM_article-title">Recent Advances in the Prediction of Blood–brain Partitioning from Molecular Structure</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">360</span><span class="NLM_x">–</span> <span class="NLM_lpage">370</span><span class="refDoi"> DOI: 10.1002/jps.10282</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1002%2Fjps.10282" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2003&pages=360-370&author=M.+Lobellauthor=L.+Moln%C3%A1rauthor=G.+M.+Keser%C3%BC&title=Recent+Advances+in+the+Prediction+of+Blood%E2%80%93brain+Partitioning+from+Molecular+Structure&doi=10.1002%2Fjps.10282"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1002%2Fjps.10282&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.10282%26sid%3Dliteratum%253Aachs%26aulast%3DLobell%26aufirst%3DM.%26aulast%3DMoln%25C3%25A1r%26aufirst%3DL.%26aulast%3DKeser%25C3%25BC%26aufirst%3DG.%2BM.%26atitle%3DRecent%2520Advances%2520in%2520the%2520Prediction%2520of%2520Blood%25E2%2580%2593brain%2520Partitioning%2520from%2520Molecular%2520Structure%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2003%26volume%3D92%26spage%3D360%26epage%3D370%26doi%3D10.1002%2Fjps.10282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Conejo-García, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Núñez, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campos, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espinosa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Homodimeric bis-Quaternary Heterocyclic Ammonium Salts as Potent Acetyl- and Butyryl-cholinesterase Inhibitors: A Systematic Investigation of the Influence of Linker and Cationic Heads Over Affinity and Selectivity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2627</span><span class="NLM_x">–</span> <span class="NLM_lpage">2645</span><span class="refDoi"> DOI: 10.1021/jm101299d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101299d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2627-2645&author=A.+Conejo-Garc%C3%ADaauthor=L.+Pisaniauthor=M.+C.+N%C3%BA%C3%B1ezauthor=M.+Cattoauthor=O.+Nicolottiauthor=F.+Leonettiauthor=J.+M.+Camposauthor=M.+A.+Galloauthor=A.+Espinosaauthor=A.+Carotti&title=Homodimeric+bis-Quaternary+Heterocyclic+Ammonium+Salts+as+Potent+Acetyl-+and+Butyryl-cholinesterase+Inhibitors%3A+A+Systematic+Investigation+of+the+Influence+of+Linker+and+Cationic+Heads+Over+Affinity+and+Selectivity&doi=10.1021%2Fjm101299d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Fjm101299d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101299d%26sid%3Dliteratum%253Aachs%26aulast%3DConejo-Garc%25C3%25ADa%26aufirst%3DA.%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DN%25C3%25BA%25C3%25B1ez%26aufirst%3DM.%2BC.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DCampos%26aufirst%3DJ.%2BM.%26aulast%3DGallo%26aufirst%3DM.%2BA.%26aulast%3DEspinosa%26aufirst%3DA.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DHomodimeric%2520bis-Quaternary%2520Heterocyclic%2520Ammonium%2520Salts%2520as%2520Potent%2520Acetyl-%2520and%2520Butyryl-cholinesterase%2520Inhibitors%253A%2520A%2520Systematic%2520Investigation%2520of%2520the%2520Influence%2520of%2520Linker%2520and%2520Cationic%2520Heads%2520Over%2520Affinity%2520and%2520Selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2627%26epage%3D2645%26doi%3D10.1021%2Fjm101299d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farina, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto-Otero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denora, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangiatordi, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendez-Alvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altomare, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Searching for Multi-Targeting Neurotherapeutics against Alzheimer ’s: Discovery of Potent AChE-MAO B Inhibitors through the Decoration of the 2H Chromen-2-one Structural Motif</span> <span class="citation_source-journal">Molecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">362</span><span class="refDoi"> DOI: 10.3390/molecules21030362</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.3390%2Fmolecules21030362" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=362&author=L.+Pisaniauthor=R.+Farinaauthor=R.+Soto-Oteroauthor=N.+Denoraauthor=G.+F.+Mangiatordiauthor=O.+Nicolottiauthor=E.+Mendez-Alvarezauthor=C.+D.+Altomareauthor=M.+Cattoauthor=A.+Carotti&title=Searching+for+Multi-Targeting+Neurotherapeutics+against+Alzheimer+%E2%80%99s%3A+Discovery+of+Potent+AChE-MAO+B+Inhibitors+through+the+Decoration+of+the+2H+Chromen-2-one+Structural+Motif&doi=10.3390%2Fmolecules21030362"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.3390%2Fmolecules21030362&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules21030362%26sid%3Dliteratum%253Aachs%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DFarina%26aufirst%3DR.%26aulast%3DSoto-Otero%26aufirst%3DR.%26aulast%3DDenora%26aufirst%3DN.%26aulast%3DMangiatordi%26aufirst%3DG.%2BF.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DMendez-Alvarez%26aufirst%3DE.%26aulast%3DAltomare%26aufirst%3DC.%2BD.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DSearching%2520for%2520Multi-Targeting%2520Neurotherapeutics%2520against%2520Alzheimer%2520%25E2%2580%2599s%253A%2520Discovery%2520of%2520Potent%2520AChE-MAO%2520B%2520Inhibitors%2520through%2520the%2520Decoration%2520of%2520the%25202H%2520Chromen-2-one%2520Structural%2520Motif%26jtitle%3DMolecules%26date%3D2016%26volume%3D21%26spage%3D362%26doi%3D10.3390%2Fmolecules21030362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Denora, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laquintana, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trapani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopedota, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latrofa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trapani, G.</span><span> </span><span class="NLM_article-title">Translocator Protein (TSPO) Ligand-Ara-C (Cytarabine) Conjugates as a Strategy to Deliver Antineoplastic Drugs and to Enhance Drug Clinical Potential</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">2255</span><span class="NLM_x">–</span> <span class="NLM_lpage">2269</span><span class="refDoi"> DOI: 10.1021/mp100235w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp100235w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlyks7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2010&pages=2255-2269&author=N.+Denoraauthor=V.+Laquintanaauthor=A.+Trapaniauthor=A.+Lopedotaauthor=A.+Latrofaauthor=J.+M.+Galloauthor=G.+Trapani&title=Translocator+Protein+%28TSPO%29+Ligand-Ara-C+%28Cytarabine%29+Conjugates+as+a+Strategy+to+Deliver+Antineoplastic+Drugs+and+to+Enhance+Drug+Clinical+Potential&doi=10.1021%2Fmp100235w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Translocator Protein (TSPO) Ligand-Ara-C (Cytarabine) Conjugates as a Strategy To Deliver Antineoplastic Drugs and To Enhance Drug Clinical Potential</span></div><div class="casAuthors">Denora, Nunzio; Laquintana, Valentino; Trapani, Adriana; Lopedota, Angela; Latrofa, Andrea; Gallo, James M.; Trapani, Giuseppe</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2255-2269</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The aim of this work was to evaluate TSPO ligand-Ara-C conjugation as an approach for the selective delivery of the antineoplastic agent to brain tumors as well as for overcome P-gp resistance induction obsd. for the majority of cytotoxic agents, enhancing the drug clin. potential.  To this end, novel N-imidazopyridinacetyl-Ara-C conjugates have been prepd. and evaluated for their cytotoxicity against glioma cell lines.  Conjugate (I) resulted stable in both phosphate buffer and physiol. medium.  In all cases, the release of free Ara-C from hydrolyzed conjugates was checked by HPLC and ESI-MS anal.  Conjugates (II) and I displayed very high in vitro TSPO affinity and selectivity, and, hence, they may possess potential for targeted brain delivery.  Due to the favorable features displayed by the conjugate I, it was further evaluated on glioma cell lines, expressing high levels of TSPO, in the presence and in the absence of specific nucleoside transport (NT) inhibitors.  In contrast to that obsd. for the free Ara-C, the presence of NT inhibitors did not reduce the cytotoxic activity of I.  Moreover, conjugate I, as N4-acyl deriv. of Ara-C, should be resistant to inactivation by cytidine deaminase, and it may possess enhanced propensity to target brain tumor cells characterized by a reduced expression of NTs.  In addn., this conjugate behaves as a clear P-gp modulator and thereby may be useful to reverse MDR.  Transport studies across the MDCKII-MDR1 monolayer indicated that conjugate I should overcome the BBB by transcellular pathway.  All these features may be useful for enhancing the clin. potential of the nucleoside drug Ara-C.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlPSCWV14q97Vg90H21EOLACvtfcHk0lixLZ6c0gxxpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlyks7nJ&md5=97dfb1bb26e96783537794143c661363</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1021%2Fmp100235w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp100235w%26sid%3Dliteratum%253Aachs%26aulast%3DDenora%26aufirst%3DN.%26aulast%3DLaquintana%26aufirst%3DV.%26aulast%3DTrapani%26aufirst%3DA.%26aulast%3DLopedota%26aufirst%3DA.%26aulast%3DLatrofa%26aufirst%3DA.%26aulast%3DGallo%26aufirst%3DJ.%2BM.%26aulast%3DTrapani%26aufirst%3DG.%26atitle%3DTranslocator%2520Protein%2520%2528TSPO%2529%2520Ligand-Ara-C%2520%2528Cytarabine%2529%2520Conjugates%2520as%2520a%2520Strategy%2520to%2520Deliver%2520Antineoplastic%2520Drugs%2520and%2520to%2520Enhance%2520Drug%2520Clinical%2520Potential%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2010%26volume%3D7%26spage%3D2255%26epage%3D2269%26doi%3D10.1021%2Fmp100235w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Denora, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laquintana, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopalco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trapani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cimmino, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laconca, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuffrida, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trapani, G.</span><span> </span><span class="NLM_article-title">Novel Codrugs with GABAergic Activity for Dopamine Delivery in the Brain</span> <span class="citation_source-journal">Int. J. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">437</span><span class="NLM_x">, </span> <span class="NLM_fpage">221</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span><span class="refDoi"> DOI: 10.1016/j.ijpharm.2012.08.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1016%2Fj.ijpharm.2012.08.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=22940209" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlaiurnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=437&publication_year=2012&pages=221-231&author=N.+Denoraauthor=T.+Cassanoauthor=V.+Laquintanaauthor=A.+Lopalcoauthor=A.+Trapaniauthor=C.+S.+Cimminoauthor=L.+Laconcaauthor=A.+Giuffridaauthor=G.+Trapani&title=Novel+Codrugs+with+GABAergic+Activity+for+Dopamine+Delivery+in+the+Brain&doi=10.1016%2Fj.ijpharm.2012.08.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Novel codrugs with GABAergic activity for dopamine delivery in the brain</span></div><div class="casAuthors">Denora, Nunzio; Cassano, Tommaso; Laquintana, Valentino; Lopalco, Antonio; Trapani, Adriana; Cimmino, Concetta Stefania; Laconca, Leonardo; Giuffrida, Andrea; Trapani, Giuseppe</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">437</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">221-231</span>CODEN:
                <span class="NLM_cas:coden">IJPHDE</span>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">This study investigates the use of codrugs of the GABAergic agent 2-phenyl-imidazo[1,2-a]pyridinacetamide and dopamine (DA) or Et ester L-Dopa (LD) as a strategy to deliver DA and simultaneously activate GABA-receptors in the brain.  For this purpose, both DA and LD Et ester were linked by carbamate bond to imidazo[1,2-a]pyridine acetamide moieties to yield two DA- and two LD-imidazopyridine derivs.  These compds. were evaluated in vitro to assess their stability, binding affinities and cell membrane transport, and in vivo to assess their bio-availability via microdialysis studies.  The two DA derivs. were adequately stable in buffered soln., but underwent cleavage in dild. human serum.  By contrast, the LD derivs. were unstable in buffered soln.  Receptor binding studies showed that the DA-imidazopyridine carbamates had binding affinity for benzodiazepine receptors in the nanomolar range.  Brain microdialysis expts. indicated that i.p. administration of the DA derivs. sustained DA levels in rat striatum over a 4-h period.  These results suggest that DA-imidazopyridine carbamates are new DA codrugs with potential application for DA replacement therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2ZywfNEZEqbVg90H21EOLACvtfcHk0lixLZ6c0gxxpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlaiurnP&md5=fb9f8c41492bfccc09a24dd20b659b90</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpharm.2012.08.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpharm.2012.08.023%26sid%3Dliteratum%253Aachs%26aulast%3DDenora%26aufirst%3DN.%26aulast%3DCassano%26aufirst%3DT.%26aulast%3DLaquintana%26aufirst%3DV.%26aulast%3DLopalco%26aufirst%3DA.%26aulast%3DTrapani%26aufirst%3DA.%26aulast%3DCimmino%26aufirst%3DC.%2BS.%26aulast%3DLaconca%26aufirst%3DL.%26aulast%3DGiuffrida%26aufirst%3DA.%26aulast%3DTrapani%26aufirst%3DG.%26atitle%3DNovel%2520Codrugs%2520with%2520GABAergic%2520Activity%2520for%2520Dopamine%2520Delivery%2520in%2520the%2520Brain%26jtitle%3DInt.%2520J.%2520Pharm.%26date%3D2012%26volume%3D437%26spage%3D221%26epage%3D231%26doi%3D10.1016%2Fj.ijpharm.2012.08.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61a','cit61b'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 60 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Horacio Pérez-Sánchez, Helena den Haan, Alfonso Pérez-Garrido, Jorge Peña-García, Sandipan Chakraborty, Ilkay Erdogan Orhan, Fatma Sezer Senol Deniz, <span class="NLM_string-name hlFld-ContribAuthor">José Manuel Villalgordo</span>. </span><span class="cited-content_cbyCitation_article-title">Combined Structure and Ligand-Based Design of Selective Acetylcholinesterase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2021,</strong> <em>61 </em>
                                    (1)
                                     , 467-480. <a href="https://doi.org/10.1021/acs.jcim.0c00463" title="DOI URL">https://doi.org/10.1021/acs.jcim.0c00463</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.0c00463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.0c00463%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DCombined%252BStructure%252Band%252BLigand-Based%252BDesign%252Bof%252BSelective%252BAcetylcholinesterase%252BInhibitors%26aulast%3DP%25C3%25A9rez-S%25C3%25A1nchez%26aufirst%3DHoracio%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D01052020%26date%3D15122020%26volume%3D61%26issue%3D1%26spage%3D467%26epage%3D480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Tana Tandarić, <span class="NLM_string-name hlFld-ContribAuthor">Robert Vianello</span>. </span><span class="cited-content_cbyCitation_article-title">Computational Insight into the Mechanism of the Irreversible Inhibition of Monoamine Oxidase Enzymes by the Antiparkinsonian Propargylamine Inhibitors Rasagiline and Selegiline. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (8)
                                     , 3532-3542. <a href="https://doi.org/10.1021/acschemneuro.9b00147" title="DOI URL">https://doi.org/10.1021/acschemneuro.9b00147</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.9b00147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.9b00147%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DComputational%252BInsight%252Binto%252Bthe%252BMechanism%252Bof%252Bthe%252BIrreversible%252BInhibition%252Bof%252BMonoamine%252BOxidase%252BEnzymes%252Bby%252Bthe%252BAntiparkinsonian%252BPropargylamine%252BInhibitors%252BRasagiline%252Band%252BSelegiline%26aulast%3DTandari%25C4%2587%26aufirst%3DTana%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D13032019%26date%3D17062019%26date%3D02072019%26date%3D17062019%26volume%3D10%26issue%3D8%26spage%3D3532%26epage%3D3542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yixiang Xu, Jian Zhang, Huan Wang, Fei Mao, Keting Bao, Wenwen Liu, Jin Zhu, Xiaokang Li, Haiyan Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Jian Li</span>. </span><span class="cited-content_cbyCitation_article-title">Rational Design of Novel Selective Dual-Target Inhibitors of Acetylcholinesterase and Monoamine Oxidase B as Potential Anti-Alzheimer’s Disease Agents. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (1)
                                     , 482-496. <a href="https://doi.org/10.1021/acschemneuro.8b00357" title="DOI URL">https://doi.org/10.1021/acschemneuro.8b00357</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.8b00357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.8b00357%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DRational%252BDesign%252Bof%252BNovel%252BSelective%252BDual-Target%252BInhibitors%252Bof%252BAcetylcholinesterase%252Band%252BMonoamine%252BOxidase%252BB%252Bas%252BPotential%252BAnti-Alzheimer%2525E2%252580%252599s%252BDisease%252BAgents%26aulast%3DXu%26aufirst%3DYixiang%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D15072018%26date%3D15082018%26date%3D29082018%26date%3D15082018%26volume%3D10%26issue%3D1%26spage%3D482%26epage%3D496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pei  Cai</span>, <span class="hlFld-ContribAuthor ">Si-Qiang  Fang</span>, <span class="hlFld-ContribAuthor ">Xue-Lian  Yang</span>, <span class="hlFld-ContribAuthor ">Jia-Jia  Wu</span>, <span class="hlFld-ContribAuthor ">Qiao-Hong  Liu</span>, <span class="hlFld-ContribAuthor ">Hao  Hong</span>, <span class="hlFld-ContribAuthor ">Xiao-Bing  Wang</span>, and <span class="hlFld-ContribAuthor ">Ling-Yi  Kong</span>  . </span><span class="cited-content_cbyCitation_article-title">Rational Design and Multibiological Profiling of Novel Donepezil–Trolox Hybrids against Alzheimer’s Disease, with Cholinergic, Antioxidant, Neuroprotective, and Cognition Enhancing Properties. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2017,</strong> <em>8 </em>
                                    (11)
                                     , 2496-2511. <a href="https://doi.org/10.1021/acschemneuro.7b00257" title="DOI URL">https://doi.org/10.1021/acschemneuro.7b00257</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.7b00257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.7b00257%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DRational%252BDesign%252Band%252BMultibiological%252BProfiling%252Bof%252BNovel%252BDonepezil%2525E2%252580%252593Trolox%252BHybrids%252Bagainst%252BAlzheimer%2525E2%252580%252599s%252BDisease%25252C%252Bwith%252BCholinergic%25252C%252BAntioxidant%25252C%252BNeuroprotective%25252C%252Band%252BCognition%252BEnhancing%252BProperties%26aulast%3DCai%26aufirst%3DPei%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D10072017%26date%3D14082017%26date%3D25082017%26date%3D15112017%26date%3D14082017%26volume%3D8%26issue%3D11%26spage%3D2496%26epage%3D2511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Asif  Husain</span>, <span class="hlFld-ContribAuthor ">Al  Balushi K</span>, <span class="hlFld-ContribAuthor ">Md Jawaid  Akhtar</span>, <span class="hlFld-ContribAuthor ">Shah Alam  Khan</span>. </span><span class="cited-content_cbyCitation_article-title">Coumarin linked heterocyclic hybrids: A promising approach to develop multi target drugs for Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2021,</strong> <em>1241 </em>, 130618. <a href="https://doi.org/10.1016/j.molstruc.2021.130618" title="DOI URL">https://doi.org/10.1016/j.molstruc.2021.130618</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2021.130618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2021.130618%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DCoumarin%252Blinked%252Bheterocyclic%252Bhybrids%25253A%252BA%252Bpromising%252Bapproach%252Bto%252Bdevelop%252Bmulti%252Btarget%252Bdrugs%252Bfor%252BAlzheimer%252527s%252Bdisease%26aulast%3DHusain%26aufirst%3DAsif%26date%3D2021%26volume%3D1241%26spage%3D130618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Changjun  Zhang</span>, <span class="hlFld-ContribAuthor ">Yangjing  Lv</span>, <span class="hlFld-ContribAuthor ">Renren  Bai</span>, <span class="hlFld-ContribAuthor ">Yuanyuan  Xie</span>. </span><span class="cited-content_cbyCitation_article-title">Structural exploration of multifunctional monoamine oxidase B inhibitors as potential drug candidates against Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>114 </em>, 105070. <a href="https://doi.org/10.1016/j.bioorg.2021.105070" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.105070</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.105070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.105070%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DStructural%252Bexploration%252Bof%252Bmultifunctional%252Bmonoamine%252Boxidase%252BB%252Binhibitors%252Bas%252Bpotential%252Bdrug%252Bcandidates%252Bagainst%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DZhang%26aufirst%3DChangjun%26date%3D2021%26volume%3D114%26spage%3D105070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vishal Payyalot  Koyiparambath</span>, <span class="hlFld-ContribAuthor ">Krishnendu  Prayaga Rajappan</span>, <span class="hlFld-ContribAuthor ">T. M.  Rangarajan</span>, <span class="hlFld-ContribAuthor ">Abdullah G.  Al‐Sehemi</span>, <span class="hlFld-ContribAuthor ">Mehboobali  Pannipara</span>, <span class="hlFld-ContribAuthor ">Vaishnav  Bhaskar</span>, <span class="hlFld-ContribAuthor ">Aathira Sujathan  Nair</span>, <span class="hlFld-ContribAuthor ">Sachithra Thazhathuveedu  Sudevan</span>, <span class="hlFld-ContribAuthor ">Sunil  Kumar</span>, <span class="hlFld-ContribAuthor ">Bijo  Mathew</span>. </span><span class="cited-content_cbyCitation_article-title">Deciphering the detailed structure–activity relationship of coumarins as Monoamine oxidase enzyme inhibitors—An updated review. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2021,</strong> <em>5 </em><a href="https://doi.org/10.1111/cbdd.13919" title="DOI URL">https://doi.org/10.1111/cbdd.13919</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13919%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DDeciphering%252Bthe%252Bdetailed%252Bstructure%2525E2%252580%252593activity%252Brelationship%252Bof%252Bcoumarins%252Bas%252BMonoamine%252Boxidase%252Benzyme%252Binhibitors%2525E2%252580%252594An%252Bupdated%252Breview%26aulast%3DKoyiparambath%26aufirst%3DVishal%2BPayyalot%26date%3D2021%26date%3D2021%26volume%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhiwei  Chen</span>, <span class="hlFld-ContribAuthor ">Piaopiao  Zeng</span>, <span class="hlFld-ContribAuthor ">Shuo  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaoxiao  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Lewis‐Acid‐Mediated One‐Pot Tandem Reactions for Synthesis of Structurally Diverse Furo[3,2‐c]coumarins. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2021,</strong> <em>6 </em>
                                    (18)
                                     , 4539-4543. <a href="https://doi.org/10.1002/slct.202101029" title="DOI URL">https://doi.org/10.1002/slct.202101029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202101029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202101029%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DLewis%2525E2%252580%252590Acid%2525E2%252580%252590Mediated%252BOne%2525E2%252580%252590Pot%252BTandem%252BReactions%252Bfor%252BSynthesis%252Bof%252BStructurally%252BDiverse%252BFuro%25255B3%25252C2%2525E2%252580%252590c%25255Dcoumarins%26aulast%3DChen%26aufirst%3DZhiwei%26date%3D2021%26date%3D2021%26volume%3D6%26issue%3D18%26spage%3D4539%26epage%3D4543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fernanda  Rodríguez‐Enríquez</span>, <span class="hlFld-ContribAuthor ">Dolores  Viña</span>, <span class="hlFld-ContribAuthor ">Eugenio  Uriarte</span>, <span class="hlFld-ContribAuthor ">Reyes  Laguna</span>, <span class="hlFld-ContribAuthor ">Maria J.  Matos</span>. </span><span class="cited-content_cbyCitation_article-title">7‐Amidocoumarins as Multitarget Agents against Neurodegenerative Diseases: Substitution Pattern Modulation. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>16 </em>
                                    (1)
                                     , 179-186. <a href="https://doi.org/10.1002/cmdc.202000454" title="DOI URL">https://doi.org/10.1002/cmdc.202000454</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000454%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3D7%2525E2%252580%252590Amidocoumarins%252Bas%252BMultitarget%252BAgents%252Bagainst%252BNeurodegenerative%252BDiseases%25253A%252BSubstitution%252BPattern%252BModulation%26aulast%3DRodr%25C3%25ADguez%25E2%2580%2590Enr%25C3%25ADquez%26aufirst%3DFernanda%26date%3D2021%26date%3D2020%26volume%3D16%26issue%3D1%26spage%3D179%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rosaria  Perone</span>, <span class="hlFld-ContribAuthor ">Claudia  Albertini</span>, <span class="hlFld-ContribAuthor ">Elisa  Uliassi</span>, <span class="hlFld-ContribAuthor ">Flaminia  Di Pietri</span>, <span class="hlFld-ContribAuthor ">Pedro  Sena Murteira Pinheiro</span>, <span class="hlFld-ContribAuthor ">Sabrina  Petralla</span>, <span class="hlFld-ContribAuthor ">Nicola  Rizzardi</span>, <span class="hlFld-ContribAuthor ">Romana  Fato</span>, <span class="hlFld-ContribAuthor ">Lenka  Pulkrabkova</span>, <span class="hlFld-ContribAuthor ">Ondrej  Soukup</span>, <span class="hlFld-ContribAuthor ">Anna  Tramarin</span>, <span class="hlFld-ContribAuthor ">Manuela  Bartolini</span>, <span class="hlFld-ContribAuthor ">Maria Laura  Bolognesi</span>. </span><span class="cited-content_cbyCitation_article-title">Turning Donepezil into a Multi‐Target‐Directed Ligand through a Merging Strategy. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>16 </em>
                                    (1)
                                     , 187-198. <a href="https://doi.org/10.1002/cmdc.202000484" title="DOI URL">https://doi.org/10.1002/cmdc.202000484</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000484&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000484%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DTurning%252BDonepezil%252Binto%252Ba%252BMulti%2525E2%252580%252590Target%2525E2%252580%252590Directed%252BLigand%252Bthrough%252Ba%252BMerging%252BStrategy%26aulast%3DPerone%26aufirst%3DRosaria%26date%3D2021%26date%3D2020%26volume%3D16%26issue%3D1%26spage%3D187%26epage%3D198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Geum Seok  Jeong</span>, <span class="hlFld-ContribAuthor ">Swafvan  Kaipakasseri</span>, <span class="hlFld-ContribAuthor ">Sang Ryong  Lee</span>, <span class="hlFld-ContribAuthor ">Najat  Marraiki</span>, <span class="hlFld-ContribAuthor ">Gaber El‐Saber  Batiha</span>, <span class="hlFld-ContribAuthor ">Sanal  Dev</span>, <span class="hlFld-ContribAuthor ">Ashique  Palakkathondi</span>, <span class="hlFld-ContribAuthor ">Fathima Sahla  Kavully</span>, <span class="hlFld-ContribAuthor ">Nicola  Gambacorta</span>, <span class="hlFld-ContribAuthor ">Orazio  Nicolotti</span>, <span class="hlFld-ContribAuthor ">Bijo  Mathew</span>, <span class="hlFld-ContribAuthor ">Hoon  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Selected 1,3‐Benzodioxine‐Containing Chalcones as Multipotent Oxidase and Acetylcholinesterase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2020,</strong> <em>15 </em>
                                    (23)
                                     , 2257-2263. <a href="https://doi.org/10.1002/cmdc.202000491" title="DOI URL">https://doi.org/10.1002/cmdc.202000491</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000491%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DSelected%252B1%25252C3%2525E2%252580%252590Benzodioxine%2525E2%252580%252590Containing%252BChalcones%252Bas%252BMultipotent%252BOxidase%252Band%252BAcetylcholinesterase%252BInhibitors%26aulast%3DJeong%26aufirst%3DGeum%2BSeok%26date%3D2020%26date%3D2020%26volume%3D15%26issue%3D23%26spage%3D2257%26epage%3D2263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rosa  Purgatorio</span>, <span class="hlFld-ContribAuthor ">Nicola  Gambacorta</span>, <span class="hlFld-ContribAuthor ">Marco  Catto</span>, <span class="hlFld-ContribAuthor ">Modesto  de Candia</span>, <span class="hlFld-ContribAuthor ">Leonardo  Pisani</span>, <span class="hlFld-ContribAuthor ">Alba  Espargaró</span>, <span class="hlFld-ContribAuthor ">Raimon  Sabaté</span>, <span class="hlFld-ContribAuthor ">Saverio  Cellamare</span>, <span class="hlFld-ContribAuthor ">Orazio  Nicolotti</span>, <span class="hlFld-ContribAuthor ">Cosimo  Altomare</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacophore Modeling and 3D-QSAR Study of Indole and Isatin Derivatives as Antiamyloidogenic Agents Targeting Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (23)
                                     , 5773. <a href="https://doi.org/10.3390/molecules25235773" title="DOI URL">https://doi.org/10.3390/molecules25235773</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25235773&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25235773%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DPharmacophore%252BModeling%252Band%252B3D-QSAR%252BStudy%252Bof%252BIndole%252Band%252BIsatin%252BDerivatives%252Bas%252BAntiamyloidogenic%252BAgents%252BTargeting%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DPurgatorio%26aufirst%3DRosa%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D23%26spage%3D5773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julian  Breidenbach</span>, <span class="hlFld-ContribAuthor ">Ulrike  Bartz</span>, <span class="hlFld-ContribAuthor ">Michael  Gütschow</span>. </span><span class="cited-content_cbyCitation_article-title">Coumarin as a structural component of substrates and probes for serine and cysteine proteases. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics</span><span> <strong>2020,</strong> <em>1868 </em>
                                    (9)
                                     , 140445. <a href="https://doi.org/10.1016/j.bbapap.2020.140445" title="DOI URL">https://doi.org/10.1016/j.bbapap.2020.140445</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbapap.2020.140445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbapap.2020.140445%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Proteins%2520and%2520Proteomics%26atitle%3DCoumarin%252Bas%252Ba%252Bstructural%252Bcomponent%252Bof%252Bsubstrates%252Band%252Bprobes%252Bfor%252Bserine%252Band%252Bcysteine%252Bproteases%26aulast%3DBreidenbach%26aufirst%3DJulian%26date%3D2020%26volume%3D1868%26issue%3D9%26spage%3D140445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sai-Sai  Xie</span>, <span class="hlFld-ContribAuthor ">Jing  Liu</span>, <span class="hlFld-ContribAuthor ">Chunli  Tang</span>, <span class="hlFld-ContribAuthor ">Chengyun  Pang</span>, <span class="hlFld-ContribAuthor ">Qing  Li</span>, <span class="hlFld-ContribAuthor ">Yuelian  Qin</span>, <span class="hlFld-ContribAuthor ">Xiaojie  Nong</span>, <span class="hlFld-ContribAuthor ">Zhipeng  Zhang</span>, <span class="hlFld-ContribAuthor ">Jie  Guo</span>, <span class="hlFld-ContribAuthor ">Maojun  Cheng</span>, <span class="hlFld-ContribAuthor ">Weizhong  Tang</span>, <span class="hlFld-ContribAuthor ">Ningsheng  Liang</span>, <span class="hlFld-ContribAuthor ">Neng  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of rasagiline-clorgyline hybrids as novel dual inhibitors of monoamine oxidase-B and amyloid-β aggregation against Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>202 </em>, 112475. <a href="https://doi.org/10.1016/j.ejmech.2020.112475" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112475</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112475%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Brasagiline-clorgyline%252Bhybrids%252Bas%252Bnovel%252Bdual%252Binhibitors%252Bof%252Bmonoamine%252Boxidase-B%252Band%252Bamyloid-%2525CE%2525B2%252Baggregation%252Bagainst%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DXie%26aufirst%3DSai-Sai%26date%3D2020%26volume%3D202%26spage%3D112475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tana  Tandarić</span>, <span class="hlFld-ContribAuthor ">Alja  Prah</span>, <span class="hlFld-ContribAuthor ">Jernej  Stare</span>, <span class="hlFld-ContribAuthor ">Janez  Mavri</span>, <span class="hlFld-ContribAuthor ">Robert  Vianello</span>. </span><span class="cited-content_cbyCitation_article-title">Hydride Abstraction as the Rate-Limiting Step of the Irreversible Inhibition of Monoamine Oxidase B by Rasagiline and Selegiline: A Computational Empirical Valence Bond Study. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (17)
                                     , 6151. <a href="https://doi.org/10.3390/ijms21176151" title="DOI URL">https://doi.org/10.3390/ijms21176151</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21176151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21176151%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DHydride%252BAbstraction%252Bas%252Bthe%252BRate-Limiting%252BStep%252Bof%252Bthe%252BIrreversible%252BInhibition%252Bof%252BMonoamine%252BOxidase%252BB%252Bby%252BRasagiline%252Band%252BSelegiline%25253A%252BA%252BComputational%252BEmpirical%252BValence%252BBond%252BStudy%26aulast%3DTandari%25C4%2587%26aufirst%3DTana%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D17%26spage%3D6151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ioannis  Fotopoulos</span>, <span class="hlFld-ContribAuthor ">Dimitra  Hadjipavlou-Litina</span>. </span><span class="cited-content_cbyCitation_article-title">Hybrids of Coumarin Derivatives as Potent and Multifunctional Bioactive Agents: A Review. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry</span><span> <strong>2020,</strong> <em>16 </em>
                                    (3)
                                     , 272-306. <a href="https://doi.org/10.2174/1573406415666190416121448" title="DOI URL">https://doi.org/10.2174/1573406415666190416121448</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1573406415666190416121448&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1573406415666190416121448%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%26atitle%3DHybrids%252Bof%252BCoumarin%252BDerivatives%252Bas%252BPotent%252Band%252BMultifunctional%252BBioactive%252BAgents%25253A%252BA%252BReview%26aulast%3DFotopoulos%26aufirst%3DIoannis%26date%3D2020%26volume%3D16%26issue%3D3%26spage%3D272%26epage%3D306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhipei  Sang</span>, <span class="hlFld-ContribAuthor ">Keren  Wang</span>, <span class="hlFld-ContribAuthor ">Jian  Shi</span>, <span class="hlFld-ContribAuthor ">Wenmin  Liu</span>, <span class="hlFld-ContribAuthor ">Xinfeng  Cheng</span>, <span class="hlFld-ContribAuthor ">Gaofeng  Zhu</span>, <span class="hlFld-ContribAuthor ">Yiling  Wang</span>, <span class="hlFld-ContribAuthor ">Yiyang  Zhao</span>, <span class="hlFld-ContribAuthor ">Zhanpin  Qiao</span>, <span class="hlFld-ContribAuthor ">Anguo  Wu</span>, <span class="hlFld-ContribAuthor ">Zhenghuai  Tan</span>. </span><span class="cited-content_cbyCitation_article-title">The development of advanced structural framework as multi-target-directed ligands for the treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>192 </em>, 112180. <a href="https://doi.org/10.1016/j.ejmech.2020.112180" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112180</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112180%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252Bdevelopment%252Bof%252Badvanced%252Bstructural%252Bframework%252Bas%252Bmulti-target-directed%252Bligands%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DSang%26aufirst%3DZhipei%26date%3D2020%26volume%3D192%26spage%3D112180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiayang  Xie</span>, <span class="hlFld-ContribAuthor ">Ruirui  Liang</span>, <span class="hlFld-ContribAuthor ">Yajiang  Wang</span>, <span class="hlFld-ContribAuthor ">Junyi  Huang</span>, <span class="hlFld-ContribAuthor ">Xin  Cao</span>, <span class="hlFld-ContribAuthor ">Bing  Niu</span>. </span><span class="cited-content_cbyCitation_article-title">Progress in Target Drug Molecules for Alzheimer's Disease. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2020,</strong> <em>20 </em>
                                    (1)
                                     , 4-36. <a href="https://doi.org/10.2174/1568026619666191203113745" title="DOI URL">https://doi.org/10.2174/1568026619666191203113745</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026619666191203113745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026619666191203113745%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DProgress%252Bin%252BTarget%252BDrug%252BMolecules%252Bfor%252BAlzheimer%252527s%252BDisease%26aulast%3DXie%26aufirst%3DJiayang%26date%3D2020%26volume%3D20%26issue%3D1%26spage%3D4%26epage%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sanjay K  Verma</span>, <span class="hlFld-ContribAuthor ">Chirag  Savani</span>, <span class="hlFld-ContribAuthor ">Vinay K.  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Photophysical, Thermal and Crystallographic Studies of 3‐Aminocoumarin Based Monobasic
              
                κ
                3
                ‐O,N,O‐
              
              tridentate
              / κ
              
                2
              
              ‐
              N,O‐
              bidentate Schiff Base Divalent Complexes. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2019,</strong> <em>4 </em>
                                    (48)
                                     , 14244-14252. <a href="https://doi.org/10.1002/slct.201903988" title="DOI URL">https://doi.org/10.1002/slct.201903988</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201903988&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201903988%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DSynthesis%25252C%252BPhotophysical%25252C%252BThermal%252Band%252BCrystallographic%252BStudies%252Bof%252B3%2525E2%252580%252590Aminocoumarin%252BBased%252BMonobasic%252B%2525CE%2525BA%252B3%252B%2525E2%252580%252590O%25252CN%25252CO%2525E2%252580%252590%252Btridentate%252B%25252F%252B%2525CE%2525BA%252B2%252B%2525E2%252580%252590%252BN%25252CO%2525E2%252580%252590%252Bbidentate%252BSchiff%252BBase%252BDivalent%252BComplexes%26aulast%3DVerma%26aufirst%3DSanjay%2BK%26date%3D2019%26date%3D2019%26volume%3D4%26issue%3D48%26spage%3D14244%26epage%3D14252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Reeta</span>, <span class="hlFld-ContribAuthor ">Seung Cheol  Baek</span>, <span class="hlFld-ContribAuthor ">Jae Pil  Lee</span>, <span class="hlFld-ContribAuthor ">T.M.  Rangarajan</span>, <span class="hlFld-ContribAuthor ">Ayushee</span>, <span class="hlFld-ContribAuthor ">Rishi Pal  Singh</span>, <span class="hlFld-ContribAuthor ">Manjula  Singh</span>, <span class="hlFld-ContribAuthor ">Giuseppe Felice  Mangiatordi</span>, <span class="hlFld-ContribAuthor ">Orazio  Nicolotti</span>, <span class="hlFld-ContribAuthor ">Hoon  Kim</span>, <span class="hlFld-ContribAuthor ">Bijo  Mathew</span>. </span><span class="cited-content_cbyCitation_article-title">Ethyl Acetohydroxamate Incorporated Chalcones: Unveiling a Novel Class of Chalcones for Multitarget Monoamine Oxidase-B Inhibitors Against Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">CNS & Neurological Disorders - Drug Targets</span><span> <strong>2019,</strong> <em>18 </em>
                                    (8)
                                     , 643-654. <a href="https://doi.org/10.2174/1871527318666190906101326" title="DOI URL">https://doi.org/10.2174/1871527318666190906101326</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1871527318666190906101326&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1871527318666190906101326%26sid%3Dliteratum%253Aachs%26jtitle%3DCNS%2520%2526%2520Neurological%2520Disorders%2520-%2520Drug%2520Targets%26atitle%3DEthyl%252BAcetohydroxamate%252BIncorporated%252BChalcones%25253A%252BUnveiling%252Ba%252BNovel%252BClass%252Bof%252BChalcones%252Bfor%252BMultitarget%252BMonoamine%252BOxidase-B%252BInhibitors%252BAgainst%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DReeta%26date%3D2019%26volume%3D18%26issue%3D8%26spage%3D643%26epage%3D654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Behzad  Jafari</span>, <span class="hlFld-ContribAuthor ">Saquib  Jalil</span>, <span class="hlFld-ContribAuthor ">Sumera  Zaib</span>, <span class="hlFld-ContribAuthor ">Sayfidin  Safarov</span>, <span class="hlFld-ContribAuthor ">Muattar  Khalikova</span>, <span class="hlFld-ContribAuthor ">Djurabay  Khalikov</span>, <span class="hlFld-ContribAuthor ">Meirambek  Ospanov</span>, <span class="hlFld-ContribAuthor ">Nazym  Yelibayeva</span>, <span class="hlFld-ContribAuthor ">Shynar  Zhumagalieva</span>, <span class="hlFld-ContribAuthor ">Zharylkasyn A.  Abilov</span>, <span class="hlFld-ContribAuthor ">Mirgul Z.  Turmukhanova</span>, <span class="hlFld-ContribAuthor ">Sergey N.  Kalugin</span>, <span class="hlFld-ContribAuthor ">Ghazwan Ali  Salman</span>, <span class="hlFld-ContribAuthor ">Peter  Ehlers</span>, <span class="hlFld-ContribAuthor ">Abdul  Hameed</span>, <span class="hlFld-ContribAuthor ">Jamshed  Iqbal</span>, <span class="hlFld-ContribAuthor ">Peter  Langer</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 2‐Alkynyl‐ and2‐Amino‐12
              H
              ‐benzothiazolo[2,3‐
              b
              ]quinazolin‐12‐ones and Their Inhibitory Potential against Monoamine Oxidase A and B. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2019,</strong> <em>4 </em>
                                    (47)
                                     , 13760-13767. <a href="https://doi.org/10.1002/slct.201903300" title="DOI URL">https://doi.org/10.1002/slct.201903300</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201903300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201903300%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DSynthesis%252Bof%252B2%2525E2%252580%252590Alkynyl%2525E2%252580%252590%252Band2%2525E2%252580%252590Amino%2525E2%252580%25259012%252BH%252B%2525E2%252580%252590benzothiazolo%25255B2%25252C3%2525E2%252580%252590%252Bb%252B%25255Dquinazolin%2525E2%252580%25259012%2525E2%252580%252590ones%252Band%252BTheir%252BInhibitory%252BPotential%252Bagainst%252BMonoamine%252BOxidase%252BA%252Band%252BB%26aulast%3DJafari%26aufirst%3DBehzad%26date%3D2019%26date%3D2019%26volume%3D4%26issue%3D47%26spage%3D13760%26epage%3D13767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Della Grace Thomas  Parambi</span>, <span class="hlFld-ContribAuthor ">Jong Min  Oh</span>, <span class="hlFld-ContribAuthor ">Seung Cheol  Baek</span>, <span class="hlFld-ContribAuthor ">Jae Pil  Lee</span>, <span class="hlFld-ContribAuthor ">Anna Rita  Tondo</span>, <span class="hlFld-ContribAuthor ">Orazio  Nicolotti</span>, <span class="hlFld-ContribAuthor ">Hoon  Kim</span>, <span class="hlFld-ContribAuthor ">Bijo  Mathew</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of oxygenated chalcones as potent and selective MAO-B inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>93 </em>, 103335. <a href="https://doi.org/10.1016/j.bioorg.2019.103335" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103335</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103335&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103335%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Boxygenated%252Bchalcones%252Bas%252Bpotent%252Band%252Bselective%252BMAO-B%252Binhibitors%26aulast%3DParambi%26aufirst%3DDella%2BGrace%2BThomas%26date%3D2019%26volume%3D93%26spage%3D103335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francesco  Mesiti</span>, <span class="hlFld-ContribAuthor ">Daniel  Chavarria</span>, <span class="hlFld-ContribAuthor ">Alexandra  Gaspar</span>, <span class="hlFld-ContribAuthor ">Stefano  Alcaro</span>, <span class="hlFld-ContribAuthor ">Fernanda  Borges</span>. </span><span class="cited-content_cbyCitation_article-title">The chemistry toolbox of multitarget-directed ligands for Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>181 </em>, 111572. <a href="https://doi.org/10.1016/j.ejmech.2019.111572" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111572</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111572&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111572%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252Bchemistry%252Btoolbox%252Bof%252Bmultitarget-directed%252Bligands%252Bfor%252BAlzheimer%252527s%252Bdisease%26aulast%3DMesiti%26aufirst%3DFrancesco%26date%3D2019%26volume%3D181%26spage%3D111572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bijo  Mathew</span>, <span class="hlFld-ContribAuthor ">Della G. T.  Parambi</span>, <span class="hlFld-ContribAuthor ">Githa E.  Mathew</span>, <span class="hlFld-ContribAuthor ">Md. Sahab  Uddin</span>, <span class="hlFld-ContribAuthor ">Sini T.  Inasu</span>, <span class="hlFld-ContribAuthor ">Hoon  Kim</span>, <span class="hlFld-ContribAuthor ">Akash  Marathakam</span>, <span class="hlFld-ContribAuthor ">Mazhuvancherry Kesavan  Unnikrishnan</span>, <span class="hlFld-ContribAuthor ">Simone  Carradori</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging therapeutic potentials of dual‐acting MAO and AChE inhibitors in Alzheimer's and Parkinson's diseases. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2019,</strong> <em>352 </em>
                                    (11)
                                     , 1900177. <a href="https://doi.org/10.1002/ardp.201900177" title="DOI URL">https://doi.org/10.1002/ardp.201900177</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201900177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201900177%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DEmerging%252Btherapeutic%252Bpotentials%252Bof%252Bdual%2525E2%252580%252590acting%252BMAO%252Band%252BAChE%252Binhibitors%252Bin%252BAlzheimer%252527s%252Band%252BParkinson%252527s%252Bdiseases%26aulast%3DMathew%26aufirst%3DBijo%26date%3D2019%26date%3D2019%26volume%3D352%26issue%3D11%26spage%3D1900177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Behzad  Jafari</span>, <span class="hlFld-ContribAuthor ">Saquib  Jalil</span>, <span class="hlFld-ContribAuthor ">Sumera  Zaib</span>, <span class="hlFld-ContribAuthor ">Jamshed  Iqbal</span>, <span class="hlFld-ContribAuthor ">Sayfidin  Safarov</span>, <span class="hlFld-ContribAuthor ">Muattar  Khalikova</span>, <span class="hlFld-ContribAuthor ">Muzafar  Isobaev</span>, <span class="hlFld-ContribAuthor ">Ali  Munshi</span>, <span class="hlFld-ContribAuthor ">Qamar  Rahman</span>, <span class="hlFld-ContribAuthor ">Meirambek  Ospanov</span>, <span class="hlFld-ContribAuthor ">Nazym  Yelibayeva</span>, <span class="hlFld-ContribAuthor ">Nazken  Kelzhanova</span>, <span class="hlFld-ContribAuthor ">Zharylkasyn A.  Abilov</span>, <span class="hlFld-ContribAuthor ">Mirgul Z.  Turmukhanova</span>, <span class="hlFld-ContribAuthor ">Sergey N.  Kalugin</span>, <span class="hlFld-ContribAuthor ">Peter  Ehlers</span>, <span class="hlFld-ContribAuthor ">Peter  Langer</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 2‐Aryl‐12
              H
              ‐benzothiazolo[2,3‐
              b
              ]quinazolin‐12‐ones and Their Activity Against Monoamine Oxidases. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2019,</strong> <em>4 </em>
                                    (37)
                                     , 11071-11076. <a href="https://doi.org/10.1002/slct.201902245" title="DOI URL">https://doi.org/10.1002/slct.201902245</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201902245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201902245%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DSynthesis%252Bof%252B2%2525E2%252580%252590Aryl%2525E2%252580%25259012%252BH%252B%2525E2%252580%252590benzothiazolo%25255B2%25252C3%2525E2%252580%252590%252Bb%252B%25255Dquinazolin%2525E2%252580%25259012%2525E2%252580%252590ones%252Band%252BTheir%252BActivity%252BAgainst%252BMonoamine%252BOxidases%26aulast%3DJafari%26aufirst%3DBehzad%26date%3D2019%26volume%3D4%26issue%3D37%26spage%3D11071%26epage%3D11076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paolo  Guglielmi</span>, <span class="hlFld-ContribAuthor ">Simone  Carradori</span>, <span class="hlFld-ContribAuthor ">Alessandra  Ammazzalorso</span>, <span class="hlFld-ContribAuthor ">Daniela  Secci</span>. </span><span class="cited-content_cbyCitation_article-title">Novel approaches to the discovery of selective human monoamine oxidase-B inhibitors: is there room for improvement?. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2019,</strong> <em>14 </em>
                                    (10)
                                     , 995-1035. <a href="https://doi.org/10.1080/17460441.2019.1637415" title="DOI URL">https://doi.org/10.1080/17460441.2019.1637415</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2019.1637415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2019.1637415%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DNovel%252Bapproaches%252Bto%252Bthe%252Bdiscovery%252Bof%252Bselective%252Bhuman%252Bmonoamine%252Boxidase-B%252Binhibitors%25253A%252Bis%252Bthere%252Broom%252Bfor%252Bimprovement%25253F%26aulast%3DGuglielmi%26aufirst%3DPaolo%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D10%26spage%3D995%26epage%3D1035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Harbinder  Singh</span>, <span class="hlFld-ContribAuthor ">Jatinder Vir  Singh</span>, <span class="hlFld-ContribAuthor ">Kavita  Bhagat</span>, <span class="hlFld-ContribAuthor ">Harmandeep Kaur  Gulati</span>, <span class="hlFld-ContribAuthor ">Mohit  Sanduja</span>, <span class="hlFld-ContribAuthor ">Nitish  Kumar</span>, <span class="hlFld-ContribAuthor ">Nihar  Kinarivala</span>, <span class="hlFld-ContribAuthor ">Sahil  Sharma</span>. </span><span class="cited-content_cbyCitation_article-title">Rational approaches, design strategies, structure activity relationship and mechanistic insights for therapeutic coumarin hybrids. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (16)
                                     , 3477-3510. <a href="https://doi.org/10.1016/j.bmc.2019.06.033" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.06.033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.06.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.06.033%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DRational%252Bapproaches%25252C%252Bdesign%252Bstrategies%25252C%252Bstructure%252Bactivity%252Brelationship%252Band%252Bmechanistic%252Binsights%252Bfor%252Btherapeutic%252Bcoumarin%252Bhybrids%26aulast%3DSingh%26aufirst%3DHarbinder%26date%3D2019%26volume%3D27%26issue%3D16%26spage%3D3477%26epage%3D3510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Silvia  Franchini</span>, <span class="hlFld-ContribAuthor ">Claudia  Sorbi</span>, <span class="hlFld-ContribAuthor ">Pasquale  Linciano</span>, <span class="hlFld-ContribAuthor ">Gianluca  Carnevale</span>, <span class="hlFld-ContribAuthor ">Annalisa  Tait</span>, <span class="hlFld-ContribAuthor ">Simone  Ronsisvalle</span>, <span class="hlFld-ContribAuthor ">Michela  Buccioni</span>, <span class="hlFld-ContribAuthor ">Fabio  Del Bello</span>, <span class="hlFld-ContribAuthor ">Antonio  Cilia</span>, <span class="hlFld-ContribAuthor ">Lorenza  Pirona</span>, <span class="hlFld-ContribAuthor ">Nunzio  Denora</span>, <span class="hlFld-ContribAuthor ">Rosa Maria  Iacobazzi</span>, <span class="hlFld-ContribAuthor ">Livio  Brasili</span>. </span><span class="cited-content_cbyCitation_article-title">1,3-Dioxane as a scaffold for potent and selective 5-HT1AR agonist with in-vivo anxiolytic, anti-depressant and anti-nociceptive activity. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>176 </em>, 310-325. <a href="https://doi.org/10.1016/j.ejmech.2019.05.024" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.05.024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.05.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.05.024%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3D1%25252C3-Dioxane%252Bas%252Ba%252Bscaffold%252Bfor%252Bpotent%252Band%252Bselective%252B5-HT1AR%252Bagonist%252Bwith%252Bin-vivo%252Banxiolytic%25252C%252Banti-depressant%252Band%252Banti-nociceptive%252Bactivity%26aulast%3DFranchini%26aufirst%3DSilvia%26date%3D2019%26volume%3D176%26spage%3D310%26epage%3D325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiraporn  Kara</span>, <span class="hlFld-ContribAuthor ">Paptawan  Suwanhom</span>, <span class="hlFld-ContribAuthor ">Chatchai  Wattanapiromsakul</span>, <span class="hlFld-ContribAuthor ">Teerapat  Nualnoi</span>, <span class="hlFld-ContribAuthor ">Jindaporn  Puripattanavong</span>, <span class="hlFld-ContribAuthor ">Pasarat  Khongkow</span>, <span class="hlFld-ContribAuthor ">Vannajan Sanghiran  Lee</span>, <span class="hlFld-ContribAuthor ">Anand  Gaurav</span>, <span class="hlFld-ContribAuthor ">Luelak  Lomlim</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 2‐(2‐oxo‐2
              H
              ‐chromen‐4‐yl)acetamides as potent acetylcholinesterase inhibitors and molecular insights into binding interactions. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2019,</strong> <em>352 </em>
                                    (7)
                                     , 1800310. <a href="https://doi.org/10.1002/ardp.201800310" title="DOI URL">https://doi.org/10.1002/ardp.201800310</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201800310&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201800310%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DSynthesis%252Bof%252B2%2525E2%252580%252590%2525282%2525E2%252580%252590oxo%2525E2%252580%2525902%252BH%252B%2525E2%252580%252590chromen%2525E2%252580%2525904%2525E2%252580%252590yl%252529acetamides%252Bas%252Bpotent%252Bacetylcholinesterase%252Binhibitors%252Band%252Bmolecular%252Binsights%252Binto%252Bbinding%252Binteractions%26aulast%3DKara%26aufirst%3DJiraporn%26date%3D2019%26date%3D2019%26volume%3D352%26issue%3D7%26spage%3D1800310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rina  Soni</span>, <span class="hlFld-ContribAuthor ">Sunil Dutt  Durgapal</span>, <span class="hlFld-ContribAuthor ">Shubhangi S.  Soman</span>, <span class="hlFld-ContribAuthor ">John J  Georrge</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and anti-diabetic activity of chromen-2-one derivatives. </span><span class="cited-content_cbyCitation_journal-name">Arabian Journal of Chemistry</span><span> <strong>2019,</strong> <em>12 </em>
                                    (5)
                                     , 701-708. <a href="https://doi.org/10.1016/j.arabjc.2016.11.011" title="DOI URL">https://doi.org/10.1016/j.arabjc.2016.11.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.arabjc.2016.11.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.arabjc.2016.11.011%26sid%3Dliteratum%253Aachs%26jtitle%3DArabian%2520Journal%2520of%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Banti-diabetic%252Bactivity%252Bof%252Bchromen-2-one%252Bderivatives%26aulast%3DSoni%26aufirst%3DRina%26date%3D2019%26volume%3D12%26issue%3D5%26spage%3D701%26epage%3D708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Balasubramanian  Lakshminarayanan</span>, <span class="hlFld-ContribAuthor ">Seung Cheol  Baek</span>, <span class="hlFld-ContribAuthor ">Jae Pil  Lee</span>, <span class="hlFld-ContribAuthor ">Nagappan  Kannappan</span>, <span class="hlFld-ContribAuthor ">Giuseppe Felice  Mangiatordi</span>, <span class="hlFld-ContribAuthor ">Orazio  Nicolotti</span>, <span class="hlFld-ContribAuthor ">Thillainayagam  Subburaju</span>, <span class="hlFld-ContribAuthor ">Hoon  Kim</span>, <span class="hlFld-ContribAuthor ">Bijo  Mathew</span>. </span><span class="cited-content_cbyCitation_article-title">Ethoxylated Head of Chalcones as a New Class of Multi‐Targeted MAO Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2019,</strong> <em>4 </em>
                                    (21)
                                     , 6614-6619. <a href="https://doi.org/10.1002/slct.201901093" title="DOI URL">https://doi.org/10.1002/slct.201901093</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201901093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201901093%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DEthoxylated%252BHead%252Bof%252BChalcones%252Bas%252Ba%252BNew%252BClass%252Bof%252BMulti%2525E2%252580%252590Targeted%252BMAO%252BInhibitors%26aulast%3DLakshminarayanan%26aufirst%3DBalasubramanian%26date%3D2019%26date%3D2019%26volume%3D4%26issue%3D21%26spage%3D6614%26epage%3D6619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rabail  Ujan</span>, <span class="hlFld-ContribAuthor ">Aamer  Saeed</span>, <span class="hlFld-ContribAuthor ">Pervaiz  Channar</span>, <span class="hlFld-ContribAuthor ">Fayaz  Larik</span>, <span class="hlFld-ContribAuthor ">Qamar  Abbas</span>, <span class="hlFld-ContribAuthor ">Mohamed  Alajmi</span>, <span class="hlFld-ContribAuthor ">Hesham  El-Seedi</span>, <span class="hlFld-ContribAuthor ">Mahboob  Rind</span>, <span class="hlFld-ContribAuthor ">Mubashir  Hassan</span>, <span class="hlFld-ContribAuthor ">Hussain  Raza</span>, <span class="hlFld-ContribAuthor ">Sung-Yum  Seo</span>. </span><span class="cited-content_cbyCitation_article-title">Drug-1,3,4-Thiadiazole Conjugates as Novel Mixed-Type Inhibitors of Acetylcholinesterase: Synthesis, Molecular Docking, Pharmacokinetics, and ADMET Evaluation. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (5)
                                     , 860. <a href="https://doi.org/10.3390/molecules24050860" title="DOI URL">https://doi.org/10.3390/molecules24050860</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24050860&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24050860%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDrug-1%25252C3%25252C4-Thiadiazole%252BConjugates%252Bas%252BNovel%252BMixed-Type%252BInhibitors%252Bof%252BAcetylcholinesterase%25253A%252BSynthesis%25252C%252BMolecular%252BDocking%25252C%252BPharmacokinetics%25252C%252Band%252BADMET%252BEvaluation%26aulast%3DUjan%26aufirst%3DRabail%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D5%26spage%3D860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Renyuan  Hong</span>, <span class="hlFld-ContribAuthor ">Xun  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of monoamine oxidase inhibitors by medicinal chemistry approaches. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2019,</strong> <em>10 </em>
                                    (1)
                                     , 10-25. <a href="https://doi.org/10.1039/C8MD00446C" title="DOI URL">https://doi.org/10.1039/C8MD00446C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8MD00446C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8MD00446C%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DDiscovery%252Bof%252Bmonoamine%252Boxidase%252Binhibitors%252Bby%252Bmedicinal%252Bchemistry%252Bapproaches%26aulast%3DHong%26aufirst%3DRenyuan%26date%3D2019%26date%3D2019%26volume%3D10%26issue%3D1%26spage%3D10%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leonardo  Pisani</span>, <span class="hlFld-ContribAuthor ">Rosa Maria  Iacobazzi</span>, <span class="hlFld-ContribAuthor ">Marco  Catto</span>, <span class="hlFld-ContribAuthor ">Mariagrazia  Rullo</span>, <span class="hlFld-ContribAuthor ">Roberta  Farina</span>, <span class="hlFld-ContribAuthor ">Nunzio  Denora</span>, <span class="hlFld-ContribAuthor ">Saverio  Cellamare</span>, <span class="hlFld-ContribAuthor ">Cosimo Damiano  Altomare</span>. </span><span class="cited-content_cbyCitation_article-title">Investigating alkyl nitrates as nitric oxide releasing precursors of multitarget acetylcholinesterase-monoamine oxidase B inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>161 </em>, 292-309. <a href="https://doi.org/10.1016/j.ejmech.2018.10.016" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.10.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.10.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.10.016%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DInvestigating%252Balkyl%252Bnitrates%252Bas%252Bnitric%252Boxide%252Breleasing%252Bprecursors%252Bof%252Bmultitarget%252Bacetylcholinesterase-monoamine%252Boxidase%252BB%252Binhibitors%26aulast%3DPisani%26aufirst%3DLeonardo%26date%3D2019%26volume%3D161%26spage%3D292%26epage%3D309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mariagrazia  Rullo</span>, <span class="hlFld-ContribAuthor ">Mauro  Niso</span>, <span class="hlFld-ContribAuthor ">Leonardo  Pisani</span>, <span class="hlFld-ContribAuthor ">Antonio  Carrieri</span>, <span class="hlFld-ContribAuthor ">Nicola Antonio  Colabufo</span>, <span class="hlFld-ContribAuthor ">Saverio  Cellamare</span>, <span class="hlFld-ContribAuthor ">Cosimo Damiano  Altomare</span>. </span><span class="cited-content_cbyCitation_article-title">1,2,3,4-Tetrahydroisoquinoline/2H-chromen-2-one conjugates as nanomolar P-glycoprotein inhibitors: Molecular determinants for affinity and selectivity over multidrug resistance associated protein 1. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>161 </em>, 433-444. <a href="https://doi.org/10.1016/j.ejmech.2018.10.043" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.10.043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.10.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.10.043%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3D1%25252C2%25252C3%25252C4-Tetrahydroisoquinoline%25252F2H-chromen-2-one%252Bconjugates%252Bas%252Bnanomolar%252BP-glycoprotein%252Binhibitors%25253A%252BMolecular%252Bdeterminants%252Bfor%252Baffinity%252Band%252Bselectivity%252Bover%252Bmultidrug%252Bresistance%252Bassociated%252Bprotein%252B1%26aulast%3DRullo%26aufirst%3DMariagrazia%26date%3D2019%26volume%3D161%26spage%3D433%26epage%3D444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jie  Yang</span>, <span class="hlFld-ContribAuthor ">Pingping  Zhang</span>, <span class="hlFld-ContribAuthor ">Yuheng  Hu</span>, <span class="hlFld-ContribAuthor ">Teng  Liu</span>, <span class="hlFld-ContribAuthor ">Jie  Sun</span>, <span class="hlFld-ContribAuthor ">Xiaojing  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of 3-arylcoumarins as potential anti-Alzheimer's disease agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2019,</strong> <em>34 </em>
                                    (1)
                                     , 651-656. <a href="https://doi.org/10.1080/14756366.2019.1574297" title="DOI URL">https://doi.org/10.1080/14756366.2019.1574297</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2019.1574297&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2019.1574297%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B3-arylcoumarins%252Bas%252Bpotential%252Banti-Alzheimer%252527s%252Bdisease%252Bagents%26aulast%3DYang%26aufirst%3DJie%26date%3D2019%26date%3D2019%26volume%3D34%26issue%3D1%26spage%3D651%26epage%3D656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qi  He</span>, <span class="hlFld-ContribAuthor ">Jing  Liu</span>, <span class="hlFld-ContribAuthor ">Jin-Shuai  Lan</span>, <span class="hlFld-ContribAuthor ">Jiaoli  Ding</span>, <span class="hlFld-ContribAuthor ">Yongbing  Sun</span>, <span class="hlFld-ContribAuthor ">Yuanying  Fang</span>, <span class="hlFld-ContribAuthor ">Neng  Jiang</span>, <span class="hlFld-ContribAuthor ">Zunhua  Yang</span>, <span class="hlFld-ContribAuthor ">Liyuan  Sun</span>, <span class="hlFld-ContribAuthor ">Yi  Jin</span>, <span class="hlFld-ContribAuthor ">Sai-Sai  Xie</span>. </span><span class="cited-content_cbyCitation_article-title">Coumarin-dithiocarbamate hybrids as novel multitarget AChE and MAO-B inhibitors against Alzheimer’s disease: Design, synthesis and biological evaluation. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2018,</strong> <em>81 </em>, 512-528. <a href="https://doi.org/10.1016/j.bioorg.2018.09.010" title="DOI URL">https://doi.org/10.1016/j.bioorg.2018.09.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2018.09.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2018.09.010%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DCoumarin-dithiocarbamate%252Bhybrids%252Bas%252Bnovel%252Bmultitarget%252BAChE%252Band%252BMAO-B%252Binhibitors%252Bagainst%252BAlzheimer%2525E2%252580%252599s%252Bdisease%25253A%252BDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%26aulast%3DHe%26aufirst%3DQi%26date%3D2018%26volume%3D81%26spage%3D512%26epage%3D528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pei  Cai</span>, <span class="hlFld-ContribAuthor ">Si-Qiang  Fang</span>, <span class="hlFld-ContribAuthor ">Hua-Li  Yang</span>, <span class="hlFld-ContribAuthor ">Xue-Lian  Yang</span>, <span class="hlFld-ContribAuthor ">Qiao-Hong  Liu</span>, <span class="hlFld-ContribAuthor ">Ling-Yi  Kong</span>, <span class="hlFld-ContribAuthor ">Xiao-Bing  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Donepezil-butylated hydroxytoluene (BHT) hybrids as Anti-Alzheimer's disease agents with cholinergic, antioxidant, and neuroprotective properties. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>157 </em>, 161-176. <a href="https://doi.org/10.1016/j.ejmech.2018.08.005" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.08.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.08.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.08.005%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDonepezil-butylated%252Bhydroxytoluene%252B%252528BHT%252529%252Bhybrids%252Bas%252BAnti-Alzheimer%252527s%252Bdisease%252Bagents%252Bwith%252Bcholinergic%25252C%252Bantioxidant%25252C%252Band%252Bneuroprotective%252Bproperties%26aulast%3DCai%26aufirst%3DPei%26date%3D2018%26volume%3D157%26spage%3D161%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuelian  Yang</span>, <span class="hlFld-ContribAuthor ">Pei  Cai</span>, <span class="hlFld-ContribAuthor ">Qiaohong  Liu</span>, <span class="hlFld-ContribAuthor ">Jiajia  Wu</span>, <span class="hlFld-ContribAuthor ">Yong  Yin</span>, <span class="hlFld-ContribAuthor ">Xiaobing  Wang</span>, <span class="hlFld-ContribAuthor ">Lingyi  Kong</span>. </span><span class="cited-content_cbyCitation_article-title">Novel 8-hydroxyquinoline derivatives targeting β-amyloid aggregation, metal chelation and oxidative stress against Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (12)
                                     , 3191-3201. <a href="https://doi.org/10.1016/j.bmc.2018.04.043" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.04.043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.04.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.04.043%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DNovel%252B8-hydroxyquinoline%252Bderivatives%252Btargeting%252B%2525CE%2525B2-amyloid%252Baggregation%25252C%252Bmetal%252Bchelation%252Band%252Boxidative%252Bstress%252Bagainst%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DYang%26aufirst%3DXuelian%26date%3D2018%26volume%3D26%26issue%3D12%26spage%3D3191%26epage%3D3201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aliya  Ibrar</span>, <span class="hlFld-ContribAuthor ">Syeda Aaliya  Shehzadi</span>, <span class="hlFld-ContribAuthor ">Faiq  Saeed</span>, <span class="hlFld-ContribAuthor ">Imtiaz  Khan</span>. </span><span class="cited-content_cbyCitation_article-title">Developing hybrid molecule therapeutics for diverse enzyme inhibitory action: Active role of coumarin-based structural leads in drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (13)
                                     , 3731-3762. <a href="https://doi.org/10.1016/j.bmc.2018.05.042" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.05.042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.05.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.05.042%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDeveloping%252Bhybrid%252Bmolecule%252Btherapeutics%252Bfor%252Bdiverse%252Benzyme%252Binhibitory%252Baction%25253A%252BActive%252Brole%252Bof%252Bcoumarin-based%252Bstructural%252Bleads%252Bin%252Bdrug%252Bdiscovery%26aulast%3DIbrar%26aufirst%3DAliya%26date%3D2018%26volume%3D26%26issue%3D13%26spage%3D3731%26epage%3D3762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leonardo  Pisani</span>, <span class="hlFld-ContribAuthor ">Mariagrazia  Rullo</span>, <span class="hlFld-ContribAuthor ">Marco  Catto</span>, <span class="hlFld-ContribAuthor ">Modesto  de Candia</span>, <span class="hlFld-ContribAuthor ">Antonio  Carrieri</span>, <span class="hlFld-ContribAuthor ">Saverio  Cellamare</span>, <span class="hlFld-ContribAuthor ">Cosimo Damiano  Altomare</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-property relationship study of the HPLC enantioselective retention of neuroprotective 7-[(1-alkylpiperidin-3-yl)methoxy]coumarin derivatives on an amylose-based chiral stationary phase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Separation Science</span><span> <strong>2018,</strong> <em>41 </em>
                                    (6)
                                     , 1376-1384. <a href="https://doi.org/10.1002/jssc.201701442" title="DOI URL">https://doi.org/10.1002/jssc.201701442</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jssc.201701442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjssc.201701442%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Separation%2520Science%26atitle%3DStructure-property%252Brelationship%252Bstudy%252Bof%252Bthe%252BHPLC%252Benantioselective%252Bretention%252Bof%252Bneuroprotective%252B7-%25255B%2525281-alkylpiperidin-3-yl%252529methoxy%25255Dcoumarin%252Bderivatives%252Bon%252Ban%252Bamylose-based%252Bchiral%252Bstationary%252Bphase%26aulast%3DPisani%26aufirst%3DLeonardo%26date%3D2018%26date%3D2018%26volume%3D41%26issue%3D6%26spage%3D1376%26epage%3D1384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shi-Chao  Chen</span>, <span class="hlFld-ContribAuthor ">Guo-Liang  Qiu</span>, <span class="hlFld-ContribAuthor ">Bo  Li</span>, <span class="hlFld-ContribAuthor ">Jing-Bo  Shi</span>, <span class="hlFld-ContribAuthor ">Xin-Hua  Liu</span>, <span class="hlFld-ContribAuthor ">Wen-Jian  Tang</span>. </span><span class="cited-content_cbyCitation_article-title">Tricyclic pyrazolo[1,5- d ][1,4]benzoxazepin-5(6H)-one scaffold derivatives: Synthesis and biological evaluation as selective BuChE inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>147 </em>, 194-204. <a href="https://doi.org/10.1016/j.ejmech.2018.02.002" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.02.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.02.002%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTricyclic%252Bpyrazolo%25255B1%25252C5-%252Bd%252B%25255D%25255B1%25252C4%25255Dbenzoxazepin-5%2525286H%252529-one%252Bscaffold%252Bderivatives%25253A%252BSynthesis%252Band%252Bbiological%252Bevaluation%252Bas%252Bselective%252BBuChE%252Binhibitors%26aulast%3DChen%26aufirst%3DShi-Chao%26date%3D2018%26volume%3D147%26spage%3D194%26epage%3D204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Angela  Stefanachi</span>, <span class="hlFld-ContribAuthor ">Francesco  Leonetti</span>, <span class="hlFld-ContribAuthor ">Leonardo  Pisani</span>, <span class="hlFld-ContribAuthor ">Marco  Catto</span>, <span class="hlFld-ContribAuthor ">Angelo  Carotti</span>. </span><span class="cited-content_cbyCitation_article-title">Coumarin: A Natural, Privileged and Versatile Scaffold for Bioactive Compounds. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (2)
                                     , 250. <a href="https://doi.org/10.3390/molecules23020250" title="DOI URL">https://doi.org/10.3390/molecules23020250</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23020250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23020250%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DCoumarin%25253A%252BA%252BNatural%25252C%252BPrivileged%252Band%252BVersatile%252BScaffold%252Bfor%252BBioactive%252BCompounds%26aulast%3DStefanachi%26aufirst%3DAngela%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D2%26spage%3D250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marco  Catto</span>, <span class="hlFld-ContribAuthor ">Daniela  Trisciuzzi</span>, <span class="hlFld-ContribAuthor ">Domenico  Alberga</span>, <span class="hlFld-ContribAuthor ">Giuseppe Felice  Mangiatordi</span>, <span class="hlFld-ContribAuthor ">Orazio  Nicolotti</span>. </span><span class="cited-content_cbyCitation_article-title">Multitarget Drug Design for Neurodegenerative Diseases. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 93-105. <a href="https://doi.org/10.1007/7653_2018_17" title="DOI URL">https://doi.org/10.1007/7653_2018_17</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7653_2018_17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7653_2018_17%26sid%3Dliteratum%253Aachs%26atitle%3DMultitarget%252BDrug%252BDesign%252Bfor%252BNeurodegenerative%252BDiseases%26aulast%3DCatto%26aufirst%3DMarco%26date%3D2018%26date%3D2018%26spage%3D93%26epage%3D105%26pub%3DSpringer%2520New%2520York%26atitle%3DMulti-Target%252BDrug%252BDesign%252BUsing%252BChem-Bioinformatic%252BApproaches%26aulast%3DRoy%26aufirst%3DKunal%26date%3D2019%26volume%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hong-Wei  Han</span>, <span class="hlFld-ContribAuthor ">Chao-Sai  Zheng</span>, <span class="hlFld-ContribAuthor ">Shu-Juan  Chu</span>, <span class="hlFld-ContribAuthor ">Wen-Xue  Sun</span>, <span class="hlFld-ContribAuthor ">Lu-Jing  Han</span>, <span class="hlFld-ContribAuthor ">Rong-Wu  Yang</span>, <span class="hlFld-ContribAuthor ">Jin-Liang  Qi</span>, <span class="hlFld-ContribAuthor ">Gui-Hua  Lu</span>, <span class="hlFld-ContribAuthor ">Xiao-Ming  Wang</span>, <span class="hlFld-ContribAuthor ">Yong-Hua  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">The evaluation of potent antitumor activities of shikonin coumarin-carboxylic acid, PMMB232 through HIF-1α-mediated apoptosis. </span><span class="cited-content_cbyCitation_journal-name">Biomedicine & Pharmacotherapy</span><span> <strong>2018,</strong> <em>97 </em>, 656-666. <a href="https://doi.org/10.1016/j.biopha.2017.10.159" title="DOI URL">https://doi.org/10.1016/j.biopha.2017.10.159</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biopha.2017.10.159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biopha.2017.10.159%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicine%2520%2526%2520Pharmacotherapy%26atitle%3DThe%252Bevaluation%252Bof%252Bpotent%252Bantitumor%252Bactivities%252Bof%252Bshikonin%252Bcoumarin-carboxylic%252Bacid%25252C%252BPMMB232%252Bthrough%252BHIF-1%2525CE%2525B1-mediated%252Bapoptosis%26aulast%3DHan%26aufirst%3DHong-Wei%26date%3D2018%26volume%3D97%26spage%3D656%26epage%3D666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandipan  Chakraborty</span>, <span class="hlFld-ContribAuthor ">Jyotirmoy  Rakshit</span>, <span class="hlFld-ContribAuthor ">Jaya  Bandyopadhyay</span>, <span class="hlFld-ContribAuthor ">Soumalee  Basu</span>. </span><span class="cited-content_cbyCitation_article-title">Multi-functional neuroprotective activity of neohesperidin dihydrochalcone: a novel scaffold for Alzheimer's disease therapeutics identified
              via
              drug repurposing screening. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2018,</strong> <em>42 </em>
                                    (14)
                                     , 11755-11769. <a href="https://doi.org/10.1039/C8NJ00853A" title="DOI URL">https://doi.org/10.1039/C8NJ00853A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8NJ00853A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8NJ00853A%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DMulti-functional%252Bneuroprotective%252Bactivity%252Bof%252Bneohesperidin%252Bdihydrochalcone%25253A%252Ba%252Bnovel%252Bscaffold%252Bfor%252BAlzheimer%252527s%252Bdisease%252Btherapeutics%252Bidentified%252Bvia%252Bdrug%252Brepurposing%252Bscreening%26aulast%3DChakraborty%26aufirst%3DSandipan%26date%3D2018%26date%3D2018%26volume%3D42%26issue%3D14%26spage%3D11755%26epage%3D11769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tereza  Padrtova</span>, <span class="hlFld-ContribAuthor ">Pavlina  Marvanova</span>, <span class="hlFld-ContribAuthor ">Klara  Odehnalova</span>, <span class="hlFld-ContribAuthor ">Renata  Kubinova</span>, <span class="hlFld-ContribAuthor ">Oscar  Parravicini</span>, <span class="hlFld-ContribAuthor ">Adriana  Garro</span>, <span class="hlFld-ContribAuthor ">Ricardo  Enriz</span>, <span class="hlFld-ContribAuthor ">Otakar  Humpa</span>, <span class="hlFld-ContribAuthor ">Michal  Oravec</span>, <span class="hlFld-ContribAuthor ">Petr  Mokry</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Analysis, Cholinesterase-Inhibiting Activity and Molecular Modelling Studies of 3-(Dialkylamino)-2-hydroxypropyl 4-[(Alkoxy-carbonyl)amino]benzoates and Their Quaternary Ammonium Salts. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2017,</strong> <em>22 </em>
                                    (12)
                                     , 2048. <a href="https://doi.org/10.3390/molecules22122048" title="DOI URL">https://doi.org/10.3390/molecules22122048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules22122048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules22122048%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%25252C%252BAnalysis%25252C%252BCholinesterase-Inhibiting%252BActivity%252Band%252BMolecular%252BModelling%252BStudies%252Bof%252B3-%252528Dialkylamino%252529-2-hydroxypropyl%252B4-%25255B%252528Alkoxy-carbonyl%252529amino%25255Dbenzoates%252Band%252BTheir%252BQuaternary%252BAmmonium%252BSalts%26aulast%3DPadrtova%26aufirst%3DTereza%26date%3D2017%26date%3D2017%26volume%3D22%26issue%3D12%26spage%3D2048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael G.  Kallitsakis</span>, <span class="hlFld-ContribAuthor ">Angelo  Carotti</span>, <span class="hlFld-ContribAuthor ">Marco  Catto</span>, <span class="hlFld-ContribAuthor ">Aikaterini  Peperidou</span>, <span class="hlFld-ContribAuthor ">Dimitra J.  Hadjipavlou-Litina</span>, <span class="hlFld-ContribAuthor ">Konstantinos E.  Litinas</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Evaluation of Novel Hybrid Molecules Containing Purine, Coumarin and Isoxazoline or Isoxazole Moieties. </span><span class="cited-content_cbyCitation_journal-name">The Open Medicinal Chemistry Journal</span><span> <strong>2017,</strong> <em>11 </em>
                                    (1)
                                     , 196-211. <a href="https://doi.org/10.2174/1874104501711010196" title="DOI URL">https://doi.org/10.2174/1874104501711010196</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1874104501711010196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1874104501711010196%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Open%2520Medicinal%2520Chemistry%2520Journal%26atitle%3DSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BNovel%252BHybrid%252BMolecules%252BContaining%252BPurine%25252C%252BCoumarin%252Band%252BIsoxazoline%252Bor%252BIsoxazole%252BMoieties%26aulast%3DKallitsakis%26aufirst%3DMichael%2BG.%26date%3D2017%26volume%3D11%26issue%3D1%26spage%3D196%26epage%3D211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hua-Li  Yang</span>, <span class="hlFld-ContribAuthor ">Pei  Cai</span>, <span class="hlFld-ContribAuthor ">Qiao-Hong  Liu</span>, <span class="hlFld-ContribAuthor ">Xue-Lian  Yang</span>, <span class="hlFld-ContribAuthor ">Si-Qiang  Fang</span>, <span class="hlFld-ContribAuthor ">Yan-Wei  Tang</span>, <span class="hlFld-ContribAuthor ">Cheng  Wang</span>, <span class="hlFld-ContribAuthor ">Xiao-Bing  Wang</span>, <span class="hlFld-ContribAuthor ">Ling-Yi  Kong</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and evaluation of salicyladimine derivatives as multitarget-directed ligands against Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (21)
                                     , 5917-5928. <a href="https://doi.org/10.1016/j.bmc.2017.08.048" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.08.048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.08.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.08.048%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bevaluation%252Bof%252Bsalicyladimine%252Bderivatives%252Bas%252Bmultitarget-directed%252Bligands%252Bagainst%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DYang%26aufirst%3DHua-Li%26date%3D2017%26volume%3D25%26issue%3D21%26spage%3D5917%26epage%3D5928" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leonardo  Pisani</span>, <span class="hlFld-ContribAuthor ">Annalisa  De Palma</span>, <span class="hlFld-ContribAuthor ">Nicola  Giangregorio</span>, <span class="hlFld-ContribAuthor ">Daniela V.  Miniero</span>, <span class="hlFld-ContribAuthor ">Paolo  Pesce</span>, <span class="hlFld-ContribAuthor ">Orazio  Nicolotti</span>, <span class="hlFld-ContribAuthor ">Francesco  Campagna</span>, <span class="hlFld-ContribAuthor ">Cosimo D.  Altomare</span>, <span class="hlFld-ContribAuthor ">Marco  Catto</span>. </span><span class="cited-content_cbyCitation_article-title">Mannich base approach to 5-methoxyisatin 3-(4-isopropylphenyl)hydrazone: A water-soluble prodrug for a multitarget inhibition of cholinesterases, beta-amyloid fibrillization and oligomer-induced cytotoxicity. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutical Sciences</span><span> <strong>2017,</strong> <em>109 </em>, 381-388. <a href="https://doi.org/10.1016/j.ejps.2017.08.004" title="DOI URL">https://doi.org/10.1016/j.ejps.2017.08.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejps.2017.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejps.2017.08.004%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DMannich%252Bbase%252Bapproach%252Bto%252B5-methoxyisatin%252B3-%2525284-isopropylphenyl%252529hydrazone%25253A%252BA%252Bwater-soluble%252Bprodrug%252Bfor%252Ba%252Bmultitarget%252Binhibition%252Bof%252Bcholinesterases%25252C%252Bbeta-amyloid%252Bfibrillization%252Band%252Boligomer-induced%252Bcytotoxicity%26aulast%3DPisani%26aufirst%3DLeonardo%26date%3D2017%26volume%3D109%26spage%3D381%26epage%3D388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jin-Shuai  Lan</span>, <span class="hlFld-ContribAuthor ">Yue  Ding</span>, <span class="hlFld-ContribAuthor ">Yun  Liu</span>, <span class="hlFld-ContribAuthor ">Ping  Kang</span>, <span class="hlFld-ContribAuthor ">Jian-Wei  Hou</span>, <span class="hlFld-ContribAuthor ">Xin-Yu  Zhang</span>, <span class="hlFld-ContribAuthor ">Sai-Sai  Xie</span>, <span class="hlFld-ContribAuthor ">Tong  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel coumarin- N -benzyl pyridinium hybrids as multi-target agents for the treatment of Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>139 </em>, 48-59. <a href="https://doi.org/10.1016/j.ejmech.2017.07.055" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.07.055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.07.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.07.055%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bcoumarin-%252BN%252B-benzyl%252Bpyridinium%252Bhybrids%252Bas%252Bmulti-target%252Bagents%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%252527s%252Bdisease%26aulast%3DLan%26aufirst%3DJin-Shuai%26date%3D2017%26volume%3D139%26spage%3D48%26epage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Duraippandi  Palanimuthu</span>, <span class="hlFld-ContribAuthor ">Rachal  Poon</span>, <span class="hlFld-ContribAuthor ">Sumit  Sahni</span>, <span class="hlFld-ContribAuthor ">Rukhsana  Anjum</span>, <span class="hlFld-ContribAuthor ">David  Hibbs</span>, <span class="hlFld-ContribAuthor ">Hsuan-Yu  Lin</span>, <span class="hlFld-ContribAuthor ">Paul V.  Bernhardt</span>, <span class="hlFld-ContribAuthor ">Danuta S.  Kalinowski</span>, <span class="hlFld-ContribAuthor ">Des R.  Richardson</span>. </span><span class="cited-content_cbyCitation_article-title">A novel class of thiosemicarbazones show multi-functional activity for the treatment of Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>139 </em>, 612-632. <a href="https://doi.org/10.1016/j.ejmech.2017.08.021" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.08.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.08.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.08.021%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252Bnovel%252Bclass%252Bof%252Bthiosemicarbazones%252Bshow%252Bmulti-functional%252Bactivity%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%252527s%252Bdisease%26aulast%3DPalanimuthu%26aufirst%3DDuraippandi%26date%3D2017%26volume%3D139%26spage%3D612%26epage%3D632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Violina T.  Angelova</span>, <span class="hlFld-ContribAuthor ">Yulian  Voynikov</span>, <span class="hlFld-ContribAuthor ">Pavlina  Andreeva-Gateva</span>, <span class="hlFld-ContribAuthor ">Slavina  Surcheva</span>, <span class="hlFld-ContribAuthor ">Nikolay  Vassilev</span>, <span class="hlFld-ContribAuthor ">Tania  Pencheva</span>, <span class="hlFld-ContribAuthor ">Jana  Tchekalarova</span>. </span><span class="cited-content_cbyCitation_article-title">In vitro and in silico evaluation of chromene based aroyl hydrazones as anticonvulsant agents. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2017,</strong> <em>26 </em>
                                    (9)
                                     , 1884-1896. <a href="https://doi.org/10.1007/s00044-017-1902-1" title="DOI URL">https://doi.org/10.1007/s00044-017-1902-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-017-1902-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-017-1902-1%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DIn%252Bvitro%252Band%252Bin%252Bsilico%252Bevaluation%252Bof%252Bchromene%252Bbased%252Baroyl%252Bhydrazones%252Bas%252Banticonvulsant%252Bagents%26aulast%3DAngelova%26aufirst%3DViolina%2BT.%26date%3D2017%26date%3D2017%26volume%3D26%26issue%3D9%26spage%3D1884%26epage%3D1896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hua-Li  Yang</span>, <span class="hlFld-ContribAuthor ">Pei  Cai</span>, <span class="hlFld-ContribAuthor ">Qiao-Hong  Liu</span>, <span class="hlFld-ContribAuthor ">Xue-Lian  Yang</span>, <span class="hlFld-ContribAuthor ">Fan  Li</span>, <span class="hlFld-ContribAuthor ">Jin  Wang</span>, <span class="hlFld-ContribAuthor ">Jia-Jia  Wu</span>, <span class="hlFld-ContribAuthor ">Xiao-Bing  Wang</span>, <span class="hlFld-ContribAuthor ">Ling-Yi  Kong</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and evaluation of coumarin-pargyline hybrids as novel dual inhibitors of monoamine oxidases and amyloid- β aggregation for the treatment of Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>138 </em>, 715-728. <a href="https://doi.org/10.1016/j.ejmech.2017.07.008" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.07.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.07.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.07.008%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bevaluation%252Bof%252Bcoumarin-pargyline%252Bhybrids%252Bas%252Bnovel%252Bdual%252Binhibitors%252Bof%252Bmonoamine%252Boxidases%252Band%252Bamyloid-%252B%2525CE%2525B2%252Baggregation%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%252527s%252Bdisease%26aulast%3DYang%26aufirst%3DHua-Li%26date%3D2017%26volume%3D138%26spage%3D715%26epage%3D728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rona  Ramsay</span>, <span class="hlFld-ContribAuthor ">Keith  Tipton</span>. </span><span class="cited-content_cbyCitation_article-title">Assessment of Enzyme Inhibition: A Review with Examples from the Development of Monoamine Oxidase and Cholinesterase Inhibitory Drugs. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2017,</strong> <em>22 </em>
                                    (7)
                                     , 1192. <a href="https://doi.org/10.3390/molecules22071192" title="DOI URL">https://doi.org/10.3390/molecules22071192</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules22071192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules22071192%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DAssessment%252Bof%252BEnzyme%252BInhibition%25253A%252BA%252BReview%252Bwith%252BExamples%252Bfrom%252Bthe%252BDevelopment%252Bof%252BMonoamine%252BOxidase%252Band%252BCholinesterase%252BInhibitory%252BDrugs%26aulast%3DRamsay%26aufirst%3DRona%26date%3D2017%26date%3D2017%26volume%3D22%26issue%3D7%26spage%3D1192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eva  Ramos</span>, <span class="hlFld-ContribAuthor ">Javier  Egea</span>, <span class="hlFld-ContribAuthor ">Cristóbal  de los Ríos</span>, <span class="hlFld-ContribAuthor ">José  Marco-Contelles</span>, <span class="hlFld-ContribAuthor ">Alejandro  Romero</span>. </span><span class="cited-content_cbyCitation_article-title">Melatonin as a versatile molecule to design novel multitarget hybrids against neurodegeneration. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2017,</strong> <em>9 </em>
                                    (8)
                                     <a href="https://doi.org/10.4155/fmc-2017-0014" title="DOI URL">https://doi.org/10.4155/fmc-2017-0014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2017-0014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2017-0014%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DMelatonin%252Bas%252Ba%252Bversatile%252Bmolecule%252Bto%252Bdesign%252Bnovel%252Bmultitarget%252Bhybrids%252Bagainst%252Bneurodegeneration%26aulast%3DRamos%26aufirst%3DEva%26date%3D2017%26volume%3D9%26issue%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Damijan  Knez</span>, <span class="hlFld-ContribAuthor ">Matej  Sova</span>, <span class="hlFld-ContribAuthor ">Urban  Košak</span>, <span class="hlFld-ContribAuthor ">Stanislav  Gobec</span>. </span><span class="cited-content_cbyCitation_article-title">Dual inhibitors of cholinesterases and monoamine oxidases for Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2017,</strong> <em>9 </em>
                                    (8)
                                     , 811-832. <a href="https://doi.org/10.4155/fmc-2017-0036" title="DOI URL">https://doi.org/10.4155/fmc-2017-0036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2017-0036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2017-0036%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DDual%252Binhibitors%252Bof%252Bcholinesterases%252Band%252Bmonoamine%252Boxidases%252Bfor%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DKnez%26aufirst%3DDamijan%26date%3D2017%26volume%3D9%26issue%3D8%26spage%3D811%26epage%3D832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giuseppe Felice  Mangiatordi</span>, <span class="hlFld-ContribAuthor ">Domenico  Alberga</span>, <span class="hlFld-ContribAuthor ">Leonardo  Pisani</span>, <span class="hlFld-ContribAuthor ">Domenico  Gadaleta</span>, <span class="hlFld-ContribAuthor ">Daniela  Trisciuzzi</span>, <span class="hlFld-ContribAuthor ">Roberta  Farina</span>, <span class="hlFld-ContribAuthor ">Andrea  Carotti</span>, <span class="hlFld-ContribAuthor ">Gianluca  Lattanzi</span>, <span class="hlFld-ContribAuthor ">Marco  Catto</span>, <span class="hlFld-ContribAuthor ">Orazio  Nicolotti</span>. </span><span class="cited-content_cbyCitation_article-title">A rational approach to elucidate human monoamine oxidase molecular selectivity. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutical Sciences</span><span> <strong>2017,</strong> <em>101 </em>, 90-99. <a href="https://doi.org/10.1016/j.ejps.2017.02.008" title="DOI URL">https://doi.org/10.1016/j.ejps.2017.02.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejps.2017.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejps.2017.02.008%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DA%252Brational%252Bapproach%252Bto%252Belucidate%252Bhuman%252Bmonoamine%252Boxidase%252Bmolecular%252Bselectivity%26aulast%3DMangiatordi%26aufirst%3DGiuseppe%2BFelice%26date%3D2017%26volume%3D101%26spage%3D90%26epage%3D99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoming  Qiang</span>, <span class="hlFld-ContribAuthor ">Yan  Li</span>, <span class="hlFld-ContribAuthor ">Xia  Yang</span>, <span class="hlFld-ContribAuthor ">Li  Luo</span>, <span class="hlFld-ContribAuthor ">Rui  Xu</span>, <span class="hlFld-ContribAuthor ">Yunxiaozhu  Zheng</span>, <span class="hlFld-ContribAuthor ">Zhongcheng  Cao</span>, <span class="hlFld-ContribAuthor ">Zhenghuai  Tan</span>, <span class="hlFld-ContribAuthor ">Yong  Deng</span>. </span><span class="cited-content_cbyCitation_article-title">DL -3- n -butylphthalide-Edaravone hybrids as novel dual inhibitors of amyloid- β aggregation and monoamine oxidases with high antioxidant potency for Alzheimer’s therapy. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (4)
                                     , 718-722. <a href="https://doi.org/10.1016/j.bmcl.2017.01.050" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.01.050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.01.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.01.050%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDL%252B-3-%252Bn%252B-butylphthalide-Edaravone%252Bhybrids%252Bas%252Bnovel%252Bdual%252Binhibitors%252Bof%252Bamyloid-%252B%2525CE%2525B2%252Baggregation%252Band%252Bmonoamine%252Boxidases%252Bwith%252Bhigh%252Bantioxidant%252Bpotency%252Bfor%252BAlzheimer%2525E2%252580%252599s%252Btherapy%26aulast%3DQiang%26aufirst%3DXiaoming%26date%3D2017%26volume%3D27%26issue%3D4%26spage%3D718%26epage%3D722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qiao-Hong  Liu</span>, <span class="hlFld-ContribAuthor ">Jia-Jia  Wu</span>, <span class="hlFld-ContribAuthor ">Fan  Li</span>, <span class="hlFld-ContribAuthor ">Pei  Cai</span>, <span class="hlFld-ContribAuthor ">Xue-Lian  Yang</span>, <span class="hlFld-ContribAuthor ">Ling-Yi  Kong</span>, <span class="hlFld-ContribAuthor ">Xiao-Bing  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and pharmacological evaluation of multi-functional homoisoflavonoid derivatives as potent inhibitors of monoamine oxidase B and cholinesterase for the treatment of Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2017,</strong> <em>8 </em>
                                    (7)
                                     , 1459-1467. <a href="https://doi.org/10.1039/C7MD00199A" title="DOI URL">https://doi.org/10.1039/C7MD00199A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7MD00199A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7MD00199A%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DSynthesis%252Band%252Bpharmacological%252Bevaluation%252Bof%252Bmulti-functional%252Bhomoisoflavonoid%252Bderivatives%252Bas%252Bpotent%252Binhibitors%252Bof%252Bmonoamine%252Boxidase%252BB%252Band%252Bcholinesterase%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%252527s%252Bdisease%26aulast%3DLiu%26aufirst%3DQiao-Hong%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D7%26spage%3D1459%26epage%3D1467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00562/20160722/images/medium/jm-2016-005625_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00562/20160722/images/large/jm-2016-005625_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00562&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00562/20160722/images/medium/jm-2016-005625_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00562/20160722/images/large/jm-2016-005625_0011.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Approved Drugs for AD (Common Name, Mechanism of Action)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00562/20160722/images/large/jm-2016-005625_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00562&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00562/20160722/images/medium/jm-2016-005625_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00562/20160722/images/large/jm-2016-005625_0001.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Rational design.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00562/20160722/images/large/jm-2016-005625_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00562&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00562/20160722/images/medium/jm-2016-005625_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00562/20160722/images/large/jm-2016-005625_0005.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>4a</b>–<b>m</b>, (±)-<b>5a</b>–<b>i</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00562/20160722/images/large/jm-2016-005625_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00562&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) methanesulfonyl chloride, triethylamine, CH<sub>2</sub>Cl<sub>2</sub>, 3 h, room temperature; (ii) for <b>2bc</b>, 3,4-dimethyl-7-hydroxycoumarin, triethylamine, Cs<sub>2</sub>CO<sub>3</sub>, dry DMF, 72 h, 70 °C; (iii) for <b>2a</b>, 3,4-dimethyl-7-hydroxycoumarin, ADDP, PPh<sub>3</sub>, triethylamine, anhydrous CH<sub>2</sub>Cl<sub>2</sub>, 15 h, room temperature; (iv) trifluoroacetic acid, CH<sub>2</sub>Cl<sub>2</sub>, 1 h, 0 °C to room temperature; (v) for <b>4a</b>, <b>4i</b>, and <b>5a</b>, methyl iodide, anhydrous K<sub>2</sub>CO<sub>3</sub>, acetone, 6 h, room temperature; for <b>4b</b>–<b>h</b>, <b>4j</b>–<b>m</b>, and <b>5b</b>–<b>h</b>, butyl iodide (for <b>4b</b>) or substituted benzyl bromide, anhydrous K<sub>2</sub>CO<sub>3</sub>, acetone, 30 min, 130 °C, MW; for <b>5i</b>, 3,4-dimethoxybenzaldehyde, sodium triacetoxyborohydride, 1,2-dichloroethane, 15 h, room temperature.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00562/20160722/images/medium/jm-2016-005625_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00562/20160722/images/large/jm-2016-005625_0006.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>7a</b>–<b>b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00562/20160722/images/large/jm-2016-005625_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00562&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) dibromoalkyl derivative, anhydrous K<sub>2</sub>CO<sub>3</sub>, acetone, 130 °C, 30 min, MW; (ii) 1,2,3,4-tetrahydroisoquinoline, anhydrous K<sub>2</sub>CO<sub>3</sub>, acetone, 130 °C, 30 min, MW.</p></p></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00562/20160722/images/medium/jm-2016-005625_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00562/20160722/images/large/jm-2016-005625_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Lineweaver–Burk plots of <i>ee</i>ACHE inhibition kinetics of compound (±)-<b>5b</b>. Reciprocals of enzyme activity (eeAChE) vs reciprocals of substrate (<i>S</i>-acetylthiocholine) concentration in the presence of different concentrations (0–8 μM) of inhibitor. Inset: Concentrations used for inhibitor are coded with different graphic symbols.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00562/20160722/images/large/jm-2016-005625_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00562&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00562/20160722/images/medium/jm-2016-005625_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00562/20160722/images/large/jm-2016-005625_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Cytotoxicity of compounds <b>4j</b>–<b>k</b>, (±)-<b>5a</b>–<b>e</b>, (±)-<b>5i</b>, and donepezil tested at concentrations in the range 0.1–50 μM in human neuroblastoma SH-SY5Y cell lines for 24 h. Data are reported as percentage of cell survival vs untreated cells (control). Data represent means ± SD (<i>n</i> = 3).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00562/20160722/images/large/jm-2016-005625_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00562&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00562/20160722/images/medium/jm-2016-005625_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00562/20160722/images/large/jm-2016-005625_0004.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Neuroprotective effect on human neuroblastoma SH-SY5Y cells of selected compounds <b>4j</b>–<b>k</b>, (±)-<b>5a</b>–<b>e</b>, and (±)-<b>5i</b> after 24 h incubation at different concentrations (1 and 10 μM) with H<sub>2</sub>O<sub>2</sub> (300 μM (4a)), oligomycin-A (10 μM (4b)), and rotenone (20 μM (4c)). Data are expressed as percentage of viable cells (referred to control) and shown as mean ± SD (<i>n</i> = 3). Untreated cells were used as control. Donepezil was used as a reference anti-AD marketed drug. Statistical significance was calculated using a two-way analysis of variance (ANOVA) followed by the Bonferroni post-hoc tests (GraphPad Prism version 5); * <i>p</i> < 0.05, ** <i>p</i> < 0.01.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-14/acs.jmedchem.6b00562/20160722/images/large/jm-2016-005625_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00562&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i76">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55538" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55538" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 80 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Wimo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonsson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bond, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prince, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winblad, B.</span><span> </span><span class="NLM_article-title">The Worldwide Economic Impact of Dementia 2010</span> <span class="citation_source-journal">Alzheimer's Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span><span class="refDoi"> DOI: 10.1016/j.jalz.2012.11.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1016%2Fj.jalz.2012.11.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=23305821" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A280%3ADC%252BC3s3osVemsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=1-11&author=A.+Wimoauthor=L.+Jonssonauthor=J.+Bondauthor=M.+Princeauthor=B.+Winblad&title=The+Worldwide+Economic+Impact+of+Dementia+2010&doi=10.1016%2Fj.jalz.2012.11.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The worldwide economic impact of dementia 2010</span></div><div class="casAuthors">Wimo Anders; Jonsson Linus; Bond John; Prince Martin; Winblad Bengt</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia : the journal of the Alzheimer's Association</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-11.e3</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  To acquire an understanding of the societal costs of dementia and how they affect families, health and social care services, and governments to improve the lives of people with dementia and their caregivers.  METHODS:  The basic design of this study was a societal, prevalence-based, gross cost-of-illness study in which costs were aggregated to World Health Organization regions and World Bank income groupings.  RESULTS:  The total estimated worldwide costs of dementia were US$604 billion in 2010.  About 70% of the costs occurred in western Europe and North America.  In such high-income regions, costs of informal care and the direct costs of social care contribute similar proportions of total costs, whereas the direct medical costs were much lower.  In low- and middle-income countries, informal care accounts for the majority of total costs; direct social care costs are negligible.  CONCLUSIONS:  Worldwide costs of dementia are enormous and distributed inequitably.  There is considerable potential for cost increases in coming years as the diagnosis and treatment gap is reduced.  There is also likely to be a trend in low- and middle-income countries for social care costs to shift from the informal to the formal sector, with important implications for future aggregated costs and the financing of long-term care.  Only by investing now in research and the development of cost-effective approaches to early diagnosis and care can future societal costs be anticipated and managed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTDQ-QL6sAr2dbHMBt0mMIXfW6udTcc2eb6wKRnPEMZ6Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s3osVemsw%253D%253D&md5=279024dbdf6d4678e070a8bae82e6ffc</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2012.11.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2012.11.006%26sid%3Dliteratum%253Aachs%26aulast%3DWimo%26aufirst%3DA.%26aulast%3DJonsson%26aufirst%3DL.%26aulast%3DBond%26aufirst%3DJ.%26aulast%3DPrince%26aufirst%3DM.%26aulast%3DWinblad%26aufirst%3DB.%26atitle%3DThe%2520Worldwide%2520Economic%2520Impact%2520of%2520Dementia%25202010%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2013%26volume%3D9%26spage%3D1%26epage%3D11%26doi%3D10.1016%2Fj.jalz.2012.11.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Querfurth, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFerla, F. M.</span><span> </span><span class="NLM_article-title">Alzheimer’s Disease</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">362</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">344</span><span class="refDoi"> DOI: 10.1056/NEJMra0909142</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1056%2FNEJMra0909142" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=20107219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1aqt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=2010&pages=329-344&author=H.+W.+Querfurthauthor=F.+M.+LaFerla&title=Alzheimer%E2%80%99s+Disease&doi=10.1056%2FNEJMra0909142"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease</span></div><div class="casAuthors">Querfurth, Henry W.; LaFerla, Frank M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">362</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">329-344</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review.  The role of β-amyloid peptide in spontaneous self-aggregation in brain in Alzheimer's disease is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPeniV_Jn6orVg90H21EOLACvtfcHk0liDrG79jDl-Nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1aqt7s%253D&md5=c116f6a6b8fed9af9f5282cc4b755c70</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1056%2FNEJMra0909142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra0909142%26sid%3Dliteratum%253Aachs%26aulast%3DQuerfurth%26aufirst%3DH.%2BW.%26aulast%3DLaFerla%26aufirst%3DF.%2BM.%26atitle%3DAlzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2010%26volume%3D362%26spage%3D329%26epage%3D344%26doi%3D10.1056%2FNEJMra0909142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Cummings, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morstorf, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, K.</span><span> </span><span class="NLM_article-title">Alzheimer’s Disease Drug-development Pipeline: Few Candidates, Frequent Failures</span> <span class="citation_source-journal">Alzheimer's Res. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="refDoi"> DOI: 10.1186/alzrt269</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1186%2Falzrt269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=25024750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A280%3ADC%252BC2cbisFWjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=37&author=J.+L.+Cummingsauthor=T.+Morstorfauthor=K.+Zhong&title=Alzheimer%E2%80%99s+Disease+Drug-development+Pipeline%3A+Few+Candidates%2C+Frequent+Failures&doi=10.1186%2Falzrt269"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease drug-development pipeline: few candidates, frequent failures</span></div><div class="casAuthors">Cummings Jeffrey L; Zhong Kate; Morstorf Travis</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's research & therapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">37</span>
        ISSN:<span class="NLM_cas:issn">1758-9193</span>.
    </div><div class="casAbstract">INTRODUCTION:  Alzheimer's disease (AD) is increasing in frequency as the global population ages.  Five drugs are approved for treatment of AD, including four cholinesterase inhibitors and an N-methyl-D-aspartate (NMDA)-receptor antagonist.  We have an urgent need to find new therapies for AD.  METHODS:  We examined Clinicaltrials.gov, a public website that records ongoing clinical trials.  We examined the decade of 2002 to 2012, to better understand AD-drug development.  We reviewed trials by sponsor, sites, drug mechanism of action, duration, number of patients required, and rate of success in terms of advancement from one phase to the next.  We also reviewed the current AD therapy pipeline.  RESULTS:  During the 2002 to 2012 observation period, 413 AD trials were performed: 124 Phase 1 trials, 206 Phase 2 trials, and 83 Phase 3 trials.  Seventy-eight percent were sponsored by pharmaceutical companies.  The United States of America (U.S.) remains the single world region with the greatest number of trials; cumulatively, more non-U.S. than U.S. trials are performed.  The largest number of registered trials addressed symptomatic agents aimed at improving cognition (36.6%), followed by trials of disease-modifying small molecules (35.1%) and trials of disease-modifying immunotherapies (18%).  The mean length of trials increases from Phase 2 to Phase 3, and the number of participants in trials increases between Phase 2 and Phase 3.  Trials of disease-modifying agents are larger and longer than those for symptomatic agents.  A very high attrition rate was found, with an overall success rate during the 2002 to 2012 period of 0.4% (99.6% failure).  CONCLUSIONS:  The Clinicaltrials.gov database demonstrates that relatively few clinical trials are undertaken for AD therapeutics, considering the magnitude of the problem.  The success rate for advancing from one phase to another is low, and the number of compounds progressing to regulatory review is among the lowest found in any therapeutic area.  The AD drug-development ecosystem requires support.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT__DMPwHFhGGPgL4LrC-0VfW6udTcc2eZKvAoAnBe-jLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbisFWjtQ%253D%253D&md5=85b84800ce02d7031a4c1046e837e568</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1186%2Falzrt269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Falzrt269%26sid%3Dliteratum%253Aachs%26aulast%3DCummings%26aufirst%3DJ.%2BL.%26aulast%3DMorstorf%26aufirst%3DT.%26aulast%3DZhong%26aufirst%3DK.%26atitle%3DAlzheimer%25E2%2580%2599s%2520Disease%2520Drug-development%2520Pipeline%253A%2520Few%2520Candidates%252C%2520Frequent%2520Failures%26jtitle%3DAlzheimer%2527s%2520Res.%2520Ther.%26date%3D2014%26volume%3D6%26spage%3D37%26doi%3D10.1186%2Falzrt269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Berk, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabbagh, M. N.</span><span> </span><span class="NLM_article-title">Successes and Failures for Drugs in Late-stage Development for Alzheimer’s Disease</span> <span class="citation_source-journal">Drugs Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">783</span><span class="NLM_x">–</span> <span class="NLM_lpage">792</span><span class="refDoi"> DOI: 10.1007/s40266-013-0108-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1007%2Fs40266-013-0108-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=23943247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVWmt7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2013&pages=783-792&author=C.+Berkauthor=M.+N.+Sabbagh&title=Successes+and+Failures+for+Drugs+in+Late-stage+Development+for+Alzheimer%E2%80%99s+Disease&doi=10.1007%2Fs40266-013-0108-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Successes and Failures for Drugs in Late-Stage Development for Alzheimer's Disease</span></div><div class="casAuthors">Berk, Camryn; Sabbagh, Marwan N.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs & Aging</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">783-792</span>CODEN:
                <span class="NLM_cas:coden">DRAGE6</span>;
        ISSN:<span class="NLM_cas:issn">1170-229X</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">A review.  To date, symptomatic medications prevail as the mainstay of treatment options for Alzheimer's disease (AD).  There have been tremendous investments made to increase the nos. of drugs approved and the targets engaged, in an effort to alter the disease course or pathophysiol. of AD.  Unfortunately, almost all studies have not met expectations and no new drug (beyond medical foods) has been approved for the treatment of AD in the last decade.  This review is a comparison of novel AD therapies in the late phases of clin. testing, including recent high-profile clin. failures, and agents in development with relatively unexplored mechanisms of action, with a focus on their potential as therapeutic agents and their proposed advantages over the treatments currently in use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGru8C4Zf__NMrVg90H21EOLACvtfcHk0lj7EEuldgSuIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVWmt7bM&md5=92a0562710d6e1e36ce087d1457a936c</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2Fs40266-013-0108-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40266-013-0108-6%26sid%3Dliteratum%253Aachs%26aulast%3DBerk%26aufirst%3DC.%26aulast%3DSabbagh%26aufirst%3DM.%2BN.%26atitle%3DSuccesses%2520and%2520Failures%2520for%2520Drugs%2520in%2520Late-stage%2520Development%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DDrugs%2520Aging%26date%3D2013%26volume%3D30%26spage%3D783%26epage%3D792%26doi%3D10.1007%2Fs40266-013-0108-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Narayan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehsani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindquist, S.</span><span> </span><span class="NLM_article-title">Combating Neurodegenerative Disease with Chemical Probes and Model Systems</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">911</span><span class="NLM_x">–</span> <span class="NLM_lpage">920</span><span class="refDoi"> DOI: 10.1038/nchembio.1663</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1038%2Fnchembio.1663" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=25325702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslOisrzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=911-920&author=P.+Narayanauthor=S.+Ehsaniauthor=S.+Lindquist&title=Combating+Neurodegenerative+Disease+with+Chemical+Probes+and+Model+Systems&doi=10.1038%2Fnchembio.1663"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Combating neurodegenerative disease with chemical probes and model systems</span></div><div class="casAuthors">Narayan, Priyanka; Ehsani, Sepehr; Lindquist, Susan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">911-920</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The disheartening results of recent clin. trials for neurodegenerative disease (ND) therapeutics underscore the need for a more comprehensive understanding of the underlying disease biol. before effective therapies can be devised.  One hallmark of many NDs is a disruption in protein homeostasis.  Therefore, investigating the role of protein homeostasis in these diseases is central to delineating their underlying pathobiol.  Here, we review the seminal role that chem. biol. has played in furthering the research on and treatment of dysfunctional protein homeostasis in NDs.  We also discuss the vital and predictive role of model systems in identifying conserved homeostasis pathways and genes therein that are altered in neurodegeneration.  Integrating approaches from chem. biol. with the use of model systems yields a powerful toolkit with which to unravel the complexities of ND biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXPyatlzrBVLVg90H21EOLACvtfcHk0lj7EEuldgSuIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslOisrzE&md5=440b79365af1fb637ad7db8e51b1149f</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1663&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1663%26sid%3Dliteratum%253Aachs%26aulast%3DNarayan%26aufirst%3DP.%26aulast%3DEhsani%26aufirst%3DS.%26aulast%3DLindquist%26aufirst%3DS.%26atitle%3DCombating%2520Neurodegenerative%2520Disease%2520with%2520Chemical%2520Probes%2520and%2520Model%2520Systems%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26spage%3D911%26epage%3D920%26doi%3D10.1038%2Fnchembio.1663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Bush, A. I.</span><span> </span><span class="NLM_article-title">The Metal Theory of Alzheimer’s Disease</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">S277</span><span class="NLM_x">–</span> <span class="NLM_lpage">S281</span><span class="refDoi"> DOI: 10.3233/JAD-2012-129011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.3233%2FJAD-2012-129011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=22635102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvV2ksr7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=S277-S281&author=A.+I.+Bush&title=The+Metal+Theory+of+Alzheimer%E2%80%99s+Disease&doi=10.3233%2FJAD-2012-129011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The Metal Theory of Alzheimer's Disease</span></div><div class="casAuthors">Perry, George; Zhu, Xiongwei; Smith, Mark A.; Sorensen, Aaron; Avila, Jesus; Bush, Ashley I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">S277-S281</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  Brain homeostasis of transition metals is severely perturbed in Alzheimer's disease (AD), with extracellular pooling of zinc and copper in amyloid, and intraneuronal accumulation of iron.  Rapidly accumulating evidence indicates that these perturbances themselves may contribute significantly to the cognitive loss and neurodegeneration, even in the absence of AD proteopathy.  There is now strong evidence that each of the major protein participants in AD pathol. has physiol. important interactions with transition metals: AβPP is the neuronal iron export ferroxidase with a major interaction with ferroportin, presenilins are needed for the import of ≈50% of cellular copper and zinc, and tau promotes the export of neuronal iron by facilitating the trafficking of AβPP to the surface.  Therefore, amyloid and tau pathol. arise in a milieu of constitutively high metal flux, and the major components of AD pathol. may contribute to the disease by failing in their metal transport roles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoloM-8UGgtLrVg90H21EOLACvtfcHk0lhZEuaGBbVbmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvV2ksr7K&md5=6332fc77a50144f8f2ea34adfebe44be</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.3233%2FJAD-2012-129011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2012-129011%26sid%3Dliteratum%253Aachs%26aulast%3DBush%26aufirst%3DA.%2BI.%26atitle%3DThe%2520Metal%2520Theory%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2013%26volume%3D33%26spage%3DS277%26epage%3DS281%26doi%3D10.3233%2FJAD-2012-129011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, B.</span><span> </span><span class="NLM_article-title">Oxidative Stress and the Pathogenesis of Alzheimer’s Disease</span> <span class="citation_source-journal">Oxid. Med. Cell. Longevity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">2013</span><span class="NLM_x">, </span> <span class="NLM_fpage">316523</span><span class="refDoi"> DOI: 10.1155/2013/316523</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1155%2F2013%2F316523" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=23983897" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A280%3ADC%252BC3sbjtVOmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2013&publication_year=2013&pages=316523&author=Y.+Zhaoauthor=B.+Zhao&title=Oxidative+Stress+and+the+Pathogenesis+of+Alzheimer%E2%80%99s+Disease&doi=10.1155%2F2013%2F316523"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative stress and the pathogenesis of Alzheimer's disease</span></div><div class="casAuthors">Zhao Yan; Zhao Baolu</div><div class="citationInfo"><span class="NLM_cas:title">Oxidative medicine and cellular longevity</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">2013</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">316523</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Alzheimer's disease (AD) is the most common neurodegenerative disease that causes dementia in the elderly.  Patients with AD suffer a gradual deterioration of memory and other cognitive functions, which eventually leads to a complete incapacity and death.  A complicated array of molecular events has been implicated in the pathogenesis of AD.  The major pathological characteristics of AD brains are the presence of senile plaques, neurofibrillary tangles, and neuronal loss.  Growing evidence has demonstrated that oxidative stress is an important factor contributing to the initiation and progression of AD.  However, the mechanisms that lead to the disruption of redox balance and the sources of free radicals remain elusive.  The excessive reactive oxygen species may be generated from mechanisms such as mitochondria dysfunction and/or aberrant accumulation of transition metals, while the abnormal accumulation of Abeta and tau proteins appears to promote the redox imbalance.  The resulted oxidative stress has been implicated in Abeta- or tau-induced neurotoxicity.  In addition, evidence has suggested that oxidative stress may augment the production and aggregation of Abeta and facilitate the phosphorylation and polymerization of tau, thus forming a vicious cycle that promotes the initiation and progression of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS8bk2b0ed4E9bHMBt0mMIXfW6udTcc2ea56OAUBJboN7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sbjtVOmsw%253D%253D&md5=876ca56576e14f4e0a3aaf2ccd512118</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1155%2F2013%2F316523&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2013%252F316523%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DB.%26atitle%3DOxidative%2520Stress%2520and%2520the%2520Pathogenesis%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DOxid.%2520Med.%2520Cell.%2520Longevity%26date%3D2013%26volume%3D2013%26spage%3D316523%26doi%3D10.1155%2F2013%2F316523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Terry, A. V.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buccafusco, J. J.</span><span> </span><span class="NLM_article-title">The Cholinergic Hypothesis of Age and Alzheimer’s Disease-related Cognitive Deficits: Recent Challenges and Their Implications for Novel Drug Development</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">306</span><span class="NLM_x">, </span> <span class="NLM_fpage">821</span><span class="NLM_x">–</span> <span class="NLM_lpage">827</span><span class="refDoi"> DOI: 10.1124/jpet.102.041616</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1124%2Fjpet.102.041616" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=12805474" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvVehsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=306&publication_year=2003&pages=821-827&author=A.+V.+Terryauthor=J.+J.+Buccafusco&title=The+Cholinergic+Hypothesis+of+Age+and+Alzheimer%E2%80%99s+Disease-related+Cognitive+Deficits%3A+Recent+Challenges+and+Their+Implications+for+Novel+Drug+Development&doi=10.1124%2Fjpet.102.041616"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: Recent challenges and their implications for novel drug development</span></div><div class="casAuthors">Terry, A. V., Jr.; Buccafusco, J. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">306</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">821-827</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  The cholinergic hypothesis was initially presented over 20 yr ago and suggests that a dysfunction of acetylcholine contg. neurons in the brain contributes substantially to the cognitive decline obsd. in those with advanced age and Alzheimer's disease (AD).  This premise has since served as the basis for the majority of treatment strategies and drug development approaches for AD to date.  Recent studies of the brains of patients who had mild cognitive impairment or early stage AD in which choline acetyltransferase and/or acetylcholinesterase activity was unaffected (or even up-regulated) have, however, led some to challenge the validity of the hypothesis as well as the rationale for using cholinomimetics to treat the disorder, particularly in the earlier stages.  These challenges, primarily based on assays of post mortem enzyme activity, should be taken in perspective and evaluated within the wide range of cholinergic abnormalities known to exist in both aging and AD.  The results of both post mortem and antemortem studies in aged humans and AD patients, as well as animal expts. suggest that a host of cholinergic abnormalities including alterations in choline transport, acetylcholine release, nicotinic and muscarinic receptor expression, neurotrophin support, and perhaps axonal transport may all contribute to cognitive abnormalities in aging and AD.  Cholinergic abnormalities may also contribute to noncognitive behavioral abnormalities as well as the deposition of toxic neuritic plaques in AD.  Therefore, cholinergic-based strategies will likely remain valid as one approach to rational drug development for the treatment of AD other forms of dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPatJs_N3wu7Vg90H21EOLACvtfcHk0lhZEuaGBbVbmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvVehsb8%253D&md5=bd52a7d752cc5e51a3866c3ed2ace8f0</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.041616&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.041616%26sid%3Dliteratum%253Aachs%26aulast%3DTerry%26aufirst%3DA.%2BV.%26aulast%3DBuccafusco%26aufirst%3DJ.%2BJ.%26atitle%3DThe%2520Cholinergic%2520Hypothesis%2520of%2520Age%2520and%2520Alzheimer%25E2%2580%2599s%2520Disease-related%2520Cognitive%2520Deficits%253A%2520Recent%2520Challenges%2520and%2520Their%2520Implications%2520for%2520Novel%2520Drug%2520Development%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2003%26volume%3D306%26spage%3D821%26epage%3D827%26doi%3D10.1124%2Fjpet.102.041616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Johnson, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotermanski, S. E.</span><span> </span><span class="NLM_article-title">Mechanism of Action of Memantine</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span><span class="refDoi"> DOI: 10.1016/j.coph.2005.09.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1016%2Fj.coph.2005.09.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=16368266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsVygtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=61-67&author=J.+W.+Johnsonauthor=S.+E.+Kotermanski&title=Mechanism+of+Action+of+Memantine&doi=10.1016%2Fj.coph.2005.09.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of action of Memantine</span></div><div class="casAuthors">Johnson, Jon W.; Kotermanski, Shawn E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-67</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Memantine is a clin. useful drug in many neurol. disorders, including Alzheimer's disease.  The principal mechanism of action of Memantine is believed to be the blockade of current flow through channels of N-methylaspartate (NMDA) receptors - a glutamate receptor subfamily broadly involved in brain function.  Surprisingly, other drugs that block NMDA receptor channels, such as ketamine, exhibit serious deleterious effects.  The unusual therapeutic utility of Memantine probably results from inhibitory mechanisms shared with ketamine, combined with actions specific to Memantine.  These potentially important differences between Memantine and ketamine include effects on gating of blocked channels and binding of Memantine to 2 sites on NMDA receptors.  Because modulation of NMDA receptor activity can increase or decrease excitability of neuronal circuits, subtle differences in the mechanisms of action of NMDA receptor antagonists can strongly impact on their clin. effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrS8uhDNxLehLVg90H21EOLACvtfcHk0lj_kS-7ewY-EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsVygtA%253D%253D&md5=5c34d27940d101a2ec674eed28a977d8</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2005.09.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2005.09.007%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DJ.%2BW.%26aulast%3DKotermanski%26aufirst%3DS.%2BE.%26atitle%3DMechanism%2520of%2520Action%2520of%2520Memantine%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2006%26volume%3D6%26spage%3D61%26epage%3D67%26doi%3D10.1016%2Fj.coph.2005.09.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Muñoz-Torrero, D.</span><span> </span><span class="NLM_article-title">Acetylcholinesterase Inhibitors as Disease Modifying Therapies for Alzheimer’s Disease</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2433</span><span class="NLM_x">–</span> <span class="NLM_lpage">2455</span><span class="refDoi"> DOI: 10.2174/092986708785909067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.2174%2F092986708785909067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=18855672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFCqsLbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=2433-2455&author=D.+Mu%C3%B1oz-Torrero&title=Acetylcholinesterase+Inhibitors+as+Disease+Modifying+Therapies+for+Alzheimer%E2%80%99s+Disease&doi=10.2174%2F092986708785909067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Acetylcholinesterase inhibitors as disease-modifying therapies for Alzheimer's disease</span></div><div class="casAuthors">Munoz-Torrero, D.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">2433-2455</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The therapeutic arsenal for the treatment of Alzheimer's disease (AD) remains confined to a group of four inhibitors of AChE and one NMDA receptor antagonist, which are used to provide a relief of the very late symptoms of the dementia, i.e. the cognitive and functional decline.  In line with the growing body of evidence of the pivotal role of the β-amyloid peptide (Aβ) in the pathogenesis of AD, alternative classes of drugs targeting mainly the formation or the aggregation of Aβ are actively pursued by the pharmaceutical industry, as they could pos. modify the course of AD, stopping or slowing down disease progression.  While the first amyloid-directed disease-modifying drugs go ahead with their clin. development and could reach the market as soon as 2009, mounting preclin. and clin. evidences is pointing towards a disease-modifying role also for currently marketed anti-Alzheimer AChE inhibitors (AChEIs), particularly for donepezil.  In this review, the neuroprotective effects exhibited by currently commercialized AChEIs will be briefly discussed, together with the secondary mechanisms through which they could exert such effects.  This review will focus also on particular classes of AChEIs, namely dual binding site AChEIs, which are being purposely designed to target Aβ aggregation and / or other biol. targets that contribute to AD pathogenesis, thus constituting very promising disease-modifying anti-Alzheimer drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqII-Yg4R84wrVg90H21EOLACvtfcHk0lj_kS-7ewY-EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFCqsLbI&md5=a27eaf0ba08a4d9e5c8363f6b5621e5d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2174%2F092986708785909067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986708785909067%26sid%3Dliteratum%253Aachs%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DAcetylcholinesterase%2520Inhibitors%2520as%2520Disease%2520Modifying%2520Therapies%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2008%26volume%3D15%26spage%3D2433%26epage%3D2455%26doi%3D10.2174%2F092986708785909067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Zimmermann, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehár, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keith, C. T.</span><span> </span><span class="NLM_article-title">Multi-target Therapeutics: When the Whole is Greater than the Sum of the Parts</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">34</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span><span class="refDoi"> DOI: 10.1016/j.drudis.2006.11.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1016%2Fj.drudis.2006.11.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=17198971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A280%3ADC%252BD2s%252Fgt1ygtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=34-42&author=G.+R.+Zimmermannauthor=J.+Leh%C3%A1rauthor=C.+T.+Keith&title=Multi-target+Therapeutics%3A+When+the+Whole+is+Greater+than+the+Sum+of+the+Parts&doi=10.1016%2Fj.drudis.2006.11.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target therapeutics: when the whole is greater than the sum of the parts</span></div><div class="casAuthors">Zimmermann Grant R; Lehar Joseph; Keith Curtis T</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">34-42</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">Drugs designed to act against individual molecular targets cannot usually combat multigenic diseases such as cancer, or diseases that affect multiple tissues or cell types such as diabetes and immunoinflammatory disorders.  Combination drugs that impact multiple targets simultaneously are better at controlling complex disease systems, are less prone to drug resistance and are the standard of care in many important therapeutic areas.  The combination drugs currently employed are primarily of rational design, but the increased efficacy they provide justifies in vitro discovery efforts for identifying novel multi-target mechanisms.  In this review, we discuss the biological rationale for combination therapeutics, review some existing combination drugs and present a systematic approach to identify interactions between molecular pathways that could be leveraged for therapeutic benefit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTI14vYK2Q1LENHe_gFldTbfW6udTcc2ebXihyYQ0903bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s%252Fgt1ygtQ%253D%253D&md5=66715499ce21c2855dc6c477aa87f161</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2006.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2006.11.008%26sid%3Dliteratum%253Aachs%26aulast%3DZimmermann%26aufirst%3DG.%2BR.%26aulast%3DLeh%25C3%25A1r%26aufirst%3DJ.%26aulast%3DKeith%26aufirst%3DC.%2BT.%26atitle%3DMulti-target%2520Therapeutics%253A%2520When%2520the%2520Whole%2520is%2520Greater%2520than%2520the%2520Sum%2520of%2520the%2520Parts%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2007%26volume%3D12%26spage%3D34%26epage%3D42%26doi%3D10.1016%2Fj.drudis.2006.11.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Leon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span> </span><span class="NLM_article-title">Recent Advances in the Multitarget-Directed Ligands Approach for the Treatment of Alzheimer’s Disease</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">189</span><span class="refDoi"> DOI: 10.1002/med.20248</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1002%2Fmed.20248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=21793014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVCktrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=139-189&author=R.+Leonauthor=A.+G.+Garciaauthor=J.+Marco-Contelles&title=Recent+Advances+in+the+Multitarget-Directed+Ligands+Approach+for+the+Treatment+of+Alzheimer%E2%80%99s+Disease&doi=10.1002%2Fmed.20248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Leon, Rafael; Garcia, Antonio G.; Marco-Contelles, Jose</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">139-189</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  With 27 million cases worldwide documented in 2006, Alzheimer's disease (AD) constitutes an overwhelming health, social, economic, and political problem to nations.  Unless a new medicine capable to delay disease progression is found, the no. of cases will reach 107 million in 2050.  So far, the therapeutic paradigm one-compd.-one-target has failed.  This could be due to the multiple pathogenic mechanisms involved in AD including amyloid β (Aβ) aggregation to form plaques, τ hyperphosphorylation to disrupt microtubule to form neurofibrillary tangles, calcium imbalance, enhanced oxidative stress, impaired mitochondrial function, apoptotic neuronal death, and deterioration of synaptic transmission, particularly at cholinergic neurons.  Approx. 100 compds. are presently been investigated directed to single targets, namely inhibitors of β and γ secretase, vaccines or antibodies that clear Aβ, metal chelators to inhibit Aβ aggregation, blockers of glycogen synthase kinase 3β, enhancers of mitochondrial function, antioxidants, modulators of calcium-permeable channels such as voltage-dependent calcium channels, N-methyl-D-aspartate receptors for glutamate, or enhancers of cholinergic neurotransmission such as inhibitors of acetylcholinesterase or butyrylcholinesterase.  In view of this complex pathogenic mechanisms, and the successful treatment of chronic diseases such as HIV or cancer, with multiple drugs having complementary mechanisms of action, the concern is growing that AD could better be treated with a single compd. targeting two or more of the pathogenic mechanisms leading to neuronal death.  This review summarizes the current therapeutic strategies based on the paradigm one-compd.-various targets to treat AD.  A treatment that delays disease onset and/or progression by 5 years could halve the no. of people requiring institutionalization and/or dying from AD.  © 2011 Wiley Periodicals, Inc.  Med Res Rev.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8YQ_Czzj5brVg90H21EOLACvtfcHk0livouThTDiJRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVCktrvL&md5=b08806a8a4ca71c35a3594338c881e74</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1002%2Fmed.20248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20248%26sid%3Dliteratum%253Aachs%26aulast%3DLeon%26aufirst%3DR.%26aulast%3DGarcia%26aufirst%3DA.%2BG.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26atitle%3DRecent%2520Advances%2520in%2520the%2520Multitarget-Directed%2520Ligands%2520Approach%2520for%2520the%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2013%26volume%3D33%26spage%3D139%26epage%3D189%26doi%3D10.1002%2Fmed.20248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnamoorthy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savelieff, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brender, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derrick, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kochi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramamoorthy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowers, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, M. H.</span><span> </span><span class="NLM_article-title">Rational Design of a Structural Framework with Potential Use to Develop Chemical Reagents that Target and Modulate Multiple Facets of Alzheimer’s Disease</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">299</span><span class="NLM_x">–</span> <span class="NLM_lpage">310</span><span class="refDoi"> DOI: 10.1021/ja409801p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja409801p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC3sXitVWnsL3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=299-310&author=S.+Leeauthor=X.+Zhengauthor=J.+Krishnamoorthyauthor=M.+G.+Savelieffauthor=H.+M.+Parkauthor=J.+R.+Brenderauthor=J.+H.+Kimauthor=J.+S.+Derrickauthor=A.+Kochiauthor=H.+J.+Leeauthor=C.+Kimauthor=A.+Ramamoorthyauthor=M.+T.+Bowersauthor=M.+H.+Lim&title=Rational+Design+of+a+Structural+Framework+with+Potential+Use+to+Develop+Chemical+Reagents+that+Target+and+Modulate+Multiple+Facets+of+Alzheimer%E2%80%99s+Disease&doi=10.1021%2Fja409801p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Design of a Structural Framework with Potential Use to Develop Chemical Reagents That Target and Modulate Multiple Facets of Alzheimer's Disease</span></div><div class="casAuthors">Lee, Sanghyun; Zheng, Xueyun; Krishnamoorthy, Janarthanan; Savelieff, Masha G.; Park, Hyun Min; Brender, Jeffrey R.; Kim, Jin Hoon; Derrick, Jeffrey S.; Kochi, Akiko; Lee, Hyuck Jin; Kim, Cheal; Ramamoorthy, Ayyalusamy; Bowers, Michael T.; Lim, Mi Hee</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">299-310</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is characterized by multiple, intertwined pathol. features, including amyloid-β (Aβ) aggregation, metal ion dyshomeostasis, and oxidative stress.  The authors report a novel compd. (ML) prototype of a rationally designed mol. obtained by integrating structural elements for Aβ aggregation control, metal chelation, reactive oxygen species (ROS) regulation, and antioxidant activity within a single mol.  Chem., biochem., ion mobility mass spectrometric, and NMR studies indicate that the compd. ML targets metal-free and metal-bound Aβ (metal-Aβ) species, suppresses Aβ aggregation in vitro, and diminishes toxicity induced by Aβ and metal-treated Aβ in living cells.  Comparison of ML to its structural moieties (i.e., 4-(dimethylamino)-phenol (DAP) and (8-aminoquinolin-2-yl)-methanol ) for reactivity with Aβ and metal-Aβ suggests the synergy of incorporating structural components for both metal chelation and Aβ interaction.  Moreover, ML is water-sol. and potentially brain permeable, as well as regulates the formation and presence of free radicals.  Overall, the authors demonstrate that a rational structure-based design strategy can generate a small mol. that can target and modulate multiple factors, providing a new tool to uncover and address AD complexity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcx8TkzbV9U7Vg90H21EOLACvtfcHk0livouThTDiJRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXitVWnsL3I&md5=808d231c5dca419453c176265d16bfe3</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fja409801p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja409801p%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DKrishnamoorthy%26aufirst%3DJ.%26aulast%3DSavelieff%26aufirst%3DM.%2BG.%26aulast%3DPark%26aufirst%3DH.%2BM.%26aulast%3DBrender%26aufirst%3DJ.%2BR.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DDerrick%26aufirst%3DJ.%2BS.%26aulast%3DKochi%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DH.%2BJ.%26aulast%3DKim%26aufirst%3DC.%26aulast%3DRamamoorthy%26aufirst%3DA.%26aulast%3DBowers%26aufirst%3DM.%2BT.%26aulast%3DLim%26aufirst%3DM.%2BH.%26atitle%3DRational%2520Design%2520of%2520a%2520Structural%2520Framework%2520with%2520Potential%2520Use%2520to%2520Develop%2520Chemical%2520Reagents%2520that%2520Target%2520and%2520Modulate%2520Multiple%2520Facets%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26spage%3D299%26epage%3D310%26doi%3D10.1021%2Fja409801p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Prati, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Simone, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisignano, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armirotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pizzirani, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarpelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Castillo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monti, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massenzio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polito, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Racchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favia, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottegoni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span> </span><span class="NLM_article-title">Multitarget Drug Discovery for Alzheimer’s Disease: Triazinones as BACE-1 and GSK-3β Inhibitors</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1578</span><span class="NLM_x">–</span> <span class="NLM_lpage">1582</span><span class="refDoi"> DOI: 10.1002/anie.201410456</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1002%2Fanie.201410456" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVyhtrjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2015&pages=1578-1582&author=F.+Pratiauthor=A.+De+Simoneauthor=P.+Bisignanoauthor=A.+Armirottiauthor=M.+Summaauthor=D.+Pizziraniauthor=R.+Scarpelliauthor=D.+I.+Perezauthor=V.+Andrisanoauthor=A.+Perez-Castilloauthor=B.+Montiauthor=F.+Massenzioauthor=L.+Politoauthor=M.+Racchiauthor=A.+D.+Faviaauthor=G.+Bottegoniauthor=A.+Martinezauthor=M.+L.+Bolognesiauthor=A.+Cavalli&title=Multitarget+Drug+Discovery+for+Alzheimer%E2%80%99s+Disease%3A+Triazinones+as+BACE-1+and+GSK-3%CE%B2+Inhibitors&doi=10.1002%2Fanie.201410456"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Multitarget Drug Discovery for Alzheimer's Disease: Triazinones as BACE-1 and GSK-3β Inhibitors</span></div><div class="casAuthors">Prati, Federica; De Simone, Angela; Bisignano, Paola; Armirotti, Andrea; Summa, Maria; Pizzirani, Daniela; Scarpelli, Rita; Perez, Daniel I.; Andrisano, Vincenza; Perez-Castillo, Ana; Monti, Barbara; Massenzio, Francesca; Polito, Letizia; Racchi, Marco; Favia, Angelo D.; Bottegoni, Giovanni; Martinez, Ana; Bolognesi, Maria Laura; Cavalli, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1578-1582</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Cumulative evidence strongly supports that the amyloid and tau hypotheses are not mutually exclusive, but concomitantly contribute to neurodegeneration in Alzheimer's disease (AD).  Thus, the development of multitarget drugs which are involved in both pathways might represent a promising therapeutic strategy.  Accordingly, reported here in is the discovery of 6-amino-4-phenyl-3,4-dihydro-1,3,5-triazin-2(1H)-ones as the first class of mols. able to simultaneously modulate BACE-1 and GSK-3β.  Notably, one triazinone showed well-balanced in vitro potencies against the two enzymes (IC50 of (18.03±0.01) μM and (14.67±0.78) μM for BACE-1 and GSK-3β, resp.).  In cell-based assays, it displayed effective neuroprotective and neurogenic activities and no neurotoxicity.  It also showed good brain permeability in a preliminary pharmacokinetic assessment in mice.  Overall, triazinones might represent a promising starting point towards high quality lead compds. with an AD-modifying potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr709_eEcKrqrVg90H21EOLACvtfcHk0lhVA_BLbrugZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVyhtrjE&md5=9d372688168ec28086c92d557a1ed708</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1002%2Fanie.201410456&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201410456%26sid%3Dliteratum%253Aachs%26aulast%3DPrati%26aufirst%3DF.%26aulast%3DDe%2BSimone%26aufirst%3DA.%26aulast%3DBisignano%26aufirst%3DP.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DSumma%26aufirst%3DM.%26aulast%3DPizzirani%26aufirst%3DD.%26aulast%3DScarpelli%26aufirst%3DR.%26aulast%3DPerez%26aufirst%3DD.%2BI.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DPerez-Castillo%26aufirst%3DA.%26aulast%3DMonti%26aufirst%3DB.%26aulast%3DMassenzio%26aufirst%3DF.%26aulast%3DPolito%26aufirst%3DL.%26aulast%3DRacchi%26aufirst%3DM.%26aulast%3DFavia%26aufirst%3DA.%2BD.%26aulast%3DBottegoni%26aufirst%3DG.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DCavalli%26aufirst%3DA.%26atitle%3DMultitarget%2520Drug%2520Discovery%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%253A%2520Triazinones%2520as%2520BACE-1%2520and%2520GSK-3%25CE%25B2%2520Inhibitors%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2015%26volume%3D54%26spage%3D1578%26epage%3D1582%26doi%3D10.1002%2Fanie.201410456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Zheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridkin, M.</span><span> </span><span class="NLM_article-title">Site-activated Chelators Targeting Acetylcholinesterase and Monoamine Oxidase for Alzheimer’s Therapy</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">603</span><span class="NLM_x">–</span> <span class="NLM_lpage">610</span><span class="refDoi"> DOI: 10.1021/cb900264w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb900264w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=603-610&author=H.+Zhengauthor=M.+B.+H.+Youdimauthor=M.+Fridkin&title=Site-activated+Chelators+Targeting+Acetylcholinesterase+and+Monoamine+Oxidase+for+Alzheimer%E2%80%99s+Therapy&doi=10.1021%2Fcb900264w"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fcb900264w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb900264w%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26aulast%3DFridkin%26aufirst%3DM.%26atitle%3DSite-activated%2520Chelators%2520Targeting%2520Acetylcholinesterase%2520and%2520Monoamine%2520Oxidase%2520for%2520Alzheimer%25E2%2580%2599s%2520Therapy%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2010%26volume%3D5%26spage%3D603%26epage%3D610%26doi%3D10.1021%2Fcb900264w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Rochais, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lecoutey, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaven, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giannoni, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamidouche, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubost, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genest, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yahiaoui, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freret, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouet, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dauphin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sopkova de Oliveira Santos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballandonne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corvaisier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malzert-Fréon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Legay, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulouard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claeysen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dallemagne, P.</span><span> </span><span class="NLM_article-title">Novel Multitarget-directed Ligands (MTDLs) with Acetylcholinesterase (AChE) Inhibitory and Serotonergic Subtype 4 Receptor (5-HT4R) Agonist Activities as Potential Agents against Alzheimer’s Disease: the Design of Donecopride</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">3172</span><span class="NLM_x">–</span> <span class="NLM_lpage">3187</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00115</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00115" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC2MXkvFWjsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3172-3187&author=C.+Rochaisauthor=C.+Lecouteyauthor=F.+Gavenauthor=P.+Giannoniauthor=K.+Hamidoucheauthor=D.+Hedouauthor=E.+Dubostauthor=D.+Genestauthor=S.+Yahiaouiauthor=T.+Freretauthor=V.+Bouetauthor=F.+Dauphinauthor=J.+Sopkova+de+Oliveira+Santosauthor=C.+Ballandonneauthor=S.+Corvaisierauthor=A.+Malzert-Fr%C3%A9onauthor=R.+Legayauthor=M.+Boulouardauthor=S.+Claeysenauthor=P.+Dallemagne&title=Novel+Multitarget-directed+Ligands+%28MTDLs%29+with+Acetylcholinesterase+%28AChE%29+Inhibitory+and+Serotonergic+Subtype+4+Receptor+%285-HT4R%29+Agonist+Activities+as+Potential+Agents+against+Alzheimer%E2%80%99s+Disease%3A+the+Design+of+Donecopride&doi=10.1021%2Facs.jmedchem.5b00115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Multitarget-Directed Ligands (MTDLs) with Acetylcholinesterase (AChE) Inhibitory and Serotonergic Subtype 4 Receptor (5-HT4R) Agonist Activities As Potential Agents against Alzheimer's Disease: The Design of Donecopride</span></div><div class="casAuthors">Rochais, Christophe; Lecoutey, Cedric; Gaven, Florence; Giannoni, Patrizia; Hamidouche, Katia; Hedou, Damien; Dubost, Emmanuelle; Genest, David; Yahiaoui, Samir; Freret, Thomas; Bouet, Valentine; Dauphin, Francois; Sopkova de Oliveira Santos, Jana; Ballandonne, Celine; Corvaisier, Sophie; Malzert-Freon, Aurelie; Legay, Remi; Boulouard, Michel; Claeysen, Sylvie; Dallemagne, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3172-3187</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors describe the synthesis and in vitro evaluation of a novel series of multitarget-directed ligands (MTDL) displaying both nanomolar dual-binding site (DBS) acetylcholinesterase inhibitory effects and partial 5-HT4R agonist activity, among which donecopride was selected for further in vivo evaluations in mice.  The latter displayed procognitive and antiamnesic effects and enhanced sAPPα release, accounting for a potential symptomatic and disease-modifying therapeutic benefit in the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmfqjY4Tl4ObVg90H21EOLACvtfcHk0lgStSCIwm3ZjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXkvFWjsrw%253D&md5=435652a2503e322ad880bd9607838103</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00115%26sid%3Dliteratum%253Aachs%26aulast%3DRochais%26aufirst%3DC.%26aulast%3DLecoutey%26aufirst%3DC.%26aulast%3DGaven%26aufirst%3DF.%26aulast%3DGiannoni%26aufirst%3DP.%26aulast%3DHamidouche%26aufirst%3DK.%26aulast%3DHedou%26aufirst%3DD.%26aulast%3DDubost%26aufirst%3DE.%26aulast%3DGenest%26aufirst%3DD.%26aulast%3DYahiaoui%26aufirst%3DS.%26aulast%3DFreret%26aufirst%3DT.%26aulast%3DBouet%26aufirst%3DV.%26aulast%3DDauphin%26aufirst%3DF.%26aulast%3DSopkova%2Bde%2BOliveira%2BSantos%26aufirst%3DJ.%26aulast%3DBallandonne%26aufirst%3DC.%26aulast%3DCorvaisier%26aufirst%3DS.%26aulast%3DMalzert-Fr%25C3%25A9on%26aufirst%3DA.%26aulast%3DLegay%26aufirst%3DR.%26aulast%3DBoulouard%26aufirst%3DM.%26aulast%3DClaeysen%26aufirst%3DS.%26aulast%3DDallemagne%26aufirst%3DP.%26atitle%3DNovel%2520Multitarget-directed%2520Ligands%2520%2528MTDLs%2529%2520with%2520Acetylcholinesterase%2520%2528AChE%2529%2520Inhibitory%2520and%2520Serotonergic%2520Subtype%25204%2520Receptor%2520%25285-HT4R%2529%2520Agonist%2520Activities%2520as%2520Potential%2520Agents%2520against%2520Alzheimer%25E2%2580%2599s%2520Disease%253A%2520the%2520Design%2520of%2520Donecopride%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3172%26epage%3D3187%26doi%3D10.1021%2Facs.jmedchem.5b00115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Pau, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinna, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frau, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murineddu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asproni, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curzu, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loza, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brea, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinna, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Multitarget-directed Tricyclic Pyridazinones as Ligands of Selected G-protein Coupled Receptors and Inhibitors of Cholinesterases</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1054</span><span class="NLM_x">–</span> <span class="NLM_lpage">1070</span><span class="refDoi"> DOI: 10.1002/cmdc.201500124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1002%2Fcmdc.201500124" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1054-1070&author=A.+Pauauthor=M.+Cattoauthor=G.+Pinnaauthor=S.+Frauauthor=G.+Murinedduauthor=B.+Asproniauthor=M.+M.+Curzuauthor=L.+Pisaniauthor=F.+Leonettiauthor=M.+I.+Lozaauthor=J.+Breaauthor=G.+A.+Pinnaauthor=A.+Carotti&title=Multitarget-directed+Tricyclic+Pyridazinones+as+Ligands+of+Selected+G-protein+Coupled+Receptors+and+Inhibitors+of+Cholinesterases&doi=10.1002%2Fcmdc.201500124"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500124%26sid%3Dliteratum%253Aachs%26aulast%3DPau%26aufirst%3DA.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DPinna%26aufirst%3DG.%26aulast%3DFrau%26aufirst%3DS.%26aulast%3DMurineddu%26aufirst%3DG.%26aulast%3DAsproni%26aufirst%3DB.%26aulast%3DCurzu%26aufirst%3DM.%2BM.%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DLoza%26aufirst%3DM.%2BI.%26aulast%3DBrea%26aufirst%3DJ.%26aulast%3DPinna%26aufirst%3DG.%2BA.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DMultitarget-directed%2520Tricyclic%2520Pyridazinones%2520as%2520Ligands%2520of%2520Selected%2520G-protein%2520Coupled%2520Receptors%2520and%2520Inhibitors%2520of%2520Cholinesterases%26jtitle%3DChemMedChem%26date%3D2015%26volume%3D10%26spage%3D1054%26epage%3D1070%26doi%3D10.1002%2Fcmdc.201500124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Fernández-Bachiller, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monjas, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rademann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodríguez-Franco, M. I.</span><span> </span><span class="NLM_article-title">New Tacrine–4-Oxo-4H-chromene Hybrids as Multifunctional Agents for the Treatment of Alzheimer’s Disease, with Cholinergic, Antioxidant, and β-Amyloid-Reducing Properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1303</span><span class="NLM_x">–</span> <span class="NLM_lpage">1317</span><span class="refDoi"> DOI: 10.1021/jm201460y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201460y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC38XntFKisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1303-1317&author=M.+I.+Fern%C3%A1ndez-Bachillerauthor=C.+P%C3%A9rezauthor=L.+Monjasauthor=J.+Rademannauthor=M.+I.+Rodr%C3%ADguez-Franco&title=New+Tacrine%E2%80%934-Oxo-4H-chromene+Hybrids+as+Multifunctional+Agents+for+the+Treatment+of+Alzheimer%E2%80%99s+Disease%2C+with+Cholinergic%2C+Antioxidant%2C+and+%CE%B2-Amyloid-Reducing+Properties&doi=10.1021%2Fjm201460y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">New Tacrine-4-Oxo-4H-chromene Hybrids as Multifunctional Agents for the Treatment of Alzheimer's Disease, with Cholinergic, Antioxidant, and β-Amyloid-Reducing Properties</span></div><div class="casAuthors">Fernandez-Bachiller, Maria Isabel; Perez, Concepcion; Monjas, Leticia; Rademann, Jorg; Rodriguez-Franco, Maria Isabel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1303-1317</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">By using fragments endowed with interesting and complementary properties for the treatment of Alzheimer's disease (AD), a new family of tacrine-4-oxo-4H-chromene hybrids has been designed, synthesized, and evaluated biol.  The tacrine fragment was selected for its inhibition of cholinesterases, and the flavonoid scaffold derived from 4-oxo-4H -chromene was chosen for its radical capture and β-secretase 1 (BACE-1) inhibitory activities.  At nano- and picomolar concns., the new tacrine-4-oxo-4H-chromene hybrids inhibit human acetyl- and butyrylcholinesterase (h-AChE and h-BuChE), being more potent than the parent inhibitor, tacrine.  They are also potent inhibitors of human BACE-1, better than the parent flavonoid, apigenin.  They show interesting antioxidant properties and could be able to penetrate into the CNS according to the in vitro PAMPA-BBB assay.  Among the hybrids investigated, 6-hydroxy-4-oxo- N-{10-[(1,2,3,4-tetrahydroacridin-9-yl)amino]decyl}-4 H-chromene-2-carboxamide (I) shows potent combined inhibition of human BACE-1 and ChEs, as well as good antioxidant and CNS-permeable properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiMx-NagCpeLVg90H21EOLACvtfcHk0lgStSCIwm3ZjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntFKisw%253D%253D&md5=9391af9439e43f5eda518919839bd473</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm201460y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201460y%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez-Bachiller%26aufirst%3DM.%2BI.%26aulast%3DP%25C3%25A9rez%26aufirst%3DC.%26aulast%3DMonjas%26aufirst%3DL.%26aulast%3DRademann%26aufirst%3DJ.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26atitle%3DNew%2520Tacrine%25E2%2580%25934-Oxo-4H-chromene%2520Hybrids%2520as%2520Multifunctional%2520Agents%2520for%2520the%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%252C%2520with%2520Cholinergic%252C%2520Antioxidant%252C%2520and%2520%25CE%25B2-Amyloid-Reducing%2520Properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1303%26epage%3D1317%26doi%3D10.1021%2Fjm201460y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span> </span><span class="NLM_article-title">Tacrine–Ferulic Acid–Nitric Oxide (NO) Donor Trihybrids as Potent, Multifunctional Acetyl- and Butyrylcholinesterase Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4309</span><span class="NLM_x">–</span> <span class="NLM_lpage">4321</span><span class="refDoi"> DOI: 10.1021/jm300106z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300106z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4309-4321&author=Y.+Chenauthor=J.+Sunauthor=L.+Fangauthor=M.+Liuauthor=S.+Pengauthor=H.+Liaoauthor=J.+Lehmannauthor=Y.+Zhang&title=Tacrine%E2%80%93Ferulic+Acid%E2%80%93Nitric+Oxide+%28NO%29+Donor+Trihybrids+as+Potent%2C+Multifunctional+Acetyl-+and+Butyrylcholinesterase+Inhibitors&doi=10.1021%2Fjm300106z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm300106z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300106z%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DFang%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DLiao%26aufirst%3DH.%26aulast%3DLehmann%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DTacrine%25E2%2580%2593Ferulic%2520Acid%25E2%2580%2593Nitric%2520Oxide%2520%2528NO%2529%2520Donor%2520Trihybrids%2520as%2520Potent%252C%2520Multifunctional%2520Acetyl-%2520and%2520Butyrylcholinesterase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4309%26epage%3D4321%26doi%3D10.1021%2Fjm300106z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Fang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appenroth, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiehntopf, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lupp, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleck, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, J.</span><span> </span><span class="NLM_article-title">NO-Donating Tacrine Hybrid Compounds Improve Scopolamine-Induced Cognition Impairment and Show Less Hepatotoxicity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">7666</span><span class="NLM_x">–</span> <span class="NLM_lpage">7669</span><span class="refDoi"> DOI: 10.1021/jm801131a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801131a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=7666-7669&author=L.+Fangauthor=D.+Appenrothauthor=M.+Deckerauthor=M.+Kiehntopfauthor=A.+Luppauthor=S.+Pengauthor=C.+Fleckauthor=Y.+Zhangauthor=J.+Lehmann&title=NO-Donating+Tacrine+Hybrid+Compounds+Improve+Scopolamine-Induced+Cognition+Impairment+and+Show+Less+Hepatotoxicity&doi=10.1021%2Fjm801131a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm801131a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801131a%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DL.%26aulast%3DAppenroth%26aufirst%3DD.%26aulast%3DDecker%26aufirst%3DM.%26aulast%3DKiehntopf%26aufirst%3DM.%26aulast%3DLupp%26aufirst%3DA.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DFleck%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLehmann%26aufirst%3DJ.%26atitle%3DNO-Donating%2520Tacrine%2520Hybrid%2520Compounds%2520Improve%2520Scopolamine-Induced%2520Cognition%2520Impairment%2520and%2520Show%2520Less%2520Hepatotoxicity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D7666%26epage%3D7669%26doi%3D10.1021%2Fjm801131a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Dvir, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silman, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberry, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sussman, J. L.</span><span> </span><span class="NLM_article-title">Acetylcholinesterase: From 3D Structure to Function</span> <span class="citation_source-journal">Chem.-Biol. Interact.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">187</span><span class="NLM_x">, </span> <span class="NLM_fpage">10</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span><span class="refDoi"> DOI: 10.1016/j.cbi.2010.01.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1016%2Fj.cbi.2010.01.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=20138030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC3cXps1Wgsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=187&publication_year=2010&pages=10-22&author=H.+Dvirauthor=I.+Silmanauthor=M.+Harelauthor=T.+L.+Rosenberryauthor=J.+L.+Sussman&title=Acetylcholinesterase%3A+From+3D+Structure+to+Function&doi=10.1016%2Fj.cbi.2010.01.042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Acetylcholinesterase: From 3D structure to function</span></div><div class="casAuthors">Dvir, Hay; Silman, Israel; Harel, Michal; Rosenberry, Terrone L.; Sussman, Joel L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">187</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">10-22</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  By rapid hydrolysis of the neurotransmitter, acetylcholine, acetylcholinesterase (AChE) terminates neurotransmission at cholinergic synapses.  AChE is a very fast enzyme, functioning at a rate approaching that of a diffusion-controlled reaction.  The powerful toxicity of organophosphate poisons is attributed primarily to their potent inhibition of AChE.  AChE inhibitors are utilized in the treatment of various neurol. disorders, and are the principal drugs approved thus far by the FDA for management of Alzheimer's disease.  Many organophosphates and carbamates serve as potent insecticides, by selectively inhibiting insect AChE.  The detn. of the crystal structure of Torpedo californica AChE permitted visualization, for the 1st time, at at. resoln., of a binding pocket for acetylcholine.  It also allowed identification of the active site of AChE, which, unexpectedly, is located at the bottom of a deep gorge lined largely by arom. residues.  The crystal structure of recombinant human AChE in its apo-state is similar in its overall features to that of the Torpedo enzyme; however, the unique crystal packing reveals a novel peptide sequence which blocks access to the active site gorge.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnLqJTiC2TYrVg90H21EOLACvtfcHk0liQlJnqukgl3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXps1Wgsbc%253D&md5=9a6121388b34b77af442d1f039ba9a9c</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.cbi.2010.01.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbi.2010.01.042%26sid%3Dliteratum%253Aachs%26aulast%3DDvir%26aufirst%3DH.%26aulast%3DSilman%26aufirst%3DI.%26aulast%3DHarel%26aufirst%3DM.%26aulast%3DRosenberry%26aufirst%3DT.%2BL.%26aulast%3DSussman%26aufirst%3DJ.%2BL.%26atitle%3DAcetylcholinesterase%253A%2520From%25203D%2520Structure%2520to%2520Function%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2010%26volume%3D187%26spage%3D10%26epage%3D22%26doi%3D10.1016%2Fj.cbi.2010.01.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Harel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schalk, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehret-Sabatier, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouet, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goeldner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirth, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Axelsen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silman, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sussman, J. L.</span><span> </span><span class="NLM_article-title">Quaternary Ligand Binding to Aromatic Residues in the Active-site Gorge of Acetylcholinesterase</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">9031</span><span class="NLM_x">–</span> <span class="NLM_lpage">9035</span><span class="refDoi"> DOI: 10.1073/pnas.90.19.9031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1073%2Fpnas.90.19.9031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=8415649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADyaK3sXmsVCgtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1993&pages=9031-9035&author=M.+Harelauthor=I.+Schalkauthor=L.+Ehret-Sabatierauthor=F.+Bouetauthor=M.+Goeldnerauthor=C.+Hirthauthor=P.+H.+Axelsenauthor=I.+Silmanauthor=J.+L.+Sussman&title=Quaternary+Ligand+Binding+to+Aromatic+Residues+in+the+Active-site+Gorge+of+Acetylcholinesterase&doi=10.1073%2Fpnas.90.19.9031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase</span></div><div class="casAuthors">Harel, M.; Schalk, I.; Ehret-Sabatier, L.; Bouet, F.; Goeldner, M.; Hirth, C.; Axelsen, P. H.; Silman, I.; Sussman, J. L.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">9031-5</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">The binding sites of Torpedo acetylcholinesterase (AChE; EC 3.1.1.7) for quaternary ligands were investigated by x-ray crystallog. and photoaffinity labeling.  The crystal structures of complexes with ligands were detd. at 2.8-Å resoln.  In a complex with edrophonium, the quaternary N atom of the ligand interacted with the indole of Trp-84, and its m-OH group displayed bifurcated H-bonding to 2 members of the catalytic triad, Ser-200 and His-440.  In a complex with tacrine, the acridine was stacked against the indole of Trp-84.  The bisquaternary ligand, decamethonium, was oriented along the narrow gorge leading to the active site; one quaternary group was apposed to the indole of Trp-84 and the other to that of Trp-279, near the top of the gorge.  The only major conformational difference between the 3 complexes was in the orientation of the Ph ring of Phe-330.  In the decamethonium complex, it lay parallel to the surface of the gorge; in the other 2 complexes it was positioned to make contact with the bound ligand.  This close interaction was confirmed by photoaffinity labeling by the photosensitive probe, 3H-labeled p-(N,N-dimethylamino)benzenediazonium fluoroborate, which labeled, predominantly, Phe-330 within the active site.  The labeling of Trp-279 was also obsd.  One mole of label was incorporated per mol of AChE inactivated, indicating that the labeling of Trp-279 and that of Phe-330 were mutually exclusive.  The structural and chem. data, together, showed the important role of arom. groups as binding sites for quaternary ligands, and they provided complementary evidence assigning Trp-84 and Phe-330 to the anionic subsite of the active site and Trp-279 to the peripheral anionic site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVCccIwJSrW7Vg90H21EOLACvtfcHk0liQlJnqukgl3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXmsVCgtrc%253D&md5=6ee8dbaf1919d254a1cb62895f1a4444</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1073%2Fpnas.90.19.9031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.90.19.9031%26sid%3Dliteratum%253Aachs%26aulast%3DHarel%26aufirst%3DM.%26aulast%3DSchalk%26aufirst%3DI.%26aulast%3DEhret-Sabatier%26aufirst%3DL.%26aulast%3DBouet%26aufirst%3DF.%26aulast%3DGoeldner%26aufirst%3DM.%26aulast%3DHirth%26aufirst%3DC.%26aulast%3DAxelsen%26aufirst%3DP.%2BH.%26aulast%3DSilman%26aufirst%3DI.%26aulast%3DSussman%26aufirst%3DJ.%2BL.%26atitle%3DQuaternary%2520Ligand%2520Binding%2520to%2520Aromatic%2520Residues%2520in%2520the%2520Active-site%2520Gorge%2520of%2520Acetylcholinesterase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1993%26volume%3D90%26spage%3D9031%26epage%3D9035%26doi%3D10.1073%2Fpnas.90.19.9031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Inestrosa, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicente, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casanueva, O. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrido, J.</span><span> </span><span class="NLM_article-title">Acetylcholinesterase Accelerates Assembly of Amyloid-β-peptides into Alzheimer’s Fibrils: Possible Role of the Peripheral Site of the Enzyme</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">891</span><span class="refDoi"> DOI: 10.1016/S0896-6273(00)80108-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1016%2FS0896-6273%2800%2980108-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=8608006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADyaK28XislCmsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1996&pages=881-891&author=N.+C.+Inestrosaauthor=A.+Alvarezauthor=C.+A.+P%C3%A9rezauthor=R.+D.+Morenoauthor=M.+Vicenteauthor=C.+Linkerauthor=O.+I.+Casanuevaauthor=C.+Sotoauthor=J.+Garrido&title=Acetylcholinesterase+Accelerates+Assembly+of+Amyloid-%CE%B2-peptides+into+Alzheimer%E2%80%99s+Fibrils%3A+Possible+Role+of+the+Peripheral+Site+of+the+Enzyme&doi=10.1016%2FS0896-6273%2800%2980108-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Acetylcholinesterase accelerates assembly of amyloid-β-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme</span></div><div class="casAuthors">Inestrosa, Nibaldo C.; Alvarez, Alejandra; Perez, Cristian A.; Moreno, Ricardo D.; Vicente, Matias; Linker, Claudia; Casanueva, Olivia I.; Soto, Claudio; Garrido, Jorge</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">881-891</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Acetylcholinesterase (AChE), an important component of cholinergic synapses, colocalizes with amyloid-β peptide (Aβ) deposits of Alzheimer's brain.  The authors report here that bovine brain AChE, as well as the human and mouse recombinant enzyme, accelerates amyloid formation from wild-type Aβ and a mutant Aβ peptide, which alone produces few amyloid-like fibrils.  The action of AChE was independent of the subunit array of the enzyme, was not affected by edrophonium, an active site inhibitor, but it was affected by propidium, a peripheral anionic binding site ligand.  Butyrylcholinesterase, an enzyme that lacks the peripheral site, did not affect amyloid formation.  Furthermore, AChE is a potent amyloid-promoting factor when compared with other Aβ-assocd. proteins.  Thus, in addn. to its role in cholinergic synapses, AChE may function by accelerating Aβ formation and could play a role during amyloid deposition in Alzheimer's brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqx2wsrjgQa0LVg90H21EOLACvtfcHk0li4jpxFABJ88Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XislCmsLk%253D&md5=299031351f764e5376b98407c3dc7278</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2FS0896-6273%2800%2980108-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0896-6273%252800%252980108-7%26sid%3Dliteratum%253Aachs%26aulast%3DInestrosa%26aufirst%3DN.%2BC.%26aulast%3DAlvarez%26aufirst%3DA.%26aulast%3DP%25C3%25A9rez%26aufirst%3DC.%2BA.%26aulast%3DMoreno%26aufirst%3DR.%2BD.%26aulast%3DVicente%26aufirst%3DM.%26aulast%3DLinker%26aufirst%3DC.%26aulast%3DCasanueva%26aufirst%3DO.%2BI.%26aulast%3DSoto%26aufirst%3DC.%26aulast%3DGarrido%26aufirst%3DJ.%26atitle%3DAcetylcholinesterase%2520Accelerates%2520Assembly%2520of%2520Amyloid-%25CE%25B2-peptides%2520into%2520Alzheimer%25E2%2580%2599s%2520Fibrils%253A%2520Possible%2520Role%2520of%2520the%2520Peripheral%2520Site%2520of%2520the%2520Enzyme%26jtitle%3DNeuron%26date%3D1996%26volume%3D16%26spage%3D881%26epage%3D891%26doi%3D10.1016%2FS0896-6273%2800%2980108-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Lockridge, O.</span><span> </span><span class="NLM_article-title">Review of Human Butyrylcholinesterase Structure, Function, Genetic Variants, History of Use in the Clinic, and Potential Therapeutic Uses</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">148</span><span class="NLM_x">, </span> <span class="NLM_fpage">34</span><span class="NLM_x">–</span> <span class="NLM_lpage">46</span><span class="refDoi"> DOI: 10.1016/j.pharmthera.2014.11.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1016%2Fj.pharmthera.2014.11.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=25448037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFOgsb%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2015&pages=34-46&author=O.+Lockridge&title=Review+of+Human+Butyrylcholinesterase+Structure%2C+Function%2C+Genetic+Variants%2C+History+of+Use+in+the+Clinic%2C+and+Potential+Therapeutic+Uses&doi=10.1016%2Fj.pharmthera.2014.11.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Review of human butyrylcholinesterase structure, function, genetic variants, history of use in the clinic, and potential therapeutic uses</span></div><div class="casAuthors">Lockridge, Oksana</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">34-46</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Phase I clin. trials have shown that pure human butyrylcholinesterase (BChE) is safe when administered to humans.  A potential therapeutic use of BChE is for prevention of nerve agent toxicity.  A recombinant mutant of BChE that rapidly inactivates cocaine is being developed as a treatment to help recovering cocaine addicts avoid relapse into drug taking.  These clin. applications rely on knowledge of the structure, stability, and properties of BChE, information that is reviewed here.  Gene therapy with a vector that sustains expression for a year from a single injection is a promising method for delivering therapeutic quantities of BChE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovtlcbO5w0-bVg90H21EOLACvtfcHk0li4jpxFABJ88Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFOgsb%252FK&md5=7219bb957d1e99415414978b948ce98e</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2014.11.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2014.11.011%26sid%3Dliteratum%253Aachs%26aulast%3DLockridge%26aufirst%3DO.%26atitle%3DReview%2520of%2520Human%2520Butyrylcholinesterase%2520Structure%252C%2520Function%252C%2520Genetic%2520Variants%252C%2520History%2520of%2520Use%2520in%2520the%2520Clinic%252C%2520and%2520Potential%2520Therapeutic%2520Uses%26jtitle%3DPharmacol.%2520Ther.%26date%3D2015%26volume%3D148%26spage%3D34%26epage%3D46%26doi%3D10.1016%2Fj.pharmthera.2014.11.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Lane, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potkin, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enz, A.</span><span> </span><span class="NLM_article-title">Targeting Acetylcholinesterase and Butyrylcholinesterase in Dementia</span> <span class="citation_source-journal">Int. J. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span><span class="refDoi"> DOI: 10.1017/S1461145705005833</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1017%2FS1461145705005833" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=16083515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1ehtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=101-124&author=R.+M.+Laneauthor=S.+G.+Potkinauthor=A.+Enz&title=Targeting+Acetylcholinesterase+and+Butyrylcholinesterase+in+Dementia&doi=10.1017%2FS1461145705005833"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting acetylcholinesterase and butyrylcholinesterase in dementia</span></div><div class="casAuthors">Lane, Roger M.; Potkin, Steven G.; Enz, Albert</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">101-124</span>CODEN:
                <span class="NLM_cas:coden">IJNUFB</span>;
        ISSN:<span class="NLM_cas:issn">1461-1457</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">A review.  The cholinesterase inhibitors (ChE-Is) attenuate the cholinergic deficit underlying the cognitive and neuropsychiatric dysfunctions in patients with AD.  Inhibition of brain acetylcholinesterase (AChE) has been the major therapeutic target of ChE-I treatment strategies for Alzheimer's disease (AD).  AChE-pos. neurons project diffusely to the cortex, modulating cortical processing and responses to new and relevant stimuli.  Butyrylcholinesterase (BuChE)-pos. neurons project specifically to the frontal cortex, and may have roles in attention, executive function, emotional memory and behavior.  Furthermore, BuChE activity progressively increases as the severity of dementia advances, while AChE activity declines.  Therefore, inhibition of BuChE may provide addnl. benefits.  The two cholinesterase (ChE) enzymes that metabolize acetylcholine (ACh) differ significantly in substrate specificity, enzyme kinetics, expression and activity in different brain regions, and complexity of gene regulation.  In addn., recent evidence suggests that AChE and BuChE may have roles beyond classical' co-regulatory esterase functions in terminating ACh-mediated neurotransmission.  Non-classical' roles in modulating the activity of other proteins, regional cerebral blood flow, tau phosphorylation, and the amyloid cascade may affect rates of AD progression.  If these addnl. mechanisms are demonstrated to underlie clin. meaningful effects, modification of the over-simplistic cholinergic hypothesis in AD that is limited to symptomatic treatment, ignoring the potential of cholinergic therapies to modify the disease process, may be appropriate.  The specificity of ChE inhibitory activity, up-regulation of AChE activity and changes in the compn. of AChE mol. forms over time, selectivity for AD-relevant ChE mol. forms, brain vs. peripheral selectivity, and pharmacokinetic profile may be important determinants of the acute and long-term efficacy, safety and tolerability profiles of the different ChE-Is.  This review focuses on new evidence for the roles of BuChE and AChE in symptom generation and rate of underlying disease progression in dementia, and argues that it may be appropriate to re-evaluate the place of ChE-Is in the treatment of dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYzIuEFXpTS7Vg90H21EOLACvtfcHk0li4jpxFABJ88Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1ehtw%253D%253D&md5=b5871dacc777b6c8769be565106cb988</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1017%2FS1461145705005833&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS1461145705005833%26sid%3Dliteratum%253Aachs%26aulast%3DLane%26aufirst%3DR.%2BM.%26aulast%3DPotkin%26aufirst%3DS.%2BG.%26aulast%3DEnz%26aufirst%3DA.%26atitle%3DTargeting%2520Acetylcholinesterase%2520and%2520Butyrylcholinesterase%2520in%2520Dementia%26jtitle%3DInt.%2520J.%2520Neuropsychopharmacol.%26date%3D2006%26volume%3D9%26spage%3D101%26epage%3D124%26doi%3D10.1017%2FS1461145705005833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Giacobini, E.</span><span> </span><span class="NLM_article-title">Selective Inhibitors of Butyrylcholinesterase: a Valid Alternative for Therapy of Alzheimer’s Disease?</span> <span class="citation_source-journal">Drugs Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">891</span><span class="NLM_x">–</span> <span class="NLM_lpage">898</span><span class="refDoi"> DOI: 10.2165/00002512-200118120-00001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.2165%2F00002512-200118120-00001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=11888344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BD38XjtFOhu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2001&pages=891-898&author=E.+Giacobini&title=Selective+Inhibitors+of+Butyrylcholinesterase%3A+a+Valid+Alternative+for+Therapy+of+Alzheimer%E2%80%99s+Disease%3F&doi=10.2165%2F00002512-200118120-00001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibitors of butyrylcholinesterase: A valid alternative for therapy of Alzheimer's disease?</span></div><div class="casAuthors">Giacobini, Ezio</div><div class="citationInfo"><span class="NLM_cas:title">Drugs & Aging</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">891-898</span>CODEN:
                <span class="NLM_cas:coden">DRAGE6</span>;
        ISSN:<span class="NLM_cas:issn">1170-229X</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">A review.  The brain of mammals contains two major forms of cholinesterases (ChEs): acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE).  The two forms differ genetically, structurally and in their kinetics.  Butyrylcholine is not a physiol. substrate in mammalian brains which makes the function of BuChE difficult to interpret.  In human brains, BuChE is found in neurons and glial cells as well as in neuritic plaques and tangles in patients with Alzheimer's disease (AD).  While AChE activity decreases progressively in the brain of patients with AD, BuChE activity shows some increase.  To study the function of BuChE, we perfused intracortically the rat brain with a selective BuChE inhibitor.  We found that extracellular acetylcholine levels increased 15-fold from 5 nmol/L to 75 nmol/L concns., with little cholinergic adverse effect in the animal.  Based on these data, we postulated that two pools of ChEs may be present in the brain: one mainly neuronal and AChE dependent; and one mainly glial and BuChE dependent.  The two pools show different kinetic properties with regard to regulation of acetylcholine concn. in the brain and can be sepd. with selective inhibitors.  The recent development of highly selective BuChE inhibitors will allow us to test these new agents in patients with AD to find out whether or not they represent an advantage for the treatment of patients with AD as compared with selective (donepezil) or relatively non-selective (rivastigmine, galantamine) ChE inhibitors presently in use.  The assocn. between a BuChE-K variant and AD has not been confirmed in several studies.  In conclusion, addnl. exptl. and clin. work is necessary to elucidate the role of BuChE in normal brain function and in the brains of patients with AD.  In the future, it may be possible that selective BuChE inhibitors will have a role in treatment of patients with advanced AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3OyEluyykwbVg90H21EOLACvtfcHk0lirDwCNW-k5cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjtFOhu7w%253D&md5=5740f558ad07fd4226f199744032be82</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.2165%2F00002512-200118120-00001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00002512-200118120-00001%26sid%3Dliteratum%253Aachs%26aulast%3DGiacobini%26aufirst%3DE.%26atitle%3DSelective%2520Inhibitors%2520of%2520Butyrylcholinesterase%253A%2520a%2520Valid%2520Alternative%2520for%2520Therapy%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%253F%26jtitle%3DDrugs%2520Aging%26date%3D2001%26volume%3D18%26spage%3D891%26epage%3D898%26doi%3D10.2165%2F00002512-200118120-00001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Riederer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielczyk, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruenblatt, E.</span><span> </span><span class="NLM_article-title">Monoamine Oxidase-B Inhibition in Alzheimer’s Disease</span> <span class="citation_source-journal">NeuroToxicology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">277</span><span class="refDoi"> DOI: 10.1016/S0161-813X(03)00106-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1016%2FS0161-813X%2803%2900106-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=14697902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtVSjtLjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=271-277&author=P.+Riedererauthor=W.+Danielczykauthor=E.+Gruenblatt&title=Monoamine+Oxidase-B+Inhibition+in+Alzheimer%E2%80%99s+Disease&doi=10.1016%2FS0161-813X%2803%2900106-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Monoamine oxidase-B inhibition in Alzheimer's disease</span></div><div class="casAuthors">Riederer, Peter; Danielczyk, Walter; Gruenblatt, Edna</div><div class="citationInfo"><span class="NLM_cas:title">Neurotoxicology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">271-277</span>CODEN:
                <span class="NLM_cas:coden">NRTXDN</span>;
        ISSN:<span class="NLM_cas:issn">0161-813X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is the most common cause of dementia in late life.  There is still no clear-cut consensus whether this disease involves genetic or environmental factors or both.  There is a great need to find a way to delay the disease, as delaying the onset of the disease will bring a great relieve on social and medical resources.  The monoamine oxidase-B (MAO-B) inhibitors were shown to be effective in treating Parkinson's disease and possibly AD, with concomitant extension of life span.  This article gives a short review on MAO-B inhibitors and their mechanism for neuroprotective effects in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGru-IfT1tqOu7Vg90H21EOLACvtfcHk0lirDwCNW-k5cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtVSjtLjJ&md5=e5966c4b79474e843f80aa939a427d35</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2FS0161-813X%2803%2900106-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0161-813X%252803%252900106-2%26sid%3Dliteratum%253Aachs%26aulast%3DRiederer%26aufirst%3DP.%26aulast%3DDanielczyk%26aufirst%3DW.%26aulast%3DGruenblatt%26aufirst%3DE.%26atitle%3DMonoamine%2520Oxidase-B%2520Inhibition%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DNeuroToxicology%26date%3D2004%26volume%3D25%26spage%3D271%26epage%3D277%26doi%3D10.1016%2FS0161-813X%2803%2900106-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">De Colibus, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binda, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lustig, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmondson, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattevi, A.</span><span> </span><span class="NLM_article-title">Three-Dimensional Structure of Human Monoamine Oxidase A (MAO A): Relation to the Structures of Rat MAO A and Human MAO B</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">12684</span><span class="NLM_x">–</span> <span class="NLM_lpage">12689</span><span class="refDoi"> DOI: 10.1073/pnas.0505975102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1073%2Fpnas.0505975102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=16129825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVWktLnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=12684-12689&author=L.+De+Colibusauthor=M.+Liauthor=C.+Bindaauthor=A.+Lustigauthor=D.+E.+Edmondsonauthor=A.+Mattevi&title=Three-Dimensional+Structure+of+Human+Monoamine+Oxidase+A+%28MAO+A%29%3A+Relation+to+the+Structures+of+Rat+MAO+A+and+Human+MAO+B&doi=10.1073%2Fpnas.0505975102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Three-dimensional structure of human monoamine oxidase A (MAO A): Relation to the structures of rat MAO A and human MAO B</span></div><div class="casAuthors">De Colibus, Luigi; Li, Min; Binda, Claudia; Lustig, Ariel; Edmondson, Dale E.; Mattevi, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">12684-12689</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The 3-dimensional x-ray crystal structure of recombinant human monoamine oxidase A (hMAO A) as its clorgyline-inhibited adduct is described.  Although the chain-fold of hMAO A was similar to that of rat MAO A and human MAO B (hMAO B), hMAO A was unique in that it crystd. as a monomer and exhibited the soln. hydrodynamic behavior of a monomeric form rather than the dimeric form of hMAO B and rat MAO A.  The hMAO A active site consisted of a single hydrophobic cavity of ∼550 Å3, which was smaller than that detd. from the structure of deprenyl-inhibited hMAO B (∼700 Å3) but larger than that of rat MAO A (∼450 Å3).  An important component of the active site structure of hMAO A was the loop conformation of residues 210-216, which differred from that of hMAO B and rat MAO A.  The origin of this structural alteration was suggested to have resulted from long-range interactions in the monomeric form of the enzyme.  In addn. to serving as a basis for the development of hMAO A-specific inhibitors, these data supported the proposal that hMAO A involves a change from the dimeric to the monomeric form through a E151K mutation that is specific to hMAO A.  These considerations place into question the use of MAO A from non-human sources in drug development for use in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPY_EaAsj_1rVg90H21EOLACvtfcHk0lirDwCNW-k5cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVWktLnJ&md5=5db5a50007df0a15df8cbfbc72670de9</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0505975102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0505975102%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BColibus%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DLustig%26aufirst%3DA.%26aulast%3DEdmondson%26aufirst%3DD.%2BE.%26aulast%3DMattevi%26aufirst%3DA.%26atitle%3DThree-Dimensional%2520Structure%2520of%2520Human%2520Monoamine%2520Oxidase%2520A%2520%2528MAO%2520A%2529%253A%2520Relation%2520to%2520the%2520Structures%2520of%2520Rat%2520MAO%2520A%2520and%2520Human%2520MAO%2520B%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D12684%26epage%3D12689%26doi%3D10.1073%2Fpnas.0505975102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Binda, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newton-Vinson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubalek, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmondson, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattevi, A.</span><span> </span><span class="NLM_article-title">Structure of Human Monoamine Oxidase B, a Drug Target for the Treatment of Neurological Disorders</span> <span class="citation_source-journal">Nat. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">22</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span><span class="refDoi"> DOI: 10.1038/nsb732</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1038%2Fnsb732" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=11753429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BD38XitV2rsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=22-26&author=C.+Bindaauthor=P.+Newton-Vinsonauthor=F.+Hubalekauthor=D.+E.+Edmondsonauthor=A.+Mattevi&title=Structure+of+Human+Monoamine+Oxidase+B%2C+a+Drug+Target+for+the+Treatment+of+Neurological+Disorders&doi=10.1038%2Fnsb732"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders</span></div><div class="casAuthors">Binda, Claudia; Newton-Vinson, Paige; Hubalek, Frantisek; Edmondson, Dale E.; Mattevi, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-26</span>CODEN:
                <span class="NLM_cas:coden">NSBIEW</span>;
        ISSN:<span class="NLM_cas:issn">1072-8368</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">Monoamine oxidase B (MAO B) is a mitochondrial outer membrane flavoenzyme that is a well-known target for antidepressant and neuroprotective drugs.  Here, the authors detd. the structure of the human liver enzyme to 3 Å resoln.  Human liver MAO B was found to bind to the membrane through a C-terminal transmembrane helix and apolar loops located at various positions in the sequence.  The electron d. showed that pargyline, an analog of the clin. used MAO B inhibitor, deprenyl, binds covalently to the flavin N5 atom.  The active site of MAO B consisted of a 420-Å3 hydrophobic substrate cavity interconnected to an entrance cavity of 290 Å3.  The recognition site for the substrate amino group was an arom. cage formed by Tyr-398 and Tyr-435.  The structure provides a framework for probing the catalytic mechanism, understanding the differences between the MAO A and B isoforms and designing specific inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8p43h-vsPi7Vg90H21EOLACvtfcHk0lirDwCNW-k5cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XitV2rsg%253D%253D&md5=261d3b1375d833bbfd0a23bdade49be6</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fnsb732&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsb732%26sid%3Dliteratum%253Aachs%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DNewton-Vinson%26aufirst%3DP.%26aulast%3DHubalek%26aufirst%3DF.%26aulast%3DEdmondson%26aufirst%3DD.%2BE.%26aulast%3DMattevi%26aufirst%3DA.%26atitle%3DStructure%2520of%2520Human%2520Monoamine%2520Oxidase%2520B%252C%2520a%2520Drug%2520Target%2520for%2520the%2520Treatment%2520of%2520Neurological%2520Disorders%26jtitle%3DNat.%2520Struct.%2520Biol.%26date%3D2002%26volume%3D9%26spage%3D22%26epage%3D26%26doi%3D10.1038%2Fnsb732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Rapaport, M. H.</span><span> </span><span class="NLM_article-title">Dietary Restrictions and Drug Interactions with Monoamine Oxidase Inhibitors: the State of the Art</span> <span class="citation_source-journal">J. Clin. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">42</span><span class="NLM_x">–</span> <span class="NLM_lpage">46</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.4088%2FJCP.0407e11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=17640157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsFGntbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2007&pages=42-46&author=M.+H.+Rapaport&title=Dietary+Restrictions+and+Drug+Interactions+with+Monoamine+Oxidase+Inhibitors%3A+the+State+of+the+Art"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Dietary restrictions and drug interactions with monoamine oxidase inhibitors: the state of the art</span></div><div class="casAuthors">Rapaport, Mark Hyman</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Psychiatry (Memphis, TN, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">Suppl. 8</span>),
    <span class="NLM_cas:pages">42-46</span>CODEN:
                <span class="NLM_cas:coden">JCLPDE</span>;
        ISSN:<span class="NLM_cas:issn">0160-6689</span>.
    
            (<span class="NLM_cas:orgname">Physicians Postgraduate Press, Inc.</span>)
        </div><div class="casAbstract">A review.  Antidepressant activity of monoamine oxidase inhibitors (MAOIs) was initially noted in the 1950s, and by the early 1960s, they were a mainstay of antidepressant treatment.  Reports of adverse events such as acute hypertensive reactions following the ingestion of certain foods and beverages tempered clinicians' enthusiasm for MAOIs.  Introduction of the tricyclic antidepressants and the selective serotonin reuptake inhibitors led to declines in the use of MAOIs.  However, MAOIs have been well established as an effective intervention for people with treatment-resistant depression, and transdermal formulations may provide a valuable therapeutic option and eliminate the drug-food interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAB7QVJPRN57Vg90H21EOLACvtfcHk0lgYryqFaIi_sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsFGntbc%253D&md5=90577be6b6c24e5e6829c40f59997271</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.4088%2FJCP.0407e11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4088%252FJCP.0407e11%26sid%3Dliteratum%253Aachs%26aulast%3DRapaport%26aufirst%3DM.%2BH.%26atitle%3DDietary%2520Restrictions%2520and%2520Drug%2520Interactions%2520with%2520Monoamine%2520Oxidase%2520Inhibitors%253A%2520the%2520State%2520of%2520the%2520Art%26jtitle%3DJ.%2520Clin.%2520Psychiatry%26date%3D2007%26volume%3D68%26spage%3D42%26epage%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Wimbiscus, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kostenko, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malone, D.</span><span> </span><span class="NLM_article-title">MAO Inhibitors: Risks, Benefits, and Lore</span> <span class="citation_source-journal">Cleve. Clin. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">859</span><span class="NLM_x">–</span> <span class="NLM_lpage">882</span><span class="refDoi"> DOI: 10.3949/ccjm.77a.09103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.3949%2Fccjm.77a.09103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=21147941" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A280%3ADC%252BC3M%252FktVehsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2010&pages=859-882&author=M.+Wimbiscusauthor=O.+Kostenkoauthor=D.+Malone&title=MAO+Inhibitors%3A+Risks%2C+Benefits%2C+and+Lore&doi=10.3949%2Fccjm.77a.09103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">MAO inhibitors: risks, benefits, and lore</span></div><div class="casAuthors">Wimbiscus Molly; Kostenko Olga; Malone Donald</div><div class="citationInfo"><span class="NLM_cas:title">Cleveland Clinic journal of medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">859-82</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Monoamine oxidase (MAO) inhibitors were the first antidepressants introduced, but their use has dwindled because of their reported side effects, their food and drug interactions, and the introduction of other classes of agents.  However, interest in MAO inhibitors is reviving.  Here, we discuss their use, risks, and benefits in clinical medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS5l3ppB6CZKLmQt-ICR3qNfW6udTcc2eYjbRVKVEssV7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M%252FktVehsw%253D%253D&md5=557ad1fb6c82cd0fa448fdc72252f690</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.3949%2Fccjm.77a.09103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3949%252Fccjm.77a.09103%26sid%3Dliteratum%253Aachs%26aulast%3DWimbiscus%26aufirst%3DM.%26aulast%3DKostenko%26aufirst%3DO.%26aulast%3DMalone%26aufirst%3DD.%26atitle%3DMAO%2520Inhibitors%253A%2520Risks%252C%2520Benefits%252C%2520and%2520Lore%26jtitle%3DCleve.%2520Clin.%2520J.%2520Med.%26date%3D2010%26volume%3D77%26spage%3D859%26epage%3D882%26doi%3D10.3949%2Fccjm.77a.09103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Barnham, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masters, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, A. I.</span><span> </span><span class="NLM_article-title">Neurodegenerative Diseases and Oxidative Stress</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">214</span><span class="refDoi"> DOI: 10.1038/nrd1330</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1038%2Fnrd1330" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=15031734" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BD2cXit12nsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=205-214&author=K.+J.+Barnhamauthor=C.+L.+Mastersauthor=A.+I.+Bush&title=Neurodegenerative+Diseases+and+Oxidative+Stress&doi=10.1038%2Fnrd1330"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Neurodegenerative diseases and oxidative stress</span></div><div class="casAuthors">Barnham, Kevin J.; Masters, Colin L.; Bush, Ashley I.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">205-214</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Oxidative stress has been implicated in the progression of Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis.  Oxygen is vital for life but is also potentially dangerous, and a complex system of checks and balances exists for utilizing this essential element.  Oxidative stress is the result of an imbalance in pro-oxidant/antioxidant homeostasis that leads to the generation of toxic reactive oxygen species.  The systems in place to cope with the biochem. of oxygen are complex, and many questions about the mechanisms of oxygen regulation remain unanswered.  However, this same complexity provides a no. of therapeutic targets, and different strategies, including novel metal-protein attenuating compds., aimed at a variety of targets have shown promise in clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPqGR8Vlz1hLVg90H21EOLACvtfcHk0lgYryqFaIi_sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXit12nsL4%253D&md5=73a09223923e8b895ebee89405e5c7fd</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fnrd1330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1330%26sid%3Dliteratum%253Aachs%26aulast%3DBarnham%26aufirst%3DK.%2BJ.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DBush%26aufirst%3DA.%2BI.%26atitle%3DNeurodegenerative%2520Diseases%2520and%2520Oxidative%2520Stress%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D205%26epage%3D214%26doi%3D10.1038%2Fnrd1330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Tonelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tasso, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iusco, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Stradis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denora, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sparatore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boido, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sparatore, F.</span><span> </span><span class="NLM_article-title">Multitarget Therapeutic Leads for Alzheimer’s disease. Quinolizidinyl Derivatives of Bi- and Tri-cyclic Systems as Dual Inhibitors of Cholinesterases and Aβ Aggregation</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1040</span><span class="NLM_x">–</span> <span class="NLM_lpage">1053</span><span class="refDoi"> DOI: 10.1002/cmdc.201500104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1002%2Fcmdc.201500104" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1040-1053&author=M.+Tonelliauthor=M.+Cattoauthor=B.+Tassoauthor=F.+Novelliauthor=C.+Canuauthor=G.+Iuscoauthor=L.+Pisaniauthor=A.+De+Stradisauthor=N.+Denoraauthor=A.+Sparatoreauthor=V.+Boidoauthor=A.+Carottiauthor=F.+Sparatore&title=Multitarget+Therapeutic+Leads+for+Alzheimer%E2%80%99s+disease.+Quinolizidinyl+Derivatives+of+Bi-+and+Tri-cyclic+Systems+as+Dual+Inhibitors+of+Cholinesterases+and+A%CE%B2+Aggregation&doi=10.1002%2Fcmdc.201500104"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500104%26sid%3Dliteratum%253Aachs%26aulast%3DTonelli%26aufirst%3DM.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DTasso%26aufirst%3DB.%26aulast%3DNovelli%26aufirst%3DF.%26aulast%3DCanu%26aufirst%3DC.%26aulast%3DIusco%26aufirst%3DG.%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DDe%2BStradis%26aufirst%3DA.%26aulast%3DDenora%26aufirst%3DN.%26aulast%3DSparatore%26aufirst%3DA.%26aulast%3DBoido%26aufirst%3DV.%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DSparatore%26aufirst%3DF.%26atitle%3DMultitarget%2520Therapeutic%2520Leads%2520for%2520Alzheimer%25E2%2580%2599s%2520disease.%2520Quinolizidinyl%2520Derivatives%2520of%2520Bi-%2520and%2520Tri-cyclic%2520Systems%2520as%2520Dual%2520Inhibitors%2520of%2520Cholinesterases%2520and%2520A%25CE%25B2%2520Aggregation%26jtitle%3DChemMedChem%26date%3D2015%26volume%3D10%26spage%3D1040%26epage%3D1053%26doi%3D10.1002%2Fcmdc.201500104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Farina, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gadaleta, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denora, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto-Otero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendez-Alvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Passos, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muncipinto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altomare, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nurisso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrupt, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Structure-Based Design and Optimization of Multitarget-Directed 2H-Chromen-2-one Derivatives as Potent Inhibitors of Monoamine Oxidase B and Cholinesterases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">5561</span><span class="NLM_x">–</span> <span class="NLM_lpage">5578</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00599</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00599" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVKitL7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=5561-5578&author=R.+Farinaauthor=L.+Pisaniauthor=M.+Cattoauthor=O.+Nicolottiauthor=D.+Gadaletaauthor=N.+Denoraauthor=R.+Soto-Oteroauthor=E.+Mendez-Alvarezauthor=C.+S.+Passosauthor=G.+Muncipintoauthor=C.+D.+Altomareauthor=A.+Nurissoauthor=P.+A.+Carruptauthor=A.+Carotti&title=Structure-Based+Design+and+Optimization+of+Multitarget-Directed+2H-Chromen-2-one+Derivatives+as+Potent+Inhibitors+of+Monoamine+Oxidase+B+and+Cholinesterases&doi=10.1021%2Facs.jmedchem.5b00599"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design and Optimization of Multitarget-Directed 2H-Chromen-2-one Derivatives as Potent Inhibitors of Monoamine Oxidase B and Cholinesterases</span></div><div class="casAuthors">Farina, Roberta; Pisani, Leonardo; Catto, Marco; Nicolotti, Orazio; Gadaleta, Domenico; Denora, Nunzio; Soto-Otero, Ramon; Mendez-Alvarez, Estefania; Passos, Carolina S.; Muncipinto, Giovanni; Altomare, Cosimo D.; Nurisso, Alessandra; Carrupt, Pierre-Alain; Carotti, Angelo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5561-5578</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The multifactorial nature of Alzheimer's disease calls for the development of multitarget agents addressing key pathogenic processes.  To this end, by following a docking-assisted hybridization strategy, a no. of aminocoumarins were designed, prepd., and tested as monoamine oxidases (MAOs) and acetyl- and butyryl-cholinesterase (AChE and BChE) inhibitors.  Highly flexible N-benzyl-N-alkyloxy coumarins 2-12 showed good inhibitory activities at MAO-B, AChE, and BChE but low selectivity.  More rigid inhibitors, bearing meta- and para-xylyl linkers, displayed good inhibitory activities and high MAO-B selectivity.  Compds. 21, 24, 37, and 39, the last two featuring an improved hydrophilic/lipophilic balance, exhibited excellent activity profiles with nanomolar inhibitory potency toward hMAO-B, high hMAO-B over hMAO-A selectivity and submicromolar potency at hAChE.  Cell-based assays of BBB permeation, neurotoxicity, and neuroprotection supported the potential of compd. 37 as a BBB-permeant neuroprotective agent against H2O2-induced oxidative stress with poor interaction as P-gp substrate and very low cytotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpy2Qk3gFsdSrVg90H21EOLACvtfcHk0ljKjoC6TZXALg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVKitL7P&md5=b15458c0ce6d2ea9c182edcd685c0aff</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00599%26sid%3Dliteratum%253Aachs%26aulast%3DFarina%26aufirst%3DR.%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DGadaleta%26aufirst%3DD.%26aulast%3DDenora%26aufirst%3DN.%26aulast%3DSoto-Otero%26aufirst%3DR.%26aulast%3DMendez-Alvarez%26aufirst%3DE.%26aulast%3DPassos%26aufirst%3DC.%2BS.%26aulast%3DMuncipinto%26aufirst%3DG.%26aulast%3DAltomare%26aufirst%3DC.%2BD.%26aulast%3DNurisso%26aufirst%3DA.%26aulast%3DCarrupt%26aufirst%3DP.%2BA.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DStructure-Based%2520Design%2520and%2520Optimization%2520of%2520Multitarget-Directed%25202H-Chromen-2-one%2520Derivatives%2520as%2520Potent%2520Inhibitors%2520of%2520Monoamine%2520Oxidase%2520B%2520and%2520Cholinesterases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D5561%26epage%3D5578%26doi%3D10.1021%2Facs.jmedchem.5b00599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Matos, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terán, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez-Castillo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uriarte, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santana, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viña, D.</span><span> </span><span class="NLM_article-title">Synthesis and Study of a Series of 3-Arylcoumarins as Potent and Selective Monoamine Oxidase B Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">7127</span><span class="NLM_x">–</span> <span class="NLM_lpage">7137</span><span class="refDoi"> DOI: 10.1021/jm200716y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200716y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1ClsLbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7127-7137&author=M.+J.+Matosauthor=C.+Ter%C3%A1nauthor=Y.+P%C3%A9rez-Castilloauthor=E.+Uriarteauthor=L.+Santanaauthor=D.+Vi%C3%B1a&title=Synthesis+and+Study+of+a+Series+of+3-Arylcoumarins+as+Potent+and+Selective+Monoamine+Oxidase+B+Inhibitors&doi=10.1021%2Fjm200716y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Study of a Series of 3-Arylcoumarins as Potent and Selective Monoamine Oxidase B Inhibitors</span></div><div class="casAuthors">Matos, Maria J.; Teran, Carmen; Perez-Castillo, Yunierkis; Uriarte, Eugenio; Santana, Lourdes; Vina, Dolores</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7127-7137</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">New series of 6-substituted-3-arylcoumarins displaying several alkyl, hydroxyl, halogen, and alkoxy groups in the two benzene rings have been designed, synthesized, and evaluated in vitro as human monoamine oxidase A and B (hMAO-A and hMAO-B) inhibitors.  Most of the studied compds. showed a high affinity and selectivity to the hMAO-B isoenzyme, with IC50 values on nanomolar and picomolar range.  Ten of the 22 described compds. displayed higher MAO-B inhibitory activity and selectivity than selegiline.  Coumarin I is the most active compd. of this series, being 64 times more active than selegiline and also showing the highest hMAO-B specificity.  In addn., docking expts. were carried out on hMAO-A and h-MAO-B structures.  This study provided new information about the enzyme-inhibitor interaction and the potential therapeutic application of this 3-arylcoumarin scaffold.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotg_Ewi_Rdz7Vg90H21EOLACvtfcHk0ljKjoC6TZXALg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1ClsLbO&md5=5d33aabf0583fa6025334ded40030177</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm200716y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200716y%26sid%3Dliteratum%253Aachs%26aulast%3DMatos%26aufirst%3DM.%2BJ.%26aulast%3DTer%25C3%25A1n%26aufirst%3DC.%26aulast%3DP%25C3%25A9rez-Castillo%26aufirst%3DY.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DSantana%26aufirst%3DL.%26aulast%3DVi%25C3%25B1a%26aufirst%3DD.%26atitle%3DSynthesis%2520and%2520Study%2520of%2520a%2520Series%2520of%25203-Arylcoumarins%2520as%2520Potent%2520and%2520Selective%2520Monoamine%2520Oxidase%2520B%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7127%26epage%3D7137%26doi%3D10.1021%2Fjm200716y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Mertens, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gütschow, M.</span><span> </span><span class="NLM_article-title">Alkynyl–coumarinyl Ethers as MAO-B Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1916</span><span class="NLM_x">–</span> <span class="NLM_lpage">1928</span><span class="refDoi"> DOI: 10.1016/j.bmc.2014.01.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1016%2Fj.bmc.2014.01.046" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=1916-1928&author=M.+D.+Mertensauthor=S.+Hinzauthor=C.+E.+M%C3%BCllerauthor=M.+G%C3%BCtschow&title=Alkynyl%E2%80%93coumarinyl+Ethers+as+MAO-B+Inhibitors&doi=10.1016%2Fj.bmc.2014.01.046"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.01.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.01.046%26sid%3Dliteratum%253Aachs%26aulast%3DMertens%26aufirst%3DM.%2BD.%26aulast%3DHinz%26aufirst%3DS.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DG%25C3%25BCtschow%26aufirst%3DM.%26atitle%3DAlkynyl%25E2%2580%2593coumarinyl%2520Ethers%2520as%2520MAO-B%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D1916%26epage%3D1928%26doi%3D10.1016%2Fj.bmc.2014.01.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Secci, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carradori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolasco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chimenti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yáñez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortuso, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcaro, S.</span><span> </span><span class="NLM_article-title">Synthesis and Selective Human Monoamine Oxidase Inhibition of 3-Carbonyl, 3-Acyl, and 3-Carboxyhydrazido Coumarin Derivatives</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">4846</span><span class="NLM_x">–</span> <span class="NLM_lpage">4852</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2011.07.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1016%2Fj.ejmech.2011.07.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=21872365" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1amt7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=4846-4852&author=D.+Secciauthor=S.+Carradoriauthor=A.+Bolascoauthor=P.+Chimentiauthor=M.+Y%C3%A1%C3%B1ezauthor=F.+Ortusoauthor=S.+Alcaro&title=Synthesis+and+Selective+Human+Monoamine+Oxidase+Inhibition+of+3-Carbonyl%2C+3-Acyl%2C+and+3-Carboxyhydrazido+Coumarin+Derivatives&doi=10.1016%2Fj.ejmech.2011.07.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and selective human monoamine oxidase inhibition of 3-carbonyl, 3-acyl, and 3-carboxyhydrazido coumarin derivatives</span></div><div class="casAuthors">Secci, Daniela; Carradori, Simone; Bolasco, Adriana; Chimenti, Paola; Yanez, Matilde; Ortuso, Francesco; Alcaro, Stefano</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4846-4852</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Several 3-acyl-, 3-carboxy-, and 3-hydrazinocarbonylcoumarins have been synthesized in high yields (72-99%) and tested in vitro for their human monoamine oxidase A and B (hMAO-A and hMAO-B) inhibitory activity.  Different substituents on the coumarin nucleus were evaluated for their effect on biol. activity and isoform selectivity.  Substitution at position 7 of coumarin-3-carboxylate, or the 3-hydrazinocarbonyl substituent, were important to obtain highly potent and selective hMAO-B inhibitors with IC50 values in the nanomolar range.  Some derivs. were also submitted to a stability test and showed no chem. cleavage in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr42WEMp4WOVLVg90H21EOLACvtfcHk0ljfF1vqIaEHlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1amt7zE&md5=2575c7e7360109c25f64c342ab6ffc4a</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.07.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.07.017%26sid%3Dliteratum%253Aachs%26aulast%3DSecci%26aufirst%3DD.%26aulast%3DCarradori%26aufirst%3DS.%26aulast%3DBolasco%26aufirst%3DA.%26aulast%3DChimenti%26aufirst%3DP.%26aulast%3DY%25C3%25A1%25C3%25B1ez%26aufirst%3DM.%26aulast%3DOrtuso%26aufirst%3DF.%26aulast%3DAlcaro%26aufirst%3DS.%26atitle%3DSynthesis%2520and%2520Selective%2520Human%2520Monoamine%2520Oxidase%2520Inhibition%2520of%25203-Carbonyl%252C%25203-Acyl%252C%2520and%25203-Carboxyhydrazido%2520Coumarin%2520Derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D4846%26epage%3D4852%26doi%3D10.1016%2Fj.ejmech.2011.07.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Patil, P. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bari, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Firke, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshmukh, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donda, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patil, D. A.</span><span> </span><span class="NLM_article-title">A Comprehensive Review on Synthesis and Designing Aspects of Coumarin Derivatives as Monoamine Oxidase Inhibitors for Depression and Alzheimer’s Disease</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2434</span><span class="NLM_x">–</span> <span class="NLM_lpage">2450</span><span class="refDoi"> DOI: 10.1016/j.bmc.2013.02.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1016%2Fj.bmc.2013.02.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=23517722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktlSiuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=2434-2450&author=P.+O.+Patilauthor=S.+B.+Bariauthor=S.+D.+Firkeauthor=P.+K.+Deshmukhauthor=S.+T.+Dondaauthor=D.+A.+Patil&title=A+Comprehensive+Review+on+Synthesis+and+Designing+Aspects+of+Coumarin+Derivatives+as+Monoamine+Oxidase+Inhibitors+for+Depression+and+Alzheimer%E2%80%99s+Disease&doi=10.1016%2Fj.bmc.2013.02.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">A comprehensive review on synthesis and designing aspects of coumarin derivatives as monoamine oxidase inhibitors for depression and Alzheimer's disease</span></div><div class="casAuthors">Patil, Pravin O.; Bari, Sanjay B.; Firke, Sandip D.; Deshmukh, Prashant K.; Donda, Shailesh T.; Patil, Dilip A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2434-2450</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Monoamine oxidase (MAO) enzyme inhibition is a crucial target for the management of depression and Alzheimer disease and inhibitors of MAO are the most important drugs for their management.  Coumarins are a large family of compds., of natural and synthetic origin, that exhibit a variety of pharmacol. activities, including MAO inhibition.  The current review highlights the design and synthetic methods of coumarin derivs. as well as coumarins obtained from plant source as MAO inhibitors for treatment of depression and Alzheimer disease with salient finding related to structure-activity relationship.  The aim of present review is to find out natural as well as synthetic coumarins as MAO inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBZYAH89AyobVg90H21EOLACvtfcHk0ljfF1vqIaEHlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktlSiuro%253D&md5=15c84861ae6fc00bcf9ffba764223694</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.02.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.02.017%26sid%3Dliteratum%253Aachs%26aulast%3DPatil%26aufirst%3DP.%2BO.%26aulast%3DBari%26aufirst%3DS.%2BB.%26aulast%3DFirke%26aufirst%3DS.%2BD.%26aulast%3DDeshmukh%26aufirst%3DP.%2BK.%26aulast%3DDonda%26aufirst%3DS.%2BT.%26aulast%3DPatil%26aufirst%3DD.%2BA.%26atitle%3DA%2520Comprehensive%2520Review%2520on%2520Synthesis%2520and%2520Designing%2520Aspects%2520of%2520Coumarin%2520Derivatives%2520as%2520Monoamine%2520Oxidase%2520Inhibitors%2520for%2520Depression%2520and%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D2434%26epage%3D2450%26doi%3D10.1016%2Fj.bmc.2013.02.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Delogu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picciau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quezada, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podda, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uriarte, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viña, D.</span><span> </span><span class="NLM_article-title">Synthesis, Human Monoamine Oxidase Inhibitory Activity and Molecular Docking Studies of 3-Heteroaryl Coumarin Derivatives</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1147</span><span class="NLM_x">–</span> <span class="NLM_lpage">1152</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2011.01.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1016%2Fj.ejmech.2011.01.033" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=1147-1152&author=G.+Deloguauthor=C.+Picciauauthor=G.+Ferinoauthor=E.+Quezadaauthor=G.+Poddaauthor=E.+Uriarteauthor=D.+Vi%C3%B1a&title=Synthesis%2C+Human+Monoamine+Oxidase+Inhibitory+Activity+and+Molecular+Docking+Studies+of+3-Heteroaryl+Coumarin+Derivatives&doi=10.1016%2Fj.ejmech.2011.01.033"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.01.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.01.033%26sid%3Dliteratum%253Aachs%26aulast%3DDelogu%26aufirst%3DG.%26aulast%3DPicciau%26aufirst%3DC.%26aulast%3DFerino%26aufirst%3DG.%26aulast%3DQuezada%26aufirst%3DE.%26aulast%3DPodda%26aufirst%3DG.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DVi%25C3%25B1a%26aufirst%3DD.%26atitle%3DSynthesis%252C%2520Human%2520Monoamine%2520Oxidase%2520Inhibitory%2520Activity%2520and%2520Molecular%2520Docking%2520Studies%2520of%25203-Heteroaryl%2520Coumarin%2520Derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D1147%26epage%3D1152%26doi%3D10.1016%2Fj.ejmech.2011.01.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesce, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanachi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cellamare, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Design, Synthesis and Biological Evaluation of Coumarin Alkylamines as Potent and Selective Dual Binding Site Inhibitors of Acetylcholinesterase</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">146</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span><span class="refDoi"> DOI: 10.1016/j.bmc.2012.10.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1016%2Fj.bmc.2012.10.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=23199476" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslCktbvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=146-152&author=M.+Cattoauthor=L.+Pisaniauthor=F.+Leonettiauthor=O.+Nicolottiauthor=P.+Pesceauthor=A.+Stefanachiauthor=S.+Cellamareauthor=A.+Carotti&title=Design%2C+Synthesis+and+Biological+Evaluation+of+Coumarin+Alkylamines+as+Potent+and+Selective+Dual+Binding+Site+Inhibitors+of+Acetylcholinesterase&doi=10.1016%2Fj.bmc.2012.10.045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of coumarin alkylamines as potent and selective dual binding site inhibitors of acetylcholinesterase</span></div><div class="casAuthors">Catto, Marco; Pisani, Leonardo; Leonetti, Francesco; Nicolotti, Orazio; Pesce, Paolo; Stefanachi, Angela; Cellamare, Saverio; Carotti, Angelo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">146-152</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Acetylcholinesterase inhibitors (AChEIs) are currently the drugs of choice, although only symptomatic and palliative, for the treatment of Alzheimer's disease (AD).  Donepezil is one of most used AChEIs in AD therapy, acting as a dual binding site, reversible inhibitor of AChE with high selectivity over butyrylcholinesterase (BChE).  Through a combined target- and ligand-based approach, a series of coumarin alkylamines matching the structural determinants of donepezil were designed and prepd. 6,7-Dimethoxycoumarin derivs. carrying a protonatable benzylamino group, linked to position 3 by suitable linkers, exhibited fairly good AChE inhibitory activity and a high selectivity over BChE.  The inhibitory potency was strongly influenced by the length and shape of the spacer and by the methoxy substituents on the coumarin scaffold.  The inhibition mechanism, assessed for the most active compd. (I) (IC50 7.6 nM) resulted in a mixed-type, thus confirming its binding at both the catalytic and peripheral binding sites of AChE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAeZ1Mvxg--bVg90H21EOLACvtfcHk0ljfF1vqIaEHlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslCktbvK&md5=c36fd204f63c76a1ad185b4535300e56</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2012.10.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2012.10.045%26sid%3Dliteratum%253Aachs%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DPesce%26aufirst%3DP.%26aulast%3DStefanachi%26aufirst%3DA.%26aulast%3DCellamare%26aufirst%3DS.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DDesign%252C%2520Synthesis%2520and%2520Biological%2520Evaluation%2520of%2520Coumarin%2520Alkylamines%2520as%2520Potent%2520and%2520Selective%2520Dual%2520Binding%2520Site%2520Inhibitors%2520of%2520Acetylcholinesterase%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D146%26epage%3D152%26doi%3D10.1016%2Fj.bmc.2012.10.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Alipour, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khoobi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moradi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadri, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moghadam, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasanpour, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foroumadi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shafiee, A.</span><span> </span><span class="NLM_article-title">Synthesis and Anti-cholinesterase Activity of New 7-Hydroxycoumarin Derivatives</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">536</span><span class="NLM_x">–</span> <span class="NLM_lpage">544</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2014.05.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1016%2Fj.ejmech.2014.05.056" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2014&pages=536-544&author=M.+Alipourauthor=M.+Khoobiauthor=A.+Moradiauthor=H.+Nadriauthor=F.+H.+Moghadamauthor=S.+Emamiauthor=Z.+Hasanpourauthor=A.+Foroumadiauthor=A.+Shafiee&title=Synthesis+and+Anti-cholinesterase+Activity+of+New+7-Hydroxycoumarin+Derivatives&doi=10.1016%2Fj.ejmech.2014.05.056"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.05.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.05.056%26sid%3Dliteratum%253Aachs%26aulast%3DAlipour%26aufirst%3DM.%26aulast%3DKhoobi%26aufirst%3DM.%26aulast%3DMoradi%26aufirst%3DA.%26aulast%3DNadri%26aufirst%3DH.%26aulast%3DMoghadam%26aufirst%3DF.%2BH.%26aulast%3DEmami%26aufirst%3DS.%26aulast%3DHasanpour%26aufirst%3DZ.%26aulast%3DForoumadi%26aufirst%3DA.%26aulast%3DShafiee%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520Anti-cholinesterase%2520Activity%2520of%2520New%25207-Hydroxycoumarin%2520Derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D82%26spage%3D536%26epage%3D544%26doi%3D10.1016%2Fj.ejmech.2014.05.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giangreco, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanachi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cellamare, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Design, Synthesis and Biological Evaluation of Coumarin Derivatives Tethered to an Edrophonium-like Fragment as Highly Potent and Selective Dual Binding Site Acetylcholinesterase Inhibitors</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1616</span><span class="NLM_x">–</span> <span class="NLM_lpage">1630</span><span class="refDoi"> DOI: 10.1002/cmdc.201000210</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1002%2Fcmdc.201000210" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=1616-1630&author=L.+Pisaniauthor=M.+Cattoauthor=I.+Giangrecoauthor=F.+Leonettiauthor=O.+Nicolottiauthor=A.+Stefanachiauthor=S.+Cellamareauthor=A.+Carotti&title=Design%2C+Synthesis+and+Biological+Evaluation+of+Coumarin+Derivatives+Tethered+to+an+Edrophonium-like+Fragment+as+Highly+Potent+and+Selective+Dual+Binding+Site+Acetylcholinesterase+Inhibitors&doi=10.1002%2Fcmdc.201000210"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201000210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201000210%26sid%3Dliteratum%253Aachs%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DGiangreco%26aufirst%3DI.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DStefanachi%26aufirst%3DA.%26aulast%3DCellamare%26aufirst%3DS.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DDesign%252C%2520Synthesis%2520and%2520Biological%2520Evaluation%2520of%2520Coumarin%2520Derivatives%2520Tethered%2520to%2520an%2520Edrophonium-like%2520Fragment%2520as%2520Highly%2520Potent%2520and%2520Selective%2520Dual%2520Binding%2520Site%2520Acetylcholinesterase%2520Inhibitors%26jtitle%3DChemMedChem%26date%3D2010%26volume%3D5%26spage%3D1616%26epage%3D1630%26doi%3D10.1002%2Fcmdc.201000210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Wang, Z.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, G.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, L.-Y.</span><span> </span><span class="NLM_article-title">Synthesis and Evaluation of 6-Substituted 3-Arylcoumarin Derivatives as Multifunctional Acetylcholinesterase/monoamine Oxidase B Dual Inhibitors for the Treatment of Alzheimer’s Disease</span> <span class="citation_source-journal">RSC Adv.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">104122</span><span class="NLM_x">–</span> <span class="NLM_lpage">104137</span><span class="refDoi"> DOI: 10.1039/C5RA22296F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1039%2FC5RA22296F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFykt7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=104122-104137&author=Z.-M.+Wangauthor=X.-M.+Liauthor=G.-M.+Xueauthor=W.+Xuauthor=X.-B.+Wangauthor=L.-Y.+Kong&title=Synthesis+and+Evaluation+of+6-Substituted+3-Arylcoumarin+Derivatives+as+Multifunctional+Acetylcholinesterase%2Fmonoamine+Oxidase+B+Dual+Inhibitors+for+the+Treatment+of+Alzheimer%E2%80%99s+Disease&doi=10.1039%2FC5RA22296F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of 6-substituted 3-arylcoumarin derivatives as multifunctional acetylcholinesterase/monoamine oxidase B dual inhibitors for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Wang, Zhi-Min; Li, Xue-Mei; Xue, Gui-Min; Xu, Wei; Wang, Xiao-Bing; Kong, Ling-Yi</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">126</span>),
    <span class="NLM_cas:pages">104122-104137</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Considering the complex etiol. of Alzheimer's disease (AD), multifunctional agents may exhibit important properties against this disease.  A series of 6-substituted 3-arylcoumarins (5a-t) were designed, synthesized and evaluated as cholinesterase (ChE) and monoamino oxidase (MAO) inhibitors.  Among them, compds. 5o [IC50, 195 nM for human acetylcholinesterase (hAChE), selectivity index, SI (human butyrylcholinesterase, hBuChE/hAChE) = 145; IC50, 63.5 nM for human monoamine oxidase-B (hMAO-B), SI (human monoamine oxidase-A, hMAO-A/hMAO-B) = 25] and 5p [IC50, 185 nM for hAChE, SI (hBuChE/hAChE) = 182; IC50, 196 nM for hMAO-B, SI (hMAO-A/hMAO-B) > 510] were found to selectively inhibit both hAChE and hMAO-B with IC50 values in the nanomolar range.  The abilities of 5o and 5p to bind to hAChE and hMAO-B were confirmed by mol. docking and kinetic studies.  Moreover, 5o and 5p were found to exhibit significant inhibition of self-induced Aβ42 aggregation (61% and 52%, at 20 μM), have antioxidant properties (0.81 and 1.17 trolox equiv. by ABTS assay), provide neuroprotection against Aβ42-induced cytotoxicity and blood-brain barrier (BBB) penetration capacity (PAMPA-BBB+), and are thus potential anti-Alzheimer agents with balanced activities.  Overall, the study provided meaningful information for further development of multifunctional drugs for AD therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqt7hLsrl0vQbVg90H21EOLACvtfcHk0lgUIUexxOU4CA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFykt7rL&md5=3437763ed8b0a5f5dc6b5c2b785be383</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1039%2FC5RA22296F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5RA22296F%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.-M.%26aulast%3DLi%26aufirst%3DX.-M.%26aulast%3DXue%26aufirst%3DG.-M.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DX.-B.%26aulast%3DKong%26aufirst%3DL.-Y.%26atitle%3DSynthesis%2520and%2520Evaluation%2520of%25206-Substituted%25203-Arylcoumarin%2520Derivatives%2520as%2520Multifunctional%2520Acetylcholinesterase%252Fmonoamine%2520Oxidase%2520B%2520Dual%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DRSC%2520Adv.%26date%3D2015%26volume%3D5%26spage%3D104122%26epage%3D104137%26doi%3D10.1039%2FC5RA22296F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Xie, S.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, K. D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, J.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, L.-Y.</span><span> </span><span class="NLM_article-title">Multi-target Tacrine-coumarin Hybrids: Cholinesterase and Monoamine Oxidase B Inhibition Properties against Alzheimer’s Disease</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">165</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2015.03.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1016%2Fj.ejmech.2015.03.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=25812965" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltFWjsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2015&pages=153-165&author=S.-S.+Xieauthor=X.+Wangauthor=N.+Jiangauthor=W.+Yuauthor=K.+D.+G.+Wangauthor=J.-S.+Lanauthor=Z.-R.+Liauthor=L.-Y.+Kong&title=Multi-target+Tacrine-coumarin+Hybrids%3A+Cholinesterase+and+Monoamine+Oxidase+B+Inhibition+Properties+against+Alzheimer%E2%80%99s+Disease&doi=10.1016%2Fj.ejmech.2015.03.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target tacrine-coumarin hybrids: Cholinesterase and monoamine oxidase B inhibition properties against Alzheimer's disease</span></div><div class="casAuthors">Xie, Sai-Sai; Wang, Xiaobing; Jiang, Neng; Yu, Wenying; Wang, Kelvin D. G.; Lan, Jin-Shuai; Li, Zhong-Rui; Kong, Ling-Yi</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">153-165</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of novel tacrine-coumarin hybrids were designed, synthesized and evaluated as multi-target agents against Alzheimer's disease.  The biol. assays indicated that most of compds. displayed potent inhibitory activity toward AChE and BuChE, and clearly selective inhibition for MAO-B.  Among these compds., 3,4-Dimethyl-7-(2-(4-(3-((1,2,3,4-tetrahydroacridin-9-yl)amino)propyl)piperazin-1-yl)ethoxy)-2H-chromen-2-one (I), exhibited strong inhibitory activity for AChE (IC50 values of 33.63 nM for eeAChE and 16.11 nM for hAChE) and BuChE (IC50 values of 80.72 nM for eqBuChE and 112.72 nM for hBuChE), and the highest inhibitory activity against hMAO-B (IC50 value of 0.24 μM).  Kinetic and mol. modeling studies revealed that (I) was a mixed-type inhibitor, binding simultaneously to catalytic, peripheral and mid-gorge sites of AChE.  It was also a competitive inhibitor, which covered the substrate and entrance cavities of MAO-B.  Moreover, (I) could penetrate the CNS and show low cell toxicity.  Overall, these results suggested that (I) might be an excellent multi-target agent for AD treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVTl9JCLOwBrVg90H21EOLACvtfcHk0lgUIUexxOU4CA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltFWjsLo%253D&md5=cd1d6c79030dd81976643ff8b14f4bd4</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.03.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.03.040%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DS.-S.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DJiang%26aufirst%3DN.%26aulast%3DYu%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DK.%2BD.%2BG.%26aulast%3DLan%26aufirst%3DJ.-S.%26aulast%3DLi%26aufirst%3DZ.-R.%26aulast%3DKong%26aufirst%3DL.-Y.%26atitle%3DMulti-target%2520Tacrine-coumarin%2520Hybrids%253A%2520Cholinesterase%2520and%2520Monoamine%2520Oxidase%2520B%2520Inhibition%2520Properties%2520against%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D95%26spage%3D153%26epage%3D165%26doi%3D10.1016%2Fj.ejmech.2015.03.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Jameel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umar, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoda, N.</span><span> </span><span class="NLM_article-title">Coumarin: A Privileged Scaffold for the Design and Development of Antineurodegenerative Agents</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">38</span><span class="refDoi"> DOI: 10.1111/cbdd.12629</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1111%2Fcbdd.12629" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=26242562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsV2lu7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2016&pages=21-38&author=E.+Jameelauthor=T.+Umarauthor=J.+Kumarauthor=N.+Hoda&title=Coumarin%3A+A+Privileged+Scaffold+for+the+Design+and+Development+of+Antineurodegenerative+Agents&doi=10.1111%2Fcbdd.12629"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Coumarin: A Privileged Scaffold for the Design and Development of Antineurodegenerative Agents</span></div><div class="casAuthors">Jameel, Ehtesham; Umar, Tarana; Kumar, Jitendra; Hoda, Nasimul</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-38</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Drug development for neurodegenerative diseases (NDs) is foremost task for the medicinal chemists in the 21st century.  Coumarins are exemplary of an assorted and aptitudinally useful set of drugs.  Coumarins play a momentous role in several pharmacol. and medicinal aspects.  Its analogs are anticipated to play a significant role in the development of new therapeutic leads for NDs.  Their promising applications in the field of ND medication are exemplified by clin. candidates such as nodakenin that have been potent for demoting memory impairment.  Apart from ND, clin. used anticoagulant warfarin, anticoagulant dicoumarol, and antibiotic coumermycin, novobiocin and chartesium grab the interest of researchers in coumarins.  It would be worthwhile to look at the different biol. processes that could cause neurodegeneration, thereby establishing a link with distinct coumarin derivs. to serve the purpose of medication.  This review undertakes estn. of the wide spectrum of studies focusing coumarin to the domain of drug research for ND.  Herein, we search for multitarget coumarin-based inhibitors and their scope for NDs.  Future challenges in coumarin-based drug development have been discussed, and emphases have been laid on the future perspectives of coumarins as possible drugs in the future for the treatment of NDs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkGmS5nfpCM7Vg90H21EOLACvtfcHk0lgdiIfUrqwx7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsV2lu7vJ&md5=bacefa47f3f14eab3b0548fc6361e655</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1111%2Fcbdd.12629&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcbdd.12629%26sid%3Dliteratum%253Aachs%26aulast%3DJameel%26aufirst%3DE.%26aulast%3DUmar%26aufirst%3DT.%26aulast%3DKumar%26aufirst%3DJ.%26aulast%3DHoda%26aufirst%3DN.%26atitle%3DCoumarin%253A%2520A%2520Privileged%2520Scaffold%2520for%2520the%2520Design%2520and%2520Development%2520of%2520Antineurodegenerative%2520Agents%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2016%26volume%3D87%26spage%3D21%26epage%3D38%26doi%3D10.1111%2Fcbdd.12629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muncipinto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miscioscia, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caccia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvati, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto-Otero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendez-Alvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Passeleu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Discovery of a Novel Class of Potent Coumarin Monoamine Oxidase B Inhibitors: Development and Biopharmacological Profiling of 7-[(3-Chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one Methanesulfonate (NW-1772) as a Highly Potent, Selective, Reversible, and Orally Active Monoamine Oxidase B Inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6685</span><span class="NLM_x">–</span> <span class="NLM_lpage">6706</span><span class="refDoi"> DOI: 10.1021/jm9010127</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9010127" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1artL3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6685-6706&author=L.+Pisaniauthor=G.+Muncipintoauthor=T.+F.+Misciosciaauthor=O.+Nicolottiauthor=F.+Leonettiauthor=M.+Cattoauthor=C.+Cacciaauthor=P.+Salvatiauthor=R.+Soto-Oteroauthor=E.+Mendez-Alvarezauthor=C.+Passeleuauthor=A.+Carotti&title=Discovery+of+a+Novel+Class+of+Potent+Coumarin+Monoamine+Oxidase+B+Inhibitors%3A+Development+and+Biopharmacological+Profiling+of+7-%5B%283-Chlorobenzyl%29oxy%5D-4-%5B%28methylamino%29methyl%5D-2H-chromen-2-one+Methanesulfonate+%28NW-1772%29+as+a+Highly+Potent%2C+Selective%2C+Reversible%2C+and+Orally+Active+Monoamine+Oxidase+B+Inhibitor&doi=10.1021%2Fjm9010127"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Novel Class of Potent Coumarin Monoamine Oxidase B Inhibitors: Development and Biopharmacological Profiling of 7-[(3-Chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one Methanesulfonate (NW-1772) as a Highly Potent, Selective, Reversible, and Orally Active Monoamine Oxidase B Inhibitor</span></div><div class="casAuthors">Pisani, Leonardo; Muncipinto, Giovanni; Miscioscia, Teresa Fabiola; Nicolotti, Orazio; Leonetti, Francesco; Catto, Marco; Caccia, Carla; Salvati, Patricia; Soto-Otero, Ramon; Mendez-Alvarez, Estefania; Passeleu, Celine; Carotti, Angelo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6685-6706</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In an effort to discover novel selective monoamine oxidase (MAO) B inhibitors with favorable physicochem. and pharmacokinetic profiles, 7-[(m-halogeno)benzyloxy]coumarins bearing properly selected polar substituents at position 4 were designed, synthesized, and evaluated as MAO inhibitors.  Several compds. with MAO-B inhibitory activity in the nanomolar range and excellent MAO-B selectivity (selectivity index SI > 400) were identified.  Structure-affinity relationships and docking simulations provided valuable insights into the enzyme-inhibitor binding interactions at position 4, which has been poorly explored.  Furthermore, computational and exptl. studies led to the identification and biopharmacol. characterization of 7-[(3-chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one methanesulfonate (I) (NW-1772) as an in vitro and in vivo potent and selective MAO-B inhibitor, with rapid blood-brain barrier penetration, short-acting and reversible inhibitory activity, slight inhibition of selected cytochrome P450s, and low in vitro toxicity.  On the basis of this preliminary preclin. profile, inhibitor I might be viewed as a promising clin. candidate for the treatment of neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX-2hebE1dsbVg90H21EOLACvtfcHk0lgdiIfUrqwx7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1artL3N&md5=b5cdda9e190504fced3ed6c5157c3266</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm9010127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9010127%26sid%3Dliteratum%253Aachs%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DMuncipinto%26aufirst%3DG.%26aulast%3DMiscioscia%26aufirst%3DT.%2BF.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DCaccia%26aufirst%3DC.%26aulast%3DSalvati%26aufirst%3DP.%26aulast%3DSoto-Otero%26aufirst%3DR.%26aulast%3DMendez-Alvarez%26aufirst%3DE.%26aulast%3DPasseleu%26aufirst%3DC.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520a%2520Novel%2520Class%2520of%2520Potent%2520Coumarin%2520Monoamine%2520Oxidase%2520B%2520Inhibitors%253A%2520Development%2520and%2520Biopharmacological%2520Profiling%2520of%25207-%255B%25283-Chlorobenzyl%2529oxy%255D-4-%255B%2528methylamino%2529methyl%255D-2H-chromen-2-one%2520Methanesulfonate%2520%2528NW-1772%2529%2520as%2520a%2520Highly%2520Potent%252C%2520Selective%252C%2520Reversible%252C%2520and%2520Orally%2520Active%2520Monoamine%2520Oxidase%2520B%2520Inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6685%26epage%3D6706%26doi%3D10.1021%2Fjm9010127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barletta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto-Otero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendez-Alvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Introcaso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanachi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cellamare, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altomare, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Discovery, Biological Evaluation, and Structure–Activity and – Selectivity Relationships of 6′-Substituted (E)-2-(Benzofuran-3(2H)-ylidene)-N-methylacetamides, a Novel Class of Potent and Selective Monoamine Oxidase Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">2651</span><span class="NLM_x">–</span> <span class="NLM_lpage">2664</span><span class="refDoi"> DOI: 10.1021/jm4000769</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4000769" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=2651-2664&author=L.+Pisaniauthor=M.+Barlettaauthor=R.+Soto-Oteroauthor=O.+Nicolottiauthor=E.+Mendez-Alvarezauthor=M.+Cattoauthor=A.+Introcasoauthor=A.+Stefanachiauthor=S.+Cellamareauthor=C.+Altomareauthor=A.+Carotti&title=Discovery%2C+Biological+Evaluation%2C+and+Structure%E2%80%93Activity+and+%E2%80%93+Selectivity+Relationships+of+6%E2%80%B2-Substituted+%28E%29-2-%28Benzofuran-3%282H%29-ylidene%29-N-methylacetamides%2C+a+Novel+Class+of+Potent+and+Selective+Monoamine+Oxidase+Inhibitors&doi=10.1021%2Fjm4000769"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm4000769&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4000769%26sid%3Dliteratum%253Aachs%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DBarletta%26aufirst%3DM.%26aulast%3DSoto-Otero%26aufirst%3DR.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DMendez-Alvarez%26aufirst%3DE.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DIntrocaso%26aufirst%3DA.%26aulast%3DStefanachi%26aufirst%3DA.%26aulast%3DCellamare%26aufirst%3DS.%26aulast%3DAltomare%26aufirst%3DC.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DDiscovery%252C%2520Biological%2520Evaluation%252C%2520and%2520Structure%25E2%2580%2593Activity%2520and%2520%25E2%2580%2593%2520Selectivity%2520Relationships%2520of%25206%25E2%2580%25B2-Substituted%2520%2528E%2529-2-%2528Benzofuran-3%25282H%2529-ylidene%2529-N-methylacetamides%252C%2520a%2520Novel%2520Class%2520of%2520Potent%2520and%2520Selective%2520Monoamine%2520Oxidase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D2651%26epage%3D2664%26doi%3D10.1021%2Fjm4000769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favia, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto-Otero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendez-Alvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Structural Insights into Monoamine Oxidase Inhibitory Potency and Selectivity of 7-Substituted Coumarins from Ligand- and Target-Based Approaches</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4912</span><span class="NLM_x">–</span> <span class="NLM_lpage">4925</span><span class="refDoi"> DOI: 10.1021/jm060183l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060183l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4912-4925&author=M.+Cattoauthor=O.+Nicolottiauthor=F.+Leonettiauthor=A.+Carottiauthor=A.+D.+Faviaauthor=R.+Soto-Oteroauthor=E.+Mendez-Alvarezauthor=A.+Carotti&title=Structural+Insights+into+Monoamine+Oxidase+Inhibitory+Potency+and+Selectivity+of+7-Substituted+Coumarins+from+Ligand-+and+Target-Based+Approaches&doi=10.1021%2Fjm060183l"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm060183l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060183l%26sid%3Dliteratum%253Aachs%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DFavia%26aufirst%3DA.%2BD.%26aulast%3DSoto-Otero%26aufirst%3DR.%26aulast%3DMendez-Alvarez%26aufirst%3DE.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DStructural%2520Insights%2520into%2520Monoamine%2520Oxidase%2520Inhibitory%2520Potency%2520and%2520Selectivity%2520of%25207-Substituted%2520Coumarins%2520from%2520Ligand-%2520and%2520Target-Based%2520Approaches%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4912%26epage%3D4925%26doi%3D10.1021%2Fjm060183l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Carotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altomare, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gnerre, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Marco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Testa, B.</span><span> </span><span class="NLM_article-title">Lipophilicity Plays a Major Role in Modulating Monoamine Oxidase B (MAO-B). Inhibition by 7-Substituted Coumarins</span> <span class="citation_source-journal">Chem. Biodiversity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">134</span><span class="NLM_x">–</span> <span class="NLM_lpage">144</span><span class="refDoi"> DOI: 10.1002/cbdv.200690017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1002%2Fcbdv.200690017" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=134-144&author=A.+Carottiauthor=C.+Altomareauthor=M.+Cattoauthor=C.+Gnerreauthor=L.+Summoauthor=A.+De+Marcoauthor=S.+Roseauthor=P.+Jennerauthor=B.+Testa&title=Lipophilicity+Plays+a+Major+Role+in+Modulating+Monoamine+Oxidase+B+%28MAO-B%29.+Inhibition+by+7-Substituted+Coumarins&doi=10.1002%2Fcbdv.200690017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1002%2Fcbdv.200690017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbdv.200690017%26sid%3Dliteratum%253Aachs%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DAltomare%26aufirst%3DC.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DGnerre%26aufirst%3DC.%26aulast%3DSummo%26aufirst%3DL.%26aulast%3DDe%2BMarco%26aufirst%3DA.%26aulast%3DRose%26aufirst%3DS.%26aulast%3DJenner%26aufirst%3DP.%26aulast%3DTesta%26aufirst%3DB.%26atitle%3DLipophilicity%2520Plays%2520a%2520Major%2520Role%2520in%2520Modulating%2520Monoamine%2520Oxidase%2520B%2520%2528MAO-B%2529.%2520Inhibition%2520by%25207-Substituted%2520Coumarins%26jtitle%3DChem.%2520Biodiversity%26date%3D2006%26volume%3D3%26spage%3D134%26epage%3D144%26doi%3D10.1002%2Fcbdv.200690017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Braccio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto-Otero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendez-Alvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanachi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gadaleta, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Fine Molecular Tuning at Position 4 of 2H-Chromen-2-one Derivatives in the Search of Potent and Selective Monoamine Oxidase B Inhibitors</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">723</span><span class="NLM_x">–</span> <span class="NLM_lpage">739</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2013.09.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1016%2Fj.ejmech.2013.09.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=24231308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFOqu7%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2013&pages=723-739&author=L.+Pisaniauthor=M.+Cattoauthor=O.+Nicolottiauthor=G.+Grossiauthor=M.+Di+Braccioauthor=R.+Soto-Oteroauthor=E.+Mendez-Alvarezauthor=A.+Stefanachiauthor=D.+Gadaletaauthor=A.+Carotti&title=Fine+Molecular+Tuning+at+Position+4+of+2H-Chromen-2-one+Derivatives+in+the+Search+of+Potent+and+Selective+Monoamine+Oxidase+B+Inhibitors&doi=10.1016%2Fj.ejmech.2013.09.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Fine molecular tuning at position 4 of 2H-chromen-2-one derivatives in the search of potent and selective monoamine oxidase B inhibitors</span></div><div class="casAuthors">Pisani, Leonardo; Catto, Marco; Nicolotti, Orazio; Grossi, Giancarlo; Di Braccio, Mario; Soto-Otero, Ramon; Mendez-Alvarez, Estefania; Stefanachi, Angela; Gadaleta, Domenico; Carotti, Angelo</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">723-739</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The effects on the inhibition potencies of monoamine oxidase isoforms A (MAO-A) and B (MAO-B) depending upon changes in the physicochem. properties (size, shape, H-bonding, lipophilicity, etc.) of substituents at the C4 position of 2H-chromen-2-one derivs. were extensively investigated, and the results significantly added to our knowledge on this class of MAO inhibitors.  All the 67 examd. compds. showed high MAO-B selectivity, some of them achieving potency in the low nanomolar range.  In particular, 7-meta-chlorobenzyloxy-4-oxyacetamido-2H-chromen-2-one showed single digit nanomolar MAO-B potency (IC50 = 3.1 nM) and high selectivity over the MAO-A isoform (selectivity ratio = 7244).  The great variety of the investigated substituents at C4 of the 2H-chromen-2-one nucleus, combined with binding models generated from docking studies carried out on selected compds., allowed us to shed light on the main mol. requirements for potent and selective MAO-B inhibition, highlighting the dominant role of the steric effects.  Interestingly, many of the designed substituents could be metabolically related to each other (e.g., CH3/CH2OH/CHO/COOH; NH2/NHCH3, NHAc), and therefore the results obtained may help in predicting the in vivo activity of some putative metabolites of lead MAO-B inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7YkDy75tEzbVg90H21EOLACvtfcHk0lg3qdBsqpkoWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFOqu7%252FJ&md5=69adf68e70301614b8b7529eb7385aff</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2013.09.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2013.09.034%26sid%3Dliteratum%253Aachs%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DGrossi%26aufirst%3DG.%26aulast%3DDi%2BBraccio%26aufirst%3DM.%26aulast%3DSoto-Otero%26aufirst%3DR.%26aulast%3DMendez-Alvarez%26aufirst%3DE.%26aulast%3DStefanachi%26aufirst%3DA.%26aulast%3DGadaleta%26aufirst%3DD.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DFine%2520Molecular%2520Tuning%2520at%2520Position%25204%2520of%25202H-Chromen-2-one%2520Derivatives%2520in%2520the%2520Search%2520of%2520Potent%2520and%2520Selective%2520Monoamine%2520Oxidase%2520B%2520Inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D70%26spage%3D723%26epage%3D739%26doi%3D10.1016%2Fj.ejmech.2013.09.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Cheung, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudolph, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burshteyn, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassidy, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gary, E. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Love, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franklin, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Height, J. J.</span><span> </span><span class="NLM_article-title">Structures of Human Acetylcholinesterase in Complex with Pharmacologically Important Ligands</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">10282</span><span class="NLM_x">–</span> <span class="NLM_lpage">10286</span><span class="refDoi"> DOI: 10.1021/jm300871x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300871x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVGqtLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10282-10286&author=J.+Cheungauthor=M.+J.+Rudolphauthor=F.+Burshteynauthor=M.+S.+Cassidyauthor=E.+N.+Garyauthor=J.+Loveauthor=M.+C.+Franklinauthor=J.+J.+Height&title=Structures+of+Human+Acetylcholinesterase+in+Complex+with+Pharmacologically+Important+Ligands&doi=10.1021%2Fjm300871x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of Human Acetylcholinesterase in Complex with Pharmacologically Important Ligands</span></div><div class="casAuthors">Cheung, Jonah; Rudolph, Michael J.; Burshteyn, Fiana; Cassidy, Michael S.; Gary, Ebony N.; Love, James; Franklin, Matthew C.; Height, Jude J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10282-10286</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human acetylcholinesterase (AChE) is a significant target for therapeutic drugs.  Here we present high resoln. crystal structures of human AChE, alone and in complexes with drug ligands; donepezil, an Alzheimer's disease drug, binds differently to human AChE than it does to Torpedo AChE.  These crystals of human AChE provide a more accurate platform for further drug development than previously available.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdjhYPmZBMf7Vg90H21EOLACvtfcHk0lg3qdBsqpkoWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVGqtLnN&md5=c27461e0288f42ac96af354cbefd387e</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm300871x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300871x%26sid%3Dliteratum%253Aachs%26aulast%3DCheung%26aufirst%3DJ.%26aulast%3DRudolph%26aufirst%3DM.%2BJ.%26aulast%3DBurshteyn%26aufirst%3DF.%26aulast%3DCassidy%26aufirst%3DM.%2BS.%26aulast%3DGary%26aufirst%3DE.%2BN.%26aulast%3DLove%26aufirst%3DJ.%26aulast%3DFranklin%26aufirst%3DM.%2BC.%26aulast%3DHeight%26aufirst%3DJ.%2BJ.%26atitle%3DStructures%2520of%2520Human%2520Acetylcholinesterase%2520in%2520Complex%2520with%2520Pharmacologically%2520Important%2520Ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10282%26epage%3D10286%26doi%3D10.1021%2Fjm300871x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farina, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gadaleta, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto-Otero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Braccio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendez-Alvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">In Silico Design of Novel 2H-Chromen-2-one Derivatives as Potent and Selective MAO-B Inhibitors</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">98</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2014.10.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1016%2Fj.ejmech.2014.10.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=25462230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslGjtrnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2015&pages=98-105&author=L.+Pisaniauthor=R.+Farinaauthor=O.+Nicolottiauthor=D.+Gadaletaauthor=R.+Soto-Oteroauthor=M.+Cattoauthor=M.+Di+Braccioauthor=E.+Mendez-Alvarezauthor=A.+Carotti&title=In+Silico+Design+of+Novel+2H-Chromen-2-one+Derivatives+as+Potent+and+Selective+MAO-B+Inhibitors&doi=10.1016%2Fj.ejmech.2014.10.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">In silico design of novel 2H-chromen-2-one derivatives as potent and selective MAO-B inhibitors</span></div><div class="casAuthors">Pisani, Leonardo; Farina, Roberta; Nicolotti, Orazio; Gadaleta, Domenico; Soto-Otero, Ramon; Catto, Marco; Di Braccio, Mario; Mendez-Alvarez, Estefania; Carotti, Angelo</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">98-105</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Inhibition data on rat monoamine oxidase B isoform of a large no. of 7-metahalobenzyloxy-2H-chromen-2-one derivs. (67 compds.) carrying at position 4 a variety of substituents differing in steric, electrostatic, lipophilic and H-bonding properties, were modeled by Gaussian field-based 3D-QSAR and docking simulations carried out on rat MAO-B homol. model.  The computational study combining two different approaches provided easily interpretable binding modes, highlighting the dominant role of the steric effects at position 4, and guided the design of new, potent and selective MAO-B inhibitors.  The 4-hydroxyethyl-, 4-chloroethyl-, 4-carboxamidoethyl-coumarin derivs. 70, 71, and 76, resp., were endowed with high MAO-B inhibitory potency (pIC50 = 8.13, 7.89 and 7.82, resp.) and good selectivity over MAO-A (pIC50 = 5.33, 3% inhibition at 10 μM, and pIC50 = 5.37, resp.).  New compds. with moderate to low MAO-B inhibitory activity were also designed and prepd. to challenge the predictive power of our docking-based 3D-QSAR model.  The good match between predicted and exptl. pIC50 values for all the newly designed compds. confirmed the robustness of our model (r2 = 0.856, RMSE = 0.421) and its transparent rationale in unveiling the main mol. determinants for high potency towards MAO-B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOjxQzx8cccrVg90H21EOLACvtfcHk0lgL-DmQXgZ8dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslGjtrnF&md5=b572643e528cef0bfe6b5e4e9fbaf13e</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.10.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.10.029%26sid%3Dliteratum%253Aachs%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DFarina%26aufirst%3DR.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DGadaleta%26aufirst%3DD.%26aulast%3DSoto-Otero%26aufirst%3DR.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DDi%2BBraccio%26aufirst%3DM.%26aulast%3DMendez-Alvarez%26aufirst%3DE.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DIn%2520Silico%2520Design%2520of%2520Novel%25202H-Chromen-2-one%2520Derivatives%2520as%2520Potent%2520and%2520Selective%2520MAO-B%2520Inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D89%26spage%3D98%26epage%3D105%26doi%3D10.1016%2Fj.ejmech.2014.10.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Bruhlmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ooms, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrupt, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Testa, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altomare, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Coumarins Derivatives as Dual Inhibitors of Acetylcholinesterase and Monoamine Oxidase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">3195</span><span class="NLM_x">–</span> <span class="NLM_lpage">3198</span><span class="refDoi"> DOI: 10.1021/jm010894d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm010894d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=3195-3198&author=C.+Bruhlmannauthor=F.+Oomsauthor=P.+A.+Carruptauthor=B.+Testaauthor=M.+Cattoauthor=F.+Leonettiauthor=C.+Altomareauthor=A.+Carotti&title=Coumarins+Derivatives+as+Dual+Inhibitors+of+Acetylcholinesterase+and+Monoamine+Oxidase&doi=10.1021%2Fjm010894d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm010894d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010894d%26sid%3Dliteratum%253Aachs%26aulast%3DBruhlmann%26aufirst%3DC.%26aulast%3DOoms%26aufirst%3DF.%26aulast%3DCarrupt%26aufirst%3DP.%2BA.%26aulast%3DTesta%26aufirst%3DB.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DAltomare%26aufirst%3DC.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DCoumarins%2520Derivatives%2520as%2520Dual%2520Inhibitors%2520of%2520Acetylcholinesterase%2520and%2520Monoamine%2520Oxidase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D3195%26epage%3D3198%26doi%3D10.1021%2Fjm010894d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Cruciani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crivori, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrupt, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Testa, B.</span><span> </span><span class="NLM_article-title">Molecular Fields in Quantitative Structure-Permeation Relationships: The VolSurf Approach</span> <span class="citation_source-journal">J. Mol. Struct.: THEOCHEM</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">503</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span><span class="refDoi"> DOI: 10.1016/S0166-1280(99)00360-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1016%2FS0166-1280%2899%2900360-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjsVehur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=503&publication_year=2000&pages=17-30&author=G.+Crucianiauthor=P.+Crivoriauthor=P.+A.+Carruptauthor=B.+Testa&title=Molecular+Fields+in+Quantitative+Structure-Permeation+Relationships%3A+The+VolSurf+Approach&doi=10.1016%2FS0166-1280%2899%2900360-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular fields in quantitative structure-permeation relationships: the VolSurf approach</span></div><div class="casAuthors">Cruciani, G.; Crivori, P.; Carrupt, P.-A.; Testa, B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Structure: THEOCHEM</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">503</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">17-30</span>CODEN:
                <span class="NLM_cas:coden">THEODJ</span>;
        ISSN:<span class="NLM_cas:issn">0166-1280</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Calcd. mol. properties from 3D mol. fields of interaction energies have become a valuable approach to correlate 3D mol. structures with physicochem. and pharmacodynamic properties.  In contrast, their use in correlations with pharmacokinetic properties is still poorly explored and exploited. 3D mol. fields can be obtained from ab initio, semiempirical or mol. mechanics levels of calcn.  The newly developed procedure called VolSurf is able to compress the relevant information present in 3D maps into a few descriptors characterized by the simplicity of their use and interpretation.  These descriptors can be quant. compared and used to build multivariate models correlating 3D mol. structures with biol. responses.  The VolSurf procedure is applied here to generate descriptors and models of structure-permeation relationships.  The VolSurf procedure, which was originally designed to handle a medium amt. of data, can easily be applied to problems of large size such as bioisostere databases, CombyChem databases and related approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoN3Z9YdGVBV7Vg90H21EOLACvtfcHk0lgL-DmQXgZ8dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjsVehur0%253D&md5=d61ee7f523b6f8b0a7d75ede0994a66f</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2FS0166-1280%2899%2900360-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0166-1280%252899%252900360-7%26sid%3Dliteratum%253Aachs%26aulast%3DCruciani%26aufirst%3DG.%26aulast%3DCrivori%26aufirst%3DP.%26aulast%3DCarrupt%26aufirst%3DP.%2BA.%26aulast%3DTesta%26aufirst%3DB.%26atitle%3DMolecular%2520Fields%2520in%2520Quantitative%2520Structure-Permeation%2520Relationships%253A%2520The%2520VolSurf%2520Approach%26jtitle%3DJ.%2520Mol.%2520Struct.%253A%2520THEOCHEM%26date%3D2000%26volume%3D503%26spage%3D17%26epage%3D30%26doi%3D10.1016%2FS0166-1280%2899%2900360-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Gnerre, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrupt, P.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altomare, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Testa, B.</span><span> </span><span class="NLM_article-title">Inhibition of Monoamine Oxidases by Functionalized Coumarin Derivatives: Biological Activities, QSARs, and 3D-QSARs</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">4747</span><span class="NLM_x">–</span> <span class="NLM_lpage">4758</span><span class="refDoi"> DOI: 10.1021/jm001028o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm001028o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnvFarsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=4747-4758&author=C.+Gnerreauthor=M.+Cattoauthor=F.+Leonettiauthor=P.+Weberauthor=P.-A.+Carruptauthor=C.+Altomareauthor=A.+Carottiauthor=B.+Testa&title=Inhibition+of+Monoamine+Oxidases+by+Functionalized+Coumarin+Derivatives%3A+Biological+Activities%2C+QSARs%2C+and+3D-QSARs&doi=10.1021%2Fjm001028o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Monoamine Oxidases by Functionalized Coumarin Derivatives: Biological Activities, QSARs, and 3D-QSARs</span></div><div class="casAuthors">Gnerre, Carmela; Catto, Marco; Leonetti, Francesco; Weber, Peter; Carrupt, Pierre-Alain; Altomare, Cosimo; Carotti, Angelo; Testa, Bernard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">4747-4758</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A large series of coumarin derivs. (71 compds.) were tested for their monoamine oxidase A and B (MAO-A and MAO-B) inhibitory activity.  Most of the compds. acted preferentially on MAO-B with IC50 values in the micromolar to low-nanomolar range; high inhibitory activities toward MAO-A were also measured for sulfonic acid esters.  The most active compd. was 7-[(3,4-difluorobenzyl)oxy]-3,4-dimethylcoumarin, with an IC50 value toward MAO-B of 1.14 nM.  A QSAR study of 7-X-benzyloxy meta-substituted 3,4-dimethylcoumarin derivs. acting on MAO-B yielded good statistical results (q2 = 0.72, r2 = 0.86), revealing the importance of lipophilic interactions in modulating the inhibition and excluding any dependence on electronic properties. CoMFA was performed on two data sets of MAO-A and MAO-B inhibitors.  The GOLPE procedure, with variable selection criteria, was applied to improve the predictivity of the models and to facilitate the graphical interpretation of results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKLfIzVMIHY7Vg90H21EOLACvtfcHk0lgL-DmQXgZ8dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnvFarsbY%253D&md5=352a58cd9a0ca135466949b75fee5137</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fjm001028o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm001028o%26sid%3Dliteratum%253Aachs%26aulast%3DGnerre%26aufirst%3DC.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DWeber%26aufirst%3DP.%26aulast%3DCarrupt%26aufirst%3DP.-A.%26aulast%3DAltomare%26aufirst%3DC.%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DTesta%26aufirst%3DB.%26atitle%3DInhibition%2520of%2520Monoamine%2520Oxidases%2520by%2520Functionalized%2520Coumarin%2520Derivatives%253A%2520Biological%2520Activities%252C%2520QSARs%252C%2520and%25203D-QSARs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D4747%26epage%3D4758%26doi%3D10.1021%2Fjm001028o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Novaroli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favre, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bravo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrupt, P.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reist, M.</span><span> </span><span class="NLM_article-title">Impact of Species-dependent Differences on Screening, Design, and Development of MAO-B Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6264</span><span class="NLM_x">–</span> <span class="NLM_lpage">6272</span><span class="refDoi"> DOI: 10.1021/jm060441e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060441e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6264-6272&author=L.+Novaroliauthor=A.+Dainaauthor=E.+Favreauthor=J.+Bravoauthor=A.+Carottiauthor=F.+Leonettiauthor=M.+Cattoauthor=P.-A.+Carruptauthor=M.+Reist&title=Impact+of+Species-dependent+Differences+on+Screening%2C+Design%2C+and+Development+of+MAO-B+Inhibitors&doi=10.1021%2Fjm060441e"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fjm060441e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060441e%26sid%3Dliteratum%253Aachs%26aulast%3DNovaroli%26aufirst%3DL.%26aulast%3DDaina%26aufirst%3DA.%26aulast%3DFavre%26aufirst%3DE.%26aulast%3DBravo%26aufirst%3DJ.%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DCarrupt%26aufirst%3DP.-A.%26aulast%3DReist%26aufirst%3DM.%26atitle%3DImpact%2520of%2520Species-dependent%2520Differences%2520on%2520Screening%252C%2520Design%252C%2520and%2520Development%2520of%2520MAO-B%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6264%26epage%3D6272%26doi%3D10.1021%2Fjm060441e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Ellman, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtney, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andres, V.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Featherstone, R. M.</span><span> </span><span class="NLM_article-title">A New and Rapid Colorimetric Determination of Acetylcholinesterase Activity</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1961</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">88</span><span class="NLM_x">–</span> <span class="NLM_lpage">95</span><span class="refDoi"> DOI: 10.1016/0006-2952(61)90145-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1016%2F0006-2952%2861%2990145-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=13726518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADyaF3MXht1Gns7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1961&pages=88-95&author=G.+L.+Ellmanauthor=K.+D.+Courtneyauthor=V.+Andresauthor=R.+M.+Featherstone&title=A+New+and+Rapid+Colorimetric+Determination+of+Acetylcholinesterase+Activity&doi=10.1016%2F0006-2952%2861%2990145-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">A new and rapid colorimetric determination of acetylcholinesterase activity</span></div><div class="casAuthors">Ellman, George L.; Courtney, K. Diane; Andres, Valentino, Jr.; Featherstone, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1961</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">88-95</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">A photometric method for detg. acetylcholinesterase activity of tissue exts., homogenates, cell suspensions, etc. was described.  The enzyme activity of acetylcholinesterase was measured by following the increase of yellow color produced from thiocholine when it reacts with dithiobisnitrobenzoate ion, based on the reactions: acetylthiocholine (enzyme.rdblhar.) thioeholine + acetate.  Thiocholine + dithiobisnitrobenzoate .rdblhar. yellow color.  The method was used to study the enzyme in human erythrocytes and homogenates of rat brain, kidney, lungs, liver, and muscle tissue.  Hydrolysis rates [(moles/l./min.) × 10-6/g. tissue] by these homogenates of tissues on acetylthiocholine were 10.31, 0.28, 1.63, 1.07, and 1.82, and on butyrylthiocholine were 0.31, 0.21, 0.54, 0.65, and 0.12, resp.  Data obtained with acetylthiocholine as substrate were similar to those with acetylcholine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq21LY6gwNKrVg90H21EOLACvtfcHk0liWRDdr8LujBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF3MXht1Gns7o%253D&md5=46f891b7e338036a7c7d4333b82b6874</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2861%2990145-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252861%252990145-9%26sid%3Dliteratum%253Aachs%26aulast%3DEllman%26aufirst%3DG.%2BL.%26aulast%3DCourtney%26aufirst%3DK.%2BD.%26aulast%3DAndres%26aufirst%3DV.%26aulast%3DFeatherstone%26aufirst%3DR.%2BM.%26atitle%3DA%2520New%2520and%2520Rapid%2520Colorimetric%2520Determination%2520of%2520Acetylcholinesterase%2520Activity%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1961%26volume%3D7%26spage%3D88%26epage%3D95%26doi%3D10.1016%2F0006-2952%2861%2990145-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Denizot, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, R.</span><span> </span><span class="NLM_article-title">Rapid Colorimetric Assay for Cell Growth and Survival. Modifications to the Tetrazolium Dye Procedure Giving Improved Sensitivity and Reliability</span> <span class="citation_source-journal">J. Immunol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">277</span><span class="refDoi"> DOI: 10.1016/0022-1759(86)90368-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1016%2F0022-1759%2886%2990368-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=3486233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A280%3ADyaL287psl2jsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=1986&pages=271-277&author=F.+Denizotauthor=R.+Lang&title=Rapid+Colorimetric+Assay+for+Cell+Growth+and+Survival.+Modifications+to+the+Tetrazolium+Dye+Procedure+Giving+Improved+Sensitivity+and+Reliability&doi=10.1016%2F0022-1759%2886%2990368-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability</span></div><div class="casAuthors">Denizot F; Lang R</div><div class="citationInfo"><span class="NLM_cas:title">Journal of immunological methods</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">271-7</span>
        ISSN:<span class="NLM_cas:issn">0022-1759</span>.
    </div><div class="casAbstract">A convenient way to estimate the number of viable cells growing in microtitre tray wells is to use a colorimetric assay and an automatic microplate scanning spectrophotometer.  One such assay, developed by Mosmann, depends on the reduction by living cells of tetrazolium salt, MTT, to form a blue formazan product.  However the original technique has several technical limitations, namely a less than optimal sensitivity, a variable background due to protein precipitation on adding an organic solvent to dissolve the blue formazan product, and a low solubility of the product.  These problems have been overcome by the following modifications: avoidance of serum in the incubation medium, thus overcoming precipitation problems in the organic solvent; avoidance of phenol red in the incubation medium, thus avoiding the use of acid in the final solvent which altered the spectral properties of the formazan; elimination of the medium containing MTT after the reaction and subsequent use of pure propanol or ethanol to rapidly solubilize the formazan; use of a higher concentration of MTT; use of half-area microtitre trays to increase the spectrophotometer readings from a given amount of formazan; use of a more judicious reference wavelength in a dual wavelength spectrophotometer.  With these modifications the reliability and sensitivity of the test have been increased to the point where it can in many cases replace the [3H]thymidine uptake assay to measure cell proliferation or survival in growth factor or cytotoxicity assays.  Examples of its use in IL-2 assays are given.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRpURYu5ihmxO98rul4nhSdfW6udTcc2ebWMS1Z-x8Ra7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL287psl2jsA%253D%253D&md5=9e5506f28a0b29b20046b7e21bb5527e</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2F0022-1759%2886%2990368-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-1759%252886%252990368-6%26sid%3Dliteratum%253Aachs%26aulast%3DDenizot%26aufirst%3DF.%26aulast%3DLang%26aufirst%3DR.%26atitle%3DRapid%2520Colorimetric%2520Assay%2520for%2520Cell%2520Growth%2520and%2520Survival.%2520Modifications%2520to%2520the%2520Tetrazolium%2520Dye%2520Procedure%2520Giving%2520Improved%2520Sensitivity%2520and%2520Reliability%26jtitle%3DJ.%2520Immunol.%2520Methods%26date%3D1986%26volume%3D89%26spage%3D271%26epage%3D277%26doi%3D10.1016%2F0022-1759%2886%2990368-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Denora, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laquintana, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopalco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iacobazzi, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopedota, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutrignelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iacobellis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annese, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cascione, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leporatti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franco, M.</span><span> </span><span class="NLM_article-title">In vitro targeting and imaging the translocator protein TSPO 18-kDa through G(4)-PAMAM-FITC labeled dendrimer</span> <span class="citation_source-journal">J. Controlled Release</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">172</span><span class="NLM_x">, </span> <span class="NLM_fpage">1111</span><span class="NLM_x">–</span> <span class="NLM_lpage">1125</span><span class="refDoi"> DOI: 10.1016/j.jconrel.2013.09.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1016%2Fj.jconrel.2013.09.024" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2013&pages=1111-1125&author=N.+Denoraauthor=V.+Laquintanaauthor=A.+Lopalcoauthor=R.+M.+Iacobazziauthor=A.+Lopedotaauthor=A.+Cutrignelliauthor=G.+Iacobellisauthor=C.+Anneseauthor=M.+Cascioneauthor=S.+Leporattiauthor=M.+Franco&title=In+vitro+targeting+and+imaging+the+translocator+protein+TSPO+18-kDa+through+G%284%29-PAMAM-FITC+labeled+dendrimer&doi=10.1016%2Fj.jconrel.2013.09.024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.jconrel.2013.09.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jconrel.2013.09.024%26sid%3Dliteratum%253Aachs%26aulast%3DDenora%26aufirst%3DN.%26aulast%3DLaquintana%26aufirst%3DV.%26aulast%3DLopalco%26aufirst%3DA.%26aulast%3DIacobazzi%26aufirst%3DR.%2BM.%26aulast%3DLopedota%26aufirst%3DA.%26aulast%3DCutrignelli%26aufirst%3DA.%26aulast%3DIacobellis%26aufirst%3DG.%26aulast%3DAnnese%26aufirst%3DC.%26aulast%3DCascione%26aufirst%3DM.%26aulast%3DLeporatti%26aufirst%3DS.%26aulast%3DFranco%26aufirst%3DM.%26atitle%3DIn%2520vitro%2520targeting%2520and%2520imaging%2520the%2520translocator%2520protein%2520TSPO%252018-kDa%2520through%2520G%25284%2529-PAMAM-FITC%2520labeled%2520dendrimer%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2013%26volume%3D172%26spage%3D1111%26epage%3D1125%26doi%3D10.1016%2Fj.jconrel.2013.09.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Crivori, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cruciani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrupt, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Testa, B.</span><span> </span><span class="NLM_article-title">Predicting Blood-Brain Barrier Permeation from Three-Dimensional Molecular Structure</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">2204</span><span class="NLM_x">–</span> <span class="NLM_lpage">2216</span><span class="refDoi"> DOI: 10.1021/jm990968+</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990968%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjtFKhtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=2204-2216&author=P.+Crivoriauthor=G.+Crucianiauthor=P.+A.+Carruptauthor=B.+Testa&title=Predicting+Blood-Brain+Barrier+Permeation+from+Three-Dimensional+Molecular+Structure&doi=10.1021%2Fjm990968%2B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Predicting blood-brain barrier permeation from three-dimensional molecular structure</span></div><div class="casAuthors">Crivori, Patrizia; Cruciani, Gabriele; Carrupt, Pierre-Alain; Testa, Bernard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2204-2216</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Predicting blood-brain barrier (BBB) permeation remains a challenge in drug design.  Since it is impossible to det. exptl. the BBB partitioning of large nos. of preclin. candidates, alternative evaluation methods based on computerized models are desirable.  The present study was conducted to demonstrate the value of descriptors derived from 3D mol. fields in estg. the BBB permeation of a large set of compds. and to produce a simple math. model suitable for external prediction.  The method used (VolSurf) transforms 3D fields into descriptors and correlates them to the exptl. permeation by a discriminant partial least squares procedure.  The model obtained here correctly predicts more than 90% of the BBB permeation data.  By quantifying the favorable and unfavorable contributions of physicochem. and structural properties, it also offers valuable insights for drug design, pharmacol. profiling, and screening.  The computational procedure is fully automated and quite fast.  The method thus appears as a valuable new tool in virtual screening where selection or prioritization of candidates is required from large collections of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoURsaBTpmsObVg90H21EOLACvtfcHk0li83nwd0ytPTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjtFKhtLk%253D&md5=569f3500268859660bb9e5206da270fe</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fjm990968%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990968%252B%26sid%3Dliteratum%253Aachs%26aulast%3DCrivori%26aufirst%3DP.%26aulast%3DCruciani%26aufirst%3DG.%26aulast%3DCarrupt%26aufirst%3DP.%2BA.%26aulast%3DTesta%26aufirst%3DB.%26atitle%3DPredicting%2520Blood-Brain%2520Barrier%2520Permeation%2520from%2520Three-Dimensional%2520Molecular%2520Structure%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D2204%26epage%3D2216%26doi%3D10.1021%2Fjm990968%2B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tropsha, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gramatica, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gombar, V.</span><span> </span><span class="NLM_article-title">The Importance of Being Earnest: Validation is the Absolute Essential for Successful Application and Interpretation of QSPR Models</span> <span class="citation_source-journal">QSAR Comb. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span><span class="refDoi"> DOI: 10.1002/qsar.200390007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1002%2Fqsar.200390007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkslOqsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=69-77&author=A.+Tropshaauthor=P.+Gramaticaauthor=V.+Gombar&title=The+Importance+of+Being+Earnest%3A+Validation+is+the+Absolute+Essential+for+Successful+Application+and+Interpretation+of+QSPR+Models&doi=10.1002%2Fqsar.200390007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61aR"><div class="casContent"><span class="casTitleNuber">61a</span><div class="casTitle"><span class="NLM_cas:atitle">The importance of being earnest: Validation is the absolute essential for successful application and interpretation of QSPR models</span></div><div class="casAuthors">Tropsha, Alexander; Gramatica, Paola; Gombar, Vijay K.</div><div class="citationInfo"><span class="NLM_cas:title">QSAR & Combinatorial Science</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">69-77</span>CODEN:
                <span class="NLM_cas:coden">QCSSAU</span>;
        ISSN:<span class="NLM_cas:issn">1611-020X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">This paper emphasizes the importance of rigorous validation as a crucial, integral component of Quant. Structure Property Relationship (QSPR) model development.  We consider some examples of published QSPR models, which in spite of their high fitted accuracy for the training sets and apparent mechanistic appeal, fail rigorous validation tests, and, thus, may lack practical utility as reliable screening tools.  We present a set of simple guidelines for developing validated and predictive QSPR models.  To this end, we discuss several validation strategies including: (1) Randomization of the modeled property, also called Y-scrambling, (2) Multiple leave-many-out cross-validations, and (3) External validation using rational division of a dataset into training and test sets.  We also highlight the need to establish the domain of model applicability in the chem. space to flag mols. for which predictions may be unreliable, and discuss some algorithms that can be used for this purpose.  We advocate the broad use of these guidelines in the development of predictive QSPR models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoh8MNeROliyrVg90H21EOLACvtfcHk0li83nwd0ytPTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkslOqsrw%253D&md5=5c3c6a74a22fc614e57f1b68d4339ae2</span></div><a href="/servlet/linkout?suffix=cit61a&amp;dbid=16384&amp;doi=10.1002%2Fqsar.200390007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fqsar.200390007%26sid%3Dliteratum%253Aachs%26aulast%3DTropsha%26aufirst%3DA.%26aulast%3DGramatica%26aufirst%3DP.%26aulast%3DGombar%26aufirst%3DV.%26atitle%3DThe%2520Importance%2520of%2520Being%2520Earnest%253A%2520Validation%2520is%2520the%2520Absolute%2520Essential%2520for%2520Successful%2520Application%2520and%2520Interpretation%2520of%2520QSPR%2520Models%26jtitle%3DQSAR%2520Comb.%2520Sci.%26date%3D2003%26volume%3D22%26spage%3D69%26epage%3D77%26doi%3D10.1002%2Fqsar.200390007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit61b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Eriksson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaworska, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worth, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cronin, M. T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDowell, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gramatica, P.</span><span> </span><span class="NLM_article-title">Methods for Reliability and Uncertainty Assessment and for Applicability Evaluations of Classification- and Regression- Based QSARs</span> <span class="citation_source-journal">Environ. Health Perspect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">1351</span><span class="NLM_x">–</span> <span class="NLM_lpage">1375</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2003&pages=1351-1375&author=L.+Erikssonauthor=J.+Jaworskaauthor=A.+Worthauthor=M.+T.+D.+Croninauthor=R.+M.+McDowellauthor=P.+Gramatica&title=Methods+for+Reliability+and+Uncertainty+Assessment+and+for+Applicability+Evaluations+of+Classification-+and+Regression-+Based+QSARs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEriksson%26aufirst%3DL.%26aulast%3DJaworska%26aufirst%3DJ.%26aulast%3DWorth%26aufirst%3DA.%26aulast%3DCronin%26aufirst%3DM.%2BT.%2BD.%26aulast%3DMcDowell%26aufirst%3DR.%2BM.%26aulast%3DGramatica%26aufirst%3DP.%26atitle%3DMethods%2520for%2520Reliability%2520and%2520Uncertainty%2520Assessment%2520and%2520for%2520Applicability%2520Evaluations%2520of%2520Classification-%2520and%2520Regression-%2520Based%2520QSARs%26jtitle%3DEnviron.%2520Health%2520Perspect.%26date%3D2003%26volume%3D111%26spage%3D1351%26epage%3D1375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ragheb, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawler, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sturgis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajwa, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melendez, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, J. P.</span><span> </span><span class="NLM_article-title">Mitochondrial Complex I Inhibitor Rotenone Induces Apoptosis through Enhancing Mitochondrial Reactive Oxygen Species Production</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">8516</span><span class="NLM_x">–</span> <span class="NLM_lpage">8525</span><span class="refDoi"> DOI: 10.1074/jbc.M210432200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1074%2Fjbc.M210432200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=12496265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhsF2htrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=8516-8525&author=N.+Liauthor=K.+Raghebauthor=G.+Lawlerauthor=J.+Sturgisauthor=B.+Rajwaauthor=A.+J.+Melendezauthor=J.+P.+Robinson&title=Mitochondrial+Complex+I+Inhibitor+Rotenone+Induces+Apoptosis+through+Enhancing+Mitochondrial+Reactive+Oxygen+Species+Production&doi=10.1074%2Fjbc.M210432200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial Complex I Inhibitor Rotenone Induces Apoptosis through Enhancing Mitochondrial Reactive Oxygen Species Production</span></div><div class="casAuthors">Li, Nianyu; Ragheb, Kathy; Lawler, Gretchen; Sturgis, Jennie; Rajwa, Bartek; Melendez, J. Andres; Robinson, J. Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">8516-8525</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Inhibition of mitochondrial respiratory chain complex I by rotenone had been found to induce cell death in a variety of cells.  However, the mechanism is still elusive.  Because reactive oxygen species (ROS) play an important role in apoptosis and inhibition of mitochondrial respiratory chain complex I by rotenone was thought to be able to elevate mitochondrial ROS prodn., we investigated the relationship between rotenone-induced apoptosis and mitochondrial reactive oxygen species.  Rotenone was able to induce mitochondrial complex I substrate-supported mitochondrial ROS prodn. both in isolated mitochondria from HL-60 cells as well as in cultured cells.  Rotenone-induced apoptosis was confirmed by DNA fragmentation, cytochrome c release, and caspase 3 activity.  A quant. correlation between rotenone-induced apoptosis and rotenone-induced mitochondrial ROS prodn. was identified.  Rotenone-induced apoptosis was inhibited by treatment with antioxidants (glutathione, N-acetylcysteine, and vitamin C).  The role of rotenone-induced mitochondrial ROS in apoptosis was also confirmed by the finding that HT1080 cells overexpressing magnesium superoxide dismutase were more resistant to rotenone-induced apoptosis than control cells.  These results suggest that rotenone is able to induce apoptosis via enhancing the amt. of mitochondrial reactive oxygen species prodn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQz9q2QbEOErVg90H21EOLACvtfcHk0li83nwd0ytPTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhsF2htrg%253D&md5=3b5921aa876f55001b3c2e83cfead91e</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M210432200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M210432200%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DN.%26aulast%3DRagheb%26aufirst%3DK.%26aulast%3DLawler%26aufirst%3DG.%26aulast%3DSturgis%26aufirst%3DJ.%26aulast%3DRajwa%26aufirst%3DB.%26aulast%3DMelendez%26aufirst%3DA.%2BJ.%26aulast%3DRobinson%26aufirst%3DJ.%2BP.%26atitle%3DMitochondrial%2520Complex%2520I%2520Inhibitor%2520Rotenone%2520Induces%2520Apoptosis%2520through%2520Enhancing%2520Mitochondrial%2520Reactive%2520Oxygen%2520Species%2520Production%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D8516%26epage%3D8525%26doi%3D10.1074%2Fjbc.M210432200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Shchepina, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pletjushkina, O. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avetisyan, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakeeva, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fetisova, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izyumov, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saprunova, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyssokikh, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chernyak, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skulachev, V. P.</span><span> </span><span class="NLM_article-title">Oligomycin, Inhibitor of the F0 Part of H+-ATP-synthase, Suppresses the TNF-induced Apoptosis</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">8149</span><span class="NLM_x">–</span> <span class="NLM_lpage">8157</span><span class="refDoi"> DOI: 10.1038/sj.onc.1206053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1038%2Fsj.onc.1206053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=12444550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BD38XovVWhsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2002&pages=8149-8157&author=L.+A.+Shchepinaauthor=O.+Y.+Pletjushkinaauthor=A.+V.+Avetisyanauthor=L.+E.+Bakeevaauthor=E.+K.+Fetisovaauthor=D.+S.+Izyumovauthor=V.+B.+Saprunovaauthor=M.+Y.+Vyssokikhauthor=B.+V.+Chernyakauthor=V.+P.+Skulachev&title=Oligomycin%2C+Inhibitor+of+the+F0+Part+of+H%2B-ATP-synthase%2C+Suppresses+the+TNF-induced+Apoptosis&doi=10.1038%2Fsj.onc.1206053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Oligomycin, inhibitor of the F0 part of H+-ATP-synthase, suppresses the TNF-induced apoptosis</span></div><div class="casAuthors">Shchepina, Liarisa A.; Pletjushkina, Olga Y.; Avetisyan, Armine V.; Bakeeva, Liora E.; Fetisova, Elena K.; Izyumov, Denis S.; Saprunova, Valeria B.; Vyssokikh, Mikhail Y.; Chernyak, Boris V.; Skulachev, Vladimir P.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">53</span>),
    <span class="NLM_cas:pages">8149-8157</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The release of cytochrome c from the intermembrane space of mitochondria into the cytosol is one of the crit. events in apoptotic cell death.  In the present study, it is shown that release of cytochrome c and apoptosis induced by tumor necrosis factor α (TNF) in HeLa cells can be inhibited by (i) overexpression of an oncoprotein Bcl-2, (ii) cyclosporin A, an inhibitor of the mitochondrial permeability transition pore (PTP) or (iii) oligomycin, an inhibitor of H+- ATP-synthase.  Staurosporine-induced apoptosis is sensitive to Bcl-2 but insensitive to cyclosporin A and oligomycin.  The effect of oligomycin is not due to changes in mitochondrial membrane potential or to inhibition of ATP synthesis/hydrolysis since (a) uncouplers (CCCP, DNP) which discharge the membrane potential fail to abolish the protective action of oligomycin and (b) aurovertin B (another inhibitor of H+-ATP-synthase, affecting its F1 component) does not affect apoptosis.  A role of the oligomycin-sensitive F0 component of H+-ATP-synthase in TNF-induced PTP opening and apoptosis is suggested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbViNtpAZkGLVg90H21EOLACvtfcHk0lgdbZwLG9_TUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovVWhsrk%253D&md5=4eed975b7d3f475da709aeb10b7ea94d</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1206053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1206053%26sid%3Dliteratum%253Aachs%26aulast%3DShchepina%26aufirst%3DL.%2BA.%26aulast%3DPletjushkina%26aufirst%3DO.%2BY.%26aulast%3DAvetisyan%26aufirst%3DA.%2BV.%26aulast%3DBakeeva%26aufirst%3DL.%2BE.%26aulast%3DFetisova%26aufirst%3DE.%2BK.%26aulast%3DIzyumov%26aufirst%3DD.%2BS.%26aulast%3DSaprunova%26aufirst%3DV.%2BB.%26aulast%3DVyssokikh%26aufirst%3DM.%2BY.%26aulast%3DChernyak%26aufirst%3DB.%2BV.%26aulast%3DSkulachev%26aufirst%3DV.%2BP.%26atitle%3DOligomycin%252C%2520Inhibitor%2520of%2520the%2520F0%2520Part%2520of%2520H%252B-ATP-synthase%252C%2520Suppresses%2520the%2520TNF-induced%2520Apoptosis%26jtitle%3DOncogene%26date%3D2002%26volume%3D21%26spage%3D8149%26epage%3D8157%26doi%3D10.1038%2Fsj.onc.1206053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">CNS Drug Design: Balancing Physicochemical Properties for Optimal Brain Exposure</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2584</span><span class="NLM_x">–</span> <span class="NLM_lpage">2608</span><span class="refDoi"> DOI: 10.1021/jm501535r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501535r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVyhsrrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2584-2608&author=Z.+Rankovic&title=CNS+Drug+Design%3A+Balancing+Physicochemical+Properties+for+Optimal+Brain+Exposure&doi=10.1021%2Fjm501535r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">CNS Drug Design: Balancing Physicochemical Properties for Optimal Brain Exposure</span></div><div class="casAuthors">Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2584-2608</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The human brain is a uniquely complex organ, which has evolved a sophisticated protection system to prevent injury from external insults and toxins.  Designing mols. that can overcome this protection system and achieve optimal concn. at the desired therapeutic target in the brain is a specific and major challenge for medicinal chemists working in CNS drug discovery.  Analogous to the now widely accepted rule of 5 in the design of oral drugs, the physicochem. properties required for optimal brain exposure have been extensively studied in an attempt to similarly define the attributes of successful CNS drugs and drug candidates.  This body of work is systematically reviewed here, with a particular emphasis on the interplay between the most crit. physicochem. and pharmacokinetic parameters of CNS drugs as well as their impact on medicinal chem. strategies toward mols. with optimal brain exposure.  A summary of modern CNS pharmacokinetic concepts and methods is also provided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8V0N1j49uuLVg90H21EOLACvtfcHk0lgdbZwLG9_TUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVyhsrrP&md5=f01e3f2dc4e2eff7b0618124277a5cf8</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fjm501535r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501535r%26sid%3Dliteratum%253Aachs%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DCNS%2520Drug%2520Design%253A%2520Balancing%2520Physicochemical%2520Properties%2520for%2520Optimal%2520Brain%2520Exposure%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2584%26epage%3D2608%26doi%3D10.1021%2Fjm501535r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Pajouhesh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, G. R.</span><span> </span><span class="NLM_article-title">Medicinal Chemical Properties of Successful Central Nervous System Drugs</span> <span class="citation_source-journal">NeuroRx</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">541</span><span class="NLM_x">–</span> <span class="NLM_lpage">553</span><span class="refDoi"> DOI: 10.1602/neurorx.2.4.541</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1602%2Fneurorx.2.4.541" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=16489364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=541-553&author=H.+Pajouheshauthor=G.+R.+Lenz&title=Medicinal+Chemical+Properties+of+Successful+Central+Nervous+System+Drugs&doi=10.1602%2Fneurorx.2.4.541"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemical properties of successful central nervous system drugs</span></div><div class="casAuthors">Pajouhesh Hassan; Lenz George R</div><div class="citationInfo"><span class="NLM_cas:title">NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">541-53</span>
        ISSN:<span class="NLM_cas:issn">1545-5343</span>.
    </div><div class="casAbstract">Fundamental physiochemical features of CNS drugs are related to their ability to penetrate the blood-brain barrier affinity and exhibit CNS activity.  Factors relevant to the success of CNS drugs are reviewed.  CNS drugs show values of molecular weight, lipophilicity, and hydrogen bond donor and acceptor that in general have a smaller range than general therapeutics.  Pharmacokinetic properties can be manipulated by the medicinal chemist to a significant extent.  The solubility, permeability, metabolic stability, protein binding, and human ether-ago-go-related gene inhibition of CNS compounds need to be optimized simultaneously with potency, selectivity, and other biological parameters.  The balance between optimizing the physiochemical and pharmacokinetic properties to make the best compromises in properties is critical for designing new drugs likely to penetrate the blood brain barrier and affect relevant biological systems.  This review is intended as a guide to designing CNS therapeutic agents with better drug-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_ncsy3yuEinl8icjszYl0fW6udTcc2eYTHll7eyG237ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D&md5=0815084e2d107b9243b785d0782dfc3a</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1602%2Fneurorx.2.4.541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1602%252Fneurorx.2.4.541%26sid%3Dliteratum%253Aachs%26aulast%3DPajouhesh%26aufirst%3DH.%26aulast%3DLenz%26aufirst%3DG.%2BR.%26atitle%3DMedicinal%2520Chemical%2520Properties%2520of%2520Successful%2520Central%2520Nervous%2520System%2520Drugs%26jtitle%3DNeuroRx%26date%3D2005%26volume%3D2%26spage%3D541%26epage%3D553%26doi%3D10.1602%2Fneurorx.2.4.541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Fernandez-Bachiller, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monjas, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rademann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodríguez-Franco, M. I.</span><span> </span><span class="NLM_article-title">New Tacrine–4-Oxo-4H-chromene Hybrids as Multifunctional Agents for the Treatment of Alzheimer’s Disease, with Cholinergic, Antioxidant, and β-Amyloid-Reducing Properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1303</span><span class="NLM_x">–</span> <span class="NLM_lpage">1317</span><span class="refDoi"> DOI: 10.1021/jm201460y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201460y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1303-1317&author=M.+I.+Fernandez-Bachillerauthor=C.+Perezauthor=L.+Monjasauthor=J.+Rademannauthor=M.+I.+Rodr%C3%ADguez-Franco&title=New+Tacrine%E2%80%934-Oxo-4H-chromene+Hybrids+as+Multifunctional+Agents+for+the+Treatment+of+Alzheimer%E2%80%99s+Disease%2C+with+Cholinergic%2C+Antioxidant%2C+and+%CE%B2-Amyloid-Reducing+Properties&doi=10.1021%2Fjm201460y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1021%2Fjm201460y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201460y%26sid%3Dliteratum%253Aachs%26aulast%3DFernandez-Bachiller%26aufirst%3DM.%2BI.%26aulast%3DPerez%26aufirst%3DC.%26aulast%3DMonjas%26aufirst%3DL.%26aulast%3DRademann%26aufirst%3DJ.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26atitle%3DNew%2520Tacrine%25E2%2580%25934-Oxo-4H-chromene%2520Hybrids%2520as%2520Multifunctional%2520Agents%2520for%2520the%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%252C%2520with%2520Cholinergic%252C%2520Antioxidant%252C%2520and%2520%25CE%25B2-Amyloid-Reducing%2520Properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1303%26epage%3D1317%26doi%3D10.1021%2Fjm201460y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Otto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penzis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaube, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adolph, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fohr, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warncke, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robaa, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appenroth, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleck, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enzensperger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winckler, T.</span><span> </span><span class="NLM_article-title">Evaluation of Homobivalent Carbolines as Designed Multiple Ligands for the Treatment of Neurodegenerative Disorders</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">6710</span><span class="NLM_x">–</span> <span class="NLM_lpage">6715</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00958</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00958" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlequ7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6710-6715&author=R.+Ottoauthor=R.+Penzisauthor=F.+Gaubeauthor=O.+Adolphauthor=K.+J.+Fohrauthor=P.+Warnckeauthor=D.+Robaaauthor=D.+Appenrothauthor=C.+Fleckauthor=C.+Enzenspergerauthor=J.+Lehmannauthor=T.+Winckler&title=Evaluation+of+Homobivalent+Carbolines+as+Designed+Multiple+Ligands+for+the+Treatment+of+Neurodegenerative+Disorders&doi=10.1021%2Facs.jmedchem.5b00958"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of Homobivalent Carbolines as Designed Multiple Ligands for the Treatment of Neurodegenerative Disorders</span></div><div class="casAuthors">Otto, Robert; Penzis, Robert; Gaube, Friedemann; Adolph, Oliver; Foehr, Karl J.; Warncke, Paul; Robaa, Dina; Appenroth, Dorothea; Fleck, Christian; Enzensperger, Christoph; Lehmann, Jochen; Winckler, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6710-6715</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Neurodegenerative diseases represent a challenge for biomedical research due to their high prevalence and lack of mechanism-based treatments.  Because of the complex pathol. of neurodegenerative disorders, multifunctional drugs have been increasingly recognized as potential treatments.  We identified homobivalent γ-carbolinium salts as potent inhibitors of both cholinesterases, N-methyl-D-aspartate receptors, and monoamine oxidases.  Homobivalent γ-carbolines displayed similar structure-activity relationships on all tested targets and may present promising designed multiple ligands for the treatment of neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoggGUTF85gz7Vg90H21EOLACvtfcHk0lgtYYEtVcQlXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlequ7fP&md5=ccd884b3ed035287c7bbfd5bf17582c8</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00958&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00958%26sid%3Dliteratum%253Aachs%26aulast%3DOtto%26aufirst%3DR.%26aulast%3DPenzis%26aufirst%3DR.%26aulast%3DGaube%26aufirst%3DF.%26aulast%3DAdolph%26aufirst%3DO.%26aulast%3DFohr%26aufirst%3DK.%2BJ.%26aulast%3DWarncke%26aufirst%3DP.%26aulast%3DRobaa%26aufirst%3DD.%26aulast%3DAppenroth%26aufirst%3DD.%26aulast%3DFleck%26aufirst%3DC.%26aulast%3DEnzensperger%26aufirst%3DC.%26aulast%3DLehmann%26aufirst%3DJ.%26aulast%3DWinckler%26aufirst%3DT.%26atitle%3DEvaluation%2520of%2520Homobivalent%2520Carbolines%2520as%2520Designed%2520Multiple%2520Ligands%2520for%2520the%2520Treatment%2520of%2520Neurodegenerative%2520Disorders%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6710%26epage%3D6715%26doi%3D10.1021%2Facs.jmedchem.5b00958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Di Pietro, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez-Areales, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juárez-Jiménez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espargaró, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clos, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavilla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabaté, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muñoz-Torrero, D.</span><span> </span><span class="NLM_article-title">Tetrahydrobenzo[h][1,6]naphthyridine-6-chlorotacrine Hybrids as a New Family of Anti-Alzheimer Agents Targeting β-Amyloid, Tau, and Cholinesterase Pathologies</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">117</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2014.07.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1016%2Fj.ejmech.2014.07.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=25016233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Grs7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2014&pages=107-117&author=O.+Di+Pietroauthor=F.+J.+P%C3%A9rez-Arealesauthor=J.+Ju%C3%A1rez-Jim%C3%A9nezauthor=A.+Espargar%C3%B3author=M.+V.+Closauthor=B.+P%C3%A9rezauthor=R.+Lavillaauthor=R.+Sabat%C3%A9author=F.+J.+Luqueauthor=D.+Mu%C3%B1oz-Torrero&title=Tetrahydrobenzo%5Bh%5D%5B1%2C6%5Dnaphthyridine-6-chlorotacrine+Hybrids+as+a+New+Family+of+Anti-Alzheimer+Agents+Targeting+%CE%B2-Amyloid%2C+Tau%2C+and+Cholinesterase+Pathologies&doi=10.1016%2Fj.ejmech.2014.07.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Tetrahydrobenzo[h][1,6]naphthyridine-6-chlorotacrine hybrids as a new family of anti-Alzheimer agents targeting β-amyloid, tau, and cholinesterase pathologies</span></div><div class="casAuthors">Di Pietro, Ornella; Perez-Areales, F. Javier; Juarez-Jimenez, Jordi; Espargaro, Alba; Clos, M. Victoria; Perez, Belen; Lavilla, Rodolfo; Sabate, Raimon; Luque, F. Javier; Munoz-Torrero, Diego</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">107-117</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Optimization of an essentially inactive 3,4-dihydro-2H-pyrano[3,2-c]quinoline carboxylic ester deriv. as acetylcholinesterase (AChE) peripheral anionic site (PAS)-binding motif by double O → NH bioisosteric replacement, combined with mol. hybridization with the AChE catalytic anionic site (CAS) inhibitor 6-chlorotacrine and mol. dynamics-driven optimization of the length of the linker has resulted in the development of the trimethylene-linked 1,2,3,4-tetrahydrobenzo[h][1,6]naphthyridine-6-chlorotacrine hybrid I as a picomolar inhibitor of human AChE (hAChE).  The tetra-, penta-, and octamethylene-linked homologs I [X = (CH2)4, (CH2)5, (CH2)8] have been also synthesized for comparison purposes, and found to retain the nanomolar hAChE inhibitory potency of the parent 6-chlorotacrine.  Further biol. profiling of hybrids I has shown that they are also potent inhibitors of human butyrylcholinesterase and moderately potent Aβ42 and tau antiaggregating agents, with IC50 values in the submicromolar and low micromolar range, resp.  Also, in vitro studies using an artificial membrane model have predicted a good brain permeability for hybrids I, and hence, their ability to reach their targets in the central nervous system.  The multitarget profile of the novel hybrids makes them promising leads for developing anti-Alzheimer drug candidates with more balanced biol. activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOcQV1Ii0VkbVg90H21EOLACvtfcHk0lgtYYEtVcQlXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Grs7fI&md5=c52fbb0243247cd8088d94a368c33186</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.07.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.07.021%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BPietro%26aufirst%3DO.%26aulast%3DP%25C3%25A9rez-Areales%26aufirst%3DF.%2BJ.%26aulast%3DJu%25C3%25A1rez-Jim%25C3%25A9nez%26aufirst%3DJ.%26aulast%3DEspargar%25C3%25B3%26aufirst%3DA.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DP%25C3%25A9rez%26aufirst%3DB.%26aulast%3DLavilla%26aufirst%3DR.%26aulast%3DSabat%25C3%25A9%26aufirst%3DR.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DTetrahydrobenzo%255Bh%255D%255B1%252C6%255Dnaphthyridine-6-chlorotacrine%2520Hybrids%2520as%2520a%2520New%2520Family%2520of%2520Anti-Alzheimer%2520Agents%2520Targeting%2520%25CE%25B2-Amyloid%252C%2520Tau%252C%2520and%2520Cholinesterase%2520Pathologies%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D84%26spage%3D107%26epage%3D117%26doi%3D10.1016%2Fj.ejmech.2014.07.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Viayna, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sola, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Simone, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tapia-Rojas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serrano, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabaté, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juarez-Jimenez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clos, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inestrosa, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muñoz-Torrero, D.</span><span> </span><span class="NLM_article-title">Synthesis and Multitarget Biological Profiling of a Novel Family of Rhein Derivatives As Disease-Modifying Anti-Alzheimer Agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">2549</span><span class="NLM_x">–</span> <span class="NLM_lpage">2567</span><span class="refDoi"> DOI: 10.1021/jm401824w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401824w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtVeqsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2549-2567&author=E.+Viaynaauthor=I.+Solaauthor=M.+Bartoliniauthor=A.+De+Simoneauthor=C.+Tapia-Rojasauthor=F.+G.+Serranoauthor=R.+Sabat%C3%A9author=J.+Juarez-Jimenezauthor=B.+Perezauthor=F.+J.+Luqueauthor=V.+Andrisanoauthor=M.+V.+Closauthor=N.+C.+Inestrosaauthor=D.+Mu%C3%B1oz-Torrero&title=Synthesis+and+Multitarget+Biological+Profiling+of+a+Novel+Family+of+Rhein+Derivatives+As+Disease-Modifying+Anti-Alzheimer+Agents&doi=10.1021%2Fjm401824w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Multitarget Biological Profiling of a Novel Family of Rhein Derivatives As Disease-Modifying Anti-Alzheimer Agents</span></div><div class="casAuthors">Viayna, Elisabet; Sola, Irene; Bartolini, Manuela; De Simone, Angela; Tapia-Rojas, Cheril; Serrano, Felipe G.; Sabate, Raimon; Juarez-Jimenez, Jordi; Perez, Belen; Luque, F. Javier; Andrisano, Vincenza; Clos, M. Victoria; Inestrosa, Nibaldo C.; Munoz-Torrero, Diego</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2549-2567</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have synthesized a family of rhein-huprine hybrids I [X = (CH2)n, n = 5-11; X = CH2-p-phenylene-CH2] to hit several key targets for Alzheimer's disease.  Biol. screening performed in vitro and in Escherichia coli cells has shown that these hybrids exhibit potent inhibitory activities against human acetylcholinesterase, butyrylcholinesterase, and BACE-1, dual Aβ42 and tau antiaggregating activity, and brain permeability.  Ex vivo studies with the leads (+)- and (-)-I [X = (CH2)9] (II) in brain slices of C57bl6 mice have revealed that they efficiently protect against the Aβ-induced synaptic dysfunction, preventing the loss of synaptic proteins and/or have a pos. effect on the induction of long-term potentiation.  In vivo studies in APP-PS1 transgenic mice treated i.p. for 4 wk with (+)- and (-)-II have shown a central sol. Aβ lowering effect, accompanied by an increase in the levels of mature amyloid precursor protein (APP).  Thus, (+)- and (-)-II emerge as very promising disease-modifying anti-Alzheimer drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeoyGkrcOQArVg90H21EOLACvtfcHk0lgtYYEtVcQlXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtVeqsrc%253D&md5=711450b3c2289a3fb2037d536e9a7a7b</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fjm401824w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401824w%26sid%3Dliteratum%253Aachs%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DSola%26aufirst%3DI.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DDe%2BSimone%26aufirst%3DA.%26aulast%3DTapia-Rojas%26aufirst%3DC.%26aulast%3DSerrano%26aufirst%3DF.%2BG.%26aulast%3DSabat%25C3%25A9%26aufirst%3DR.%26aulast%3DJuarez-Jimenez%26aufirst%3DJ.%26aulast%3DPerez%26aufirst%3DB.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DInestrosa%26aufirst%3DN.%2BC.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DSynthesis%2520and%2520Multitarget%2520Biological%2520Profiling%2520of%2520a%2520Novel%2520Family%2520of%2520Rhein%2520Derivatives%2520As%2520Disease-Modifying%2520Anti-Alzheimer%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D2549%26epage%3D2567%26doi%3D10.1021%2Fjm401824w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Wu, M.; Esteban, G.; Brogi, S.; Shionoya, M.; Wang, L.; Campiani, G.; Unzeta, M.; Inokuchi, T.; Butini, S.; Marco-Contelles, J.</span><span> </span><span class="NLM_article-title">Donepezil-like Multifunctional Agents: Design, Synthesis, Molecular Modeling and Biological Evaluation</span>.  <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span>DOI:<span class="refDoi"> DOI: 10.1016/j.ejmech.2015.10.001</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1016%2Fj.ejmech.2015.10.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=M.+Wu&author=G.+Esteban&author=S.+Brogi&author=M.+Shionoya&author=L.+Wang&author=G.+Campiani&author=M.+Unzeta&author=T.+Inokuchi&author=S.+Butini&author=J.+Marco-Contelles&title=Donepezil-like+Multifunctional+Agents%3A+Design%2C+Synthesis%2C+Molecular+Modeling+and+Biological+Evaluation&doi=10.1016%2Fj.ejmech.2015.10.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.10.001%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DM.%26atitle%3DDonepezil-like%2520Multifunctional%2520Agents%253A%2520Design%252C%2520Synthesis%252C%2520Molecular%2520Modeling%2520and%2520Biological%2520Evaluation%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26doi%3D10.1016%2Fj.ejmech.2015.10.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esteban, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ojima, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bautista-Aguilera, O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inokuchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moraleda, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iriepa, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samadi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soriano, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández Fernández, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martínez-Murillo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unzeta, M.</span><span> </span><span class="NLM_article-title">Donepezil + Propargylamine + 8-Hydroxyquinoline Hybrids as New Multifunctional Metal-chelators, ChE and MAO Inhibitors for the Potential Treatment of Alzheimer’s Disease</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">543</span><span class="NLM_x">–</span> <span class="NLM_lpage">561</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2014.04.078</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1016%2Fj.ejmech.2014.04.078" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=24813882" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovVensL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2014&pages=543-561&author=L.+Wangauthor=G.+Estebanauthor=M.+Ojimaauthor=O.+M.+Bautista-Aguileraauthor=T.+Inokuchiauthor=I.+Moraledaauthor=I.+Iriepaauthor=A.+Samadiauthor=M.+B.+H.+Youdimauthor=A.+Romeroauthor=E.+Sorianoauthor=R.+Herreroauthor=A.+P.+Fern%C3%A1ndez+Fern%C3%A1ndezauthor=R.+Mart%C3%ADnez-Murilloauthor=J.+Marco-Contellesauthor=M.+Unzeta&title=Donepezil+%2B+Propargylamine+%2B+8-Hydroxyquinoline+Hybrids+as+New+Multifunctional+Metal-chelators%2C+ChE+and+MAO+Inhibitors+for+the+Potential+Treatment+of+Alzheimer%E2%80%99s+Disease&doi=10.1016%2Fj.ejmech.2014.04.078"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Donepezil + propargylamine + 8-hydroxyquinoline hybrids as new multifunctional metal-chelators, ChE and MAO inhibitors for the potential treatment of Alzheimer's disease</span></div><div class="casAuthors">Wang, Li; Esteban, Gerard; Ojima, Masaki; Bautista-Aguilera, Oscar M.; Inokuchi, Tsutomu; Moraleda, Ignacio; Iriepa, Isabel; Samadi, Abdelouahid; Youdim, Moussa B. H.; Romero, Alejandro; Soriano, Elena; Herrero, Raquel; Fernandez Fernandez, Ana Patricia; Ricardo-Martinez-Murillo; Marco-Contelles, Jose; Unzeta, Mercedes</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">543-561</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The synthesis, biochem. evaluation, ADMET, toxicity and mol. modeling of novel multi-target-directed Donepezil + Propargylamine + 8-Hydroxyquinoline (DPH) hybrids for the potential prevention and treatment of Alzheimer's disease is described.  The most interesting deriv. was racemic α-aminotrile4-(1-benzylpiperidin-4-yl)-2-(((8-hydroxyquinolin-5-yl)methyl)(prop-2-yn-1-yl)amino) butanenitrile (DPH6) [MAO A (IC50 = 6.2±0.7 μM); MAO B (IC50 = 10.2±0.9 μM); AChE (IC50 = 1.8±0.1 μM); BuChE (IC50 = 1.6±0.25 μM)], an irreversible MAO A/B inhibitor and mixed-type AChE inhibitor with metal-chelating properties.  According to docking studies, both DPH6 enantiomers interact simultaneously with the catalytic and peripheral site of EeAChE through a linker of appropriate length, supporting the obsd. mixed-type AChE inhibition.  Both enantiomers exhibited a relatively similar position of both hydroxyquinoline and benzyl moieties with the rest of the mol. easily accommodated in the relatively large cavity of MAO A.  For MAO B, the quinoline system was hosted at the cavity entrance, whereas for MAO A this system occupied the substrate cavity.  In this disposition the quinoline moiety interacted directly with the FAD arom. ring.  Very similar binding affinity values were also obsd. for both enantiomers with ChE and MAO enzymes.  DPH derivs. exhibited moderate to good ADMET properties and brain penetration capacity for CNS activity.  DPH6 was less toxic than donepezil at high concns.; while at low concns. both displayed a similar cell viability profile.  Finally, in a passive avoidance task, the antiamnesic effect of DPH6 was tested on mice with exptl. induced amnesia.  DPH6 was capable to significantly decrease scopolamine-induced learning deficits in healthy adult mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphrIxeM4RW2rVg90H21EOLACvtfcHk0ljrAIUaqxrI8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovVensL8%253D&md5=2e1f262b4002653cbac7a6dafabe3548</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.04.078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.04.078%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DEsteban%26aufirst%3DG.%26aulast%3DOjima%26aufirst%3DM.%26aulast%3DBautista-Aguilera%26aufirst%3DO.%2BM.%26aulast%3DInokuchi%26aufirst%3DT.%26aulast%3DMoraleda%26aufirst%3DI.%26aulast%3DIriepa%26aufirst%3DI.%26aulast%3DSamadi%26aufirst%3DA.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26aulast%3DRomero%26aufirst%3DA.%26aulast%3DSoriano%26aufirst%3DE.%26aulast%3DHerrero%26aufirst%3DR.%26aulast%3DFern%25C3%25A1ndez%2BFern%25C3%25A1ndez%26aufirst%3DA.%2BP.%26aulast%3DMart%25C3%25ADnez-Murillo%26aufirst%3DR.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26aulast%3DUnzeta%26aufirst%3DM.%26atitle%3DDonepezil%2520%252B%2520Propargylamine%2520%252B%25208-Hydroxyquinoline%2520Hybrids%2520as%2520New%2520Multifunctional%2520Metal-chelators%252C%2520ChE%2520and%2520MAO%2520Inhibitors%2520for%2520the%2520Potential%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D80%26spage%3D543%26epage%3D561%26doi%3D10.1016%2Fj.ejmech.2014.04.078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Weinstock, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bejar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poltyrev, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finberg, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span> </span><span class="NLM_article-title">TV3326, a Novel Neuroprotective Drug with Cholinesterase and Monoamine Oxidase Inhibitory Activities for the Treatment of Alzheimer’s Disease</span> <span class="citation_source-journal">J. Neural Transm. Suppl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">169</span><span class="refDoi"> DOI: 10.1007/978-3-7091-6301-6_10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1007%2F978-3-7091-6301-6_10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=11205137" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=157-169&author=M.+Weinstockauthor=C.+Bejarauthor=R.+H.+Wangauthor=T.+Poltyrevauthor=A.+Grossauthor=J.+P.+Finbergauthor=M.+B.+Youdim&title=TV3326%2C+a+Novel+Neuroprotective+Drug+with+Cholinesterase+and+Monoamine+Oxidase+Inhibitory+Activities+for+the+Treatment+of+Alzheimer%E2%80%99s+Disease&doi=10.1007%2F978-3-7091-6301-6_10"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1007%2F978-3-7091-6301-6_10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-7091-6301-6_10%26sid%3Dliteratum%253Aachs%26aulast%3DWeinstock%26aufirst%3DM.%26aulast%3DBejar%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DR.%2BH.%26aulast%3DPoltyrev%26aufirst%3DT.%26aulast%3DGross%26aufirst%3DA.%26aulast%3DFinberg%26aufirst%3DJ.%2BP.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26atitle%3DTV3326%252C%2520a%2520Novel%2520Neuroprotective%2520Drug%2520with%2520Cholinesterase%2520and%2520Monoamine%2520Oxidase%2520Inhibitory%2520Activities%2520for%2520the%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Neural%2520Transm.%2520Suppl.%26date%3D2000%26volume%3D60%26spage%3D157%26epage%3D169%26doi%3D10.1007%2F978-3-7091-6301-6_10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Sterling, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herzig, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goren, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finkelstein, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldenberg, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miskolczi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molnar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rantal, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamas, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zagyva, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zekany, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavian, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Razin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krais, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chorev, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstock, M.</span><span> </span><span class="NLM_article-title">Novel Dual Inhibitors of AChE and MAO Derived from Hydroxy Aminoindan and Phenethylamine as Potential Treatment for Alzheimer’s Disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">5260</span><span class="NLM_x">–</span> <span class="NLM_lpage">5279</span><span class="refDoi"> DOI: 10.1021/jm020120c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020120c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BD38XotVymsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=5260-5279&author=J.+Sterlingauthor=Y.+Herzigauthor=T.+Gorenauthor=N.+Finkelsteinauthor=D.+Lernerauthor=W.+Goldenbergauthor=I.+Miskolcziauthor=S.+Molnarauthor=F.+Rantalauthor=T.+Tamasauthor=G.+Tothauthor=A.+Zagyvaauthor=A.+Zekanyauthor=G.+Lavianauthor=A.+Grossauthor=R.+Friedmanauthor=M.+Razinauthor=W.+Huangauthor=B.+Kraisauthor=M.+Chorevauthor=M.+B.+H.+Youdimauthor=M.+Weinstock&title=Novel+Dual+Inhibitors+of+AChE+and+MAO+Derived+from+Hydroxy+Aminoindan+and+Phenethylamine+as+Potential+Treatment+for+Alzheimer%E2%80%99s+Disease&doi=10.1021%2Fjm020120c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Dual Inhibitors of AChE and MAO Derived from Hydroxy Aminoindan and Phenethylamine as Potential Treatment for Alzheimer's Disease</span></div><div class="casAuthors">Sterling, Jeffrey; Herzig, Yaacov; Goren, Tamar; Finkelstein, Nina; Lerner, David; Goldenberg, Willy; Miskolczi, Istvan; Molnar, Sandor; Rantal, Ferenc; Tamas, Tivadar; Toth, Gyorgy; Zagyva, Adela; Zekany, Andras; Lavian, Gila; Gross, Aviva; Friedman, Rachel; Razin, Michal; Huang, Wei; Krais, Boris; Chorev, Michael; Youdim, Moussa B.; Weinstock, Marta</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">5260-5279</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Carbamate derivs. of N-propargylaminoindanes (Series I) and N-propargylphenethylamines (Series II) were synthesized via multistep procedures from the corresponding hydroxy precursors.  The resp. rasagiline- and selegiline-related series were designed to combine inhibitory activities of both acetylcholine esterase (AChE) and monoamine oxidase (MAO) by virtue of their carbamoyl and propargylamine pharmacophores.  Each compd. was tested for these activities in vitro in order to find mols. with similar potencies against each enzyme.  Compds. with such dual AChE and MAO inhibitory activities are expected to have potential for the treatment of Alzheimer's disease.  The obsd. SAR also offers insight into the requirements of the active sites on these enzymes.  A carbamate moiety was found to be essential for AChE inhibition, which was absent in the corresponding hydroxy precursors.  The propargyl group caused 2-70-fold decrease in AChE inhibitory activity (depending on the position of the carbamoyl group) of Series I, but had little or no effect in Series II.  Thus, the 6- and 7-carbamyloxyphenyls in Series I were either equipotent to, or slightly (2- to 5-fold) less active as AChE inhibitors than, the corresponding compds. in Series II, while the 4-carbamyloxyphenyls were more potent.  The presence of the carbamate moiety in 6- and 7-carbamyloxyphenyls of Series I, considerably decreased MAO-A and -B inhibitory activity, compared to that of the parent hydroxy analogs, while the opposite was true for Series II.  Thus, the 6- and 7-carbamyloxyphenyls in Series I were 2-3 orders of magnitude weaker MAO inhibitors while the 4- carbamyloxyphenyls were equipotent with the corresponding compds. in Series II.  In both series, N-methylation of the propargylamine enhanced the MAO (A and B equally) inhibitory activities and decreased the AChE inhibitory activity.  Two candidates belonging to the indan and tetralin ring systems (HCl salts of I and II) and one phenethylamine (mesylate salt of III) were identified as possible leads for further development based on the following criteria: (a) comparable AChE and MAO-B inhibitory activities, (b) good to moderate AChE inhibitory activity, and (c) lack of strong MAO-A selectivity.  However, it is likely that these compds. will be metabolized to the corresponding phenols, with inhibitory activities against AChE and/or MAO-A or -B, different from those of the parent carbamates.  Thus, the apparent enzyme inhibition will be a result of the combined inhibition of all of these individual metabolites.  The results of our ongoing in vivo screening programs will be published elsewhere.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0RScteajUEbVg90H21EOLACvtfcHk0ljrAIUaqxrI8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotVymsLg%253D&md5=62136a48889ce0fe28a76aa70e577eb9</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Fjm020120c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020120c%26sid%3Dliteratum%253Aachs%26aulast%3DSterling%26aufirst%3DJ.%26aulast%3DHerzig%26aufirst%3DY.%26aulast%3DGoren%26aufirst%3DT.%26aulast%3DFinkelstein%26aufirst%3DN.%26aulast%3DLerner%26aufirst%3DD.%26aulast%3DGoldenberg%26aufirst%3DW.%26aulast%3DMiskolczi%26aufirst%3DI.%26aulast%3DMolnar%26aufirst%3DS.%26aulast%3DRantal%26aufirst%3DF.%26aulast%3DTamas%26aufirst%3DT.%26aulast%3DToth%26aufirst%3DG.%26aulast%3DZagyva%26aufirst%3DA.%26aulast%3DZekany%26aufirst%3DA.%26aulast%3DLavian%26aufirst%3DG.%26aulast%3DGross%26aufirst%3DA.%26aulast%3DFriedman%26aufirst%3DR.%26aulast%3DRazin%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DKrais%26aufirst%3DB.%26aulast%3DChorev%26aufirst%3DM.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26aulast%3DWeinstock%26aufirst%3DM.%26atitle%3DNovel%2520Dual%2520Inhibitors%2520of%2520AChE%2520and%2520MAO%2520Derived%2520from%2520Hydroxy%2520Aminoindan%2520and%2520Phenethylamine%2520as%2520Potential%2520Treatment%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D5260%26epage%3D5279%26doi%3D10.1021%2Fjm020120c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span> </span><span class="NLM_article-title">Avraham Pharmaceuticals Announces Successful Second Interim Results in Phase 2b Study of Ladostigil for the Treatment of Mild Cognitive Impairment</span>, Business Wire July 28,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">, </span><a href="http://www.businesswire.com/news/home/20150728005672/en/Avraham-Pharmaceuticals-Announces-Successful-Interim-Results-Phase" class="extLink">http://www.businesswire.com/news/home/20150728005672/en/Avraham-Pharmaceuticals-Announces-Successful-Interim-Results-Phase</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Avraham+Pharmaceuticals+Announces+Successful+Second+Interim+Results+in+Phase+2b+Study+of+Ladostigil+for+the+Treatment+of+Mild+Cognitive+Impairment%2C+Business+Wire+July+28%2C+2015%2C+http%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20150728005672%2Fen%2FAvraham-Pharmaceuticals-Announces-Successful-Interim-Results-Phase."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26atitle%3DAvraham%2520Pharmaceuticals%2520Announces%2520Successful%2520Second%2520Interim%2520Results%2520in%2520Phase%25202b%2520Study%2520of%2520Ladostigil%2520for%2520the%2520Treatment%2520of%2520Mild%2520Cognitive%2520Impairment%26jtitle%3DBusiness%2520Wire%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Anderson, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCrodden, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tipton, K. F.</span><span> </span><span class="NLM_article-title">Monoamine Oxidase Inhibitors and the Cheese Effect</span> <span class="citation_source-journal">Neurochem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1145</span><span class="NLM_x">–</span> <span class="NLM_lpage">1149</span><span class="refDoi"> DOI: 10.1007/BF00978365</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1007%2FBF00978365" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=8255365" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADyaK2cXitlWjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1993&pages=1145-1149&author=M.+C.+Andersonauthor=F.+Hasanauthor=J.+M.+McCroddenauthor=K.+F.+Tipton&title=Monoamine+Oxidase+Inhibitors+and+the+Cheese+Effect&doi=10.1007%2FBF00978365"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Monoamine oxidase inhibitors and the cheese effect</span></div><div class="casAuthors">Anderson, Mary C.; Hasan, Farris; McCrodden, John M.; Tipton, Keith F.</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemical Research</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1145-9</span>CODEN:
                <span class="NLM_cas:coden">NEREDZ</span>;
        ISSN:<span class="NLM_cas:issn">0364-3190</span>.
    </div><div class="casAbstract">The behavior of inhibitors of monoamine oxidase-A (MAO-A) is considered in terms of the possibility of having an effective antidepressant that does not give rise to hypertensive interactions with dietary tyramine.  Studies with punch-biopsy samples of human intestine and rat intestinal samples show MAO-A to be the predominant form of the enzyme in both species.  Transport studies with everted rat intestinal prepns. indicate that tyramine is extensively metabolized during transport through the intestine.  Selective inhibition of MAO-A by clorgyline results in a large increase in the amt. of unchanged tyramine transported, whereas selective inhibition of MAO-B with L-deprenyl (selegiline) has no significant effect.  The behavior of reversible MAO-A inhibitors can significantly reduce, but not entirely eliminate, these effects on the intestinal metab. of tyramine, but only if the inhibition is competitive in nature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDISgk8VH-8LVg90H21EOLACvtfcHk0lh9bmu7TXqhIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXitlWjsQ%253D%253D&md5=e9d85b743f7fdde68276428940940cac</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1007%2FBF00978365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00978365%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DM.%2BC.%26aulast%3DHasan%26aufirst%3DF.%26aulast%3DMcCrodden%26aufirst%3DJ.%2BM.%26aulast%3DTipton%26aufirst%3DK.%2BF.%26atitle%3DMonoamine%2520Oxidase%2520Inhibitors%2520and%2520the%2520Cheese%2520Effect%26jtitle%3DNeurochem.%2520Res.%26date%3D1993%26volume%3D18%26spage%3D1145%26epage%3D1149%26doi%3D10.1007%2FBF00978365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Lobell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molnár, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keserü, G. M.</span><span> </span><span class="NLM_article-title">Recent Advances in the Prediction of Blood–brain Partitioning from Molecular Structure</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">360</span><span class="NLM_x">–</span> <span class="NLM_lpage">370</span><span class="refDoi"> DOI: 10.1002/jps.10282</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1002%2Fjps.10282" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2003&pages=360-370&author=M.+Lobellauthor=L.+Moln%C3%A1rauthor=G.+M.+Keser%C3%BC&title=Recent+Advances+in+the+Prediction+of+Blood%E2%80%93brain+Partitioning+from+Molecular+Structure&doi=10.1002%2Fjps.10282"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1002%2Fjps.10282&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.10282%26sid%3Dliteratum%253Aachs%26aulast%3DLobell%26aufirst%3DM.%26aulast%3DMoln%25C3%25A1r%26aufirst%3DL.%26aulast%3DKeser%25C3%25BC%26aufirst%3DG.%2BM.%26atitle%3DRecent%2520Advances%2520in%2520the%2520Prediction%2520of%2520Blood%25E2%2580%2593brain%2520Partitioning%2520from%2520Molecular%2520Structure%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2003%26volume%3D92%26spage%3D360%26epage%3D370%26doi%3D10.1002%2Fjps.10282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Conejo-García, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Núñez, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campos, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espinosa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Homodimeric bis-Quaternary Heterocyclic Ammonium Salts as Potent Acetyl- and Butyryl-cholinesterase Inhibitors: A Systematic Investigation of the Influence of Linker and Cationic Heads Over Affinity and Selectivity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2627</span><span class="NLM_x">–</span> <span class="NLM_lpage">2645</span><span class="refDoi"> DOI: 10.1021/jm101299d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101299d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2627-2645&author=A.+Conejo-Garc%C3%ADaauthor=L.+Pisaniauthor=M.+C.+N%C3%BA%C3%B1ezauthor=M.+Cattoauthor=O.+Nicolottiauthor=F.+Leonettiauthor=J.+M.+Camposauthor=M.+A.+Galloauthor=A.+Espinosaauthor=A.+Carotti&title=Homodimeric+bis-Quaternary+Heterocyclic+Ammonium+Salts+as+Potent+Acetyl-+and+Butyryl-cholinesterase+Inhibitors%3A+A+Systematic+Investigation+of+the+Influence+of+Linker+and+Cationic+Heads+Over+Affinity+and+Selectivity&doi=10.1021%2Fjm101299d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Fjm101299d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101299d%26sid%3Dliteratum%253Aachs%26aulast%3DConejo-Garc%25C3%25ADa%26aufirst%3DA.%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DN%25C3%25BA%25C3%25B1ez%26aufirst%3DM.%2BC.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DCampos%26aufirst%3DJ.%2BM.%26aulast%3DGallo%26aufirst%3DM.%2BA.%26aulast%3DEspinosa%26aufirst%3DA.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DHomodimeric%2520bis-Quaternary%2520Heterocyclic%2520Ammonium%2520Salts%2520as%2520Potent%2520Acetyl-%2520and%2520Butyryl-cholinesterase%2520Inhibitors%253A%2520A%2520Systematic%2520Investigation%2520of%2520the%2520Influence%2520of%2520Linker%2520and%2520Cationic%2520Heads%2520Over%2520Affinity%2520and%2520Selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2627%26epage%3D2645%26doi%3D10.1021%2Fjm101299d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farina, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto-Otero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denora, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangiatordi, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendez-Alvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altomare, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Searching for Multi-Targeting Neurotherapeutics against Alzheimer ’s: Discovery of Potent AChE-MAO B Inhibitors through the Decoration of the 2H Chromen-2-one Structural Motif</span> <span class="citation_source-journal">Molecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">362</span><span class="refDoi"> DOI: 10.3390/molecules21030362</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.3390%2Fmolecules21030362" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=362&author=L.+Pisaniauthor=R.+Farinaauthor=R.+Soto-Oteroauthor=N.+Denoraauthor=G.+F.+Mangiatordiauthor=O.+Nicolottiauthor=E.+Mendez-Alvarezauthor=C.+D.+Altomareauthor=M.+Cattoauthor=A.+Carotti&title=Searching+for+Multi-Targeting+Neurotherapeutics+against+Alzheimer+%E2%80%99s%3A+Discovery+of+Potent+AChE-MAO+B+Inhibitors+through+the+Decoration+of+the+2H+Chromen-2-one+Structural+Motif&doi=10.3390%2Fmolecules21030362"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.3390%2Fmolecules21030362&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules21030362%26sid%3Dliteratum%253Aachs%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DFarina%26aufirst%3DR.%26aulast%3DSoto-Otero%26aufirst%3DR.%26aulast%3DDenora%26aufirst%3DN.%26aulast%3DMangiatordi%26aufirst%3DG.%2BF.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DMendez-Alvarez%26aufirst%3DE.%26aulast%3DAltomare%26aufirst%3DC.%2BD.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DSearching%2520for%2520Multi-Targeting%2520Neurotherapeutics%2520against%2520Alzheimer%2520%25E2%2580%2599s%253A%2520Discovery%2520of%2520Potent%2520AChE-MAO%2520B%2520Inhibitors%2520through%2520the%2520Decoration%2520of%2520the%25202H%2520Chromen-2-one%2520Structural%2520Motif%26jtitle%3DMolecules%26date%3D2016%26volume%3D21%26spage%3D362%26doi%3D10.3390%2Fmolecules21030362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Denora, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laquintana, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trapani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopedota, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latrofa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trapani, G.</span><span> </span><span class="NLM_article-title">Translocator Protein (TSPO) Ligand-Ara-C (Cytarabine) Conjugates as a Strategy to Deliver Antineoplastic Drugs and to Enhance Drug Clinical Potential</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">2255</span><span class="NLM_x">–</span> <span class="NLM_lpage">2269</span><span class="refDoi"> DOI: 10.1021/mp100235w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp100235w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlyks7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2010&pages=2255-2269&author=N.+Denoraauthor=V.+Laquintanaauthor=A.+Trapaniauthor=A.+Lopedotaauthor=A.+Latrofaauthor=J.+M.+Galloauthor=G.+Trapani&title=Translocator+Protein+%28TSPO%29+Ligand-Ara-C+%28Cytarabine%29+Conjugates+as+a+Strategy+to+Deliver+Antineoplastic+Drugs+and+to+Enhance+Drug+Clinical+Potential&doi=10.1021%2Fmp100235w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Translocator Protein (TSPO) Ligand-Ara-C (Cytarabine) Conjugates as a Strategy To Deliver Antineoplastic Drugs and To Enhance Drug Clinical Potential</span></div><div class="casAuthors">Denora, Nunzio; Laquintana, Valentino; Trapani, Adriana; Lopedota, Angela; Latrofa, Andrea; Gallo, James M.; Trapani, Giuseppe</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2255-2269</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The aim of this work was to evaluate TSPO ligand-Ara-C conjugation as an approach for the selective delivery of the antineoplastic agent to brain tumors as well as for overcome P-gp resistance induction obsd. for the majority of cytotoxic agents, enhancing the drug clin. potential.  To this end, novel N-imidazopyridinacetyl-Ara-C conjugates have been prepd. and evaluated for their cytotoxicity against glioma cell lines.  Conjugate (I) resulted stable in both phosphate buffer and physiol. medium.  In all cases, the release of free Ara-C from hydrolyzed conjugates was checked by HPLC and ESI-MS anal.  Conjugates (II) and I displayed very high in vitro TSPO affinity and selectivity, and, hence, they may possess potential for targeted brain delivery.  Due to the favorable features displayed by the conjugate I, it was further evaluated on glioma cell lines, expressing high levels of TSPO, in the presence and in the absence of specific nucleoside transport (NT) inhibitors.  In contrast to that obsd. for the free Ara-C, the presence of NT inhibitors did not reduce the cytotoxic activity of I.  Moreover, conjugate I, as N4-acyl deriv. of Ara-C, should be resistant to inactivation by cytidine deaminase, and it may possess enhanced propensity to target brain tumor cells characterized by a reduced expression of NTs.  In addn., this conjugate behaves as a clear P-gp modulator and thereby may be useful to reverse MDR.  Transport studies across the MDCKII-MDR1 monolayer indicated that conjugate I should overcome the BBB by transcellular pathway.  All these features may be useful for enhancing the clin. potential of the nucleoside drug Ara-C.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlPSCWV14q97Vg90H21EOLACvtfcHk0lgRRC9GzXVnxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlyks7nJ&md5=97dfb1bb26e96783537794143c661363</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1021%2Fmp100235w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp100235w%26sid%3Dliteratum%253Aachs%26aulast%3DDenora%26aufirst%3DN.%26aulast%3DLaquintana%26aufirst%3DV.%26aulast%3DTrapani%26aufirst%3DA.%26aulast%3DLopedota%26aufirst%3DA.%26aulast%3DLatrofa%26aufirst%3DA.%26aulast%3DGallo%26aufirst%3DJ.%2BM.%26aulast%3DTrapani%26aufirst%3DG.%26atitle%3DTranslocator%2520Protein%2520%2528TSPO%2529%2520Ligand-Ara-C%2520%2528Cytarabine%2529%2520Conjugates%2520as%2520a%2520Strategy%2520to%2520Deliver%2520Antineoplastic%2520Drugs%2520and%2520to%2520Enhance%2520Drug%2520Clinical%2520Potential%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2010%26volume%3D7%26spage%3D2255%26epage%3D2269%26doi%3D10.1021%2Fmp100235w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Denora, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laquintana, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopalco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trapani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cimmino, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laconca, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuffrida, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trapani, G.</span><span> </span><span class="NLM_article-title">Novel Codrugs with GABAergic Activity for Dopamine Delivery in the Brain</span> <span class="citation_source-journal">Int. J. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">437</span><span class="NLM_x">, </span> <span class="NLM_fpage">221</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span><span class="refDoi"> DOI: 10.1016/j.ijpharm.2012.08.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=10.1016%2Fj.ijpharm.2012.08.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=22940209" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlaiurnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=437&publication_year=2012&pages=221-231&author=N.+Denoraauthor=T.+Cassanoauthor=V.+Laquintanaauthor=A.+Lopalcoauthor=A.+Trapaniauthor=C.+S.+Cimminoauthor=L.+Laconcaauthor=A.+Giuffridaauthor=G.+Trapani&title=Novel+Codrugs+with+GABAergic+Activity+for+Dopamine+Delivery+in+the+Brain&doi=10.1016%2Fj.ijpharm.2012.08.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Novel codrugs with GABAergic activity for dopamine delivery in the brain</span></div><div class="casAuthors">Denora, Nunzio; Cassano, Tommaso; Laquintana, Valentino; Lopalco, Antonio; Trapani, Adriana; Cimmino, Concetta Stefania; Laconca, Leonardo; Giuffrida, Andrea; Trapani, Giuseppe</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">437</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">221-231</span>CODEN:
                <span class="NLM_cas:coden">IJPHDE</span>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">This study investigates the use of codrugs of the GABAergic agent 2-phenyl-imidazo[1,2-a]pyridinacetamide and dopamine (DA) or Et ester L-Dopa (LD) as a strategy to deliver DA and simultaneously activate GABA-receptors in the brain.  For this purpose, both DA and LD Et ester were linked by carbamate bond to imidazo[1,2-a]pyridine acetamide moieties to yield two DA- and two LD-imidazopyridine derivs.  These compds. were evaluated in vitro to assess their stability, binding affinities and cell membrane transport, and in vivo to assess their bio-availability via microdialysis studies.  The two DA derivs. were adequately stable in buffered soln., but underwent cleavage in dild. human serum.  By contrast, the LD derivs. were unstable in buffered soln.  Receptor binding studies showed that the DA-imidazopyridine carbamates had binding affinity for benzodiazepine receptors in the nanomolar range.  Brain microdialysis expts. indicated that i.p. administration of the DA derivs. sustained DA levels in rat striatum over a 4-h period.  These results suggest that DA-imidazopyridine carbamates are new DA codrugs with potential application for DA replacement therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2ZywfNEZEqbVg90H21EOLACvtfcHk0lgndIo-8p-e_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlaiurnP&md5=fb9f8c41492bfccc09a24dd20b659b90</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpharm.2012.08.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpharm.2012.08.023%26sid%3Dliteratum%253Aachs%26aulast%3DDenora%26aufirst%3DN.%26aulast%3DCassano%26aufirst%3DT.%26aulast%3DLaquintana%26aufirst%3DV.%26aulast%3DLopalco%26aufirst%3DA.%26aulast%3DTrapani%26aufirst%3DA.%26aulast%3DCimmino%26aufirst%3DC.%2BS.%26aulast%3DLaconca%26aufirst%3DL.%26aulast%3DGiuffrida%26aufirst%3DA.%26aulast%3DTrapani%26aufirst%3DG.%26atitle%3DNovel%2520Codrugs%2520with%2520GABAergic%2520Activity%2520for%2520Dopamine%2520Delivery%2520in%2520the%2520Brain%26jtitle%3DInt.%2520J.%2520Pharm.%26date%3D2012%26volume%3D437%26spage%3D221%26epage%3D231%26doi%3D10.1016%2Fj.ijpharm.2012.08.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i72"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00562">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_48260"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b00562">10.1021/acs.jmedchem.6b00562</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Applicability domain for Volsurf+ predictions; chiral-HPLC analysis on enantiomeric excess for (+)-<b>5b</b>, (−)-<b>5b</b>, (+)-<b>5d</b>, and (−)-<b>5d</b>; protocols of MAOs and ChEs inhibition assays (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00562/suppl_file/jm6b00562_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00562/suppl_file/jm6b00562_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00562/suppl_file/jm6b00562_si_001.pdf">jm6b00562_si_001.pdf (452.77 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00562/suppl_file/jm6b00562_si_002.csv">jm6b00562_si_002.csv (1.42 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b00562&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b00562%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-14%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b00562" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679920e55f8f1985","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
